Tailor-made polymers as nanocarriers for drug and gene delivery by Rinkenauer, Alexandra Cynthia
  
Friedrich-Schiller-Universität Jena 
______________________________________________________________________________________ 
Chemisch-Geowissenschaftliche Fakultät 
 
Tailor-made polymers as nanocarriers for         
drug and gene delivery 
 
Dissertation 
(kumulativ) 
zur Erlangung des akademischen Grades 
doctor rerum naturalium (Dr. rer. nat.) 
 
 
 
vorgelegt dem Rat der Chemisch-Geowissenschaftlichen Fakultät 
der Friedrich-Schiller-Universität Jena 
 
von Alexandra C. Rinkenauer 
M.sc. Molecular Biology and Biochemistry 
geboren am 04.06.1986 in Friedrichshafen 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gutachter: 
1. Prof. Dr. Ulrich S. Schubert (Universität Jena) 
2. Prof. Dr. Michael Bauer (Universitätsklinikum Jena) 
3. Prof. Dr. Achim Göpferich (Universität Regensburg) 
Tag der öffentlichen Verteidigung: 08.04.2016 
Table of contents 
 
1 
 
Table of contents 
 
Table of contents .............................................................................................................. 1
Documentation of authorship ............................................................................................ 3
1 Introduction ............................................................................................................... 9
2 Biological challenges for polymer-based nanocarriers .................................................. 13
3 Linear cationic polymers as nanocarriers for gene delivery ........................................... 21
4 Triblock terpolymer based micelles as nanocarriers ..................................................... 31
5 Polymer-based nanoparticles for drug delivery ............................................................ 47
6 Summary ................................................................................................................... 57
7 Zusammenfassung ..................................................................................................... 61
8 References ................................................................................................................. 67
List of abbreviations ......................................................................................................... 71
Curriculum vitae ............................................................................................................... 73
Publication list ................................................................................................................. 75
Acknowledgement / Danksagung ...................................................................................... 77
Declaration of authorship / Selbstständigkeitserklärung .................................................... 79
Publication P1 to P8 ........................................................................................................ 81
 
 2 
 
Documentation of authorship 
 
3 
 
Documentation of authorship 
This section contains a list of the individual author contributions to the publications 
reprinted in this thesis. 
 
P1)  A. C. Rinkenauer,1 S. Schubert,2 A. Taeger,3 U. S. Schubert,4 Influence of polymer 
architecture on in vitro pDNA delivery, J. Mater. Chem. B 2015, 3, 7477-7493. 
Author 1 2 3 4 
Conceptual development x    
Preparation of the manuscript x    
Correction of the manuscript  x x x 
Supervision of A. C. Rinkenauer    x x 
Proposed publication equivalent 0.5    
 
 
P2) M. Wagner,1 A. C. Rinkenauer,2 A. Schallon,3 U. S. Schubert,4 Opposites attract: Influence 
of the molar mass branched poly(ethylene imine) on biophysical characteristics of siRNA-
based polyplexes, RSC Adv. 2013, 3, 12774-12785.   
Author 1 2 3 4 
Conceptual development x  x  
Physico-chemical characterization x    
Biological studies  x   
Preparation of the manuscript x x   
Correction of the manuscript   x x 
Supervision of M. Wagner   x  
Supervision of A. C. Rinkenauer    x x 
Proposed publication equivalent  0.5   
 
 
Documentation of authorship 
 
4 
 
P3) A. C. Rinkenauer,1# L. Tauhardt,2# F. Wendler,3 K. Kempe,4 M. Gottschaldt,5 A. Traeger,6 
U. S. Schubert,7 A cationic poly(2-oxazonline) with high in vitro transfection efficiency 
identified by a library approach, Macromol. Biosci. 2015, 15, 414-425.   
# Both authors contributed equally 
Author 1 2 3 4 5 6 7 
Conceptual development x x  x  x  
Polymer synthesis & characterization  x x     
Biological studies x       
Preparation of the manuscript x x      
Correction of the manuscript    x x x x 
Supervision of L. Tauhardt    x    
Supervision of A. C. Rinkenauer      x x 
Proposed publication equivalent 1.0       
 
 
P4)  A. C. Rinkenauer,1# A. Vollrath,2# A. Schallon,3 L. Tahuhardt,4 K. Kempe,5 S. 
Schubert,6 D. Fischer,7 U. S. Schubert,8 Parallel high-throughput screening of polymer 
vectors for nonviral gene delivery: evaluation of structure-property relationships of 
transfection, ACS Comb. Sci. 2013, 15, 475-482.   
# Both authors contributed equally 
Author 1 2 3 4 5 6 7 8 
Conceptual development x x x      
Scientific discussion       x  
Polymer synthesis & characterization    x x    
Biological studies x        
Polyplex preparation & DLS measurement  x       
Preparation of the manuscript x x x      
Correction of the manuscript    x x x x x 
Supervision of A. Vollrath      x  x 
Supervision of A. C. Rinkenauer   x     x 
Proposed publication equivalent 1.0        
 
 
Documentation of authorship 
 
5 
 
P5)  A. C. Rinkenauer,1 A. Schallon,2 U. Günther,3 M. Wagner,4 E. Betthausen,5 U. S. 
Schubert,6 F. H. Schacher,7 A paradigm change: Efficient transfection of human 
leukemia cells by stimuli-responsive multicompartment micelles, ACS Nano 2013, 7, 
9624-9631.   
Author 1 2 3 4 5 6 7
Conceptual development x x     x
Polymer synthesis & characterization     x   
Biological studies x       
Cryo-TEM measurements   x     
AF4, ultracentrifugation, DLS, zeta potential    x    
Preparation of the manuscript x x      
Correction of the manuscript    x  x x
Supervision of U. Günther       x
Supervision of A. C. Rinkenauer   x    x  
Proposed publication equivalent 1.0       
 
 
P6)  M. J. Barthel,1# A. C. Rinkenauer,2# M. Wagner,3 U. Mansfeld,4 S. Höppner,5 J. A. 
Czaplewska,6 M. Gottschaldt,7 A. Traeger,8 F. H. Schacher,9 U. S. Schubert,10 Small but 
powerful: Co-assembly of polyether-based triblock terpolymer into sub-30 nm micelles 
and synergistic effects on cellular interactions, Biomacromolecules 2014, 15, 2426-2439.  
# Both authors contributed equally 
Author 1 2 3 4 5 6 7 8 9 10
Conceptual development x x     x x  
Polymer synthesis & characterization x         
Biological studies  x        
AF4, DLS, zeta potential, electrophoretic studies  x x        
Cryo-TEM measurements   x x      
Synthesis of acetylated thiogalatose     x     
Preparation of the manuscript x x        
Correction of the manuscript   x    x x x x 
Supervision of M. J. Barthel        x x 
Supervision of A. C. Rinkenauer       x  x 
Proposed publication equivalent  0.5        
     
Documentation of authorship 
 
6 
 
P7)  T. Yildrim,1 A. C. Rinkenauer,2 C. Weber,3 A. Traeger,4 S. Schubert,5 U. S. Schubert,6 
RAFT made methacrylate copolymers for reversible pH-responsive nanoparticles, J. Polym. 
Sci. Part A: Polym. Chem. 2015, 53, 2711-2721.   
Author 1 2 3 4 5 6 
Conceptual development x   x x  
Scientific discussions   x    
Polymer synthesis & characterization x      
Biological studies  x     
Preparation of the manuscript x      
Correction of the manuscript  x x x x x 
Supervision of T. Yildrim     x x 
Supervision of A. C. Rinkenauer     x  x 
Proposed publication equivalent  0.25     
 
P8)   A. C. Rinkenauer,1# A. T. Press,2# M. Raasch,3 C. Pietsch,4 S. Schweizer,5 S. Schwörer,6 K. 
L. Rudolph,7 A. Mosig,8 M. Bauer,9 A. Traeger,10 U. S. Schubert,11 Comparison of the 
uptake of methacrylate-based nanoparticles in static and dynamic in vitro systems as well 
as in vivo, J. Controll. Release 2015, 216, 158-168. 
# Both authors contributed equally 
Author 1 2 3 4 5 6 7 8 9 10 11
Conceptual development x x         
Scientific discussion        x x  
Polymer synthesis & characterization    x       
Nanoparticle preparation & characterization x   x x      
In vitro investigations x          
Dynamic cell culture   x        
In vivo investigations  x         
Preparation of the manuscript x x         
Correction of the manuscript   x x x x x x x x x 
Supervision of A. T. Press         x   
Supervision of M. Raasch        x   
Supervision of A. C. Rinkenauer         x x 
Proposed publication equivalent 0.5          
 Erklärung zu den Eigenanteilen des Promovenden/der Promovendin sowie der 
weiteren Doktoranden/Doktorandinnen als Koautoren an den Publikationen 
und Zweitpublikationsrechten bei einer kumulativen Dissertation 
 
Für alle in dieser kumulativen Dissertation verwendeten Manuskripte liegen die notwendigen 
Genehmigungen der Verlage („Reprint permissions“) für die Zweitpublikation vor. 
Die Co-Autoren der in dieser kumulativen Dissertation verwendeten Manuskripte sind 
sowohl über die Nutzung als auch über die oben angegebenen Eigenanteile informiert und 
stimmen dem zu. 
Die Anteile der Co-Autoren an den Publikationen sind in den vorausgehenden Tabellen 
(Documentation of authorship) aufgeführt. 
Ich bin mit der Abfassung der Dissertation als publikationsbasiert, d.h. kumulativ, 
einverstanden und bestätige die vorstehenden Angaben. Eine entsprechend begründete 
Befürwortung mit Angabe des wissenschaftlichen Anteils des Doktoranden/der Doktorandin 
an den verwendeten Publikationen werde ich parallel an den Rat der Fakultät der Chemisch-
Geowissenschaftlichen Fakultät richten. 
 
Prof. Dr. Ulrich S. Schubert   …….2015  Jena______________ 
Alexandra C. Rinkenauer   …….2015  Jena______________ 
 
 
  
7 
 
 8 
 
 
 
1 Introduction 
 
9 
 
1 Introduction 
Over the last 30 years nanomedicine represents a rapidly growing new field of research. This 
arising topic is very promising as there is a relatively high chance for the translation into 
clinical trials.[1] Only symptomatic treatment of genetic disorders like cystic fibrosis, 
Parkinson or cancer is possible when hazarding the detrimental side effects. For instance, 
the enormous side effects of therapeutics due to off-target delivery represent a severe 
drawback. Nanocarriers represent an ideal approach to avoid such problems. They have the 
possibility by encapsulation to reduce side effects and further enhance the bioavailability of 
poorly soluble drugs. A mitotic inhibitor, Paclitaxel, shows a high potential as 
chemotherapeutics, but is restricted due to its low water solubility.[2] Nanocarriers can be 
applied for drug and gene delivery, whereas the distinction is mainly based on the 
differences of their chemical properties. As a consequence, the nanocarrier material has to 
show properties which fits to the delivered substrate. The delivery of drugs via nanocarriers 
can be achieved by various strategies, e.g. by encapsulation, covalent attachment or 
physical adsorption. In this thesis the focus will be on encapsulation strategies of 
hydrophobic drugs or drug models. Therein, spherical micelles and nanoparticles are 
frequently used, as they can provide a hydrophobic interior (Figure 1.1). On the other hand, 
gene delivery via nanocarriers can transport diverse nucleic acids, like small interfering RNA 
(siRNA) or plasmid DNA (pDNA). Besides physical differences of siRNA and pDNA like the 
size or flexibility, also the site of action in cells differs. In the case of siRNA, a suppression 
of the protein expression occurs on the mRNA level in the cytoplasm. pDNA encodes a 
specific sequence for a protein and results in protein production, starting with the 
transcription of the pDNA in the cell nuclei. For the delivery of pDNA via nanocarriers, 
which will be discussed in this thesis, cationic charges are required to provide a sufficient 
interaction with the negatively charged phosphates of the pDNA. In this case, cationic 
polymers as well as cationic micelles can be applied (Figure 1.1). The mainly used materials 
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for nanocarriers represent lipid and polymer based systems, whereas polymers show a high 
tuning potential as they can be synthesized with varying physical and chemical properties 
(e.g. architectures, monomer class and functionalization).[3, 4] The biological challenges for 
nanocarriers and different polymer features like architecture are described in detail in 
Chapter 2. 
 
Figure 1.1: Schematic depiction of a possible subdivision of the nanocarriers discussed in this thesis. 
Polymer-based gene delivery, also called transfection, is less pronounced in clinical trials in 
contrast to polymer-based drug delivery. A more detailed understanding of the transfection 
mechanism is necessary, starting from the impact of different polymer properties in vitro. In 
particular, cationic polymer systems like poly(ethylenimine) (PEI), poly(2-
(dimethylamino)ethyl methacrylate (PDMAEMA) or poly(L-lysin) (PLL) are commonly used 
and well characterized concerning their delivery potential.[5] Herein, PEI represents the gold 
standard for polymer based transfection agents in vitro, due to high transfection efficiency 
and commercial availability.[6] However, PEI shows high cytotoxicity and reduced 
transfection efficiency compared to viruses, restricting the in vivo application. In the last 
years PEI is often used as template for numerous polymer modifications. For instance, the 
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functionalization with biocompatible polymers like poly(ethylene glycol) (PEG) or poly(2-
oxazoline)s (POx) reduce the cytotoxicity and unspecific protein interactions.[7, 8] However, 
this benefit of PEGylated or POxylated polymers accompanies with a decreased efficiency.[8, 
9] The opportunities to design tailor-made nanocarriers are manifold from the perspective of 
polymer chemistry. Varying the chain length, composition, functionalization, or architecture 
leads to different properties and, therefore, to other efficiencies. For example the effect of 
molar mass of polymers (chain length) was investigated in detail and was presented as one 
main aspect for an efficient pDNA delivery and a low cytotoxicity.[10] Detailed information 
concerning PEI as gene delivery agent and how to overcome the drawbacks of POx on 
cellular uptake are given in Chapter 3.  
The polymer architecture and the self-assembled structures have an important role on the 
delivery performance; spherical micelles show a high potential for the delivery of pDNA as 
well as of drugs. The main polymer topology to self-assemble into highly ordered structures 
like spherical micelles is based on amphiphilic block copolymers. The ratio of the 
hydrophobic to hydrophilic segments is the driving force for self-assembly in aqueous 
solutions. The main application of spherical micelles as nanocarriers is the delivery of drugs, 
due to the fact that the hydrophobic interior represents an ideal environment for 
hydrophobic drugs.[11] In addition, the minor size of drugs allows the formation of spherical 
micelles with small diameters. Spherical micelles for pDNA delivery have to carry positive 
charges to enable the polyplex formation. Thus, the balance on charges represents a 
criterion, but it can be also a promising tool for efficient delivery. Triblock terpolymers are 
well suited for this requirement. In Chapter 4 the application potential of triblock 
terpolymers-based spherical micelles will be discussed for gene and drug delivery by using 
200 and 30 nm micelles, respectively.  
Besides micelles also polymer-based nanoparticles represent promising systems as 
nanocarriers for drug delivery. Poly(lactic-co-glycolic acid) (PLGA), poly(ܭ-caprolactone) 
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(PCL) and poly(methyl methacrylate (PMMA) derivatives are frequently used polymer 
systems for nanoparticle preparation. Although, nanoparticles often enter clinical trials, the 
main challenge is the gap between the in vitro and in vivo behavior. In particular, in vitro 
screenings reveal no information concerning the biodistribution or interaction with the 
reticuloendothelial system (RES). The bloodstream induces mechanical force on endothelial 
cells, which are abundant in the inner layer of the blood vessels. This influences the cell 
biology like morphology, cytoskeleton, surface proteins, cellular interactions and, in the end, 
the nanoparticle uptake. A promising technique is the microfluidically-supported dynamic 
cell culture, which allows investigations concerning different shear stress. Chapter 5 
provides detailed information how methacrylate-based nanoparticles of different charges can 
be used as drug carrier to systematically investigate the differences of static and dynamic in 
vitro systems as well as in vivo models. 
2 Biological challenges for polymer-based nanocarriers 
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2 Biological challenges for polymer-based nanocarriers  
Parts of this chapter have been published in: P1) A C. Rinkenauer, S. Schubert, A. Traeger, U. S. Schubert, 
Influence of polymer architecture on in vitro pDNA delivery, J. Mater. Chem. B 2015, 3, 7477-7493. 
For the treatment of many different diseases with nanocarriers two main approaches can be 
pursued, namely drug and gene delivery. Herein, polymer-based nanocarriers show high 
potential, for example they can increase the bioavailability. Drugs and genes differ 
particularly in their chemical properties, which result in different requirements of the 
encapsulation strategies. In detail, drugs are small molecules either with hydrophobic or 
hydrophilic character: (i) Hydrophobic drugs can be encapsulated into nanoparticles and 
micelles, whereas, (ii) the encapsulation of hydrophilic drugs can be realized just in 
nanoparticles. The main differences between micelles and nanoparticles are the used 
polymers. Micelles are mainly formed by spontaneously self-organization of amphiphilic 
block copolymers. A defined and ordered inner structure can be achieved and their size 
depends directly on the polymer chain length. In contrast, nanoparticles are often based on 
hydrophobic homo- or statistical copolymers with hard spheres (between the water phase 
and the nanoparticle). The formation of defined nanoparticles is frequently realized via 
emulsification techniques and nanoprecipitation.[12, 13] In both cases spherical nanoparticles 
can be obtained with tunable sizes and small dispersities. The advantage of 
nanoprecipitation is the absence of surfactants, which are necessary for the stabilization of 
the nanoparticles prepared via the emulsion technique in aqueous solutions.[12] The double 
emulsion technique allows the encapsulation of hydrophilic drugs. The frequently used 
polymers for nanoparticle preparation, like PLGA, PCL and PMMA derivatives, are featured 
by a hydrophobic character (Figure 2.1).[14] In contrast to common drugs, the application of 
pDNA is limited in emulsification techniques, because the mechanical force by sonication 
and their exposure to organic solvent might damage the pDNA.[15] Therefore, pDNA delivery 
is based on the formation of complexes with electrostatic interactions, called polyplexes. 
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Figure 2.1: Schematic representation of the chemical structures of selected cationic and hydrophobic polymers 
(lPEI = linear PEI, bPEI = branched PEI). 
In order to complex pDNA a polymer needs to contain cationic charges on the polymer 
chain; PEI, PLL as well as PDMAEMA represent the most frequently investigated cationic 
polymers (Figure 2.1). The formation of polyplexes between positive charged polymers and 
the negative charged pDNA is driven by the gain of entropy due to the release of the small 
counter ions.[16, 17] The binding capacity of the polymer represents an important factor, as a 
balance of strong binding for an enhanced polyplex stability under physiological conditions 
and a weak binding for the later release of the genetic material has to be carefully 
considered.[18] 
After the formation of nanocarriers (drug carriers or polyplexes) the biological barriers have 
to be overcome (Figure 2.2). The interaction between the positive charged nanocarriers and 
the negative charged cell membrane is enhanced, if compared to the utilization of negative 
charged carriers. However, positive charges can induce membrane destabilization and 
subsequently mostly local, the destruction results in an increased cytotoxicity.[10, 19] 
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Figure 2.2: Schematic depiction of the delivery of genes or drugs via nanocarriers, in vitro. 
The cellular interaction and internalization is mainly based on endocytosis[20] and this 
process is well–known to be size dependent and additionally varies between different cell 
types. In general, nanocarriers with diameters between 50 and 200 nm are taken up via 
endocytosis.[21] Up to now, the mechanisms underlying on endocytosis are in detail not fully 
understood and can be divided into phagocytosis, clathrin- and caveolin-mediated 
endocytosis as well as macropinocytosis.[20] Concerning the internalization of polyplexes, 
different uptake mechanisms and intracellular trafficking are observed, depending on the 
polymer class and structure.[22] For example, PEI polyplexes show caveolin- and clathrin-
mediated endocytosis.[23] After efficient internalization via endocytosis, the nanocarriers have 
to escape from the endosome to prevent digestion in the lysosome or excretion by 
exocytosis.[24] In case of drug delivery the release of drugs from the nanocarrier can occur 
already in the endosome, because most hydrophobic drugs can passively diffuse through the 
endosomal membrane (Figure 2.2).[25] Subsequently, the drugs diffuse to their site of action 
like microtubule in case of Paclitaxel. Possible mechanisms to release drugs are the swelling 
of the nanoparticles or degradation of the polymer backbone.[26] On the other hand, pDNA 
is too large and charged for such passive diffusion, which makes an endosomal escape 
triggered by nanocarriers indispensable (Figure 2.2). Cationic polymers like PEI are known 
for its high buffer capacity. The caused influx of protons and chloride ions in the endosome 
leads to an osmotic swelling, resulting in a disruption of the endosomal membrane, named 
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proton sponge effect.[27-29] When the pDNA is released in the cytoplasm, it has to enter the 
cell nuclei for the transcription mechanism and efficient protein production. The 
mechanisms for polyplex dissociation and how the pDNA enters the cell nuclei are up to 
now only barely investigated.[30] There is evidence that the polyplex dissociation occurs at 
the same time as the endosomal release indicating a transfer of the pure pDNA into the 
nuclei.[31] In other studies polyplexes were also detected in the nuclei.[32] An increased 
transfection efficiency in cells with a high division rate was observed, confirming the entry 
of pDNA into the nuclei during mitosis.[33] However, it was shown that the entry of pDNA 
can occur through nuclear pores.[34] Since the first polymers were used as transfection agent 
numerous studies helped to understand the relying mechanism for most of the biological 
barriers. Concerning the polymer properties, different strategies and design rules were 
developed to overcome the transfection steps (Figure 2.3). For example the pKa value is 
one characteristic criterion of cationic polymers and is responsible for the degree of 
protonation, influencing the complexation behavior as well as the endosomal escape.[35] 
Figure 2.3 depicts an overview of general polymer features showing an influence on the 
pDNA delivery performance of cationic polymers. 
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Figure 2.3: Overview of set screws of selected polymer properties for an efficient pDNA delivery. 
The complexity of the pDNA transfection mechanism results in defined requirements for the 
used polymers. For this purpose, living and controlled polymerization techniques like 
reversible addition-fragmentation chain transfer (RAFT) polymerization, cationic ring 
opening polymerization (CROP) or living anionic polymerization enable the synthesis of 
polymers in a controlled or living manner. Tailor-made polymers with defined chain length 
(degree of polymerization (DP)), composition, and architecture can be realized. In general, 
polymers can be classified by their composition and/or topology. Polymer compositions 
meaning the order of repeating units and can be divided into homopolymers, statistical, 
gradient-, alternated-, and block copolymers.[36, 37] In contrast to homopolymers, copolymers 
contain at least two different monomers. Copolymers can be beneficial in order to tune the 
polymer characteristics towards a high transfection and a low cytotoxicity. For instance, an 
increased polyplex stability of methacrylate-based polymers can be achieved by using 
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tertiary and primary amines in the same polymer chain.[38] These effects can be attributed to 
a higher charge density of the primary amines at physiological pH values. Furthermore, the 
copolymerization with hydrophobic monomers leads to an increased internalization efficiency 
and endosomal escape, resulting in enhanced transfection efficiency.[39] Concerning the 
tuning potential of polymers for drug delivery, the drug release of PLGA-based nanoparticles 
can be tuned by molar mass and the ratio of lactic to glycolic acid.[26] Regarding the 
polymer topology, a distinction is drawn between linear, branched, graft (combs and 
brushes), and star-shaped polymers. The most frequently used polymers for drug delivery 
have a linear topology. Branched polymers, like branched PEI (bPEI) or dendrimers, are 
composed of polymer chains with at least two branching points and more than four end-
groups. Other topologies like graft polymers or star-shaped polymer represent an upcoming 
strategy for gene delivery.[40, 41] A further possibility is the formation of self-assembled 
structures of amphiphilic polymers in solution, meaning the arrangement into highly ordered 
structures by non-covalent interactions. For instance, spherical or worm-like micelles and 
vesicular structures can be realized and are applied as nanocarriers. The responsible 
principles for the mechanism of self-assembly depend on several factors starting from the 
used solvent to the block ratios.[42] Spherical micelles are often used for the delivery of 
hydrophobic drugs.[11] Concerning the micellar structures for pDNA delivery, it should be 
distinguished if preformed spherical micelles are used for polyplex formation or so called 
polyion complex (PIC) micelles are applied (Figure 2.4). In detail, a block copolymer can 
consist of a cationic and a hydrophilic segment which probably form polyplex micelles with 
pDNA due to electrostatical interactions (Figure 2.4a). Thus, the pDNA is located in the 
core and the hydrophilic part in the shell.[43] K. Kataoka firstly presented this concept of PIC 
micelles in 1990.[44, 45] Preformed micelles are only rarely used for pDNA delivery. The size of 
the micelle plays an important role, because two different polyplex formations can occur 
regarding the pDNA size (Figure 2.4b and c). Small micelles of around 20 nm in diameter 
probably results in polyplexes consisting of multiple micelles surrounding the pDNA (Figure 
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2.4c).[46] In contrast large micelles provide the opportunity that the pDNA is wrapped 
around in the shell (Figure 2.4b). A deeper insight is given in Chapter 4. Another study 
pointed out that larger micelles of around 200 nm show a higher transfection efficiency than 
90 nm micelles. Herein, the question arises if the higher transfection efficiency can be 
attributed to the higher amount of cationic charges (based on the longer polymer chains) or 
to the micellar size and the resulting polyplex properties.[47] 
Furthermore, micelles can provide pH responsive shape changes, which are – concerning 
biological applications – a promising strategy for an enhanced uptake or a low cytotoxicity. 
A fine-tuning of the pH dependent membrane destabilizing character can lead to an 
enhanced endosomal escape and a higher transfection efficiency.[46] In addition, the delivery 
of drugs and genes at the same time, called multidrug nanocarriers, can be realized by a 
hydrophobic core and a cationic shell. [38, 48, 49] 
 
Figure 2.4: Polyplex micelles (a) vs. polyplexes formed with large (b) and small (c) preformed micelles and pDNA. 
(+) Represents the cationic charges of the block copolymers or the surface charges of the preformed micelles and 
(–) represents the negative charges of the pDNA. 
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Nowadays, nanoparticle-based drug delivery has the obstacles mainly in vivo, besides drug 
encapsulation efficiency and drug release. In particular, the biodistribution and 
bioavailability represent important factors and are influenced by the nanoparticle 
characteristics. The biodistribution is influenced by the RES because nanoparticles once in 
the blood circulation interact with various plasma proteins influencing their fate in different 
manner.[50] These factors are mainly influenced by the nanoparticle characteristics like 
particle size, surface charge, modification and hydrophobicity.[51]  
3 Linear cationic polymers as nanocarriers for gene delivery 
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3 Linear cationic polymers as nanocarriers for gene delivery 
Parts of this chapter have been published in: P2) M. Wagner, A. C. Rinkenauer, A. Schallon, U. S. Schubert, 
Opposites attract: Influence of the molar mass branched poly(ethylene imine) on biophysical characteristics of 
siRNA-based polyplexes, RSC Advances 2013, 3, 12774-12785; P3) A. C. Rinkenauer, L. Tauhardt, F. 
Wendler, K. Kempe, M. Gottschaldt, A. Traeger, U. S. Schubert, A cationic poly(2-oxazonline) with high in 
vitro transfection efficiency identified by a library approach, Macromol. Biosci. 2015, 15, 414-425; P4) A. C. 
Rinkenauer, A. Vollrath, A. Schallon, L. Tauhardt, K. Kempe, S. Schubert, D. Fischer, U. S. Schubert, 
Parallel high-throughput screening of polymer vectors for nonviral gene delivery: Evaluation of strucutre-
property relationships of transfection, ACS Comb. Sci. 2013, 15, 475-482. 
Nanocarriers for gene delivery based on cationic polymers have to combine low cytotoxicty 
and high transfection efficiency.[52, 53] PEI represents the most intensively applied agent for 
pDNA delivery, in particular for in vitro investigations. The high transfection efficiency and 
commercial availability of branched and linear PEI are the main reasons for this 
dominance.[54] In addition, a wide range of molar masses are available. The above mentioned 
reasons lead to the application of PEI as control polymer, beside other commercial 
transfection agents like Lipofectamine (liposome based) or FuGENE (dendrimer based). 
However, PEI shows cytotoxic effects and, therefore, some modifications with other 
polymers like PEG or POx were realized and investigated. These modifications lead to a 
negative impact on the transfection efficiency, which implies further modifications like the 
introduction of hydrophobic moieties into the polymer chain. PEI is excelled by its high 
charge density due to the high amino content. In contrast to lPEI (only secondary amines), 
bPEI contains primary, secondary and tertiary amines.[55, 56] It is known that the 
architecture, with respect to the different amino types, as well as the molar mass influence 
the transfection efficiency. However, more insights into the performance during the single 
transfections steps are necessary. In a first step, the polyplex formation of diverse PEIs was 
investigated and in general high molar masses bPEIs ( 10 kDa) show an enhanced 
complexation ability, compared to high molar masses lPEI ( 10 kDa). This can be 
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attributed to the presence of primary amines in bPEI, due to the fact that these amino 
types show an enhanced pDNA interaction/complexation.[57] The impact of the molar mass 
is evidenced by an insufficient polyplex formation either due to the inability to complex 
pDNA or to the reduced polyplex stability in the presence of heparin in the case of low 
molar mass PEI (< 10 kDa). Another criterion is the escape from the endosome; PEI is 
known for its good buffer capacity due to the proton sponge effect. With regard to this, the 
pKa values of different molar mass bPEI were investigated (Figure 3.1a). The pKa values of 
bPEI decrease slightly from 10 to 8 with increasing molar mass. In detail, the high molar 
mass bPEI (10 and 25 kDa) differ from the low molar mass bPEIs. However, the buffer 
capacity at pH values around 7 is similar for all polymers. Furthermore, no significant 
differences between bPEI 25kDa (pKa 8.3) and lPEI 25kDa (pKa 8.6) are reported.[55]  
The cytotoxicity represents one crucial characteristic for a transfection agent. Herein, the 
molar mass shows a high impact; with increasing molar mass the cytotoxicity increases 
(Figure 3.1b). The molar masses influence also the transfection efficiency. Low molar mass 
PEI show lower transfection efficiency compared to high molar mass PEI independent on 
the used architecture. 
 
Figure 3.1: Titration curve of bPEI of different molar masses in water against HCl (a) and cytotoxicity of different 
bPEI at various end concentrations (b). 
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The main requirements for transfection agents are an efficient delivery, combined with a low 
cytotoxicity. High molar mass PEI reveals cytotoxic effects at concentrations around 
10 µg mL-1 (Figure 6b). An often used approach to overcome this drawback is the 
functionalization with biocompatible compounds like PEG or POx. Both polymers are 
known for the so called “stealth effect”.[7, 8] The resulting copolymers lead to an enhanced 
permeability and retention in vivo as well as a reduced cytotoxicity. POx, in particular 
poly(2-ethyl-2-oxazoline), (PEtOx) and poly(2-methyl-2-oxazoline), (PMeOx), have been 
intensively investigated as PEG alternative. However, it was demonstrated that the 
functionalization with hydrophilic POx can also result in an inefficient delivery, due to a 
reduced interaction with the genetic material as well as the cellular membranes caused by 
the cell- and protein-repellent character of the polymers.[8] One possibility to increase the 
pDNA interaction as well as cellular uptake is the introduction of hydrophobic groups.[39] In 
order to investigate the influence of hydrophobicity and amino type (primary versus tertiary) 
in a systematically way, a library of POx copolymer was synthesized. In total 18 statistical 
copolymers either based on poly((2-methyl-2-oxazoline)-co-(2-(3-butenyl)-2-oxazoline), 
(P(MeOx-co-ButEnOx)) or poly((2-methyl-2-oxazoline)-co-(2-(9-decenyl)-2-oxazoline), 
(P(MeOx-co-DecEnOx)) were synthesized, varying the amount of hydrophobic content of 
10, 20, 30 and 40 mol% (Figure 3.2). A DP of 200 was chosen to achieve a successful 
pDNA complexation. The cationic character, required for pDNA binding, was acquired by 
functionalization of ButEnOx or DecEnOx with either primary or tertiary amine (Figure 
3.2). The library was then systematically investigated with regard to: (i) The ability to form 
stable polyplexes, (ii) the cytotoxicty and (iii) the transfection efficiency.  
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Figure 3.2: Schematic representation of the chemical structures of the poly(oxazolines) library based on 
functionalized P(MeOx-co-ButEnOx)stat and P(MeOx-co-DecEnOx)stat. Product terms: s = short butyl side chain, l 
= long decenyl side chain, N = amino content in mol%, p = primary amine, t = tertiary amine. 
The ability to form polyplexes was investigated via ethidium bromide exclusion assay 
(EBA)[58] and physiochemical analysis like dynamic light scattering (DLS) and zeta potential 
measurements. In case of the EBA, all 18 polymers lead to a decrease in ethidium bromide 
(EB) fluorescence intensity, indicating polyplex formation (Figure 3.3). The following 
structure-activity relationships could be observed: (i) For the longer side chains the amino 
type shows a high impact on the polyplex formation (primary amines leads to an increased 
exclusion of EB), (ii) the amount of amines and the degree of hydrophobicity correlates 
with the pDNA condenstation, (iii) polymers with longer side chain increase the pDNA 
complexation. Based on the obtained data the impact of hydrophobicity is more pronounced 
as compared to the amino type. With regard to the size and zeta potential all polymers 
show a positive zeta potential and acceptable sizes, except the copolymers with 10 mol% 
indicating an insufficient polyplex formation (Figure 3.3). The reasons for that behavior are 
the low amino contents. 
Another investigated parameter is the polyplex stability, where an optimum between strong 
and weak binding has to be found. This can be analyzed with negatively charged heparin 
that competes against the pDNA binding. Compared to the polyplexes formed of polymers 
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with short side chains (sNp and sNt), the ones of long side chain (lNp and lNt) are more 
stable, as indicated by the higher used heparin concentrations to release the pDNA (Figure 
3.3). This is in particular the case for l40p, where 50 U mL-1 of heparin is required to 
dissociate the polyplexes, which correlates with the strong pDNA condensation. In contrast, 
the s40p polyplexes release the pDNA already at heparin concentration of 10 U mL-1. This 
indicates a stronger binding of l40p and could result in an inefficient release of pDNA in the 
cytoplasm and, probably, a low transfection efficiency. It was further found that for sNt 
and lNt polyplexes a low amount of heparin is necessary for polyplex dissociation compared 
to their counterparts with primary amines. This is another indication that the interaction of 
the genetic material with polymers with tertiary amines are weaker and that the polymers 
are probably not able to protect the pDNA from degradation.  
 
Figure 3.3: Overview of all copolymers regarding their characteristics and bottlenecks for the transfection process. 
Probable reasons for transfection failure or drawbacks are described as comments. 
Further investigations showed that sNp and sNt polymers have no cytotoxicity or hemolytic 
activity at the tested concentrations (Figure 3.3). In contrast, cytotoxic and hemolytic 
effects were observed for polymers with long side chains (lNp and lNt), showing 
furthermore a dependency on the amino content and the amino type. An increased amino 
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content leads to an increased cytotoxicity; the primary amine systems show higher cytotoxic 
effects. IC50 values of 4 to 14 µg mL-1 were obtained, meaning a comparable cytotoxicity to 
lPEI200 (lPEI DP = 200), (Figure 3.3). The hemolytic activity can be ascribed to strong 
membrane interactions of the more hydrophobic side chains leading to membrane 
destruction, as also reported elsewhere.[59] Due to their low amino/side chain content the 
l10p and l10t copolymers did not cause any hemolytic effect. All together, the results 
showed that the interaction between the polymers and membranes is much more influenced 
by the hydrophobic nature of the polymers than by the amino type and content. This is in 
accordance with the results of the pDNA condensation study (EBA). Moreover, the lNp 
copolymers are more hemolytic compared to lNt, which also indicates an enhanced 
interaction of primary amines with the negative cellular membrane or their proteins. In 
contrast to the lNp copolymers, where l40p showed a lower cytotoxicity than l30p, an 
increasing cytotoxicity with increasing amino content was observed for the lNt copolymers. 
The decreased toxicity of l40p might be caused by (electrostatic) interactions with serum 
components and will be investigated in further studies. In summary, the alkyl content and 
the hydrophobicity of the side chains showed again a high impact on the interaction of the 
polymers with cellular membranes.  
Often, a paradigm exists, namely high transfection efficiency is associated with high 
cytotoxicity, which is e.g. the case for PEI. Interestingly, the polymer s40p, showed 
transfection efficiency (30.5 ± 7.6%) similar to lPEI (31.2 ± 1.7%) without cytotoxic 
effects, whereas all other polymers revealed lower transfection efficiencies (below 10%), 
(Figure 3.4). The comparable transfection efficiency of s40p and lPEI is surprising, since 
the same DP was used and, hence, s40p exhibits a much lower amino content (only 80 of 
200 repeating units bear an amino group).  
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Figure 3.4: Transfection efficiency of all copolymers with short side chains (sNp and sNt) and lPEI200 for adherent 
HEK293 (human embryonic kidney) cells in serum reduced media at the indicated NP ratios. Values represent the 
mean (n = 3). 
The question arises if higher amino contents over 40 mol% lead to a further increased 
transfection efficiency. Thus, a polymer with a short side chain and 50 mol% of primary 
amines was synthesized (s50p). Again, the transfection efficiency and the cytotoxicity were 
investigated. For this polymer (s50p), the transfection efficiency was slightly lower but 
showed no significant differences to the s40p polymer. However, it was cytotoxic at higher 
concentration, whereas no cytotoxicity was observed for s40p (Figure 3.4). Obviously, the 
polymer s40p represents an optimal combination of cationic charges, hydrophobicity and 
biocompatible monomers for an enhanced cellular interaction and a high transfection 
efficiency as well as a reduced cytotoxicity. 
Based on a 18-membered 2-oxazoline-functionalized library the promising copolymer s40p 
was identified due to the screening of different parameter, such as the hydrophobicity, the 
type as well as the content of amino groups. It was found that independent of the amino 
content, long hydrophobic side chains enhance the pDNA condensation to the genetic 
material but interrupt the cellular membranes, leading to a higher cytotoxicity, hemolysis, 
and lactate dehydrogenase (LDH) release. POx with short side chains and an amino content 
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below 50 mol% were found to be biocompatible at all studied concentrations. In addition, 
primary amines are more suitable for an efficient polyplex formation and a high polyplex 
stability. Further investigations, like polyplex uptake or LDH release assay studies, provided 
more information for the possible failure of some polymers (Figure 3.3). All in all, the best 
performer s40p showed no cytotoxic effects and similar transfection efficiency to lPEI200.  
This study demonstrates the importance to understand the interplay between different 
parameters for the development of non-toxic cationic polymers used as non-viral vectors in 
gene delivery applications. However, the screening of a polymer library is time consuming 
with standard techniques for the investigation of biological properties of polymers. 
Therefore, a high-throughput (HT) workflow for the investigation of cationic polymers for 
gene delivery applications would provide faster insights into structure-activity relationships, 
e.g. regarding the biological activity. For this purpose, various PEI polymers were used as 
representative cationic polymers and investigated via HT-assays in a 96-well plate format, 
starting from polyplex preparation up to the examination of the transfection process. In 
detail, automated polyplex preparation, complex size determination, DNA binding affinity, 
polyplex stability, cytotoxicity, and transfection efficiency were performed in the well plate 
format. The transfection efficiency of the polyplexes was quantified using EGFP as reporter 
protein in a fluorescence plate reader, allowing a fast and facile screening, in contrast to 
flow cytometry or microscopy (Figure 3.5a) The polymers can be ranked from high to low 
transfection efficiency: lPEI600 > lPEI200 > bPEI200 > bPEI600 > bPEI20 > lPEI20 
(numbers denote the DP), whereby the obvious increase in standard derivation compared to 
the flow cytometry measurements must be taken into account. Another example for the 
benefit of HT is the heparin assay: It can be used for 23 polymers at four different NP 
ratios resulting in 92 samples plus controls (n = 1). By using only one NP ratio, a further 
increase in polymer samples up to 30 (triplicate), 46 (duplicate), or 94 (single) is possible 
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(Figure 3.5b). The HT investigation showed trends and are eligible for a suitable approach 
to spot high potential candidates, which can subsequently be investigated in depth.  
 
Figure 3.5: Transfection efficiency by fluorescence intensity measurements, HEK293 cells transfected with PEI of 
different molar mass and architecture (a). pDNA release of lPEI600 based polyplexes at different NP ratios after 
automated titration with heparin (b). 
To proof whether the developed workflow is applicable for polymers systems or not, the 
obtained results were compared with literature and data obtained via the classical way 
(handmade). Furthermore, conditions enabling a fast and efficient screening in terms of 
important vector parameters, such as polyplex formation, transfection and release, were 
found. The possible screening of polymer libraries for the best transfection candidate will 
help to elucidate the main polymer characteristics and to understand why some polymers 
are high performers and others not. Thus, an enhanced development of more efficient 
polymers and polyplexes can be realized. 
In summary, the characterization of PEI demonstrated the paradigm between transfection 
efficiency and cytotoxicity, particularly for high molar mass polymers. Combinations with 
POx-based copolymers, which are functionalized with hydrophobic and cationic moieties, 
were investigated regarding their delivery potential. By screening the copolymer library, one 
polymer was identified with superior performance, namely s40p, showing a low cytotoxicity 
and a high transfection efficiency. In addition, an HT approach was evaluated to allow a 
screening of such polymer libraries in a fast and efficient way. 
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4 Triblock terpolymer based micelles as nanocarriers 
Parts of this chapter have been published in: P5) A C. Rinkenauer, A. Schallon, U. Günther, M. Wagner, E. 
Betthausen, U. S. Schubert, F. H. Schacher, A Paradigm Change: Efficient transfection of human leukemia 
cells by stimuli-responsive multicompartment micelles, ACS Nano 2013, 7, 9624-9631; P6) M. J. Barthel, A. 
C. Rinkenauer, M. Wagner, U. Mansfeld, S. Höppner, J. A. Czaplewska, M. Gottschaldt, A. Traeger, F. H. 
Schacher, U. S. Schubert, Small but powerful: Co-assembly of polyether-based triblock terpolymer into sub-
30 nm micelles and synergistic effects on cellular interactions, Biomacromolecules 2014, 15, 2426-2439.   
The most frequently used nanocarriers for drug and gene delivery represent nanoparticles 
and linear cationic polymers, respectively. However, the self-assembly of amphiphilic block 
copolymers into micellar structures of defined size, shape, and composition is a further 
active field of research.[42, 60, 61] Triblock terpolymers represent an ideal platform to study the 
biological applications of self-assembled multicompartment micelles. This topology is also 
favored for the introduction of different functionalities, like amino or carboxy groups, to 
achieve a stimuli-responsive behavior. The subdivision of the micelle into core, shell and 
corona allows the usage of simultaneously loading with different payloads like drugs or 
pDNA.[62] Typically, each segment of the ABC triblock terpolymers is attributed to a specific 
“task” in solution: The first block A often represents a hydrophobic segment leading to an 
amphiphilic character together with the blocks B and C, which are also used to achieve 
stimuli-responsive behavior or allow the introduction of different functionalizations, e.g. 
PEGylation (Figure 4.1). The size of the spherical micelles can be tuned by the polymer 
chain length. The here used polymers with low DP results in small micelles of around 
30 nm, whereas with high DP micelles with diameter of 200 nm can be obtained (Figure 
4.1). 
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Figure 4.1: Schematic representation of the chemical structures of ABC triblock terpolymers and cyro-TEM 
micrographs of the corresponding micelles. a) Poly(ethylene oxide)-block-poly(allyl glycidyl ether)-block-poly(tert-
butyl glycidyl ether) and b) poly(butadiene-block-poly(methacrylic acid)-block-poly(2-(dimethylamino)ethyl 
methacrylate). 
Commonly, nanocarriers with diameters between 50 to 200 nm are used, because 
endocytosis can be assumed as a predominant internalization process. The interaction with 
the immune system is reduced, and glomerular filtration can be avoided.[63, 64] In contrast, 
polymeric micelles with sizes below 50 nm are rare in literature and, up to now, barely 
studied with regard to interactions with biological matter. In this context, spherical core-
shell micellar structures of approximately 30 nm were found to effectively penetrate poorly 
permeable tumor membranes.[65] Hydrophobic drugs are well suited for encapsulation into 
such small micellar cores. In contrast, pDNA cannot be encapsulated into nanocarriers 
below 50 nm due to its large size. Moreover, a direct control over the charge balance in 
nanocarriers can be a promising strategy to balance cellular interactions, an efficient uptake, 
and simultaneously to suppress non-specific interactions and lower cytotoxicity.[66] This can 
be achieved, e.g. via the combination of positively and negatively charged segments within 
one block copolymer. 
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For pDNA delivery a multicompartment micelle based on stimuli-responsive triblock 
terpolymers, poly(butadiene-block-poly(methacrylic acid)-block-poly(2-(dimethylamino)ethyl 
methacrylate) (BMAAD), was used (Figure 4.1b). The polymer and the corresponding 
micelle with a diameter of around 200 nm exhibits a pH dependency concerning shape, size 
and surface charge, due to the PMAA and PDMAEMA block.[67] At an endosomal pH value 
(~ 5), PMAA is uncharged and PDMAEMA forms a cationic corona, whereas at pH 10, 
PDMAEMA is uncharged, collapsed, and merely PMAA now forms a negatively charged 
corona (Figure 4.2). Under physiological conditions both blocks are charged, leading to the 
formation of an intra-micellar interpolyelectrolyte complexed (im-IPEC) shell. Hence, the 
micellar surface is patchy, featuring both charge neutral (im-IPEC) and cationic domains 
(the DP of PDMAEMA is higher than for the PMAA segment, resulting in an excess 
positive net charge).  
In contrast to this relative large micelle another triblock terpolymer poly(ethylene oxide)-
block-poly(allyl glycidyl ether)-block-poly(tert-butyl glycidyl ether) (PEO-b-PAGE-b-PtBGE) 
with different functionalities was used for drug delivery experiments (Figure 4.1). Here, very 
small spherical micelles with diameters below 30 nm were achieved allowing the 
encapsulation of hydrophobic compounds inside the core.  
 
Figure 4.2: Cryo-TEM micrographs (a-c) and corresponding schematic depictions (d-f) of BMAAD micelles at 
indicated pH values. 
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As first step, transfection studies of BMAAD with pDNA under serum reduced conditions 
as well as with media containing 10% bovine serum were performed in adherent HEK293 
cells, using lPEI 25 kDa and PDMAEMA 30 kDa as control. The BMAAD micelles showed 
enhanced transfection efficiency, compared to lPEI 25 kDa and PDMAEMA under both 
conditions (Figure 4.3b). The fact that BMAAD performs even better under serum 
conditions (74 ± 8%) is remarkable as in general serum leads to unspecific interactions and 
lower transfection efficiencies for cationic polymers. Next, the transfection of suspension 
Jurkat T cells, a model cell line for human leukemia cells and known to be hard to transfect 
with pDNA, was evaluated. Again, the BMAAD micelles demonstrate superior transfection 
efficiency, 5-fold higher than lPEI 25kDa (Figure 4.3c). With regard to cytotoxic effects, 
BMAAD show no cytotoxicity up to the tested concentrations (320 µg mL-1), in contrast 
to PDMAEMA and lPEI 25 kDa, which show IC50 values of 30 µg mL-1 and 6 µg mL-1, 
respectively (Figure 4.3a). This can be attributed to the PMAA block of BMAAD and the 
patchy surface featuring cationic domains and neutral charged im-IPECs. This remarkable 
performance of the BMAAD micelles, showing high transfection efficiency and no 
cytotoxicity, was further investigations concerning the underlying mechanism. Therefore, the 
physicochemical properties of the polyplexes were investigated using EBA and DLS 
experiments. BMAAD and the control polymers lead to a decrease in EB fluorescence 
intensity, indicating the successful formation of polyplexes. At physiological pH value all 
investigated polyplexes exhibit a positive net charge, as it is shown in zeta potential 
measurements. Hydrodynamic diameters of 64 nm (lPEI 25 kDa), 237 nm (BMAAD), and 
52 nm (PDMAEMA) can be observed. For BMAAD, the formed polyplexes are of 
comparable size to the “bare” micelles (212 nm), which can be explained by a rather tight 
wrapping of pDNA around the particles (see also to Chapter 2). The results could also be 
confirmed by asymmetric flow field flow fractionation, where an Rg of 97 nm was obtained 
for BMAAD and 111 nm for the corresponding polyplex. With decreasing pH value, the 
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zeta potential as well as the hydrodynamic diameter increases from 16.5 mV and 237 nm to 
30.3 mV and 420 nm indication a stretching of the PDMAEMA block.  
To achieve a successful transfection of human leukemia cells an enhanced cellular 
interaction and uptake of the cells has to be realized. This was accessed via the 
sedimentation rate of the polyplexes, as determined by analytical ultracentrifugation. 
Presumably, larger particles with higher sedimentation coefficients lead to an increased 
particle uptake in case of in vitro transfections. Indeed, a higher sedimentation rate of the 
BMAAD polyplexes (6480 S) compared to lPEI 25kDa (3140 S) and PDMAEMA (230 S) 
was obtained, most probably due to the rather dense PB core. This might lead to longer 
and more intensive interactions between the cells and the polyplexes and, an increased 
internalization, in vitro.[68, 69]  
 
Figure 4.3: Cytotoxicity of BMAAD, lPEI 25 kDa and PDMAEMA 30 kDa tests using L929 cells (a). Transfection 
efficiency for adherent HEK293 cells in serum-containing media (b) and human leukemia cell (Jurkat T cells) (c) at 
different NP ratios. Mean fluorescence intensity (MFI) of HEK293 cells transfection with YOYO-1 labeled pDNA 
for indicated time points using BMAAD, lPEI 25 kDa and PDMAEMA (d). Values represent the mean ± S.D; * 
represents a significant difference (p < 0.05) to lPEI 25 kDa and PDMAEMA 30 kDa. 
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Further investigations concerning the polyplex uptake were performed using YOYO-1 
labeled pDNA in a time dependent manner. The labeled pDNA complexed with BMAAD 
show an impressive behavior. Beside a faster uptake also the overall amount is enhanced 
compared to lPEI 25 kDa and PDMAEMA (Figure 4.3d). The uptake kinetics of the 
polyplexes was investigated, but, due to the relative large size of the micelle and their 
corresponding polyplexes the relying uptake mechanism was questionable. Thus, 
transfections at 4 °C and with bafilomycin (an inhibitor for the ATPases in the endosome 
and therefore prevention of an acidification) were performed. In both cases, the transfection 
efficiency of BMAAD is significantly decreased from around 70% to less than 20%. This 
indicates that the uptake of BMAAD polyplexes occur via endocytosis. To further confirm 
the uptake mechanism, localization of transported pDNA was investigated using confocal 
laser scanning microscopy (CLSM). Interestingly, already after 1 h no co-localization of the 
labeled BMAAD polyplexes with the late endosome and lysosome was detected, in contrast 
to lPEI 25 kDa and PDMAEMA polyplexes (Figure 4.4). However, the polyplexes were 
observed in early endosome, indicating a fast and efficient escape from the endosome within 
30 min.  
 
Figure 4.4: CLSM images of HEK293 cells transfected with indicated polymer based polyplexes and YOYO-1 labled 
pDNA (green); late endosome/lysosome were stained with lysoTracker Red (red), and cell nuclei were stained with 
Hoechst 33342 (blue). Each scale bar represents 20 µm; colocalization of pDNA and endosomal compartments are 
depicted in yellow. 
For lPEI 25kDa, a rather high buffer capacity is known, causing the proton sponge effect. In 
contrast to lPEI 25 kDa, PDMAEMA has lower buffer capacities,[70] which might explain the 
lower transfection efficiency of the linear homopolymer PDMAEMA but not the outstanding 
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performance of BMAAD. Here, the stimuli-responsive behavior of BMAAD is the key 
factor, an increased amount of positive charges at pH value of 5 lead to strong interactions 
with cellular membranes and, potentially, a destabilization. This was confirmed both for the 
polymers and the polyplexes by a hemolysis assay at different pH values.  
Once the polyplexes are released into the cytoplasm, their dissociation is of great 
importance; this behavior was investigated using the heparin assay. Typically, heparin 
concentrations of 10 U mL-1 are necessary to achieve a total release of pDNA from PEI-
based polyplexes,[71] whereas 50 U mL-1 were required for linear PDMAEMA, which is a 
further explanation for the lower transfection efficiency. Although, BMAAD and 
PDMAEMA showed comparable binding affinities, the addition of only 10 U mL-1 heparin 
led to an almost complete release of pDNA from the BMAAD -based polyplexes. This can 
be attributed to the PMAA block acting as a competing polyanion.  
The structure of the formed polyplexes was further investigated using cryo-TEM 
measurements at different pH-values (Figure 4.5). At pH 7.4, the BMAAD micelles are 
close to their isoelectric point and polyplex formation with pDNA leads to rather 
homogeneous structures of spherical shape. The observed clustering can be explained by the 
rather low zeta potential of 16.5 mV. A decreased pH value of 5 leads to full protonation 
and stretching of the PDMAEMA corona (pKa ~ 7.7, zeta potential of 30.3 mV). 
Afterwards, severe structural changes occur, as shown in Figure 4.5b. Parts of the micellar 
core are covered by collapsed PMAA patches (blue) and, in addition, the polyplexes formed 
of PDMAEMA (red) and pDNA (black) appear more dense and rigid, as seen in the 
protrusions connecting several micellar structures.[67]  
These observations and the data provided by hemolysis support the assumption of an 
endosomal burst at acidic conditions. Subsequently, if the polyplex is released from the 
endosome, the pH value within the cytoplasm rises to approximately 7.4, which was also 
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simulated for the same polyplex solution (Figure 4.5c). The cryo-TEM micrograph now 
shows polyplexes with the combined characteristics of Figure 4.5 and Figure 4.5b: PMAA is 
resolubilized via deprotonation, leading to a more homogeneous overall appearance, and the 
rather rigid PDMAEMA/pDNA strands are still present, interconnecting several micelles. 
The latter can be explained by a closer look at the linear homopolymer of PDMAEMA, 
showing a rather strong binding between PDMAEMA and pDNA. Since the polyplex is 
formed, neither an increase in the pH value nor the addition of heparin facilitated an easy 
release of pDNA. Hence, in the case of the BMAAD the negatively charged PMAA block 
acts as a competing polyelectrolyte, presumably reducing the binding between PDMAEMA 
and pDNA, and enabling the release of genetic material in the cytoplasm.  
 
Figure 4.5: Schematic depiction of the proposed polyplex structure and the corresponding cryo-TEM micrographs 
at pH 7.4, the black arrow indicates the presence of im-IPEC (a), pH 5 (b), and pH 7.4 (c). Zeta potentials (ZP) 
of BMAAD polyplexes at pH 7.4 (16.5 mV) and pH 5 (30.3 mV). Color code: Grey (PB), blue (PMAA), red 
(PDMAEMA), white (im-IPEC), and black (pDNA-polyplex). Scale bars indicate 200 nm and 50 nm in the insets. 
The detailed investigations of the underlying mechanism revealed a number of advantages 
for the BMAAD micelle. The dense core leads to higher sedimentation rates and a superior 
cellular uptake. Furthermore, the neutral charged im-IPECs probably lead to reduced serum 
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aggregation, unaffected viability, enhanced cellular uptake, and an improved pDNA release. 
In addition, under acidic conditions PDMAEMA provokes an increase in size and zeta 
potential, responsible for membrane destabilization and the release of the polyplex from the 
endosome.  
The BMAAD micelle demonstrates the importance of control over the charge balance in 
(block co-) polymer nanostructures. Resulting in a promising strategy to balance cellular 
interactions, efficient uptake, and to simultaneously suppress non-specific interactions and 
reduced cytotoxicity.  
Besides the combination of positively and negatively charged segments within one block 
copolymer the simple mixing of different charged block copolymers during micelle formation 
represents an alternative approach. For this purpose, a small library of structurally similar 
ABC triblock terpolymers (PEO-b-PAGE-b-PtBGE = EAT) (Figure 4.1a) with different 
functional groups being present within the segment B were synthesized. In detail, the 
pendant double bonds of the PAGE block were functionalized to introduce galactose 
(EGT), amino groups to provide positive charges (ENT), as well as carboxylic groups to 
generate negative charges (ECT) (Figure 4.6). Galactose was chosen to enable selective 
cellular uptake into hepatocytes, as an interaction with the asialoglycoprotein receptor can 
be assumed.[72] The obtained triblock terpolymers were subsequently used for the co-
assembly into well-defined spherical core-shell-corona micelles with diameters below 30 nm 
and precisely adjustable charge and composition. In addition, nile red, a hydrophobic red 
fluorescent dye, was encapsulated into the hydrophobic PtBGE core. Nile red is poorly 
soluble in water and exhibits a strong fluorescence in hydrophobic environment, herein it 
was used as model drug.[73] The characterization via DLS, cryo-TEM (Figure 4.6) as well as 
AF4 measurements, confirmed the assembly into spherical micelles with hydrodynamic 
diameter between 10 and 34 nm. 
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To create mixed micelles the co-assembly of the different triblock terpolymers was 
performed leading to the formation of core-shell-corona micelles. Here, a PEO corona and a 
hydrophobic PtBGE core formed by identical segments (A and C) should be achieved. The 
shell (B segment) should be composed of a combination of different functional groups, 
depending on which materials are used. Mixed micelles formed of two different triblock 
terpolymers (ENT and ECT) as well as ternary micelles (ENT, ECT and EGT) were 
assembled. Moreover, the binary mixed micelles were formed with different ratios, an excess 
of positive charges (ENT/ECT)3.5:1, a slight excess of positive charges (ENT/ECT)1.2:1, 
and an excess of negative charges (ENT/ECT)1:2.6. Here, the superscripts represent the 
mixing ratio regarding the functional groups of the involved triblock terpolymers. For the 
ternary systems, two ratios were prepared via co-assembly: (ENT/ECT/EGT)3.5:1:0.5 and 
(ENT/ECT/EGT)3.4:1:2.3, featuring almost identical charge ratios and mainly differing in 
the amount of incorporated galactose. In all cases, evaluation by DLS and cryo-TEM led to 
comparable results to the pure micelles, regarding size and shape of both binary and ternary 
mixed micelles, also supported by AF4 measurements.  
 
Figure 4.6: Schematic representation of the co-assembly of functionalized triblock terpolymers and the 
corresponding cyro-TEM micrographs of the prepared micelles. Due to the rather low contrast an arrow highlights 
representative ENT and EGT micellar cores. 
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Subsequently, further characterization of the micelles and mixed micelles was necessary. In 
particular, if two separate populations of micelles composed of only one polymer exist or if 
the co-assembly was successful. For this purpose, the zeta potential was analyzed (Figure 
4.7b). As expected, a negative value is found for ECT (–36 mV) whereas the zeta potential 
for ENT is positive (48 mV). Both EAT and EGT revealed negative values (–10 and 
-27 mV), which can be attributed to the complexation of ions within the PEO corona or 
charge-dipole and dipole-dipole interactions, which are both known to influence the zeta 
potential. For binary mixed micelles (ENT/ECT), a clear dependence of the zeta potential 
on the mixing ratio can be observed, as with increasing amount of ENT the zeta potential 
increases (from –24 mV for (ENT/ECT)1:2.6 to 14 mV for (ENT/ECT)3.5:1). Thus, zeta 
potential measurements indicate that mixed micelles are formed. If the co-assembly in case 
of, e.g. (ENT/ECT)3.5:1, would lead to two separate populations of ENT and ECT, 
aggregation of oppositely charged micelles due to electrostatic interactions might be 
expected. In this case, an increase of the aggregates size and, presumably, precipitation 
might occur. Moreover, the ternary mixed micelles exhibit a decreased zeta potential if 
compared to the binary (ENT/ECT)3.5:1 structures with 6 mV for 
(ENT/ECT/EGT)3.5:1:0.5 and 7 mV for (ENT/ECT/EGT)3.4:1:2.3, thus, indicating the 
presence of EGT within the structures. In this case the zeta potential measurements 
confirm again that mixed micelles are formed.  
 
Figure 4.7: Gel electrophoresis using 1% agarose gel and TBE buffer (1 = ENT, 2 = (ENT/ECT)3.5:1, 3 = 
(ENT/ECT)1.2:1, 5 = ECT, 6 = (ENT/ECT/EGT)3.5:1:0.5, 7 = (ENT/ECT/EGT)3.4:1:2.3, 8 = (EGT). Zeta potential of 
different tribock terpolymer micelles and mixed micelles diluted in water. 
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Beside zeta potential measurements, gel-electrophoresis is another method for the 
investigation of charged macromolecules (e.g. DNA). Here, the samples are placed in an 
agarose gel and an electrical field is applied. The electrical field induces movements within 
the gel towards the positive or negative pole, depending on the charge of the sample. An 
advantage of this method is the visualization of the material depending on its charge and 
size. It was anticipated that mixed micelles should feature only one band, as additional 
confirmation of the zeta potential measurements. As shown in Figure 4.7a, micelles formed 
by ENT reveal the highest shift to the negative pole, whereas ECT moved towards the 
positive pole. The bands observed for ENT/ECT mixed micelles of different mixing ratios 
can be found in between, in accordance with their zeta potential. As only one band is visible 
for all samples, we regard this as another indication for an efficient co-assembly. In 
addition, ternary ENT/ECT/EGT exhibited movement towards the negative pole, again 
confirming the results from zeta potential measurements. EGT did not show any movement 
in gel electrophoresis.  
Aiming for a later use of such triblock terpolymer micelles in targeting and/or delivery 
applications, their cytotoxicity was investigated. At first, triblock terpolymer micelles formed 
via the self-assembly of one kind of polymer were investigated. Micelles formed of EAT, 
ECT or EGT did not show any cytotoxic effects for concentrations up to 0.5 mg mL-1, only 
in case of the ENT the situation was different (Figure 4.8a). Regarding EAT, ECT, and 
EGT these results are in accordance with literature report as all structures exhibited 
negative zeta potentials. For micelles based on ENT, the IC50 of 300 µg mL-1 can be 
explained by the presence of cationic charges within the shell (zeta potential of +47.5 mV), 
which could lead to stronger interactions with or even destabilization of the cell membrane. 
This was also confirmed by an increased hemolytic activity. These results can be taken as 
further proof that the functionalization of the middle block (PAGE) significantly influences 
interactions of such micelles with biological matter, even though all structures feature a 
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rather long PEO corona (compared to the degrees of polymerization for PAGE and 
PtBGE). Furthermore, the internalization efficiency of micelles from EAT, ENT, ECT, and 
EGT into HEK293 cells, a model cell line for unspecific uptake studies, was analyzed under 
serum reduced and serum containing conditions (Figure 4.8b). From this data set it 
becomes obvious that ENT revealed the best uptake into 79.7 ± 4.5% cells (at 
10 µg mL-1). This can be attributed to the presence of positive charges in the shell and an 
increased interaction with the cell membrane. Compared to ENT, the decreased uptake of 
ECT and EGT can be explained by the negative zeta potential of these particles, resulting 
in decreased interactions with the cells. Nevertheless, the introduction of charges (COOH) 
or targeting units (galactose) enhanced the uptake if compared to EAT (1 ± 1.11%). As 
the presence of a PEO corona has been shown in many examples to prevent unspecific 
protein adsorption (“stealth effect”), the uptake was also analyzed in the presence of serum 
(Figure 4.8b). Here, only the uptake of ENT decreased significantly from 86 ± 11% to 
13 ± 0.6% at 10 µg mL-1, presumably due to stronger interactions with the negatively 
charged serum proteins. However, the uptake of both, ENT and ECT, is significantly higher 
compared to EAT. The internalization of EGT is similar to EAT, thus, also reduced from 
15 to 2.9% in the presence of serum proteins. As the functionalization with galactose is 
supposed to result in a specific uptake into liver cells, the internalization efficiency of the 
EGT micelles was investigated in HepG2 cells. Unfortunately, no increased uptake at low 
concentrations (3.9% ± 5 at 10 µg mL-1) could be detected, which would hint towards a 
targeted internalization process. One explanation might be that the galactose side chains 
are not sufficiently exposed at the surface and, thus, the interaction with the 
asialoglycoprotein receptor, specific for galactose in HepG2 cells, is hampered. As the pure 
micelles (EAT, ENT, ECT, and EGT) already showed significant differences regarding 
cellular uptake and cytotoxicity, the influence of the composition in binary and ternary 
mixed micelles on the cytotoxicity was studied. (ENT/ECT)3.5:1 exhibited a positive zeta 
potential and a similar cytotoxicity (IC50 of 350 µg mL-1), if compared to ENT (Figure 4.8a 
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and c). In case of (ENT/ECT)1.2:1 and (ENT/ECT)1:2.6, no cytotoxicity was observed, in 
accordance with the negative zeta potential. Interestingly, both ternary mixed micelles, 
(ENT/ECT/EGT)3.5:1:0.5 and (ENT/ECT/EGT)3.4:1:2.3, which feature the same charge 
ratio as (ENT/ECT)3.5:1 and exhibited positive zeta potentials, did not show any 
cytotoxicity at all tested concentrations (Figure 4.8c). This is indeed remarkable, and can 
be attributed to the presence of EGT terpolymer chains in the micelles. With regard to the 
uptake, the (ENT/ECT)3.5:1 demonstrated an outstanding uptake compared to the other 
samples. Under serum containing conditions already 75% ± 11.5 (10 µg mL-1) of the cells 
showed an internalization of (ENT/ECT)3.5:1 (Figure 4.8d). These results are comparable 
to ENT micelles under serum reduced conditions, thus indicating decreased non-specific 
interactions of (ENT/ECT)3.5:1 with serum proteins. For the other binary and ternary 
micelles a reduced uptake (compared to (ENT/ECT)3.5:1) was found (Figure 4.8d). In the 
case of ternary micelles, the decreased uptake compared to (ENT/ECT)3.5:1, can be 
attributed to the presence of EGT. Further increase of the galactose content leads to even 
the lower values, which is in accordance with lower uptake of EGT compared to ECT and 
ENT. Nevertheless, it should be noted that, in contrast to (ENT/ECT)3.5:1, both ternary 
micelles did not show any observable cytotoxicity. In summary, by adjusting the micellar 
composition via co-assembly of ENT, ECT, and EGT both cellular uptake and cytotoxicity 
can be controlled and optimized. Thus, by fine tuning the charges in the shell either higher 
uptake rates or reduced cytotoxicity can be achieved. 
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Figure 4.8: Cytotoxicity of the indicated triblock terpolymer micelles (a) and mixed micelles (c) using L929 cells 
and cellular uptake in HEK293 cells at concentration of 10 µg mL-1 under serum reduced conditions (dashed bar) 
and serum containing conditions (filled bars) (b and d). Values represent the mean ± SD. 
Triblock terpolymers based micelles are very promising nanocarriers for drug and gene 
delivery. It was demonstrated that large micelles allow a wrapping around the pDNA, which 
results in a superior performance. In all transfection steps beneficial properties were 
obtained, which can be attributed to the pH dependent stimuli-responsiveness and the 
patchy surface of this micelle. In contrast, very small micelles were demonstrated as possible 
drug delivery agents. Based on a polymer toolbox, the tuning of the charges, in the shell, 
results in synergistic effects, whereby the cytotoxicity and uptake efficiency can be 
controlled.  
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5 Polymer-based nanoparticles for drug delivery 
Parts of this chapter will be published in: P7) T. Yildrim, A. C. Rinkenauer, C. Weber, A. Traeger, S. 
Schubert, U. S. Schubert, RAFT made methacrylate copolymers for reversible pH-responsive nanoparticles, J. 
Polym. Sci, Part A: Polym. Chem. 2015, 53, 2711-2721; P8) A. C. Rinkenauer, A. T. Press, M. Raasch, C. 
Pietsch, S. Schweizer, S. Schwörer, K. L. Rudolph, A. Mosig, M. Bauer, A. Traeger, U. S. Schubert, 
Comparison of the uptake of methacrylate-based nanoparticles in static and dynamic in vitro systems as well 
as in vivo, J. Controll. Release 2015, 216, 158-168. 
 
Nanocarriers applied for drug delivery are based either on spherical micelles or on 
nanoparticles. In both cases pH-dependent stimuli-responsiveness can be one feature of the 
polymers for enhanced uptake or drug release. Besides PLGA, PMMA derivates are the 
commonly used hydrophobic polymers for nanoparticle preparation. The statistical P(MMA-
co-MAA) copolymers are applied e.g. as coating material (EUDRAGIT-S100), because it 
shows a pH dependency behavior, no cytotoxicity and a good biocompatibility.[74] In 
addition, PMMA derivatives can be used for the preparation of well-defined nanoparticle via 
nanoprecitpitation.[74] These polymers are non-biodegradable and, thus, particularly suited to 
analyze the internalization behavior depending on the structural properties of nanoparticles, 
e.g. the surface charge or the nanoparticle size. Detailed investigations of nanoparticle 
efficiencies result in numerous factors which affect their uptake in vitro. However, direct 
translation of their uptake efficiency to their behavior in vivo is challenging. In particular, 
the prediction concerning the biodistribution and the interaction with the RES remains a 
challenge.[75] Thus, cost and time consuming in vivo experiments are applied to evaluate new 
nanoparticle systems and to answer the question, whether they improve the biodistribution 
and the availability of a compound to the target cell. Microfluidically-supported cell cultures 
represent promising new developments to model physiological relevant conditions more 
accurately by mimicking key-features (e.g. the shear stress).[76] In blood vessels the inner 
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layer – exposed to the bloodstream are endothelial cells. As a consequence, their cell biology 
morphology, permeability, and the expression of other important features are affected by 
shear stress.[77] This mechanical force evolved to an important factor investigating 
physiological processes in the context of endothelial and substance interaction and 
internalization. First results demonstrate the impact of shear stress on the nanoparticle 
uptake.[78-81]  
To gain more insight into the impact of shear stress and co-cultivation in microfluidically-
supported dynamic cell cultures, PMMA derivatives-based nanoparticles were applied. The 
copolymers were synthesized via the RAFT polymerization technique to obtain polymers 
with narrow molar mass distributions and tailored polymer properties.[82, 83] Here, pH 
dependent copolymers were synthesized consisting on the one hand of negatively charged 
MAA groups at basic conditions and on the other hand of cationic charges (DMAEMA 
units) at acidic conditions. A fine-tuning of the pH dependency, which goes hand in hand 
with the negative charges (-COOH groups), as well as the hydrophobicity (MMA units) was 
realized by synthesizing statistical copolymer libraries with a systematic variation in the 
compositions. Thus, MAA amounts of 3, 5, 8 and 13%, as well as 20% of DMAEMA were 
used as a comonomer in the polymerization procedure.  
As a first step, nanoparticles were prepared by nanoprecipitation with subsequent solvent 
evaporation without any need of stabilizers/surfactants.[12] In this study nanoparticles of 
around 200 nm in diameter were chosen due to the size dependent cellular internalization 
via endocytosis. In order to obtain such nanoparticles, with defined size the “dropping 
method” was applied (polymer diluted in acetone and dropped into water). The 
characterization of diameter and shape of the nanoparticles were performed using DLS as 
well as SEM measurements (Figure 5.1a-c). Spherical nanoparticles with diameters of 190 
to 210 nm were obtained. The zeta potential measurements confirmed the negative surface 
charges of nanoparticles consisting of PMMA-co-PMAA (3, 5, 8, 13% PMAA 
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nanoparticles) and positive charges for PMMA-co-PDMAEMA (20% PDMAEMA 
nanoparticle) nanoparticles, indicating a high colloidal stability.[84] In case of PDMAEMA-
based nanoparticles a pH-responsive behavior under acidic condition can be assumed due to 
the pKa value of 7.5 of PDMAEMA.[35, 85] Thus, the pH-response behavior was investigated 
by DLS measurements of nanoparticle suspensions at various pH values (Figure 5.1d). The 
20% PDMAEMA nanoparticles did not show any instability at pH 7, whereas, at pH 
values of 3.4 to 5, the nanoparticles are protonated and show a disassembling or swelling. 
This protonation was detected by an increased zeta potential, and furthermore the 
disassembly or swelling can be explained by increase of the dispersity. 
 
Figure 5.1: SEM micrographs of methacrylate based nanoparticles a) 3% PMAA, b) 13% PMAA and c) 
20% PDMAEMA. Scale bar = 500 nm. d) Z-Average diameter (represented up to 1000 nm) and nanoparticle 
dispersity values of 20% PDMAEMA nanoparticles as a function of the pH value. 
Initially, the nanoparticles were investigated regarding their internalization in HEK293 cells. 
A clear correlation of cellular internalization rates depending on the PMAA amount of the 
nanoparticles was observed. Increasing amounts of PMAA resulted in an increased uptake of 
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the nanoparticles (Figure 5.2a). In particular, the differences in the uptake behavior of 
3% PMAA (rel. SSC/FSC = 1.2) and 13% PMAA (rel. SSC/FSC = 1.7) are 
remarkable. The differences in polymer composition and related negative charge increase of 
the particle surface as well as a decreased hydrophobicity appear to be beneficial for the 
cellular uptake. The cationic charged nanoparticles (20% PDMAEMA) showed the 
highest cellular uptake (rel. SSC/FSC = 2). This increased internalization rate can be 
explained by the cationic charges that are known to be beneficial for interactions with the 
cell membrane.[86] Nanoparticles carrying negative as well as positive charges show an 
adsorption of serum proteins that impact their uptake efficiency.[50, 51] The nanoparticle 
uptake of 3% PMAA, 13% PMAA and 20% PDMAEMA was tested in the presence 
of fetal calf serum (FCS) in the cell culture medium (Figure 5.2b). No impact of FCS on 
the internalization of 13% PMAA and 20% PDMAEMA nanoparticles was found. In 
contrast to this observation, an increased cellular uptake of 3% PMAA in the absence of 
FCS was observed. It can be assumed that the differences in cellular uptake of 3% and 
13% PMAA nanoparticles are attributed to the presence of serum proteins. The 
dependency of nanoparticle uptake on the protein coronas is known, but is hard to 
investigate due to its complexity.[87, 88] First hints concerning the impact of the protein 
corona on the nanoparticle uptake were given by SDS-PAGE. The 3% PMAA 
nanoparticles show in contrast to both other nanoparticles an increased protein adsorption, 
indicating a negative impact on the uptake. Furthermore, cell line and type independent 
uptake trends support the assumption of an impact of the protein corona on the 
internalization efficiency.  
Besides, the nanoparticle uptake measurement via flow cytometry, also confocal microscopy 
was performed to proof the internalization of the nanoparticles (Figure 5.2c-d). For this 
purpose, nile red as hydrophobic dye was encapsulated. All investigated nanoparticles were 
detectable inside the cells. 20% PDMAEMA showed higher fluorescence intensity and a 
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more diffuse distribution compared to PMAA nanoparticles. This supports the swelling and 
disassembly of nanoparticles under acidic conditions within the endosome and the release of 
nile red. 
 
Figure 5.2: Internalization of methacrylate-based nanoparticles in HEK293 cells treated for 24 h with 100 µg mL-1 
nanoparticle in media containing serum proteins, rel. SSC/FSC regarding the control. a) Negative and cationic 
charged nanoparticle uptake # represent significant difference compared to 20% PDMAEMA and b) comparison of 
nanoparticle uptake in media with and without serum. Internalization of 3% PMAA (c), 13% PMAA (d) and 
20% PDMAEMA (e) in HEK293 cells stained with Hoechst for DNA-staining (blue) and CellMask DeepRed (red) 
for plasma membrane staining previous to the addition of nanoparticles (green). Images were taken 25 to 30 min 
after addition of nanoparticles. Scale bar = 10 µm. a, b) bars show mean + s.e.m (n = 3), significance tested a) 
using Two-way ANOVA with post-hoc Turkey test and b), using Kruskal-Wallis Anova in combination with Dunn’s 
multiple comparison test,# p<0.05. 
Taken together, static in vitro studies depict relevant properties of the nanoparticles: (i) 
Uptake effectiveness depending on nanoparticle characteristics, (ii) crucial assays to 
understand the interaction of nanoparticles with soluble molecules of, e.g. serum proteins , 
and (iii) first assessment of nanoparticle toxicity. In addition, by analyzing the cellular 
uptake in different cell types as well as in co-cultivation of primary human umbilical vein 
endothelial cells (HUVEC) and primary human macrophages (MΦ) the same trend 
concerning an enhanced uptake of charged nanoparticles was observed. Interaction of 
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particles and proteins were shown by SDS-PAGE, indicating serum interaction as one aspect 
of the internalization of nanoparticles. However, static cell culture conditions provide 
sedimentation effect which are strongly altered under dynamic condition, e.g. in the blood 
stream.[89]  
Cell culture under dynamic conditions allows the investigation of nanoparticle binding and 
internalization under physiologically relevant conditions in vitro. HUVEC were dynamically 
cultured with physiological stimulation by shear stress. Shear stress values from 0.7, 3.0, 6.0 
and 10.0 dyn cm-2 were applied. Interestingly, increasing shear stress positively correlates 
with the total amount of internalized nanoparticles (Figure 5.3). Similar to PMAA-based 
nanoparticles 20% PDMAEMA show a positive correlation of the cellular uptake 
efficiency with applied shear stress in the dynamic cell culture. This indicates that 
nanoparticle cell interactions are sufficient to induce adhesion and internalization even at 
shear stress. However, in case of 20% PDMAEMA a plateau for the cellular uptake was 
already reached at 3 dyn cm-2. The findings of the methacrylate-based nanoparticles 
concerning shear stress can be attributed to a higher frequency of nanoparticle interaction 
per cell compared to static in vitro conditions. In addition, dynamic microfluidically-
supported cell cultures revealed different nanoparticle uptake tendencies as seen under static 
in vitro conditions: The uptake rate of 20% PDMAEMA under flow conditions is reduced 
to comparable levels to 13% PMAA (Figure 5.3). This might be due to an activation of 
HUVEC under dynamic conditions leading to a different surface receptor expression pattern 
and, thus, different nanoparticle-cell interaction.[79, 90] 
Additionally, HUVECs were co-cultured with MΦ under dynamic conditions to investigate 
cell-cell interactions, which are known to influence cellular physiology. MΦ are known to be 
responsible for the clearance of cell debris and circulating nanoparticles in the blood stream 
by phagocytosis.[91] MΦ in general exhibited a higher uptake rate compared to HUVEC for 
the methacrylate-based nanoparticles (Figure 5.3). The investigations in static and dynamic 
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cell culture conditions lead to the assumptions that the 13% PMAA as well as the 
20% PDMAEMA could be also taken up by macrophages in vivo. With regard to the 
uptake-tendencies between the different nanoparticles in the co-culture experiments, similar 
patterns were obtained under static and dynamic conditions at 3 and 6 dyn cm-2, 
respectively. However, at 0.7 dyn cm-2, which is assumed to be present in hepatic sinusoids, 
the uptake of 13% PMAA and 20% PDMAEMA did not significantly differ in contrast 
to the results obtained under static conditions. 
 
Figure 5.3: Different nanoparticles in the microfluidically-assisted cell culture. Uptake of methacrylate-based 
nanoparticles containing nile red in a HUVEC monoculture or a co-culture with MΦ which were subjected to 
different shear stress (0.7, 3, 7 or 10 dyn cm-2) were analyzed after 60 min. Uptake and distribution of 
nanoparticles (orange) in the HUVEC mono-culture (upper panels) and co-culture (lower panels) with MΦ. Cells 
were subsequently stained with DAPI (blue) and macrophages were stained using CMFDA (green). All scale 
bars = 10 µm. 
The liver plays an important role for drug- and nanoparticle clearance. In particular Kupffer 
cells, the local tissue-macrophages, possess endocytic activity against blood-borne materials 
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entering the liver and contribute to tissue modulation and regulation of the immune system 
in response to stimulants. For a rational drug development, possible immune-modulatory 
effects as well as nanoparticle clearance are key factors that need to be investigated under 
physiological conditions. Using intravital microscopy the cellular distribution of 3%, 
13% PMAA and 20% PDMAEMA nanoparticles in the liver could be observed. In vivo 
Kupffer cells mainly cleared all tested nanoparticles in the liver. However to a lower extend 
also endothelial cells took up 13% PMAA and 20% PDMAEMA nanoparticles (Figure 
5.4a). 
Beside the differences in the cellular distribution also the speed and kinetic of nanoparticle 
uptake varies between the different nanoparticles. Charged cationic 20% PDMAEMA 
were taken up fastest followed by the 13% PMAA nanoparticles (Figure 5.4b). The 
slowest uptake was shown by the lower charged 3% PMAA nanoparticles. These different 
uptake kinetics and cellular distributions represent the different abilities to unspecifically 
interact with cellular membranes and to subsequently activate endocytotic or phagocytotic 
pathways. The uptake of all nanoparticles reached a plateau after 30 to 60 min reflecting a 
saturation of the processes or a clearance of the nanoparticles in the body (Figure 5.4b). 
The MFI of 20% PDMAEMA even decreased constantly by 0.5% per min after 30 min 
within the time of observation, implying a release of nile red from 20% PDMAEMA. 
Finally the comparison between the nanoparticle uptake in Kupffer cells in vivo reveals that 
13% PMAA and 20% PDMAEMA are cleared more effective by the liver than the 
3% PMAA and that Kupffer cells showed a higher nanoparticle uptake than the 
endothelial cells. However, higher charged nanoparticles excerpt a smaller difference 
between the uptake in Kupffer cells and endothelial lining (Figure 5.4c). Beside the 
relevance of shear stress and surface charge also the cellular distribution between certain 
cell types can be compared. Here, the uptake of different nanoparticles (represented by the 
MFI) in endothelial lining and Kupffer cells was assessed.  
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Figure 5.4. a) Intravital microscopy of different nanoparticles in the liver (liver architecture: blue, nile red 
containing nanoparticles red) showing accumulation of nanoparticles mostly in Kupffer cells (examples marked with 
a white arrows) and only little in endothelial cells (examples marked with a white triangle); scale bar upper column 
250 µm, lower column 50 µm. Contrast of all images were harmonized. b) Uptake kinetic of nile red containing 
nanoparticles in Kupffer cells in vivo; graph show mean ± s.e.m. of three independent experiments. c) Maximal 
fluorescence intensity of PMAA and PDMAEMA-nanoparticles containing nile red in murine Kupffer cells and 
endothelial lining in the liver 60 min after administration; bars show mean + s.e.m. of the MFI-corrected FI of 
three independent experiments; significance was testes using a two-way ANOVA with Tukey post-hoc test 
performed on three independent experiments * p<0.01 between 13% PMAA or 20% PDMAEMA and 3% PMAA 
within one cell type. # p<0.01 between both cell types of one nanoparticle. 
 
Altogether, methods for pre-screening of nanoparticle internalization under physiological 
relevant conditions are required. Static cultures represent a fast and useful tool to assess 
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nanoparticle uptake in general. However, the impact of flow conditions on the nanoparticle-
cell interaction as well as different cell phenotypes can not be comprehended. The 
microfluidically-supported cell culture mimics shear stress as one key-factor influencing the 
nanoparticle uptake in general and might represent an important screening option for cell-
type specific nanoparticle uptake. Since animal experiments are cost and time consuming, 
new models and automated systems for dynamic cell culture should be developed for 
screening purposes to increase the success of new animal studies. 
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6 Summary 
The treatment of genetic disorders like cystic fibrosis, Parkinson or cancer by therapeutics is 
nowadays still challenging. The major drawbacks like side effects and decreased 
bioavailability of therapeutic substances can be reduced or overcome using nanocarriers. 
The most used materials for nanocarriers represent lipid and polymer based systems, 
whereas polymers show a high tuning potential due to the fact that they can be synthesized 
with varying physical and chemical properties (e.g. topology or functionalization). 
Nanocarriers are distinguished regarding their delivered substances; either they can be 
applied for genes, like plasmid DNA (pDNA) delivery, or for drugs, e.g. chemotherapeutics. 
Based on the different chemical properties different encapsulation strategies have to be 
used. As a consequence, the nanocarrier material has to fit to the desired substrate. 
 
Figure 6.1: Overview about the presented polymer-based nanocarriers for potential gene and drug delivery 
application. 
pDNA delivery is commonly based on the formation of complexes, called polyplexes, by the 
interaction of negatively charged phosphates and cationic polymer charges. Up to now, 
polymer-based pDNA transfection shows less success in clinical trials, demonstrating the 
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need to understand the transfection mechanism in vitro. In particular, poly(ethylenimine) 
(PEI) are frequently used and well characterized concerning its delivery potential. For 
instance, the high buffer capacity, which is based on high amino amount, results in an 
enhanced endosomal escape. However, the cytotoxic effects of PEI restrict its in vivo 
application. Thus, PEI is often used as template for numerous new polymer modifications 
like the functionalization with biocompatible polymers e.g. poly(2-oxazoline)s (POx). Here, 
a reduced cytotoxicity and decrease of unspecific protein interactions can be achieved, but 
on the other hand also a reduced transfection efficiency was observed. One possibility to 
overcome this drawback is the functionalization with hydrophobic units. For this purpose a 
library of 18 copolymers either poly((2-methyl-2-oxazoline)-co-(2-(3-butenyl)-2-oxazoline), 
(P(MeOx-co-ButEnOx)) or poly((2-methyl-2-oxazoline)-co-(2-(9-decenyl)-2-oxazoline), 
(P(MeOx-co-DecEnOx)) as precursor polymer was synthesized, varying the amount of 
hydrophobicity (10, 20, 30 and 40 mol%). ButEnOx and DecEnOx were then functionalized 
with either primary or tertiary amines for pDNA binding. Based on detailed investigations 
concerning the single transfection steps, like polyplex formation, stability and cytotoxicity, 
one polymer was identified with superior performance. Beside, transfection efficiencies 
similar to PEI (linear PEI DP = 200) no cytotoxic effects were detected. The screening of 
such polymer libraries is time consuming with conventional methods, thus a HT approach 
was established, starting with an automated polyplex formation.  
Besides cationic polymers, cationic preformed micelles provide also the opportunity for 
pDNA delivery. Herein, spherical micelles based on triblock terpolymers represent promising 
candidates. The assembly of poly(butadiene-b-poly(methacrylic acid)-b-poly(2-
(dimethylamino)ethyl methacrylate) (BMAAD) results in micelles of around 200 nm in 
diameter and both segments of poly(2-(dimethylamino)ethyl methacrylate) (PMAA) and 
poly(2-(dimethylamino)ethyl methacrylate (PDMAEMA) lead to pH dependent shapes. A 
patchy surface containing intra-micellar interpolyelectrolyte complexed (im-IPEC) at 
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physiological pH values leads to superior cell interaction and internalization also at the 
presence of serum proteins. Moreover, the expansion of the PDMAEMA block under acidic 
conditions results in an enhanced endosomal escape by explosion of the positively charged 
block. In total, the single hurdles of the transfection procedure can be overcome by this 
micelle resulting in high transfection efficiencies and no cytotoxicity. In contrast to such a 
relative large micelles, a small one with diameter below 30 nm was demonstrated as possible 
drug delivery carrier. The balance of charges is a promising tuning possibility and beside 
uptake efficiencies also the cytotoxicity can be influenced. For this purpose, spherical 
micelles based on poly(ethylene oxide)-block-poly(allyl glycidyl ether)-block-poly(tert-butyl 
glycidyl ether) (PEO-b-PAGE-b-PtBGE) were prepared. In addition, the PAGE block was 
functionalized with different groups to introduce cationic, anionic or targeting units. Simple 
mixing of the block copolymers prior micelle preparation results in mixed micelles. On the 
one hand binary micelles, consisting of two polymer and on the other hand ternary micelles 
were obtained with different polymer ratios. The resulting fine tuning of charges in the shell 
leads to synergistic effects, because either the internalization can be enhanced or the 
cytotoxicity might be reduced.   
The main challenge for drug delivery via nanoparticles is the translation of the efficiency 
from in vitro to in vivo. In general, the prediction of the biodistribution, interaction with the 
reticuloendothelial system (RES) and the behavior under flow conditions is not possible. 
Thus, methacrylate-based nanoparticles were systematically investigated concerning their 
uptake under static and dynamic in vitro conditions as well as in vivo. The screening of 
different nanoparticle uptake ratios, the influence of serum proteins as well as the 
cytotoxicity can be efficiently and fast assessed by static in vitro investigations. Based on 
different charged methacrylate-based nanoparticles the influence of the charge on the 
uptake was observed. Subsequently, the microfluidically-supported dynamic cell culture was 
used to investigate the impact of shear stress on the nanoparticle uptake properties. Under 
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dynamic cell culture conditions, a shear stress dependent increased uptake was observed, 
indicating a sufficient interaction of the nanoparticle with the cells. Furthermore, the 
nanoparticle uptake in primary endothelial cells is significantly influenced by physiological 
shear stress and differs to the tendencies obtained under static conditions. In the co-culture 
of macrophages and endothelial cells an increased uptake of the nanoparticles by 
macrophages compared to endothelial cells were observed. Additionally, at a shear stress of 
0.7 dyn cm-2 less pronounced differences between the dynamic co-cultivation and in vivo is 
observed in contrast to static conditions. Thus, shear stress represents a key-factor 
influencing nanoparticle uptake in general and might represent an important screening 
option for nanoparticle uptake and design.   
Altogether, polymer-based nanocarriers represent an ideal tool to deliver different 
therapeutics, like pDNA or drugs. The continuous development in polymer science, biology 
and medicine are the basis for the design of new delivery systems. Based on the delivered 
substrate, genes and drugs, different encapsulation strategies are applied and, as a 
consequence, resulting in different bottlenecks. In the case of gene delivery, the main 
bottleneck is the performance of polymer-based nanocarriers in vitro. In contrast to that, 
drug delivery via nanocarriers is beyond this in vitro restriction and shows limits in the 
transfer from in vitro to in vivo. This thesis presents insight in new promising gene delivery 
carriers based on cationic charged polymers as well as cationic charged spherical micelles. In 
addition, new possible drug delivery systems based on small micelles were presented. In the 
end the microfluidically-supported dynamic cell culture was demonstrated as a powerful 
technique to obtain more information about the behavior of nanoparticles under 
physiological relevant conditions. 
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7 Zusammenfassung 
Heutzutage stellt die Therapie genetisch bedingter Erkrankungen, wie beispielsweise 
zystische Fibrose, Parkinson oder Krebs, noch immer eine der größten Herausforderung der 
Medizin dar. Als Ursache gelten unter anderem die hohen Nebenwirkungen und die geringe 
Bioverfügbarkeit heutiger Arzneimittel. Neuartige Formulierungen auf Basis nanoskaliger 
Trägermaterialien sollen hier helfen, diese Nachteile zu reduzieren bzw. vollständig zu 
überwinden. Für die Trägermaterialien haben sich vor allem lipid- und polymerbasierte 
Systeme als vielversprechend herausgestellt. Polymere Systeme bieten zudem den Vorteil, 
dass ihre chemischen und physikalischen Eigenschaften, aufgrund ihrer vielen 
Variationsmöglichkeiten, an die aktuelle Problemstellung angepasst werden können. Neben 
dem Trägermaterial unterscheidet man derartige Systeme nach der Art, der zu 
transportierenden Substanz. Einerseits können genetische Strukturen, z.B. basierend auf 
Plasmid-Desoxyribonukleinsäure (pDNS) und andererseits Wirkstoffe, wie zum Beispiel 
Chemotherapeutika transportiert werden (Abbildung 7.1). Die zu transportierende Substanz 
ist hierbei der limitierende Faktor für die Anforderungen, die an das Trägermaterial und die 
entsprechenden Verkapselungsstrategien gestellt werden. Im Falle von pDNS, stellt die 
Bildung von Polymer-pDNS-Komplexen, sog. Polyplexe, die bisherige Grundlage für aktuelle 
Strategien dar. Diese Komplexbildung beruht auf den Wechselwirkungen zwischen den 
negativ geladenen Phosphatgruppen der pDNS und den positiven Ladungen des Polymers. 
Der bisher ausbleibende Erfolg derartiger Systeme in klinischen Studien zeigt allerdings die 
Notwendigkeit, die zugrunde liegenden Mechanismen, in vivo und in vitro, besser zu 
verstehen und aufzuklären. 
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Abbildung 7.1: Übersicht über die vorgestellten Polymer-basierten nanoskalierten Trägermaterialien für die 
potenzielle Anwendung von Gene-und Wirkstoff-Transport. 
Zur Zeit ist Poly(ethylenimin) (PEI), das am besten für solche Zwecke untersuchte Polymer, 
wodurch sein Potential als Trägermaterial detailliert charakterisiert ist. Vor allem die hohe 
Pufferkapazität, welche auf dem hohen Gehalt an Amino-Gruppen basiert, führt, im 
Vergleich zu anderen Polymeren, zu einer verbesserten Freisetzung aus dem Endosom. 
Jedoch zeigt PEI bei relevanten Konzentrationen zytotoxische Effekte, wodurch seine in vivo 
Anwendung stark einschränkt ist. Dies hat zur Folge, dass PEI oft als Baustein für neue 
Homo- oder Copolymere verwendet wird. So führt beispielsweise die Einführung von Poly(2-
oxazolin) (POx) zu einer Reduktion der Zytotoxizität, sowie zur Unterdrückung 
unspezifischer Proteininteraktionen. Die Transfektionseffizienz sinkt jedoch im gleichen Maß. 
Eine Möglichkeit, die Verringerung der Transfektionseffizienz zu umgehen, ist die 
Funktionalisierung mit hydrophoben Gruppen. Aus diesem Grund wurde eine 
Polymerbibliothek aus insgesamt 18 Copolymeren, bestehend aus Poly((2-methyl-2-
oxazolin)-co-(2-(3-butenyl)-2-oxazolin) (P(MeOx-co-ButEnOx)) und Poly((2-methyl-2-
oxazolin)-co-(2-(9-decenyl)-2-oxazolin) (P(MeOx-co-DecEnOx)) hergestellt. Dabei wurde 
der jeweils hydrophobe Anteil, variiert (ButEnOx bzw. DecEnOx je 10, 20, 30 und 
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40 mol%) und um eine effiziente Interaktion mit pDNS zu gewährleisten, wurden ButEnOx 
und DecEnOx mit primären oder tertiären Aminen (kationischer Charakter) funktionalisiert. 
Auf der Grundlage detaillierter Untersuchungen der einzelnen Transfektionsschritte, welche 
auch die Polyplexbildung, die Polyplexstabilität und die Zytotoxizität umfassten, konnte ein 
Polymer identifiziert werden, welches herausragende Transfektionseffizienzen zeigt. Auf 
diese Weise wurden Transfektionseffizienzen, vergleichbar zu PEI (lineares PEI DP = 200) 
erzielt, während zytotoxische Effekte ausblieben. Da Forschungen an solch einer 
Polymerbibliothek mit konventionellen Methoden sehr zeitaufwendig sind, wurde in der 
vorliegenden Arbeit ebenfalls ein passendes Hochdurchsatzverfahren (high-throughput 
approach) etabliert. 
Neben kationischen Polymeren eignen sich auch kationische Mizellen als Trägermaterial für 
pDNS. Vor allem sphärische Mizellen basierend auf dem Triblock Terpolymer Polybutadien-
block-poly(methacrylsäure)-block-poly(2-(dimethylamino)ethyl methacrylat) (BMAAD) 
wurden im Rahmen dieser Arbeit als ein vielversprechender Kandidat identifiziert. BMAAD 
bildet in wässriger Umgebung sphärische Mizellen mit einem Durchmesser von ca. 200 nm, 
wobei sich, bedingt durch die beiden Blocksegmente Poly(methacrylsäure) (PMAA) und 
Poly(2-(dimethylamino)ethyl methacrylat (PDMAEMA), pH-abhängige Variationen 
bezüglich Geometrie und Größe ergeben können. Bei einem neutralen pH Wert entsteht eine 
ungleichmäßige Oberfläche, welche intra-mizellare Interpolyelektrolytkomplexe (im-IPEC) 
enthält, welche in Gegenwart von Serumproteinen zu einer herausragenden Zellinteraktion 
und -aufnahme führen. Unter sauren Bedingungen dehnt sich der kationisch geladenen 
PDMAEMA-Block aus, was zu einer effizienten Freisetzung der Polyplexe aus dem Endsom 
führt. Weiterhin konnte in der vorliegenden Arbeit gezeigt werden, dass dieses System die 
einzelnen Hürden einer erfolgreichen Transfektion überwinden kann und sehr hohe 
Transfektionseffizienzen ohne zytotoxische Effekte erzielt. 
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Im Rahmen dieser Arbeit wurden neben Mizellen im oberen Bereich der Nanometerskala, 
auch deutlich kleinere Systeme als potentieller Wirkstoffträger untersucht (Durchmesser 
< 30 nm). Wie mehrfach gezeigt (Kapitel 4), spielt das Gleichgewicht der positiven und 
negativen Ladungen eine Schlüsselrolle zur Steuerung der Zellaufnahme und Zytotoxizität. 
Aus diesem Grund wurden sphärische Mizellen basierend auf Poly(ethylen oxid)-block-
poly(allyl glycidyl ether)-block-poly(tert-butyl glycidyl ether) (PEO-b-PAGE-b-PtBGE) 
hergestellt. Zusätzlich wurde der PAGE Block mit kationischen (Aminogruppen), 
anionischen (Carboxgruppen) oder zuckerbasierten (zur zielgerichteten Aufnahme, sog. 
„Targeting“) Gruppen funktionalisiert. Neben den Untersuchungen der klassischen Mizellen, 
welche aus jeweils einem Polymertyp bestehen, wurde durch Mischen der unterschiedlichen 
Polymertypen vor der Mizellbildung auch sog. Mix-Mizellen hergestellt. Dabei wurden binäre 
Mizellen (zwei unterschiedlichen Polymertypen) sowie ternäre Mizellen (drei 
unterschiedlichen Polymertypen) hergestellt und charakterisiert. Es konnte gezeigt werden, 
dass es durch eine entsprechende Justierung der Mischverhältnisse und damit der Ladungen 
in der Schale der Mizelle zu synergistischen Effekten in Bezug auf die Zellaufnahme und 
Zytotoxizität kommt. 
Eine weitere große Herausforderung für nanoskalige Trägermaterialien für den 
Wirkstofftransport stellt der Analogieschluss und der Wissenstransfer zwischen in vivo und 
in vitro Versuchen dar. Grundsätzlich ist es nicht möglich, auf Grundlage von statischen in 
vitro Ergebnissen eine Vorhersage über die Bioverteilung, die Interaktionen mit dem 
retikuloendothelialen System (RES) und dem Verhalten unter Flussbedingen zu treffen. Aus 
diesem Grund wurden Methacrylat-basierte Nanopartikel systematisch auf ihre Zellaufnahme 
unter statischen und dynamischen in vitro Bedingungen untersucht und mit deren in vivo 
Verhalten verglichen. Statische in vitro Experimente eigenen sich besonders für ein 
Screening der Zellaufnahme geeigneter Nanopartikel in Abhängigkeit von deren physikalisch-
chemischen Eigenschaften, der Anwesenheit bestimmter Serumproteine und der 
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Zytotoxizität. Im vorliegenden Fall konnte dabei unter anderem eine Ladungsabhängigkeit 
der Zellaufnahme beobachtet werden. Anschließend wurden diese Nanopartikel, im Hinblick 
auf Scherspannungs-abhängige Einflüsse, in der Mikrofluidik-unterstützten, dynamischen 
Zellkultur untersucht. Neben einer Scherspannungs-abhängigen Aufnahme, welche eine 
ausreichende Interaktion zwischen den Zellen und den Nanopartikeln wiederspiegelt, konnte 
in den Experimenten mit primären Endothelzellen unterschiedliche Aufnahmetendenzen 
zwischen den Nanopartikeln im Vergleich zu statischen Bedingungen festgestellt werden. In 
Co-Kulturexperimenten wurde eine erhöhte Aufnahme in Makrophagen festgestellt, welche 
einherging mit einer verringerten Aufnahme in den Endothelzellen. Makrophagen, vor allem 
Kupfferzellen, sind für die Beseitigung von Fremdkörpern und -partikeln in der Leber 
verantwortlich. Zudem stellte sich scherspannungs-abhängig nur ein gering ausgeprägter 
Unterschied in den Aufnahmetendenzen der Nanopartikel zu in vivo heraus, im Gegensatz zu 
dem statistisch System. Die Scherspannung stellt ein Schlüsselfaktor dar, der die Aufnahme 
von Nanopartikeln stark beeinflusst und somit als Screening Option für Nanopartikel Design 
herangezogen werden sollte. 
Zusammenfassend konnte im Rahmen dieser Arbeit gezeigt werden, das polymerbasierte, 
nanoskalige Trägermaterialien eine ideale Plattform für den Transport von unterschiedlichen 
Therapeutika, wie pDNS, bilden. Basierend auf der zu transportierenden Substanz müssen 
unterschiedliche Verkapselungsstrategien verfolgt und deren individuelle Hürden überwunden 
werden. Im Falle von pDNS sind die größten Herausforderungen derzeit in den 
Transfektionseffizienzen der Polymere in in vitro Versuchen zu finden. Wohingegen der 
Schwerpunkt bei verkapselten Wirkstoffen im limitierten Transfer der Ergebnisse zwischen in 
vitro und in vivo Experimenten liegt. 
In dieser Arbeit konnten neue Erkenntnisse in Bezug auf moderne, vielversprechende 
Transportsysteme basierend auf kationischen Polymeren und kationischen, sphärischen 
Mizellen gewonnen werden. Weiterhin wurden, basierend auf kleinen Mizellen, neue multi-
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komponenten Wirkstofftransportsysteme untersucht. Am Ende wurde die mikrofluidik-
unterstützte, dynamische Zellkultur als vielversprechende Technik aufgezeigt um mehr 
Informationen über das Verhalten von Nanopartikeln unter physiologisch relevanten 
Bedingung zu erlangen. 
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The influence of polymer architecture on in vitro
pDNA transfection
Alexandra C. Rinkenauer,ab Stephanie Schubert,bc Anja Traeger*ab and
Ulrich S. Schubert*ab
In 2012, the first gene therapy agent was approved by the Europe Medicines Agency leading to
increased interest in this research field. Beside viruses, non-viral agents based on lipids or polymers
represent aspiring alternatives to deliver the genetic material. Diﬀerent hurdles have to be overcome
depending on the kind of nucleic acid used, where plasmid DNA (pDNA) and small interfering RNA
represent the common ones. The main challenge for transfection agents, in particular for pDNA delivery,
is the transfer to the cell and into the cell nuclei. Within the group of transfection vesicles, cationic
polymers show promising features and variability, as they can be synthesized with tailor-made physical
and chemical properties (architectures and functionalisation). In the field of polymer-based gene
delivery, the tuning potential of polymers by using diﬀerent architectures like graft and star-shaped
polymers as well as self-assembled block copolymers is immense. In particular, in the last few years
numerous new polymer designs showed enhanced transfection properties in combination with good
biocompatibility. Furthermore, new insights into the transfection mechanism demonstrated the continuous
progress in this field. Polymer architecture influences the polyplex characteristics and the latter has an
impact on the transfection mechanism, e.g. the interaction with the cellular membrane depends on the
polyplex shape. Moreover, polyplex dissociation can be easily influenced by the polymer chemistry, thus
biodegradable linkers lead to well suited polymers with reduced toxicity and high delivery potential, and
are also promising for in vivo applications. This review focuses on the influence of polymer architectures
for pDNA transfection in vitro, showing recent developments and insights. The theoretical background
concerning the biological challenges for cationic polymers and the impact of graft- or star-shaped
architectures as well as self-assembled structures will be presented in detail.
1 Introduction
Nowadays, genetic disorder diseases like cystic fibrosis, Parkinson’s
disease or cancer1 can be treated only with low success rates. Since
1995, causal treatment on the genetic level has come into focus and
gene therapy has become a prominent matter of research.2,3
However, several drawbacks had to be overcome, for instance the
tragic history of young children, who developed leukemia as a
consequence of gene therapy.4 Themissing success of gene delivery
vesicles in clinical trials also supports the attitudes of gene therapy
criticism. However, in 2012 the first gene therapy agent was
approved by the Europe Medicines Agency, and a revival started.2,5
For gene therapy, twomain routes can be applied, namely viral and
non-viral delivery. Using viruses, very high eﬃciency can be
achieved due to their evolutionary development. However, besides
the risk of causing immune response after repeated administration
the limited DNA packing capacity has also to be taken into
consideration.4,6 Thus, non-viral delivery methods are promising
tools as alternative delivery vehicles to viruses. Herein, cationic
lipids or polymers can be applied in vitro but also in vivo. In the
field of gene delivery, diverse genetic materials are applied for
instance plasmid DNA (pDNA) or small interfering RNA (siRNA).
Besides physical diﬀerences such as size or flexibility, the site of
action in cells also diﬀers. In case of siRNA, down regulation of
proteins occurs on the mRNA level in the cytoplasm. pDNA delivery
results in protein production, starting with the transcription of the
pDNA in the cell nuclei. It should be noted that the large size of
pure pDNA (hydrodynamic diameter of 300 to 400 nm) and the
short half-life in the presence of serum proteins make it indis-
pensable to pack and protect pDNA in vesicles and particles.7,8
However, the main challenge is their delivery to the desired site of
action in vitro and in vivo. Cationic polymers show a high tuning
potential as they can be synthesized with varying physical and
a Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller
University Jena, Humboldtstrasse 10, 07743 Jena, Germany
b Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena,
Philosophenweg 7, 07743 Jena, Germany. E-mail: ulrich.schubert@uni-jena.de,
anja.traeger@uni-jena.de
c Institute of Pharmacy, Department of Pharmaceutical Technology, Friedrich
Schiller University Jena, Otto-Schott-Str. 41, 07745 Jena, Germany
Received 27th April 2015,
Accepted 22nd July 2015
DOI: 10.1039/c5tb00782h
www.rsc.org/MaterialsB
Journal of
Materials Chemistry B
REVIEW
Pu
bl
is
he
d
on
23
Ju
ly
20
15
D
ow
nl
oa
de
d
by
Th
ue
rin
ge
rU
ni
ve
rs
ita
ts
La
nd
es
bi
bl
io
th
ek
Je
na
on
21
/0
4/
20
16
09
:1
0:
52
View Article Online
View Journal  | View Issue
7478 | J. Mater. Chem. B, 2015, 3, 7477--7493 This journal is©The Royal Society of Chemistry 2015
chemical properties (functionalisation and architectures).6,9 In
particular cationic polymer systems like polyethylenimine (PEI),
poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) or poly-
(L-lysin) (PLL) are commonly used and well characterized con-
cerning their delivery potential. Herein, PEI represents the gold
standard for polymer based transfection agents in vitro, due to
high eﬃciency and commercial availability.10 Drawbacks like a
low transfection eﬃciency compared to viruses and a high
cytotoxicity restricted so far the in vivo application of cationic
polymers. Significant research on pDNA delivery was triggered
leading to numerous polymer modifications in the last few years.
For instance, functionalisation with biocompatible polymers like
poly(ethylene glycol) (PEG) reduces the cytotoxicity and unspecific
protein interactions.11,12 Nevertheless, this benefit of PEGylated
polymers includes a decreased eﬃciency.13,14 Therefore, the journey
of identifying the perfect polymer for pDNA delivery did not end.
The opportunities are manifold from the perspective of polymer
chemistry. Varying the chain length, composition, functionalisa-
tion, or architecture leads to diﬀerent properties and eﬃciencies.
For example, the eﬀect of the molar mass of the polymers was
investigated in detail and was presented as one main aspect of an
eﬃcient pDNA delivery but also cytotoxic properties.9,15,16 Beside,
it was elucidated that the polymer architecture has an important
impact. This may be one of the most promising opportunities to
design eﬃcient delivery polymers, as high eﬃciency is not always
linked with an increased cytotoxicity. Moreover, also viruses like
adenovirus (spherical shape) or ebola (worm like shape) represent
diﬀerent shapes.17,18 In particular in the last five years, architec-
tures like star-shaped polymers or filamentous micelles were
presented as eﬃcient pDNA delivery vehicles.19–21
This review addresses the influence of the molecular polymer
architectures as well as of self-assembled structures concerning
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pDNA transfection properties. More precisely, the recent achieve-
ments in in vitro transfection, utilizing the most important
synthetic polymer systems PEI, PLL and PDMAEMA of diﬀerent
architectures, will be highlighted. For this purpose, the theore-
tical background concerning the biological challenges for catio-
nic polymers and the diﬀerent possible polymer architectures as
well as self-assembled structures will be summarized. The main
characteristics of linear and branched systems will be only briefly
addressed as they were recently reviewed in detail elsewhere.22,23
The focus will be on graft and star-shaped as well as self-
assembled polymer systems as they have emerged as eﬃcient
delivery systems in the last few years.
1.1 Biological challenges for cationic polymers
Polymer science meets biology when discussing barriers that
have to be overcome for eﬃcient gene transfection. The major
obstacles of transfection polymers are eﬃciency and cytotoxi-
city. Unfortunately, the desired high eﬃciency is often com-
bined with a high cytotoxicity. In the last couple of decades,
scientists have been trying to overcome this paradigm. Never-
theless, a perfect polymer for in vivo gene therapy has yet to be
developed. The transfection process can be divided into several
steps starting from the formation of complexes of the positively
charged polymer and the negatively charged pDNA, named
polyplexes. The complexation is driven by the gain of entropy
due to the release of small counter ions from the pDNA and the
polymer.22,24 The balance between the polyplex stability under
physiological conditions and the release of the genetic material
for the transcription mechanism has to be found.25 After
polyplex formation, cellular interaction followed by internalisa-
tion takes place, mainly via endocytosis.26 Due to the negatively
charged cell membrane, the interaction and internalisation
with cationically charged polymer or polyplexes is enhanced.
However, the cationic polymer can also induce membrane
destabilisation resulting in membrane destructive eﬀects and,
thus a high cytotoxicity.15,27 Up to now, the mechanisms relying
on endocytosis are not yet understood in detail. There are
basically phagocytosis, clathrin- and caveolin-mediated endo-
cytosis as well as macropinocytosis. Concerning the inter-
nalisation of polyplexes, diﬀerent uptake mechanisms and
intracellular traﬃcking dependent on the polymer class and
architecture were observed.28 For example, PEI polyplexes show
caveolin- and clathrin-mediated endocytosis.29 After eﬃcient
internalisation via endocytosis, the polyplexes have to escape
from the endosome to prevent digestion of the pDNA in the
lysosome or exocytosis.30 Due to the high buﬀer capacity of PEI,
the influx of protons and chloride ions lead to an osmotic
swelling of the endosome and disruption of the endosomal
membrane, the so called proton sponge eﬀect.31–33 In the last
few years, it was found that the proton-sponge effect is not the
only reason for the endosomal release of the polyplexes.34 A
combination of swelling and local mechanical disruption is
assumed.35 Released in the cytoplasm, the pDNA has to enter
the cell nuclei for the transcription mechanism and efficient
protein production. The mechanism of polyplex dissociation
and in particular how the pDNA enters the cell nuclei is only
barely investigated to date.36 There are hints that polyplex dis-
sociation occurs at the same time as the endosomal release35 but
polyplexes were also detected in the nuclei.37 An increased
transfection efficiency in cells with a high division rate was
observed, confirming the entry of pDNA into the nuclei during
mitosis.38 Due to the breakdown of the nuclear envelope, the
pDNA can enter the transcription mechanism more easily. How-
ever, it was also shown that the entry can occur through nuclear
pores.39 The introduction of a nuclear localisation sequence was
also presented as a possible route to enhance the active transport
of genetic materials into the nuclei.40
Since the first polymers were used as transfection agents, a
large number of studies were performed to understand the
relying mechanism, successful for most of the steps. Diﬀerent
strategies were developed to overcome the transfection barriers
(Fig. 1). For example the pKa value is one characteristic of
cationic polymers responsible for the degree of protonation
and, thus, influencing the complexation behavior as well as the
endosomal escape.41 Fig. 1 depicts an overview of general polymer
properties showing an influence on themain characteristics of the
polymer vectors. However, a number of questions need to be
solved. For this purpose studies have to be performed in detail to
adjust the ideal polymer properties.
1.2 Polymer architecture
The use of controlled and living polymerisation techniques like
reversible addition-fragmentation chain transfer (RAFT) polymer-
isation, atom-transfer radical polymerisation (ATRP), cationic ring
opening polymerisation (CROP) or living anionic polymerisation
enable the synthesis of polymers in a controlled manner. More
precisely, tailor-made polymers with defined chain length
(characterized by the degree of polymerisation (DP)), composi-
tion, and architecture can be realized. A detailed overview
about the synthesis strategy of polymers for gene delivery
concerning their architecture was recently published.42 In general,
polymers can be classified by their composition and topology.
Polymer compositions, meaning the order of repeating units,
include homopolymers and statistical, gradient-, periodic-, and
block copolymers (Fig. 2).43,44 In contrast to homopolymers,
copolymers contain at least two diﬀerent monomers with the
advantage of combining diﬀerent monomer properties in one
polymer chain. For instance, cationic units, which are necessary
for the pDNA complexation, can be combined with hydrophobic
units that can be responsible for an enhanced internalisation.45,46
Hydrophilic monomers like ethylene glycol or ethyl oxazolines can
be used to introduce the so-called stealth eﬀect and to reduce
cytotoxicity.47 In contrast to statistical copolymers, block
copolymers are built up by at least two diﬀerent block segments.
Regarding the polymer topology, a distinction is drawn between
linear, branched, graft (comb and brushes), and star-shaped
polymers (Fig. 2). Branched polymers, like branched PEI (bPEI)
or dendrimers, are composed of polymer chains with at least two
branching points. These specific end-groups can be used for
multiple end-functionalisation. Graft polymers, or more speci-
fied, comb- or brush-like polymers, comprise of several block
segments that were grafted through, onto or from a main chain,
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the backbone. Comb- or brush-like polymers are often used to
mimic a branched character but are formed of low molar mass
segments.
Star-shaped polymers are formed by several linear chains
(arms), which are attached to a central core.43 In case of the
arm-first approach, the linear polymer chains are synthesized
first and then attached to the core. In the core-first method, the
arm chains are synthesized from initiation sites at the core.42
A third approach represents the utilisation of conjugation/
coupling reactions with multifunctional coupling agents as
cores.19,48 As branching points multifunctional cores or cross-
linking agents like ethylene glycol dimethacrylate (EGDMA) can
be used. Star-shaped polymers based on a crosslinking agent
rather present a star-like structure, and the characterisation of
them is more diﬃcult.19 There are several possibilities to
prepare star-shaped polymers. An overview of possible cores
used for star-shaped polymers for pDNA delivery is presented in
Table 1. It should be noted that one benefit of star-shaped
polymers is the utilisation of multifunctional cores, which
reveals a stimuli-response behaviour. For instance, porphyrin
exhibits photosensitizer abilities; more precisely the absorption
of light leads to chemical or physical changes and can induce
cytotoxicity due to membrane disruption. This characteristic of
porphyrin is often used in photodynamic therapy for the
treatment of cancer.49 Furthermore, a photochemical inter-
nalisation (PCI) can be realized for example by a porphyrin core,
Fig. 2 Possible polymer architectures and self-assembled systems: polymer composition (left), topology (middle), and self-assembled structures (right).
Fig. 1 Overview of the set screws of selected polymer properties for an eﬃcient pDNA delivery.
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meaning an increased release behaviour from endosome/
lysosome into the cytoplasm.49,50 PCI is already successfully
applied in clinical studies phase II for drug delivery in combi-
nation with bleomycin (anticancer agent).51 Cyclodextrin-based
systems are often applied due to the biodegradability and reduced
cytotoxic eﬀects. In addition, a co-delivery of pDNA and drugs can
be realized due to the hydrophobic cavity.52,53
Furthermore, block copolymers can form self-assembled
structures in solution, meaning the arrangement into highly
ordered structures by non-covalent interactions. For instance,
spherical or worm-like micelles and vesicular structures can be
realized (Fig. 2). In particular, block copolymers with hydro-
phobic and hydrophilic segments are capable to self-assemble,
due to their amphiphilic character.43 The principles responsible for
the mechanism of self-assembly depend on several factors starting
from the used solvents to the block ratios.72 Concerning biological
applications, one crucial factor is the critical micelle concentration
(cmc), meaning the concentration at which the polymers dis-
assemble. For pDNA delivery often very low concentrations are
applied, in particular with respect to in vivo applications, where
high dilution occurs in the bloodstream post administration.
Crosslinking of the micellar core can stabilize the structures.20
2 Linear polymers
Linear polymers, classified into homopolymers, statistical,
random, gradient and block copolymers (polymer composition)
represent the most commonly used polymer-based non-viral
gene delivery agents with a high annual number of publications
and clinical trials. In particular, PLL, linear PEI (lPEI), and
PDMAEMA were often applied as homopolymers for the delivery
of pDNA, as already investigated and reviewed in detail in the last
few years.22,23,73–75 Fig. 3 depicts the chemical structures of
several linear cationic polymers, which are used for gene delivery.
PLL is a cationic polymer based on the biodegradable natural
compound L-lysine and can be synthesized in a controlled
manner via ring-opening polymerisation. A molar mass of
3000 Da is at least necessary for an efficient polyplex formation.1
However, 20 kDa PLL shows higher transfection efficiency but
also significant cytotoxic effects compared to lowmolar mass PLL
(PLL 36 kDa, IC50 = 38 mg mL
1).27 The high cytotoxicity is
probably caused by the disruption of the cell membrane, which
leads to apoptotic cell death.27,76 PLL has only primary amines
(pKa of e-amine in lysine is around 10.8),
75 which are mostly
protonated at physiological pH values leading to a low buffer
capacity, maybe resulting in an inefficient endosomal release.23
In contrast to PLL, linear PEI(lPEI) comprises of mainly secondary
amines. The synthesis of lPEI can be realized via hydrolysis of
poly(2-ethyl-2-oxazoline) (PEtOx), which can be obtained via
CROP. The unique feature of lPEI is a pKa of 8.44 and the high
amine density; every third atom in the polymer chain can be
protonated leading to a high buffer capacity.77 In fact, more
than 70% of the amine residues of lPEI are protonated at
physiological pH values.78 Beside the high transfection effi-
ciency, lPEI also shows cytotoxic effects (lPEI 22 kDa IC50 =
6.4 mg mL1)79 due to membrane destabilisation.41 Another
commonly used linear polymer system is PDMAEMA, a cationic
methacrylate. PDMAEMA can be synthesized by free radical
polymerisation as well as by ATRP, RAFT, and anionic poly-
merisation. To achieve acceptable transfection efficiencies
molar masses of around 30 kDa are necessary.1 In contrast to
PLL or lPEI, PDMAEMA contains only tertiary amines (pKa = 7.5)
with adequate buffer capacity.41,74 Nevertheless, also PDMAEMA
shows cytotoxic effects (PDMAEMA 112 kDa, IC50 = 10 mg mL
1).80
Based on the studies of the homopolymers PLL,76 PEI81 and
PDMAEMA,15,62 it generally can be assumed that with increas-
ing molar mass the transfection eﬃciency and cytotoxicity both
increase at the same time. For instance, low molar mass
polymers (o5 kDa) are insuﬃcient in polyplex formation/
stability and high molar mass polymers (Z10 kDa) can show
significant cytotoxic eﬀects.81
Table 1 Selected cores for the synthesis of star polymers with regard to the polymer class, number of arms, polymerisation techniques and
polymerisation strategy
Cores Cationic polymers Number of arms Polymerisation technique Polymerisation strategy Ref.
PEG PEI 3 to 6 Coupling reaction Arm-first 54 and 55
PEG–PCL PEI 5 Coupling reaction Arm-first 56
Porphyrin PLL 4 Coupling reaction Arm-first 50 and 57
Cyclodextrin PLL 7 Coupling reaction Arm-first 52
PPI dendrimer (G2-5) PLL 8 to 64 ROP Core-first 58
POSS PDMAEMA 8 ATRP Core-first 59
Silica nanoparticle PDMAEMA 20 ATRP Core-first 60
Cyclodextrin PDMAEMA 4, 7, 14, 21 ATRP Core-first 61
Glucose PDMAEMA 3 ATRP Core-first 62
Saccharose PDMAEMA 5 ATRP Core-first 62
Cyclodextrin PAMAM 7 Coupling reaction Arm-first 63 and 64
Cyclodextrin PGEA 4 ATRP Core-first 65
Crosslinking substances
EGDMA PDMAEMA — GTP/ATRP Arm-first 66–69
Glutharaldehyde PLL — ROP Arm-first 70
BAC PDMAEMA — ATRP Arm-first 71
PCL – poly(caprolactone), PPI – poly(propylenimine), POSS – poly(hedral oligomeric silesquioxane); PGEA – ethanolamine functionalised
poly(glycidyl methacrylate), GTP – group transfer polymerisation; ROP – ring opening polymerisation; BAC – N,N-bis(acryloyl cystamine).
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The use of copolymers can therefore be beneficial in order to
tune the polymer characteristics to high transfection rates with
low cytotoxicity issues. For instance, an increased polyplex
stability of methacrylate-based polymers can be achieved by
using tertiary and primary amines in the same polymer chain.82
This was realized by the synthesis of poly(2-(dimethylamino)-
ethyl methacrylate-stat-aminoethyl methacrylate) (PDMAEMA-
stat-PAEMA). Increased pDNA condensation combined with
increased transfection eﬃciency was observed. These eﬀects
can be attributed to the higher charge density of the primary
amines at physiological pH values.82 Furthermore, the copoly-
merisation with 2-hydroxyethyl methacrylate (HEMA), which
has hydrophobic properties, leads to an increased internalisation
eﬃciency and endosomal escape, resulting in enhanced trans-
fection eﬃciency.83 Another example is partially hydrolysed
PEtOx and the influence on the transfection eﬃciency com-
pared to lPEI. In this study, diﬀerent degrees of hydrolysation
were analysed. In contrast to the 70% hydrolysed PEtOx, the
50% hydrolysed PEtOx shows no cytotoxicity but also no
transfection eﬃciency.84 To sum up, statistical copolymers
are suitable for analysing the influence of diﬀerent monomer
properties like hydrophobicity or amine type as well as
biocompatibility.
Block copolymers have the advantages of a defined structure
in block segments compared to statistical polymers. A frequently
used approach is the combination of a PEG block and a cationic
block, resulting in reduced cytotoxicity and stealth behaviour.
But this combination also often leads to a decreased transfection
eﬃciency, probably due to decreased cell interactions.7,85 How-
ever, this can be also used to prevent non-specific interactions
and allow specific internalisation due to targeting moieties at the
same time, in particular in vivo.86 To avoid serum interactions,
the utilisation of zwitterionic units represents an alternative to
PEG. A block copolymer comprising of PDMAEMA-b-PMPDSAH
(poly-(N(3-(methacryloylamino)propyl)-N,N-dimethyl-N-(3-sulfo-
propyl)ammonium hydroxide)) shows decreased cytotoxicity
and increased transfection eﬃciency in the presence of serum
proteins. The reduced cytotoxicity compared to the PDMAEMA
homopolymer can be attributed to a lower amount of cationic
charges per polymer at the same concentration.87 Another
example uses a decreased charge density while achieving
eﬃcient transfection and low cytotoxicity, also in vivo, by using
Fig. 3 Schematic representation of chemical structures of selected cationic polymers used for non-viral gene delivery. PAsp(DET) – poly(N-(N-(2-
aminoethyl)-2-aminoethyl)aspartamide), PAMAM – poly(amidoamine).
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hydrophobic units.88 The benefit of reducing the cationic
charge was further demonstrated by decationisation of the
polymer after polyplex formation while preserving the polyplex
stability by crosslinking of the polyplexes via disulfide bonds.89
A recent study deals with block copolymers versus statistical
copolymers with the same composition (PDMAEMA-co-PAEMA).
They showed that diblock copolymers form polyplexes with a
higher colloidal stability compared to statistical ones.90 This can
be attributed to a more likely condensed pDNA in the core of the
polyplex. In contrast, more looser complexation occurs with the
statistical counterpart. In addition, block copolymers are able to
self-assemble into spherical or worm-like micellar structures.
These properties will be discussed in detail in Section 6.
3 Branched polymers
Similar to the linear topology also branched polymers represent
a large group of polymer systems used and investigated for
pDNA delivery. Herein, the main investigations were performed
with dendrimers like poly(amidoamine) (PAMAM) and bPEI
(Fig. 3). In contrast to dendrimers like PAMAM, branched
polymers like bPEI possess a broad molar mass distribution
(Ð) and a randomly branched architecture. However, they are
easy to synthesize in large scale, also in a one-step process.91
bPEI is synthesized via acid-catalyzed ring-opening polymer-
isation of aziridine and contains primary, secondary and tertiary
amines in a 1 : 2 : 1 ratio independent of its molar mass.41,92 With
regard to its transfection eﬃciency, high eﬃciency is again
accompanied by high cytotoxicity for 25 kDa bPEI (IC50 =
4.9 mg mL1).79 The high delivery eﬃciency of bPEI can be
attributed to a high buﬀer capacity of the secondary and tertiary
amines as well as to a good ability to complex pDNA, as primary
amines condense nucleic acids in a more eﬃcient way than
other amines.93 Numerous eﬀorts were performed regarding the
decrease of the cytotoxic eﬀects via modification of bPEI.93 For
instance, the inability of low molar mass bPEI (1.8 kDa) to form
stable complexes with pDNA was solved by modifications with
hydrophobic groups.94 Another study presents 25 kDa bPEI
functionalized with PMPC (poly(2-methacryloyloxethyl phos-
phorylcholine)), leading to reduced non-specific protein inter-
actions, increased transfection eﬃciency and reduced cytotoxicity
due to the zwitterionic character.95 Very recently, biodegradable,
branched PDMAEMA polymers were presented and the influence
of the degree of branching was examined. Copolymerisation of
DMAEMA and BADS (bis(2-acryloyl)oxyethyl disulfide) leads to
biodegradation into short primary-chain molecules. Beside a
decreased cytotoxicity also an enhanced transfection eﬃciency
was observed using polymers with a higher degree of branching.96
Dendrimers are perfectly branched polymers with a specific
tree-like structure and monodispersity (Ð = 1.0).22,97 In the
convergent way they are engineered stepwise in generations,
meaning the branching is constructed by ‘‘single layers’’. Based on
this unique structure, high numbers of generations are hard to
synthesize due to sterical hindrance. A high number of generations
decreases the flexibility unfavourable for pDNA condensation.
The most commonly used dendrimer families for pDNA delivery
are PAMAM and poly(propylenimine) (PPI).97 In the case of
PAMAM, the primary amines at the surface lead to a high ability
of pDNA condensation, and the tertiary amines in the interior
are responsible for good buﬀer capacity.98 PAMAM dendrimers
with generations of 5 to 10 show the best transfection eﬃ-
ciency.99 One interesting feature of PAMAM dendrimers is the
generation or expansion of holes in cell membranes. In the case
of PAMAM dendrimers of the 7th generation, hole formation in
the cell membrane of around 15 to 40 nm diameter was detected.
In contrast, PAMAM dendrimers of the 5th generation lead to
expansion of existing holes.100 Furthermore, the multivalent
properties due to the high degree of surface functionalities was
investigated in detail, in particular with PAMAM dendrimers of
the 5th generation.101 It is interesting to know that degraded
dendrimers with an imperfect shape show a higher transfection
eﬃciency.102 A comparative study investigated the diﬀerences
between linear, hyperbranched and dendritic PLL concerning
their transfection potential. Herein, the most promising archi-
tecture concerning the transfection eﬃciency was the hyper-
branched structure, as a transfection eﬃciency comparable to
lPEI was achieved. With regard to cytotoxicity, the linear polymer
shows less cytotoxic eﬀects compared to the branched systems.103
Based on the results, the higher delivery potential can be attrib-
uted to an increased adhesion of the hyperbranched polyplexes at
the cell surface and also an increased buﬀer capacity. This can be
ascribed to the fact that the hyperbranched polymers contain
e- and a-amino groups in contrast to the linear or dendritic PLL
with only e- or a-amino groups.91
4 Graft polymers
The main motivation for synthesizing graft, comb- or brush-
like polymers is the imitation of the beneficial properties of
branched polymers by using low molar mass segments as linear
side chains (Fig. 4). Moreover, it is possible to synthesize graft
polymers in a controlled manner, meaning that the polymers
show a narrow molar mass distribution.104 An overview of the
applied polymers or oligoamines used as the backbone or as
side chains is depicted in Fig. 4. One of the first examples
imitating degradable high molar mass polymers was demon-
strated by W. E. Hennink and his group, using a PHEMA
backbone (DP B 110) grafted with low molar mass PDMAEMA
(DP B 50). Higher transfection eﬃciencies and reduced cyto-
toxicities compared to PEI or linear PDMAEMA were achieved.
The comb copolymers have carbonate esters as biodegradable
linkers at the branching points, thus PDMAEMA side chains
can be slowly cleaved oﬀ under physiological conditions.105
Another example for PDMAEMA-based comb-like polymers con-
sists of a ethanolamine/cystamine-functionalised poly(glycidyl
methacrylate) backbone, at which PDMAEMA side chains of
diﬀerent DP values (14 to 57) are linked by disulfide bonds. Higher
transfection eﬃciency and lower cytotoxicity values compared to
PEI were observed also in this case. In addition, the known trend
regarding the molar mass was observed: with increasing DP of the
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PDMAEMA side chains, transfection eﬃciency and cytotoxicity
increased. However, it should be noted that lower cytotoxicity
was obtained compared to 25 kDa bPEI although the molar mass
increased to 78 kDa. The usage of disulfide bonds enables an
increased polyplex dissociation under reducing conditions.106
Another study investigated PDMAEMA of diﬀerent DPs linked
via disulfide bonds to dextran as the main chain. Here, higher
DP values (12 to 42) lead to an increased cytotoxicity, but the
introduction of poly(ethylene glycol)ethyl ether methacrylate
(PEGEEMA) segments at the end of the PDMAEMA side chains
reduced the cytotoxicity and increased the transfection eﬃciency
compared to PEI.107 Beside PDMAEMA, also PEI was used to create
comb-like polymers, which showed higher transfection eﬃciencies
or at least less cytotoxicity than highmolar mass PEI. Furthermore,
a poly(glycidyl methacrylate) (P(GMA)) backbone was synthesised
with varying DP (50 and 100) and functionalised with diﬀerent
oligoamines, tetraethylenepentamine (TEPA), pentaethylene-
hexamine (PEHA) and tris(2-aminoethylamine) (TREN) (Fig. 4).
The polymer with a shorter backbone (DP 50) and TEPA and
PEHA (carrying primary and secondary amines) in the side chain
shows comparable transfection eﬃciencies like PEI with reduced
cytotoxicity. This study demonstrates the important relationship
of complexation and disassembly. In particular the TREN (primary
and tertiary amines) functionalised polymer shows the most
eﬃcient binding, probably leading to an insuﬃcient polyplex
dissociation.108 Using another backbone, polyaspartamide (PASP),
and diﬀerent oligoamines as side chains, reduced cytotoxicity and
similar transfection eﬃciencies were obtained compared to PEI.109
An impressive example of using low molar mass bPEI (800 Da) in
the side chain was demonstrated with a poly(styrene-co-maleic
anhydride) backbone. A twofold transfection eﬃciency of the gold
standard bPEI was achieved. bPEI of 800 Da is usually not able to
condense pDNA, but the comb like polymers (23.6 kDa) show a
high transfection eﬃciency combined with a reduced cytotoxicity.
These investigations demonstrate the successful mimic of high
molar mass bPEI. The amphiphilic character of the polymer is
probably also beneficial because the enhanced transfection eﬃ-
ciency can be related to an increased internalisation eﬃciency.110
Another example confirming the benefit of comb-like architectures
is a PHEMA-g-(PEI-b-PEG) polymer. An increased internalisation,
reduced cytotoxicity and comparable or even higher transfection
eﬃciency compared to PEI were observed depending on the cell
type.111 A diﬀerent polymer class, namely PLL, was used to
synthesise a comb-like polymer. In this study PLL was used as
a backbone substituted with histidine residues in order to
circumvent the low buﬀer capacity of PLL, by the introduction
of histidine. The authors showed an increased transfection
eﬃciency with reduced cytotoxicity compared to the PLL homo-
polymers.112 Also, diﬀerent oligoaminoethanes were coupled to
a PLL backbone. The benefit of comb-like architecture could be
demonstrated again, as the comb-shaped polymers were inter-
nalised in a more eﬃcient way than their linear counterpart.
Moreover, the so-called even–odd effect was observed.113 To
introduce stealth behaviour, a PLL backbone was function-
alised with poly(2-methyl-2-oxazoline) (PMOXA) with different
grafting density. Only polymers with a low grafting density
(10%) show higher transfection efficiency than the homo-
polymer PLL. In the case of higher grafting density, the trans-
fection efficiency is decreased, which can be attributed to the
stealth effect. Nevertheless, by adjusting favourable conditions
the polyplex stability can be enhanced for an increased trans-
fection efficiency.114
In order to investigate the influence of the polyplex shape
on the transfection eﬃciency, PHEMA150-co-PLL comb-like
polymers were applied. The utilisation of two polymers with
the same composition and molar mass but diﬀerent side chain
length (DP of 10 or 15) leads to diﬀerent polyplex structures. Short
side chains result in rectangular particles (B25 byB74 nm), and
higher DP leads to longer, rod-like (width of B18 nm, length of
B102 nm), toroid, and twisted structures. A decreased inter-
nalisation eﬃciency and endosomal/lysosomal accumulation
as well as a delayed nuclear delivery could be observed for the
Fig. 4 Schematic representation of selected polymers used for the preparation of comb- and brush-like polymers.
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longer rod-like particles. However, the uptake mechanism,
intracellular traﬃcking, or the decomplexation behaviour of
the two polymers is similar, indicating the internalisation
eﬃciency as a critical factor.115,116
All together, one advantage of graft polymers is the easy
introduction of biodegradable properties. On the one hand
biodegradable or compatible backbones can be applied or on
the other hand low molar mass side chains can be connected to
the backbone via degradable linkers.117,118 This degradation
into low molar mass segments reduces the cytotoxicity and
enhances the polyplex dissociation and is, therefore, beneficial
to overcome these two barriers for eﬃcient transfection. With
regard to the main characteristics of comb-like polymers, three
principles can be pointed out:
(i) If backbones with high DPs (4100 DP) are applied, it is
beneficial to connect the side chains via degradable linkers, in
order to enhance the intracellular polyplex dissociation;
(ii) if short backbones (o50 DP) are applied the length of the
side chains and the type of amines have to be adjusted to
achieve an eﬃcient polyplex formation; and
(iii) relatively low DPs of the side chain are beneficial
(DP between 10 and 50), to maintain a low cytotoxicity.
These principles are somewhat limited in their implementa-
tion as always three variables have to be considered: the length
of the backbone, the length of the side chains, and monomer
characteristics.98 In case of the overall molar mass, the optimum
seems to be between 25 and 50 kDa, but these values have to be
handled with care due to mentioned variables. Graft polymers
are very promising candidates as gene delivery agents due to the
fact that higher transfection eﬃciency and lower cytotoxicity
compared to the current gold standard PEI can be obtained.
5 Star-shaped polymers
About one decade ago the first star-shaped polymer was inves-
tigated with pDNA transfection eﬃciency ability.66 The idea was
to transfer and improve the preferred properties of dendritic
and branched polymers to star-shaped polymers for trans-
fection. In contrast to dendritic structures, star-shaped polymers
show a higher flexibility, which may result in better pDNA
complexation properties.42,59 In addition, star-shaped polymers
are suitable for the introduction of targeting units via diverse end
functionalities. There are multitude studies about PDMAEMA-
based stars. PDMAEMA can be synthesized via controlled radical
polymerisation techniques like RAFT and ATRP, which show a
higher tolerance against functional groups. In particular, T. K.
Georgiou demonstrated the benefit of PDMAEMA stars as trans-
fection agents. By using EGDMA as a bifunctional coupling agent,
a star-like polymer comprising diﬀerent PDMAEMA chain lengths
(DP 10 to 100) was developed for performing GTP.66 In addition,
star-like polymers consisting of PDMAEMA-co-PMAA68 and poly-
(2-(dimethylamino)ethyl methacrylate)-co-hexa(ethylene glycol)-
methacrylate (PDMAEMA-co-HEGMA)67 were investigated concerning
their transfection eﬃciency. Regarding the PDMAEMA homo-
polymer an increase of DP leads to an increased cytotoxicity.66
The introduction of PMAA and HEGMA showed a decrease of
cytotoxicity while maintaining the transfection eﬃciency. In
addition, the position of either PMAA or HEGMA in the
PDMAEMA based block copolymers was varied, resulting in
diﬀerent performance. In the case of PDMAEMA-b-PMAA star-
like polymers, higher transfection eﬃciencies were obtained in
which PMAA is located in the exterior. In contrast, higher
transfection eﬃciency of PDMAEMA-b-HEGMA star-like poly-
mers was achieved with HEGMA in the interior of the star.
Additionally, a trend of an increased cytotoxicity combined with
longer arm length of PDMAEMA was found, this was further
confirmed by the group of A. H. E. Mu¨ller. In one approach, star-
shaped polymers comprising of a glucose or a saccharose core
functionalised with diﬀerent PDMAEMA arm lengths were inves-
tigated. The number of arms as well as the arm length were
varied. Interestingly, less cytotoxicity of the star-shaped polymers
with the same molar mass but a higher amount of arms was
found.62 The influence of molar mass, arm length and number
of arms was further investigated utilising a cyclodextrin core.
On one hand, a higher cytotoxicity was observed when keeping
the arm length constant and increasing the number of arms
(4, 7, 14, 21), thus, also increasing the molar mass. On the other
hand, a decrease in cytotoxicity was observed when keeping the
molar mass constant and increasing the number of arms while
decreasing the arm length (23, 34, 70, 140 DP).61 A star-shaped
polymer comprising of a silsesquioxane core and 20 PDMAEMA
arms with a DP of 230 was synthesised showing superior
transfection eﬃciency even in hard-to-transfect Jurkat T-cells
and primary T-lymphocytes.60 Star-shaped polymers provide a
good opportunity to introduce biodegradable bonds. Their
advantage regarding the cytotoxicity and the polyplex dissocia-
tion was demonstrated by using a POSS(SS-PDMAEMA15–24)8
star. The star-shaped polymer without disulfide bonds showed
a reduced transfection efficiency compared to the polymer
containing disulfide bonds, with transfection efficiencies higher
than PEI.59 The POSS core further allows the loading with drugs
like paclitaxel.119 Another approach for the construction of star-
shaped polymers is based on cyclodextrin (CD) cores. Here, the
hydroxyl groups can be modified to be used as initiators for
ATRP.120 The advantage of using cyclodextrin is the cub-shaped
structure with a hydrophilic exterior and a hydrophobic interior.
Moreover, the bioavailability is improved due to enhanced cell
membrane adsorption.53 By using ß-CD as a core, a 4-arm
star was synthesized with either PDMAEMA homopolymers or
PDMAEMA-b-PEGEEMA copolymers. The homo-star polymers
show transfection efficiencies like PEI, however, the block
copolymers result in superior transfection efficiencies, although
PEGEEMA is known to reduce cell interactions.121 Grafting of
four PDMAEMA (DP 20, 30, 40) chains from a ß-CD core via
disulfide bonds results in a bioreducible behaviour. Moreover,
the star-shaped polymer with the highest DP showed the highest
transfection efficiency even higher compared to PEI. Adamantane
end-functionalised PEGEEMA was assembled to the CD core,
resulting in higher transfection efficiency and lower cytotoxicity.
The increased efficiency can be attributed to a higher stability
against serum proteins leading to an enhanced internalisation.53
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PDMAEMA can also be used as a core, as shown for PDMAEMA
crosslinked with EGDMA and PEG as a shell. An increased
transfection efficiency was demonstrated combined with a
reduced cytotoxicity.69
Another example of a biodegradable star-like polymer is
based on a mPEG-SS-PLL15 block copolymer crosslinked with
glutaraldehyde. The star-like architecture results in eﬃcient
pDNA condensation and an enhanced buﬀer capacity, in con-
trast to the corresponding linear block copolymers. Moreover,
the degradable disulfide bonds enhance the polyplex dissocia-
tion in the cytoplasm.70 A star-shaped polymer based on a
porphyrin core with four PLL dendron (G3) arms shows an
enhanced transfection eﬃciency after irradiation due to the
photochemical internalisation behaviour of a porphyrin core.50
In another approach, a star-shaped polymer was constructed by
using a PPI dendrimer of diﬀerent generations (G2-5) as a core,
with diﬀerent amounts of PLL40 arms. This study demonstrates
the benefit of high charge density per molecule: the star-shaped
polymers with a high generation in the core showed an
increased ability for pDNA complexation as well as a higher
transfection eﬃciency compared to PLL. The spherical shape
is also beneficial for internalisation of the polyplexes.58 The
driving force for PEI-based star-shaped polymers can be
realized by using a multifunctional PEG core and low molar
mass PEI as arms. An example was already demonstrated by the
group of T. Kissel in 2002 wherein multi-stars (4- and 8-arm)
composed of a PEG core and bPEI with diﬀerent molar masses
(600 and 800 Da) were synthesized.54 In contrast to the single
linear homopolymers, the star-shaped polymers are able to
condense the pDNA into polyplexes with sizes between 100
and 200 nm. Unfortunately, there are no data available con-
cerning their cytotoxicity and transfection eﬃciency. In another
study, star-shaped polymers were synthesized with a multi-arm
PEG core and 3 as well as 6 arms of 2500 Da lPEI. In particular,
the 6-arm star with a total molar mass of 25 kDa showed
comparable or even higher transfection eﬃciencies combined
with lower cytotoxicity values compared to the 25 kDa lPEI.55
Another example for mimicking high molar mass PEI by
utilizing the low molar mass one was realized by Ladewig
et al. using a PEG or PEG–PCL core and lPEI arms. A decreased
cytotoxicity while maintaining the transfection efficiency was
demonstrated.56 In the case of PAMAM dendrimers, a star-shaped
architecture was synthesized using a ß-CD core functionalized with
7 PAMAM (G = 4) arms. Due to the higher flexibility as compared
to dendrimers of higher generations, a twofold transfection
efficiency and a reduced cytotoxicity was achieved.63,64
As a summary it can be said that transferring the branched
structure to star-shaped polymers can result in promising
transfection properties while the cytotoxicity can be reduced
and the transfection eﬃciency can be maintained or even
increased. This behaviour can be attributed to a superior pDNA
condensation, resulting in spherical polyplexes, where the
pDNA is located in the polyplex core ensuring an eﬃcient
protection against enzymatical degradation.19,58 Such spherical
structures are beneficial for the internalisation eﬃciency. An
increased buﬀer capacity and charge density can be realized
due to the star-shaped architecture in case of PLL-shaped
stars.50,58 The introduction of bioreducible linkers like disulfide
bonds results in a lower cytotoxicity and a higher transfection
eﬃciency.65 The decreased intracellular compatibility of the
polymers results from degraded low molar mass segments with
reduced cytotoxicity. Another advantage of degradable linkers is
the enhanced polyplex dissociation in the cytoplasm. Concern-
ing the molar mass, a trend can be observed as already known
for linear polymers: with increasing molar mass the cytotoxicity
increases.19 Nevertheless, these aspects have to be handled with
care as cytotoxicity and transfection eﬃciency depends on the
number of arms and the arm length.19 It is advantageous to use
few arms, e.g., 4 and low DP values (B40 to 50 DP) or many arms
(20 or higher) with higher DP values (around 200). The final
optimal molar masses are between 50 and 100 kDa.19 Keeping
the in vivo application in mind, the strategy of using less arms
and low DP combined with disulfide bonds might be the most
promising strategy.
6 Self-assembly of polymers
Beside dendritic, star-like, or graft polymers, in particular
linear block copolymers represent the main polymer structure
to self-assemble into highly-ordered structures. The hydrophobi-
city and hydrophilicity of at least two block segments can be
tuned in a way to self-assemble in aqueous solution.72 Possible
architectures include worm-like or vesicular micellar structures
as well as spherical micelle formation.
The main application of micelles is the delivery of drugs,
due to the fact that the hydrophobic interior represents an ideal
environment for hydrophobic drugs.122 In addition, the use as
multidrug delivery vehicle, meaning the delivery of drugs and
genes at the same time, can be realized.123,124 Concerning
micellar structures for pDNA delivery it should be mentioned
that preformed spherical micelles are used for polyplex forma-
tion or self assembly of block copolymers with plasmid DNA
leads to so-called polyplex micelles (Fig. 5). In detail, a block
copolymer built up of a cationic and a hydrophilic segment
probably forms polyplex micelles with pDNA due to electro-
statical interactions of the pDNA and the cationic segment
(Fig. 5a). Thus, the pDNA is located in the core and the
hydrophilic part in the shell.125 K. Kataoka first presented the
concept of so called polyionic (PIC) micelles in 1990.126,127 In
the following years the behaviour of this system was investi-
gated in detail. One finding is that the size of the polyplex
micelles can be tuned by the length of the hydrophilic segments.
Thus, smaller polyplex micelles were obtained by increasing the
hydrophilic part. This can be attributed to a sterical hindrance
during the micelle association.127–129 In particular, PEG-b-
PAsp(DET) (poly(N-(N-(2-aminoethyl)-2-aminoethyl)aspartamide))
(Fig. 3) polyplex micelles showed high efficiency in delivering
pDNA and represent systems, which are studied and reviewed in
detail.129 Further modifications were performed based on this
initial structure, like the investigations of ternary complexes. In
that case different polymers were mixed for complexation.130
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Pre-formed micelles are only rarely used for pDNA delivery
(Fig. 5b and c). In one approach, amphiphilic PDMAEMA star-
like and linear polymers were investigated regarding their
self-assembly and transfection eﬃciency behaviour. Beside
the comparison of linear and star-shaped polymers, also
diﬀerent hydrophobic blocks were examined, namely poly(styrene)
(PS) and poly(n-butyl acrylate) (PBuA). Both polymer systems form
spherical micelles or micellar structures with hydrodynamic
radii of around 60 to 90 nm. The spherical micelles formed of
PS containing polymers show a stiﬀ and glassy core in contrast
to the micelles with PBuA, with a more rubbery core. The
highest transfection eﬃciency was obtained with spherical
micelles formed of the linear PDMAEMA-b-PBuA-b-PDMAEMA
block copolymers. The authors attributed this behaviour to an
inability of the PS containing polymer to suﬃcient complex
pDNA based on the restricted core. Unfortunately, no detailed
polyplex analysis concerning size, shape and micelle stability
was presented.131 In another study, biodegradable poly-((N-
methyldietheneamine sebacate)-co-((cholesteryl oxocarbonyl-
amido ethyl)methyl bis(ethylene)ammonium bromid)sebacate))
was used for the formation of spherical micelles. Micelles of
around 100 nm (diameter) were obtained showing a positive
zeta potential. With these preformed micelles higher trans-
fection eﬃciency and less cytotoxicity compared to bPEI were
obtained.132 One advantage of micellar structures is the
co-delivery of drugs and pDNA due to the hydrophobic core
and the cationic shell.123,124,133 Such a multidrug delivery agent
was realized with poly(3-caprolactone)-b-poly(N,N-dimethylamino-
2-ethylmethacrylate) (PCL-SS-PDMAEMA) based micelles. An
enhanced release mechanism of the drug doxorubicin due to
the disulfide bridges could be realized as well as a higher
transfection eﬃciency compared to PEI in human oral carci-
noma cells. The polymers with higher DP of PDMAEMA form
larger micelles. Thus, PCL80-SS-PDMAEMA155 results in
spherical micelles of around 205 nm in diameter, whereas
PCL80-SS-PDMAEMA115 forms micelles with sizes of around
93 nm. The larger the micelles are, the higher is the trans-
fection eﬃciency (with a maximum diameter of 205 nm). The
authors attributed this to the higher PDMAEMA content.134
Anyhow, the question arises, how the polyplexes are formed
and if this influences the transfection eﬃciency. In the case of
the micelles with a diameter of 205 nm rather a wrapping
around of the pDNA occurs in contrast to the polyplexes
obtained with the smaller micelles (Fig. 5b and c). Unfortu-
nately, also in this case no detailed polyplex characterisation
was performed. In contrast to these relatively large micelles,
small spherical micelles of around 20 nm in diameter were
achieved by using PDMAEMA47-b-P(DEAMA-co-BMA)n polymers.
Studies at diﬀerent pH values showed an impact of the BMA
content and a possible tuning ability from spherical micelles to
the unimers depending on the pH value. Hence, higher BMA
content leads to a shift of the transition to lower pH values.
The pH dependent conformational change was also analyzed
regarding the hemolytic activity. It was demonstrated that
at a pH value of 7.4 none of the micelles are hemolytic. In
contrast to this, hemolytic activity was achieved at lower pH
values of around 5.8. The best pH dependent transfection
behaviour is shown for the polymer with a BMA content of
40%, because fast transition from micelles to unimers could
be observed at a pH value of 6.6. Concerning the transfection
eﬃciency, the most promising candidates are the polymers
containing 30% and 40% BMA, better performing than lipo-
fectamine. The complexation with pDNA results in polyplexes
of around 250 nm in diameter, suggesting polyplexes formed
by multiple micelles and pDNA (Fig. 5c).135 Another example
for polyplexes formed by spherical micelles is based on
Fig. 5 Polyplex micelles (a) vs. polyplexes formed with preformed micelles and pDNA (b and c). (+) Represents the cationic charges of the block
copolymers or the surface charges of the preformed micelles and () represents the negative charges of the pDNA.
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poly(butadiene)-b-poly(methacrylic acid)-b-poly(2-(dimethyl-
amino)ethyl methacrylate) (PB-b-PMAA-b-PDMAEMA) triblock
terpolymers. The polymers self-assemble into spherical micelles
of around 200 nm in diameter. Higher transfection eﬃciency
and no detectable cytotoxicity compared to lPEI were demon-
strated. Due to the pH dependent protonation/deprotonation
behaviour of the PDMAEMA and the PMAA block, an increased
endosomal escape is achieved. At physiological pH values both
blocks are partially charged leading to a patchy surface with neutral
and cationic charged domains. At decreased pH values in the
endosome, the PMAA blocks collapse partially to the corona and
the PDMAEMA blocks are stretched, forming the corona. This
stimuli-responsive behaviour leads to an enhanced endosomal
membrane destabilisation resulting in a release to the cytoplasm.
Concerning the polyplex properties, it was assumed that the pDNA
is wrapped around the micelle (Fig. 5b), which is confirmed by
Cryo-TEM and DLS investigations.136 Beside block copolymers, also
dendritic structures were used for the self-assembly into complex
architectures, as recently reported in detail.137 A few examples of
pre-formed spherical micelles demonstrate the potential of these
architectures for the pDNA delivery. However, it is obvious that
polyplexes formed of spherical micellar structures have to be
divided into three groups (Fig. 5) to investigate the influence on
the transfection mechanism in more detail. The limited data set
does not enable us to conclude general findings yet.
Polymersomes or vesicular structures have the advantage of
a lower permeability compared to liposomes. By tuning the
properties of the copolymers, also a higher mechanical stability
can be achieved. However, most polymersomes are only applied
for drug delivery.122,138–140 G. Battaglia and his group mainly
work on polymersomes or vesicles for gene delivery, such as
poly(2-(methacryloyloxy)ethyl-phosphorylcholine)-co-poly(2-(diiso-
propylamino)ethyl methacrylate). One way to encapsulate DNA
into 200 to 400 nm (diameter) polymersomes is the use of a pH
transition. At a low pH value of 6 the polymer exists as a unimer.
If the pH value is increased, the polymers assemble into poly-
mersomes and the DNA is partially encapsulated. The second
fraction of pDNA is aggregated into general polyplexes that are
hard to remove from the solution. Nevertheless, much higher
transfection efficiencies can be obtained compared to lipo-
fectamine demonstrating the benefit of vesicular structures.141
Other interesting classes are worm-like micellar structures,
which showed unique features of biological application. The
inspiration for filamentous polymer-based systems arises from
nature as for instance the ebola viruses represent this structure.
However, the examples are rare in the literature concerning
pDNA delivery. One of the rare but very impressive examples is
a PEG–PPA (poly(phoramidate)) block copolymer. Herein,
pDNA was used as a template to generate different shapes
depending on the solvent polarity (Fig. 6a–e). In addition to
worm-like micellar structures, also rod-like and spherical
micelles were obtained. The stabilisation of the different
shapes also in water was realized by disulfide bridges. Con-
cerning transfection efficiency, worm-like micelles (average
length: 581 nm) show the highest gene expression in liver
followed by rod like (130 nm) structures and spherical micelles
(diameter 40 nm) (Fig. 6f).20
7 Conclusion and perspective
The progress in understanding the performance of polymer-
based gene delivery in vitro is still ongoing and results in
numerous studies of new polymer designs. The ongoing devel-
opment of controlled polymerisation techniques, but also mole-
cular biological techniques like high resolution microscopy,
Fig. 6 PEG-b-PPA/DNA micelles. TEM images of crosslinked micelles obtained by diﬀerent DMF–water mixtures, all scale bars represent 200 nm (a–d),
average length and diameter of micelles (e), luciferase expression in vivo after 4 h with indicated micelles, control as benchmark expression level after
hydrodynamic infusion of pDNA (f) (adopted from ref. 17).
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allows us to provide more and more insights into the behaviour
of polymers in vitro in order to conclude several findings also for
in vivo applications. In the last few years, in particular more
polymer architectures come into focus of research dealing with
pDNA transfection. Linear homopolymers are well suited for the
investigation of basic properties like pDNA complexation or
buﬀer capacity. Statistical polymers can be applied to investigate
‘‘easy’’ combinations of various monomers. However, the rather
diﬀerent performance of statistical and block copolymers should
be always kept inmind. In particular, the polyplex formation and
properties thereof can vary significantly. Irregular branching
seems to be beneficial showing that the polymer flexibility is
advantageous for polyplex formation. The main goal to reduce
the cytotoxicity of linear or branched systems without harming
the transfection eﬃciency can be achieved by reducing the
cationic charge and introducing at the same time an ampholytic
or amphiphilic character that ensures polyplex stability and
cellular internalisation. Also more complex architectures like
brush- or comb-like polymers were presented in the last few
years as promising vectors. This can be attributed to an
enhanced polyplex formation and the possibility to introduce a
biodegradable linker between backbone and side chain, which is
responsible for the reduced cytotoxicity. A similar behaviour can
be observed for star-shaped polymers, as here the transfer of
dendritic structures can be achieved while maintaining a flexible
behaviour. In case of the self-assembled structures, diﬀerent
polyplex types have to be considered meaning if polyplexes in
micelles are applied or preformed spherical micelles interact
with the pDNA. The rare examples of preformed micelles show
the potential to outperform the gold standard PEI. Beside
spherical, also worm-like micelles are investigated, here, in
particular the in vivo behaviour is outstanding (Fig. 6).
All together, the usage of diﬀerent architectures in the field
of polymer-based gene delivery is immense and, in particular,
the diﬀerent polyplex properties seem to be a crucial factor. For
this purpose, further investigations concerning the polyplex
characteristics and their impact on the transfection mechanism
are required. It was demonstrated that the interaction with the
cellular membrane depends on the polyplex shape. Moreover,
the paradigm between polyplex stability and dissociation can
be successfully overcome by using biodegradable linkers like
disulfide bonds because the intracellular polyplex dissociation
is enhanced due to the degradation into low molar mass
segments. The utilization of this strategy appears very promis-
ing for in vivo application as the balance between high polyplex
stability and dissociation can be achieved. The prediction of
cytotoxicity and transfection eﬃciency remains still challen-
ging, but a few conclusions, in particular concerning the molar
mass, can be drawn. Usually, high molar masses of 10 to 20 kDa
lead to an increased transfection eﬃciency but also to a high
cytotoxicity. Interestingly, in the case of graft and star polymers
higher molar masses up to 100 kDa were presented without
aﬀecting the cytotoxicity and still showing high eﬃciency (Fig. 7).
The interaction between the polymers and the cellular membrane
probably diﬀers, but this should be further investigated in
detail. The open question, which architecture or system is the most
promising one, cannot be answered up to now as every system
has its pro and contra and further investigations are required.
Fig. 7 Critical design parameter for an increased transfection eﬃciency and low cytotoxicity (L = linear polymers, B = branched polymers, G = graft
polymers, S = star polymers).
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However, in our opinion the graft- and star-based systems seem
to be the most promising ones as with these systems high
transfection eﬃciency and low cytotoxicity can be achieved.
Moreover, with regard to the in vivo application, these systems
provide the opportunity to synthesize biodegradable polymers in
a defined way. The limited number of self-assembled systems
like preformed spherical micelles or worm like structures were
demonstrated as very eﬃcient. Unfortunately, a few studies
do not allow a conscience conclusion and further research is
required. In the last few years, the research on diﬀerent polymer-
based pDNA transfection agents has led to numerous new
insights of possible design rules for the optimized polymer,
implicating the continuous progress in this field (Fig. 7).
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Received 26th February 2013,
Accepted 15th May 2013
DOI: 10.1039/c3ra42069h
www.rsc.org/advances
Michael Wagner,ab Alexandra C. Rinkenauer,ab Anja Schallonab and Ulrich
S. Schubert*ab
Polymer-based carriers, in particular polycations, represent an interesting alternative to viral vectors, as
they form so-called polyplexes with nucleic acids by entropic driven, electrostatic interactions. In this study,
we investigate in detail polyplexes based on small interfering RNA (siRNA), the delivery of which into
eukaryotic cells represents an attractive route for treating genetic diseases by inhibition of harmful gene
expression. Although plasmid DNA (pDNA) based polyplexes are well characterized, we show that not all
knowledge can be adopted from pDNA, as siRNA is around 250 times smaller and shows a higher rigidity.
The used polymer component is the polycation branched poly(ethylene imine) (B-PEI) of a high range of
molar masses (0.6, 1.8, 10, 25 kDa), which are further analyzed by potentiometric titration and cytotoxicity
tests. The formation, size, and net-charge of the polyplexes are examined at different ratios of nitrogen of
the different polymers and phosphates of the RNA (N/P). Moreover, the stability of siRNA polyplexes
against heparin and time was investigated. The obtained physicochemical parameters were then
correlated to the cellular internalization of polyplexes. A strong dependency of the molar mass on the
polyplex characteristics of the used B-PEI was found. Thereby, high molar mass B-PEI ¢ 10 kDa forms
smaller polyplexes of around 50 nm radius with zeta potentials. 25 mV, increased long-term stability, and
enhanced cellular uptake compared to low molar mass ones. To gain deeper insight into the differences
and characteristics of siRNA based polyplexes, the characterization by analytical and preparative
ultracentrifugation (AUC, PUC) is applied on siRNA polyplexes for the first time and referred to
conventional characterization methods such as DLS. AUC was also used to identify non-complexed PEI in
the polyplex solutions. A virtual N/P of 1.3 for siRNA was measured, independent of the used molar masses
of B-PEI. Additionally, differences in cellular uptakes of siRNA and pDNA based polyplexes were found. The
results of this study will help to understand the properties of siRNA-based polyplexes and could lead to
more efficient polymer design.
Introduction
Since the discovery of the RNA interference mechanism by Fire
et al. in 1998,1 siRNA delivery represents an attractive route for
treating genetic diseases by inhibition of the expression of
harmful genes. Compared to the delivery of pDNA, siRNA only
needs to be delivered into the cytoplasm of the cells but not
into the nucleus, which avoids the need for transport of the
delivered molecules across the nuclear membrane. There are,
however, two serious limitation of siRNA as a therapeutic
agent. One of them is its high negative net-charge, which
renders its delivery through the also negatively charged cell
membrane difficult.2 Beside this, genetic material, in parti-
cular siRNA, is not stable under physiological conditions but
will be rapidly degraded by RNAses.3 Thus, the half-life time of
siRNA in blood serum varies from several minutes to an hour.4
Both problems make the application of siRNA for in vitro and
in vivo gene delivery challenging. To overcome them, non-viral
polymeric carriers, in particular polycations, can be applied for
the delivery of the genetic material into the cells and the
subsequent expression of foreign genes,5–7 as has been shown
by recent intense research.8–10 Although the transfection
efficiencies of polymeric vectors, the so-called polyplexes, are
lower compared to viral vectors, they have substantial
advantages,11,12 as their easy large-scale production, their
safety for clinical uses,13,14 and their potential for chemical
modifications.15–17 Among the polymers applied, the commer-
cially available poly(ethylene imine) (PEI), which is intensively
characterized in literature, is the most popular one and is
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widely investigated for the delivery of pDNA as well as
siRNA.18–22 Despite the broad interest, the polyplex formation
of siRNA and PEI and their characteristics are only partially
understood and not yet investigated in detail.
The primary driving force for complexation of nucleic acids
by PEI is entropy. The ionic interactions between the negative
phosphates in the nucleic acids and the protonated amine
groups in the polymer induce a release of counter ions, which
leads to an increase of translational entropy.12,23 The gain of
entropy is of course significantly smaller for siRNA than for
pDNA, due to its shorter chain length. This results in a weaker
binding in the polyplexes. The complexation is influenced also
by other factors, like the 3-D structure of the polymers (linear
or branched),24 their molar mass,25 or further intermolecular
forces e.g. hydrophobic interactions. While linear PEI (L-PEI)
contains mainly secondary amines, branched PEI (B-PEI)
consists of primary, secondary, and tertiary amines. The
resulting degree of protonation is essential for polyplex
formation and for the release of the polyplexes from the
endosome according to the postulated proton sponge effect.5
Non-complexed PEI also influences the transfection efficien-
cies of polyplexes as well as the toxicity.26 Besides the polymer
itself, also the complexation conditions, e.g. buffer compo-
nents, pH value, or ionic strength play an important role.
Added salts can interact with the polyplexes or screen
electrostatic forces. It was shown that, e.g., low ionic strength
promotes the formation of smaller pDNA polyplexes.27
An efficient gene carrier has to combine two features. On
the one hand, the complexation has to be sufficiently strong to
protect against degradation and to transport the siRNA
through the cell membrane. On the other hand, the cellular
uptake should be promoted and the release of the genetic
material from the polyplex in the cytosol has to be possible.
The development of polymers that offer a balance between the
two features is an important goal. Above all, of course, the
perfect gene carrier should be non-toxic.
For the detailed biophysical and physicochemical charac-
terization of nanoparticles in general, different techniques and
methods were established, in the first place light scattering (in
particular dynamic light scattering) for measuring the transla-
tional diffusion coefficient and the hydrodynamic radius,
respectively. Other hydrodynamic methods, e.g., analytical
ultracentrifugation (AUC), were up to now not used for
analyzing siRNA-based polyplexes. AUC is well-known as a
means for the characterization of the molar mass and size of
proteins28–30 but can be also applied for studying nanoparti-
cles and synthetic polymers.31–33 The efficiency of gene
delivery depends on the molar mass of the polymer applied.
For B-PEI, the best results for transfection of pDNA were
obtained up to now with molar masses of 25 kDa.34 Beside
this, an increase in the molar mass of B-PEI and various other
polymers often caused higher cytotoxic effects.35,36 However,
with siRNA 25 kDa B-PEI did not yield an efficient delivery of
the nucleic acid, without any obvious reason.34 This accent-
uates the importance of a detailed understanding of the
polyplex properties.
Herein, the importance of a wide range of molar masses of
B-PEI used for siRNA delivery will be presented. Therefore, the
influence of the polymer on the formation, stability, size, and
net-charge of the polyplexes at different N/P ratios (ratio of
nitrogen in the polymer and phosphates in the RNA) will be
elucidated in detail. As the knowledge of siRNA polyplexes
based on results obtained with pDNA, we also focus on the
differences of both genetic materials concerning their stiff-
ness, amount of free PEI, and cellular uptake behavior. In
addition, AUC will be applied for the characterization of such
polyplexes and the obtained results compared to the revealed
data by conventional methods. The potential of this powerful
technique for detailed analysis of free and complexed PEI will
be demonstrated.
Experimental
Materials
B-PEI of molar masses of 0.6, 1.8, and 10 kDa was purchased
from Polysciences (Eppelheim, Germany), and 25 kDa B-PEI as
well as heparin were purchased from Sigma Aldrich
(Steinhausen, Germany). B-PEI was dissolved in sterile 20
mM 4-(2-hydroxethyl) piperazine-1-ethanesulfonic acid
(HEPES) and 5% (w/w) glucose buffer (HBG, pH 7.2) to obtain
stock solutions of 0.2 mg mL21. The quality of B-PEI was
checked by dynamic light scattering and analytical ultracen-
trifugation to exclude an influence on the polyplex experi-
ments later on. Control siRNA duplex negative control with
19 bp and Cy3 labeled siRNA was obtained from Eurogentech
(Cologne, Germany). Stock solutions of siRNA were prepared
by dissolving solid siRNA in sterile RNase free water to yield a
concentration of 20 mM. Ethidium bromide solution 1% was
purchased from Carl Roth (Karlsruhe, Germany). AlamarBlue
and YOYO-1 was obtained from Life Technologies (Darmstadt,
Germany). Cell culture materials, cell culture media, and
solutions were obtained from PAA (Pasching, Austria). All
other chemicals were purchased from Sigma Aldrich and are of
analytical grade or better and used without further purifica-
tion.
Polyplex preparation
Polyplexes of siRNA and B-PEI were prepared by mixing stock
solutions of siRNA and B-PEI at a certain N/P ratio. The
indicated amounts of B-PEI were added to a certain volume of
20 mM siRNA solution. Subsequently, the solutions were
vortexed for 5 s at 2500 rpm. After incubation at room
temperature for 20 min the mixture was diluted with HBG to a
total volume of 1 mL and an overall siRNA concentration of
15 mg mL21.
Potentiometric titration
For potentiometric titration, 6 mg B-PEI were dissolved in
6 mL pure water. Titration experiments were performed using
a Metrohm 765 Dosimat (Filderstadt, Germany) and a
Greisinger GMH 3530 pH meter (Regenstauf, Germany), using
0.1 M hydrochloric acid or 0.1 M sodium hydroxide as titrant.
The titration was started at pH . 11. For this, a defined
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amount of 0.1 M sodium hydroxide solution was added. Then,
the solution was titrated against 0.1 M hydrochloric acid. The
titration was stopped at pH 2. Each experiment was carried out
in triplicate at 25 uC as described in the literature.37
Ethidiumbromide quenching assay (EBA)
The polyplex formation of siRNA and B-PEI was detected by
quenching of the ethidium bromide (EB) fluorescence as
described previously.38 Briefly, 15 mg mL21 siRNA in a total
volume of 100 mL HBG was incubated with EB (0.4 mg mL21)
for 10 min at room temperature, and then polyplexes with
increasing amounts of B-PEI were formed in black 96-well
plates (Nunc, Langenselbold, Germany). The samples were
equilibrated for 20 min before the fluorescence was measured
using a Tecan Genios Pro fluorescence microplate reader
(Tecan, Crailsheim, Germany); the excitation and emission
wavelength were 525 and 605 nm, respectively. A sample
containing only siRNA and EB was used to calibrate the device
to 100% fluorescence against a background of 0.4 mg mL21 of
EB in HBG solution. The percentage of dye displaced upon
polyplex formation was calculated using eqn (1):
RFU~
Fsample{F0
FsiRNA{F0
(1)
Here, RFU is the relative fluorescence and Fsample, F0, and
FsiRNA are the fluorescence intensities of a given sample, the
EB in HBG alone, and the EB intercalated into siRNA alone.
Heparin dissociation assay
To investigate the release of siRNA from polyplexes, the
heparin dissociation assay was used.24 For this purposee, 15 mg
mL21 siRNA were incubated for 10 min with EB (0.4 mg mL21)
in a total volume of 100 mL HBG before polyplexes at N/P 10
were formed. After 15 min the polyplexes were transferred into
black 96-well plates and heparin at the indicated concentra-
tions was added. The solution was mixed and incubated for
further 30 min at 37 uC. The fluorescence of EB (Ex 525 nm/Em
605 nm) was measured, and the percentage of intercalated EB
was calculated as described before (1).
Dynamic light scattering
Dynamic light scattering (DLS) was performed on an ALV-CGS-
3 system (ALV, Langen, Germany) equipped with a He–Ne laser
operating at a wavelength of l = 633 nm. The counts were
detected at an angle of 90u. All measurements were carried out
at 25 uC after an equilibration time of 120 s. For analyzing the
autocorrelation function (ACF), the cumulant analysis and the
CONTIN algorithm39 were applied. Apparent hydrodynamic
radii were calculated according to the Stokes–Einstein
Equation (eqn (2)):
RH~
kT
6pgD0
(2)
Here, RH is the hydrodynamic radius, k the Boltzmann
constant, T the absolute temperature, g the viscosity of the
sample, and D0 the translational diffusion coefficient.
Electrophoretic light scattering
Electrophoretic light scattering was used to measure the
electrokinetic potential, also known as zeta potential. The
measurements were performed on a Zetasizer Nano ZS
(Malvern Instruments, Herrenberg, Germany) by applying
laser Doppler velocimetry.40 For each measurement, 20 runs
were carried out using the slow-field reversal and fast-field
reversal mode at 150 V. Each experiment was performed in
triplicate at 25 uC. The zeta potential (f) was calculated from
the electrophoretic mobility (m) according to the Henry
Equation (eqn (3)) with f(ka) = 1.5 (Smoluchowski model):
f~
3gm
2ef kað Þ (3)
Here, g is the viscosity of the solution, e the dielectric
constant, and f(ka) the Henry constant.
Analytical and preparative ultracentrifugation
Analytical ultracentrifugation was performed on a Beckman
XL-I analytical ultracentrifuge (Krefeld, Germany).
Experiments were carried out in double-sector aluminum
centerpieces with optical path length of 12 mm in a four holes
rotor setup. Each cell was filled with 0.42 mL of solvent (HBG)
and 0.4 mL of sample. A rotor speed between 1000 to 40 000
rpm was used, depending on the sample. The system was
equilibrated for 40 min at 25 uC in the centrifuge.
Sedimentation data were recorded by absorbance or inter-
ference optics, depending on the sample. Data analysis was
done by the Sedfit software.41 For c(s) analysis of sedimenta-
tion data, the partial specific volume of the compound was
determined via AUC using the ‘‘density variation method’’ as
described by Ma¨chtle.42 The partial specific volume (u) of pure
siRNA was taken from the literature.43 For calculating the
hydrodynamic radius (RH) and the molar mass (M), the
Svedberg equation was transformed into eqn (4) and (5),
respectively.44
RH~
3
2
2 s½ uð Þ1=2 (4)
M~9p
ﬃﬃﬃ
2
p
NA s½  f
fsph
  3
2
u
1
2 (5)
Here, NA is Avogadro’s constant, [s] the intrinsic sedimenta-
tion coefficient, f the frictional coefficient of the solute, and
fsph that of a hard sphere. Preparative ultracentrifugation
(PUC) in combination with photometric detection of PEI by
forming a copper complex was used to determine the amount
of non complexed PEI. Therefore the polyplex solutions were
formed in a volume of 2.5 mL at the stoichiometry of N/P 10
and centrifuged at 20 000 rpm for 2 h on a Beckmann Optima
L-XP to remove the polyplexes. Afterwards the supernatant was
collected. The concentration of PEI was determined by mixing
of 100 mL supernatant and 100 mL copper acetate solution
(20 mM) in a clear 96-well plate and determination of the
absorbance at 285 nm of the copper–PEI complex.45 The
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concentration was determined from a calibration, which was
recorded in the same way as the samples. Each measurement
was repeated three times.
Cytotoxicity
For L929 cells (CCL-1, ATCC), the cytotoxicity assay was
performed as described by ISO10993-5. In detail, cells were
seeded at 10 000 cells per well in a 96-well plate and incubated
for 24 h. No cells were seeded in the outer wells. Afterwards,
polymers at the indicated concentrations were added, and the
cells were incubated at 37 uC for further 24 h. Subsequently,
the medium was replaced by D-PBS and AlamarBlue as
recommended by the supplier. After incubation for 4 h, the
fluorescence was measured at Ex 570/Em 610 nm, with
untreated cells on the same well plate serving as controls.
Cellular uptake studies
For cellular uptake HEK-293 cells (CRL-1573, ATCC) were
seeded at 105 cells per mL in a 12-well plate with 500 mL growth
media (RPMI 1640 media, 10% fetal calf serum (FCS), 100 mg
mL21 streptomycin, 100 IU mL21 penicillin, and 2 mM L-
glutamine). The cells were cultured at 37 uC in a humidified
5% CO2 atmosphere for 24 h. The media was changed by
OptiMEM 1 h before polyplexes were added. Polyplexes
containing siRNA were prepared at a final Cy3 labeled siRNA
concentration of 15 mg mL21 in HBG as described before. The
labeling of pDNA was realized 1 h before polyplex formation.
Therefore, 0.026 mL YOYO-1 (1 mM) per 1 mg pDNA were mixed
in a small amount of pure water. Afterwards, HBG was added
to a final concentration of 15 mg mL21 pDNA Polymers were
added at the indicated N/P ratio, and the polyplex solution was
treated as described before and added to the cells. After 4 h of
incubation, the cells were harvested and 10% trypan blue was
added to quench the outer fluorescence of cells and identify
only cells, taken up the genetic material. To determine the
relative uptake of NPs, 10 000 cells were quantified by flow
cytometry using a Cytomics FC 500 (Beckman Coulter).
Statistical analysis
Group data are reported as mean ¡ SD. To determine the
significance of more than two groups of data, ANOVA was
used.
Results and discussion
Cytotoxicity of the polymers used
As cationic polymers are known to cause toxic effects, the
influence of the B-PEI molar mass on the cytotoxicity was
investigated. The current ‘‘gold standard’’ for transfection of
pDNA is 25 kDa PEI.5 Here, the investigated polyplexes were
formed with siRNA that is 250 times smaller compared to
pDNA; therefore the use of PEIs with molar masses much
lower than 25 kDa seemed to be adequate. The toxicity was
tested in a worst case scenario, where only the polymers were
used instead of the less toxic polyplexes. The polymers were
incubated for 24 h and analyzed by AlamarBlue.46 The relative
viability of cells incubated with PEI compared to non-treated
cells is shown in Fig. 1, where a strong correlation between
molar mass and toxicity can be seen. The IC50-value (the
concentration of polymer where only 50% of the cells are
viable) distinctly decreases with higher molar mass, meaning a
toxic effect at lower compound concentration. Furthermore,
the smallest B-PEI (0.6 kDa) shows no significant toxicity up to
360 mg mL21 (ANOVA). The investigated concentration range
of PEI is adequate, keeping in mind that 360 mg mL21 PEI
corresponds to a N/P ratio above 200 (15 mg mL21 siRNA) and
all experiments were carried out below this ratio. It should be
noted that all polymers investigated by us are not toxic (.80%
viability) at N/P ratios up to 20. Polyplexes of B-PEI with molar
masses higher than 25 kDa will not be investigated here, due
to their high toxicity which makes them unsuitable for in vitro
and in vivo studies.47
Potentiometric titration of branched PEI
One of the major postulated advantages of PEI as gene carrier
is its high buffer capacity, which leads to osmotic swelling
under the acidic conditions in the endosome and the release
of the polyplexes into the cytosol.48,49 Beside this, the degree of
protonation can also have an impact on the stability and
formation of the siRNA polyplexes. To study the influence of
molar mass on the pKa and the degree of protonation, titration
curves of all four B-PEIs, at the same nitrogen (monomer unit)
concentration, were measured by potentiometric titration. It
must be mentioned that the titration behavior as well as the
pKa values strongly depend on the ionic strength and the
polymer concentration itself, as reported first by Suh et al.37
The data shown in Fig. 2 represents only apparent values, due
to the fact that at lower pH value the protonated amines
electrostatically suppress further protonation of neighboring
amines. The corresponding apparent pKa values were listed in
Table 1. Values of pKa
b correspond mainly to protonation of
secondary amines, whereas pKa
a is probably based on
protonation of tertiary ones.50 It was found that the titration
behavior as well as the pKa values of 10 and 25 kDa B-PEI do
not differ significantly, whereas the protonation of 0.6 and 1.8
kDa B-PEIs differ (Fig. 2, Table 1). Both pKa values decrease
with increasing molar mass from 5.7 to 4.8 and 9.8 to 8.3,
respectively, which is in good accordance with values reported
by others for PEI polymers.6,18 Even if there are small
Fig. 1 Cytotoxicity of B-PEI with different molar masses at increasing concen-
tration. The IC50 of 1.8, 10 and 25 kDa B-PEI was 335 mg ml
21, 140 mg ml21 and
62 mg ml21, respectively.
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differences in the pKa values, this probably does not influence
polyplex formation. One reason is that these values only
represent apparent ionization data as mentioned above. In
addition, the buffer capacity at pH 7.2, where the polyplexes
were prepared, is very similar for all commercial B-PEIs as well
as the ratio of primary, secondary, and tertiary amines as
reported in the literature.47 It is, however, not known which
nitrogen atoms of the branched polymer are accessible for
siRNA interaction during polyplex formation.
Polyplex formation and binding affinity
Polyplexes can be formed in different buffer solutions or non-
buffered 150 mM NaCl. It was reported that the kind of buffer
used has an influence on the polyplex characteristics, e.g.
size.51 Therefore, the polyplexes were always prepared in HBG
(20 mM HEPES, 5% (w/v) glucose) to circumvent any influence
due to changes of the solution conditions, like ionic strength
or adsorption of ions. In contrast to saline buffers or
physiological NaCl, the ionic strength is relatively low, which
minimizes electrolysis during electrophoretic light scattering.
The sugar content provides the physiological osmolarity for
biological applications. A dependence of the results on the
mixing protocol was not observed (data not shown).
To characterize the polyplex formation of siRNA and PEI, the
ethidium bromide quenching assay (EBA) was used. The
fluorescence intensity of ethidium bromide (EB) increases
significantly when it intercalates into the double stranded
siRNA.52 After complexation of the siRNA with polymers like
PEI, EB is excluded from the nucleic acid, which leads to a
decrease of the fluorescence signal, as seen in Fig. 3. This
displacement is probably caused by electrostatic and hydro-
phobic interactions of the polymer and the genetic material.
Polyplex formation was observed for all B-PEIs, as indicated by
RFU (eqn (1)) below 35%. At small N/P ratios (,2), 0.6 kDa and
1.8 kDa B-PEI show a higher affinity to siRNA compared to the
10 and 25 kDa analogues. Between N/P ratios of 2 and 5, no
significant differences between data for different molar
masses of B-PEI could be found. At N/P . 5, a constant
fluorescence level is reached for all B-PEIs, indicating a
complete complexation of the siRNA with the polymers. The
fluorescence for higher molar mass B-PEI is slightly lower
(Fig. 3B), indicating that the binding affinity increases with
increasing molar mass of B-PEI. The dependency of binding
affinity on the molar mass of B-PEI is stronger if pDNA was
used as genetic material.
From these results, it can be concluded that a N/P ratio of 5
or higher is necessary for a complete complexation of the
siRNA. The binding affinity of the polyplexes seems to
increases with increasing molar mass of the polymer. A
slightly decreased affinity of a 0.8 kDa B-PEI in comparison to
the 25 kDa analogue was also reported in the literature;24,25
this tendency was confirmed here over a wide range of molar
masses.
Surface charge density-electrokinetic potential
As siRNA is negatively charged, it needs to be complexed by
cationic polymers to be transported through the negatively
charged cell membrane. The electrokinetic potential, also
known as zeta potential, can serve as an indicator of the
surface charge density of the complexes; it is one of the
characteristics measured by electrophoretic light scattering
and can be calculated from it by applying the Henry equation.
We have used it for measuring the net-charge of the siRNA/B-
PEI polyplexes at different N/P ratios. The results are shown in
Fig. 4. At N/P ratios,1, no zeta potential could be measured as
there was no detectable Doppler shift during the experiment.
Binding between siRNA and B-PEI could, however, be detected
even at low N/P ratios by EBA. This could indicate the
formation of rather small polyplexes or the formation of a
loosely bound network. All polyplexes at small N/P ratios (1 to
Fig. 2 Titration curves of 1 mg ml21 B-PEI of indicated molar mass in water
against HCl.
Table 1 pKa values determined by potentiometric titration against HCl
Polymer pKa
a pKa
b
0.6 kDa 5.7 9.8
1.8 kDa 5.3 9.5
10 kDa 4.9 8.2
25 kDa 4.8 8.3
a protonation of tertiary amines. b protonation of secondary amines.
Fig. 3 Binding affinity of siRNA to B-PEI according to EBA (n = 3). A: different
molar masses of B-PEI at different N/P ratios. B: binding affinity at N/P 20. The
fluorescence of pure siRNA (N/P 0) is normalized to 100%.
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3) show a negative zeta potential, ranging from 250 to
225 mV. At a N/P ratio of around 4, the zeta potential
increases and shifts to positive values. At N/P 5, a nearly
constant positive value of 35, 50, 12, and 5 mV for 25, 10, 1.8,
and 0.6 kDa B-PEI polyplexes is reached, respectively.
Obviously, a higher molar mass of the B-PEI leads to a higher
zeta potential. A zeta potential of around 25 mV indicates
stable polyplexes with positive charge density, whereas at
10 mV the complexes seem to be less stable. Higher values of
the zeta potential are, however, difficult to interpret since the
Helmholtz–Smoluchowski model is not valid any more.40
Nevertheless, there is no further significant change in zeta
potential at N/P . 5. These findings are in agreement with the
binding affinities, where also a constant plateau is reached at
those N/P ratios.
Investigation of polyplex size by DLS
It is well-known that the uptake of nanoparticles53 as well as
polyplexes54 is influenced by their size. The internalization
route resulting in successful gene expression therefore
depends not only on the cell line but also on the PEI polyplex
type.55 Large polyplexes interact with the membrane, but the
uptake is rather inefficient. Because of the importance of
polyplex size for biological applications, the hydrodynamic
radius of the polyplexes was analyzed in detail by DLS.
The hydrodynamic radii of polyplexes made of siRNA and
the four different B-PEIs studied, at different N/P ratios, are
presented in Fig. 5. For the calculations, the CONTIN
algorithm was used. Radius measurements were unsuccessful
for polyplexes at N/P ratios,1 due to a counting rate too small
for application of the CONTIN algorithm, probably caused by
the presence of very small polyplexes or of a loosely bound
network only (see above). At N/P ratios from 1 to 3,
hydrodynamic radii ,100 nm were found: 30 to 50 nm for
0.6, 10, and 25 kDa B-PEI, and 60 up to 90 nm for 1.8 kDa
B-PEI polyplexes, respectively. An increase in the B-PEI
concentration and, thus, in the N/P ratio causes an increase
in the hydrodynamic radius for all B-PEIs used. At N/P ratios of
approximately 4 ¡ 0.5, maxima were observed: at 350 nm for
0.6 kDa, 600 nm for 1.8 kDa, .1000 nm for 10 kDa, and
450 nm for 25 kDa B-PEI polyplexes. At N/P ratios¢5, again a
constant value was reached. For polyplexes of high molar mass
B-PEIs (10 and 25 kDa), the hydrodynamic radius decreases to
around 40 nm and 50 nm for 25 and 10 kDa B-PEI,
respectively. The 0.6 and 1.8 kDa B-PEI formed larger
polyplexes, with radii at around 350 nm and 500 nm,
respectively. Taking all facts together, smaller polyplexes were
formed using high molar mass B-PEI. As the uptake of large
polyplexes into cells is less efficient, this could be one reason,
why low molar mass B-PEI is less efficient for gene delivery.56
Fig. 6A–D shows, analogous to Fig. 5, the distributions of the
hydrodynamic radii (linear number weighted) versus N/P. It
should be noted that, according to Fig. 6, for all B-PEIs and
investigated N/P ratios also some larger aggregates with high
polydispersity are present besides the main polyplex popula-
tion. For polyplexes of 0.6 kDa B-PEI, the amount of aggregates
increases at higher N/P ratio (Fig. 6A). In addition, the radius
of the aggregates increases from around 100 nm (N/P 2) to
above 400 nm at N/P ratio 3. Polyplexes of 1.8 kDa B-PEI
(Fig. 6B) show a similar behavior. For polyplexes of 10 kDa
(Fig. 6C) and 25 kDa (Fig. 6D) B-PEI, the results are more
complex. At N/P , 4, the behavior is comparable to that
described above, which means that the amount of aggregates
increases with increasing N/P ratio. At N/P 4 ¡ 0.5, only large
aggregates (around 1000 nm for 10 kDa B-PEI, 400 nm for 25
kDa B-PEI) are present, whereas at N/P ratio of ¢5 also
polyplexes with small hydrodynamic radii (,50 nm) and only a
low amount of aggregates with a radius of around 150 nm were
observed. This confirms the previous results that N/P ¢ 5 is
necessary for complete complexation of the siRNA and the
formation of compact nanocomplexes. In general, this is in
accordance with literature, but it has to be kept in mind that
often different buffers, concentrations and N/P ratios were
investigated.25
Furthermore, the pure B-PEI polymers were also measured
by DLS at concentrations between 5 to 20 mg mL21. For 25 and
10 kDa B-PEI a hydrodynamic radius of around 4 and 2 nm
was found, respectively. For 1.8 and 0.6 kDa B-PEI no DLS
measurements could be performed as the molar mass of the
Fig. 4 Zeta potential of siRNA and B-PEI of different molar masses at different
N/P ratios (n = 3).
Fig. 5 Apparent hydrodynamic radius of the main population of polyplexes
containing B-PEI of different molar masses at different N/P ratios, as obtained by
CONTIN analysis. Radii larger than 1000 nm are presented as ‘‘.1000’’, due to
the fact that the values determined are outside the reliable measuring range (n
= 3).
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polymer, or to be more precisely, oligomer, is too low to yield
any reliable data. At the concentrations, used for formation of
polyplexes, no autocorrelation function could be obtained for
all B-PEI samples. Therefore, an influence of the free PEI on
the DLS results of the polyplex solutions can be excluded.
A comparison of zeta potential and hydrodynamic radii of
the polyplexes reveals a good correlation. At N/P ratios ,3,
where the zeta potential is highly negative, small radii for
polyplexes of all four tested B-PEIs were observed. Large
aggregates occur for all B-PEI polyplexes at N/P ratio of 4 ¡
0.5, where the zeta potential is around 0 mV. At higher N/P
ratios, the radius decreases for polyplexes of higher molar
mass B-PEI (10, 25 kDa), whereas the zeta potential reaches
high positive values (.25 mV). In addition, polyplexes formed
of low molar mass B-PEI (0.6, 1.8 kDa) showed only low
positive zeta potentials (,15 mV) and a high tendency to form
larger aggregates. From the results, it becomes clear that the
electrostatic repulsion, indicated by the zeta potential,
dominates the polyplex size and stability in solution. High
repulsive interactions stabilize the polyplexes which results in
small polyplexes with only low amounts of larger aggregates.
In contrast, the presence of low or no repulsive interactions
leads to fast aggregation and complexes with high hydro-
dynamic radius. Both, zeta potential and hydrodynamic radius
also correlate with the relative fluorescence of the EBA, where
a higher affinity for high molar mass B-PEI was found. To sum
up, the binding affinity, the zeta potential as well as the
hydrodynamic radius reaches a constant value at N/P ratio .5.
With increasing molar mass of B-PEI, smaller, more positively
charged polyplexes with a high binding affinity are formed.
These are all arguments that the stability of the polyplexes
increases with increasing molar mass of the used B-PEI. A
schematic visualization of this situation can be seen in
Scheme 1. It is assumed that with low molar mass B-PEI (left)
a network-like polyplex is formed, where the polymer acts as a
kind of linker. The result is a large, fast aggregating polyplex
with only a low excess of positive charges, indicated by low zeta
potential. In contrast, high molar mass B-PEI (right) forms
smaller polyplexes, and the high excess of positive charges
stabilizes the polyplexes electrostatically. Moreover, it becomes
also clear that not all nitrogen atoms in the polymer are
Fig. 6 Distribution of the hydrodynamic radii of siRNA/B-PEI polyplexes at
different N/P ratios. The CONTIN algorithm was used for analyzing the ACF. The
B-PEI molar masses were A) 0.6, B) 1.8, C) 10, and D) 25 kDa.
Scheme 1 Model of the polyplex formation by PEI of different molar masses.
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accessible to siRNA due to its rigidity in comparison with
pDNA and the branched structure of PEI.57 However, this first
assumption should be investigated further in future.
Long-term stability of polyplexes
For the qualitative comparison of the polyplex solutions, the
cumulant analysis and the z-average are powerful tools, since
the whole system can be described by one single parameter
which is sensitive to any changes occurring in the solution.
The correct calculation of distributions of the hydrodynamic
radius, as shown in Fig. 7, is more difficult. In this case, the
analysis of the autocorrelation function (ACF) requires
application of a multiple C algorithm (e.g. CONTIN). The
cumulant analysis would reflect the distribution very inaccu-
rately in this case, due to the strong influence of a relatively
low amount of aggregates on the obtained z-average and PDI
value.
In this study, the cumulant analysis of DLS measurements is
used to record the long-term stability of the polyplexes (Fig. 7).
It can be seen that the long-term stability of the polyplexes
increases with increasing molar mass of the B-PEI used. The
polyplexes of 0.6 and 1.8 kDa B-PEI, where already aggregates
are present in the solutions, further aggregate within a few
hours. Polyplexes of 10 kDa B-PEI are stable for approximately
24 h, whereas 25 kDa polyplexes are stable for more than 4
days. The time-dependent aggregation of the low molar mass
B-PEI polyplexes can also be due to their low zeta potential, but
this will not explain the aggregation of the 10 kDa B-PEI after
one day, since its zeta potential is comparable to that of the
25 kDa B-PEI polyplexes. Even if the stability of all polyplexes is
sufficient to carry out the physicochemical experiments, it is
questionable, if the stability is high enough for transfections.
Polyplex dissociation (heparin assay)
A suitable polymer for gene delivery should form stable and
small polyplexes but also release its genetic material inside the
cell. To investigate the dissociation of the polyplex and the
release of siRNA, the well-known heparin dissociation assay
was applied.24 Heparin is a sulfated glycosaminoglycan with
high negative charge density that is widely used in medicine as
anticoagulant. Due to its anionic character, heparin serves as
competitor to siRNA and interacts with the cationic polymer.
With increasing amount of heparin, the polyplexes of siRNA
and PEI dissolve. To measure the release of siRNA, again EB
was used as described before. The polyplexes were prepared at
N/P 10, because the polyplex is fully formed at this N/P ratio
(compare EBA, zeta potential and size measurements). Fig. 8
clearly shows that it was possible to dissociate all polyplexes
studied here. At heparin concentration of 30 U mL21 nearly
100% of the siRNA present is free. The low molar mass PEI
polyplex shows a higher stability against heparin at 10 U mL21
than the other ones. This can be explained be a weaker affinity
to anionic substances than the high molar mass ones. So,
B-PEI with a weak binding to anionic substances like siRNA, as
shown in the EB assay, should also show weaker binding to
heparin. Furthermore, no significant difference between B-PEI
of higher molar masses on the release of siRNA can be found.
Analytical and preparative ultracentrifugation experiments
AUC is a powerful technique for characterization of polymers,
both biological and synthetic, and of nanoparticles. To the
best of our knowledge, AUC has not been applied so far to
investigate the solution behavior of siRNA-based polyplexes.
As it is known, that for DLS the intensity of scattered light
scales with r6, the amount of aggregates is overestimated in
the intensity distribution. The calculation of number weighted
distributions tries to correct this effect, but the obtained
distributions cannot be interpreted quantitatively. Therefore,
we apply analytical ultracentrifugation to proof whether the
DLS results are precise.
At first, all polyplexes which were analyzed by DLS, were also
investigated by AUC to compare both methods. The distribu-
tion of hydrodynamic radii of polyplexes formed with 10 kDa
B-PEI at different N/P ratios is shown in Fig. 9. The results are
in good agreement with those obtained by DLS (Fig. 6C). At
N/P ratios below and above 4 ¡ 0.5, the polyplex radius is
around 30 to 50 nm; some larger aggregates are also present.
At N/P 3.7, the radius shifts to higher values of around 150 nm.
At N/P 4.5, it was not possible to obtain any reliable
sedimentation data. The reason for this is the formation of
large aggregates and their extremely fast sedimentation, even
Fig. 7 Time dependency of the z-average radius, as obtained by cumulant
analysis of polyplexes of siRNA and B-PEI of different molar masses at N/P 5.
Radii larger than 1000 nm are presented as ‘‘.1000’’ in the upper part of the
graphic, due to the fact that they are at the limit of the measurement range.
Fig. 8 Heparin-induced dissociation of polyplexes formed from siRNA and B-PEI
of different molar masses, at N/P 10.
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at a rotor speed of only 1000 rpm. This was also the case for
other polyplex solutions and explains why the fraction of larger
aggregates cannot be detected by AUC and why no reliable
sedimentation data could be obtained for most N/P ratios of
0.6 and 1.8 kDa B-PEI polyplexes.
Typical sedimentation profiles of polyplexes formed of 10
kDa B-PEI at N/P 3.7, together with the corresponding residual
plots, are shown in Fig. 10. The large contribution from noise
is mainly due to the high sedimentation velocity of the
particles. Consequently, the lowest possible rotor speed (1000
rpm) and a high radial step size (for each scan) of 0.1 mm had
to be chosen to obtain sufficient data (note: in AUC resolution
increases with speed58). With polyplex samples containing 10
and 25 kDa B PEI at N/P . 5, after sedimentation of the
polyplexes at 1000 rpm, the supernatants of the solution were
centrifuged at 40 000 rpm. This revealed the presence of a
second particle population. Its molar mass was calculated
according to eqn (5) as 10.9 and 25.6 kDa for 10 kDa B-PEI and
25 kDa B-PEI polyplex solutions, respectively; it thus repre-
sents free B-PEI. Free siRNA could not be detected in the
polyplex solution, which is in accordance with gel electro-
phoresis experiments in literature.16
As there are hints that free PEI is necessary for cellular
uptake26 the amount was quantified by preparative ultracen-
trifugation and photometrically determination of the copper
chelate complex. In principle the amount of excess PEI can
also be determined by AUC, but for the used N/P ratios and
concentrations, the amount of PEI was too low to give accurate
results. Nevertheless, quantification via the copper chelate
method45 shows that at N/P 10 around 85% of the PEI is free
and not complexed. This corresponds to a virtual N/P ratio of
around 1.3 for the polyplexes. Interestingly, this amount
depends not on the molar mass of the used polymer. This
correlates well to the small differences found in the EB assay
and support the theory that only few amine groups of the
polymer interact with the polymer whereas the other amines
are responsible for the positive surface charge and interaction
with other polyplexes.59 Even if all polyplexes contain the same
amount of positive charges, they have different zeta potentials
(surface charge densities). This is probably due to their
different radii and the different distribution of the charges
in the polyplexes (Scheme 1). These results highlight the
difference between complexation of siRNA and pDNA, where a
value of 2.5 was described.26 It is also known that polyplexes
containing siRNA are slightly larger than pDNA polyplexes.24,27
Both can be explained by a higher flexibility of pDNA
compared to the stiff siRNA. While pDNA consists of more
than thousand base pairs, siRNA has only 19 to 23 (y5 nm).
With respect to the persistence length of RNA (the length
where the chain behaves as a rigid rod) ofy70 nm (260 bp),57
it becomes obvious that short siRNA cannot condense and
behaves as a rigid rod. Fitting of the frictional ratio f/fsph from
sedimentation velocity data (f/fsph ¢ 2, data not shown) also
indicates a rod-like molecule. For this structure it is more
difficult to become fully complexed. This can explain the
already mentioned high N/P ratios required for complete
complexation and lower virtual NP ratio of siRNA based
polyplexes compared to pDNA ones and shows that not all
insights gathered from pDNA can be adopted for siRNA.
Uptake study
The uptake behavior of the used B-PEIs of different molar
masses was investigated using a Cy3 labeled siRNA. Therefore,
the amount of internalized siRNA was detected with flow
cytometry after 4 h, as this time is common for changing the
transfection media to growth media during transfection
procedure. Here, two N/P ratios were studied, in detail 1.3
and 10, what represent the virtual N/P and fully complexed
siRNA (Fig. 3). For the virtual N/P ratio no significant uptake
was achieved for B-PEI at all molar masses (Fig. 11). Besides, a
significant uptake was detected using higher molar mass (10
and 25 kDa) B-PEI at N/P 10. This shows the potential of B-PEI
¢ 10 kDa and the necessity of an excess of polymer for cellular
uptake of polyplexes. Taken the previous results into account,
the inability of low molar mass PEI could be a consequence of
increased polyplex sizes within 4 h, next to less stability
indicated by lower zeta potentials, and lower pKa values.
Furthermore these results draw attention to the importance of
size and zeta potential for efficient uptake, next to the
potential of polymers to bind and release genetic material.
To gain deeper insights into the mechanism of siRNA delivery
in contrast to pDNA, the uptake of the latest was investigated
using YOYO-1 labeled pDNA (Fig. 11). Again, higher molar
masses at N/P 10 lead to a cellular uptake, but in comparison
to siRNA, also B-PEI ¢ 10 kDa at N/P 1.3 showed internaliza-
tion. This could be explained by the different molecular ratios
Fig. 10 Sedimentation velocity data of polyplexes of siRNA and 10 kDa B-PEI at
N/P 3.7 in HBG at 25 uC. Rotor speed was 1000 rpm; scans were collected every
minute. Top: Sedimentation profiles obtained by absorbance optics at 257 nm.
Bottom: Corresponding plot of the residuals.
Fig. 9 Distribution of the hydrodynamic radii calculated from the distribution of
sedimentation coefficents (eqn (4)) obtained by AUC of polyplexes of 10 kDa
B-PEI and siRNA in HBG at 25 uC.
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(polymer/nucleic acid). While around 54 molecules of 10 kDa
B-PEI for one pDNA molecule represents N/P 1.3, this ratio is
around 0.23 for siRNA (or 4.4 siRNA molecules per polymer)
due to its 250 times shorter length. Obvious, the complexation
of y4 siRNA molecules by one B-PEI molecule is more
difficult.
Additionally the question arises, how far the phosphates of a
stiff molecule like siRNA (in contrast to pDNA) are accessible
for branched PEI. Here, linear PEI with higher chain flexibility
might be more effective. Since, this issue concerning the
uptake and length/stiffness of the genetic material still
remains to be unclear, it will be part of further investigations.
However, using both genetic materials, the molar mass
showed a strong impact onto cellular internalization, indicat-
ing a critical molar mass for efficient polyplex formation and
therefore better cellular uptake.
Conclusions
In this study, the influence of the molar mass of B-PEI on the
stability, formation, and uptake of siRNA-based polyplexes was
investigated. We show that the stability of such polyplexes
strongly depends on the molar mass of the used B-PEI. Taking
the results from EBA, dynamic, and electrophoretic light
scattering into account, it becomes clear that complete
complexation of siRNA is reached at N/P . 5. No significant
differences in the binding affinity and release of siRNA were
observed using different molar masses of B-PEI. A high
correlation between net charge (zeta potential) and hydro-
dynamic radius of the polyplexes was found. At high values of
the zeta potential, regardless if negative or positive, small radii
occur, whereas at low zeta potential we observe large
aggregates. Small hydrodynamic radii and high values of zeta
potential were observed at N/P , 3 for all molar masses of
B-PEI and at N/P ¢ 5 for 10 and 25 kDa B-PEI.
For the first time, we have successfully applied AUC for the
characterization of siRNA polyplexes, suitable for polyplexes
with radii smaller than 150 nm. Limitations occur due to the
high sedimentation velocity of the polyplexes and the
aggregates which requiring low rotor speeds and limited time
for data collection only and, thus, leads to low resolution. To
assess the problem of accurate size distributions of polyplex
systems, containing different species, the establishment of
asymmetric flow field-flow fractionation for such samples is
currently under investigation.
Nevertheless, AUC represents a powerful technique for
characterizing polyplexes in detail, in particular since also free
PEI beside the polyplexes can be detected, which is not
possible by DLS. By using PUC, a virtual N/P ratio of 1.3 was
found. This decreased value compared to pDNA indicates
differences of siRNA based polyplexes compared to pDNA
based ones due to their shorter length and higher rigidity.
Further differences, regarding the genetic material used, were
found in cellular uptake. Whereas both, siRNA and pDNA, can
be efficiently delivered into cells using B-PEI ¢ 10 kDa at N/P
10, no siRNA uptake was detected at N/P 1.3. B-PEI with a
molar mass higher 10 kDa seems to be the most promising
candidates for siRNA-based polyplexes at N/P . 5, as the
resultant polyplexes show a positive net charge, complete
complexation of siRNA, a radius between 20 and 150 nm,
necessary for internalization by endocytosis, and a significant
cellular uptake.60,61 Unfortunately, in terms of biological
application these two polymers have higher toxicity than the
low molar mass ones. Whereas most previous studies used 25
kDa PEI and a single low molar mass PEI (,1 kDa), our work
shows the optimal molar mass is in between these values. E.g.,
the 10 kDa B-PEI, which was not investigated for gene
silencing before, is less toxic compared to the 25 kDa one
and forms stable polyplexes with optimal net-charge and size
for efficient cellular uptake. Furthermore, the influence of
branching can be elucidated in future studies by investigation
of linear, branched or star-shaped architectures of PEI.
Moreover, statistical copolymers of PEI and poly(2-ethyl-2-
oxazoline) might be interesting for gene delivery and polyplex
formation, regarding reduced cytotoxicity.
Not all of the insights gathered for pDNA-based polyplexes
can be adopted for siRNA, because of a 250 times lower molar
mass, a higher rigidity and less flexibility. This study high-
lights the importance of a detailed analysis of polyplexes in the
field of siRNA gene delivery as it not behaves identical as
pDNA in all aspects.
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A Cationic Poly(2-oxazoline) with High
In Vitro Transfection Efﬁciency Identiﬁed
by a Library Approacha
Alexandra C. Rinkenauer, Lutz Tauhardt, Felix Wendler, Kristian Kempe,
Michael Gottschaldt, Anja Traeger,* Ulrich S. Schubert*
To date, cationic polymers with high transfection efﬁciencies (TE) often have a high
cytotoxicity. By screening an 18-membered library of cationic 2-oxazoline-based polymers, a
polymer with similar TE as linear poly(ethylene imine) but no detectable cytotoxicity at the
investigated concentrations could be identiﬁed. The inﬂuence of the polymer side chain
hydrophobicity and the type and content of amino groups on the pDNA condensation, the TE,
the cytotoxicity, the cellular membrane interaction
as well as the size, charge, and stability of the
polyplexes was studied. Primary amines and an
amine content of at least 40% were required for an
efﬁcient TE. While polymers with short side chains
were non-toxic up to an amine content of 40%, long
hydrophobic side chains induced a high cytotoxicity.
1. Introduction
Nanomaterials and their applications are of great interest
for scientists of different disciplines such as biology,
pharmacy, chemistry, biotechnology, physics, and medi-
cine.[1] Within the ﬁeld of nanomedicine, non-viral gene
delivery has a high potential for the treatment of a large
variety of diseases.[2,3] Althoughmanyproblems have been
solved during the last three decades, the ideal delivery
agent, i.e., vector, still has to be found.[4] To design
successful non-viral vectors for genetic materials, several
bottlenecks have to be overcome.[5,6]
Non-viral vectors, in particular synthetic polymers,
offer the advantage of being tailor-made systems, which
can be produced in large scale and stored without
further complications. Due to their good interaction with
negatively charged genetic material such as plasmid
DNA (pDNA) or small interfering RNA (siRNA), cationic
polymers play an important role within the ﬁeld of gene
delivery.[1,7–12] Prominent examples of this polymer class
are poly(ethylene imine) (PEI),[13–16] poly(L-lysine) (PLL),[17]
and poly(methacrylate)s (e.g., PDMAEMA)[18–20] in which
PEI represent the ‘‘gold standard’’ for in vitro transfections.
Previous studies on structure–property relationships
revealed the inﬂuence of molar mass, pKa value, polymer
end groups, side chain substitution, and polyplex size on
the transfection efﬁciency (TE).[21–23] However, compre-
hensive structure–property relationships are rare[24] and
the results of the different studies often cannot be
transferred tootherpolymerclasses leading to thenecessity
to perform detailed analyses for every material.
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The main requirement for transfection agents is an
efﬁcient delivery, combined with a low cytotoxicity.
However, most cationic polymers are either efﬁcient in
delivering the genetic material but cytotoxic or they are
non-toxic and fail in their delivery potential.[25,26] An often
used method to overcome this drawback is the function-
alization with non-toxic and biocompatible compounds
such as carbohydrates or non-ionic polymers, e.g., poly-
(ethylene glycol) (PEG) and poly(2-oxazoline)s (POx).[27–35]
Due to the so called ‘‘stealtheffect’’, thepolymers reduce the
nonspeciﬁc interactions with blood components, e.g., by
shielding of positive charges. Moreover, a prolonged blood
circulation time leading to an enhanced permeability and
retention (EPR) effect as well as a reduced cytotoxicity
can be observed and the water solubility is increased.[31]
POx, in particular poly(2-ethyl-2-oxazoline) (PEtOx) and
poly(2-methyl-2-oxazoline) (PMeOx),havebeen intensively
investigated as PEG alternative.[36–46] Compared to PEG,
the synthesis of POx by a living cationic ring-opening
polymerization (CROP) is rather undemanding, but also
leads to well-deﬁned polymers.[47–50] The preparation of
cationic PEtOx copolymers with primary amine units,[51]
and their usage in DNA binding hydrogels has been
reported earlier.[52] However, the 2-(4-aminobutyl)-2-oxa-
zoline/EtOx copolymers showed no TE (unpublished data).
In addition, it was reported that partially hydrolyzed
POxs, i.e., P(Ox-stat-EI), show less cytotoxicity but also
less TE with increasing POx concentrations.[32,34] Further
studies described a correlation between the polyplex
stability and the amount of positive charges. Often, a
decrease of the positive charge goes alongwith a reduction
of the polyplex stability and, hence, leads to an inefﬁcient
cellular uptake and endosomal release. Moreover, the
functionalization with PEG or hydrophilic POx (e.g.,
PMeOx, PEtOx) can result in an inefﬁcient delivery, due
to a reduced interaction with the genetic material and
the cellular membranes caused by the cell- and protein-
repellent character of the polymers, the so called PEG
dilemma.[53–58] To solve this problem, additional polymer
features have to be considered. Besides modifying poly-
cations with ‘‘stealth’’ polymers,[31,37] the introduction of
more neutral or hydrophobic characteristics have been
discussed for gene delivery applications.[59,60] It is known
from the development of antimicrobial POx that the
introduction of long alkyl spacers leads to an enhanced
membrane interaction.[61] Hence, it is assumed that the
cellular uptake of modiﬁed cationic polymers, which is
often reduced due to the ‘‘stealth effect’’, can be improved
by introducing hydrophobic moieties.
In this study, the inﬂuence of hydrophobicity, type of
amine, and amine content of 2-oxazoline-based polymers
on the transfection behavior was systematically investi-
gated. In detail, copolymers of alkene containing 2-oxazo-
lines, namely 2-(9-decenyl)-2-oxazoline (DecEnOx) or 2-(3-
butenyl)-2-oxazoline (ButEnOx), and 2-methyl-2-oxazoline
(MeOx) were synthesized and further functionalized
by thiol-ene photoaddition.[62–66] MeOx was chosen as
comonomer to improve the water-solubility, which is
limited for P(EtOx-co-ButEnOx) and P(EtOx-co-DecEnOx)
due to the LCST behavior of PEtOx.[67] These copolymers
were further systematically investigated with regard to:
i) their ability to interact with pDNA and the cellular
membrane, ii) their cellular uptake, iii) cytotoxicity, and
iv) the TE.
2. Experimental Section
See Supporting Information.
3. Results and Discussion
3.1. Synthesis of a Cationic Poly(2-oxazoline) Library
To investigate the inﬂuenceof the typeofamine (primaryor
tertiary), the amine content, and the side chain hydropho-
bicity, a library of 18newcationic POx copolymershas been
synthesized (Scheme 1). Starting from MeOx and ButEnOx
aswell as DecEnOx, a series of copolymers containing up to
50mol% of the double bond bearing comonomer has been
prepared. In a straightforward approach, these double
bonds have been functionalized with different amines
(primary or tertiary) using the thiol-ene photoaddition
procedure. For clarity, the ﬁnal products have been labeled
according to the following pattern: s, for all copolymers
based on a ‘‘short’’ side chain of ButEnOx; l, for all polymers
based on a ‘‘long’’ side chain ofDecEnOx; the amine content
is given as number in mol%; p or t, characterize the type of
amine, namely primary (p) or tertiary amine (t) (Scheme 1).
If not stated otherwise, there is a C2H4 spacer between the
sulfur and the ﬁnal amine group. In case of a hexam-
ethylene spacer the term h is added to the compound
abbreviation.
3.2. Synthesis of P(MeOx-co-ButEnOx) and
P(MeOx-co-DecEnOx)
In order to synthesize well deﬁned P(MeOx-co-ButEnOx), a
kinetic studywasperformed for this copolymer system.The
linearity of the ﬁrst-order kinetic plots shows the living
character of the copolymerization (Figure S1, Supporting
Information). Having a higher polymerization rate,
MeOx (kp¼ 0.097 Lmol1 s1) is incorporated faster into
the polymer chain than ButEnOx (kp¼ 0.052 Lmol1 s1)
indicative for the formation of a gradient copolymer.
Characterization by size exclusion chromatography (SEC)
showed an increasing molar mass with increasing conver-
sion (Table S1, Supporting Information). Similar results
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were obtained for P(MeOx-co-DecEnOx), as reported
elsewhere.[68]
To achieve a sufﬁcient bindingwith the geneticmaterial
and a low cytotoxicity, an overall degree of polymerization
(DP) of 200 was chosen. Copolymers with a ButEnOx/
DecEnOx content of 10, 20, 30, and 40mol%, respectively,
have been prepared. Full conversion of the monomers was
proven by 1H NMR investigations. Copolymers with
dispersity (ÐM) values between 1.43 and 1.63 (Table S2,
Supporting Information) were obtained. The rather high
ÐM values for a living cationic polymerization can be
attributed to two aspects: i) The different hydrodynamic
volumes and column interactions of the polymers com-
pared to the used poly(styrene) standard and ii) the
occurrence of chain-transfer,[69,70] commonly observed
for PMeOx systems with DP values higher than 100.[50]
Due to the monomodality of the obtained SEC curves
(exemplarily shown for the P(MeOx-co-ButEnOx) co-
polymer in Figure S2, Supporting Information), it is
assumed that no chain coupling or ‘‘long chain branch-
ing’’[70] reactions occurred, since those would lead to a
shoulder at lower elution volumes, i.e., higher molar
masses. Instead tailing of the SEC curves is observed,
indicating the existence of low molar mass polymer
chains, originating from chain-transfer and termination
reactions. The extent of chain transfer reactions might
have been reduced using EtOx as comonomer (more
controlled reaction up to a DP of 200). However, to avoid
low critical solution temperature (LCST) behavior known
of PEtOx-containing copolymers, MeOx was chosen as
comonomer.[62,67,71]
The 1H NMR spectra showed that both monomers are
incorporated (Figure 1, Figure S3, Supporting Information).
In each case, two signals for the double bonds are visible
around 5.86 and 5.00 ppm. The polymer backbone signal
is found around 3.52 ppm. The signals of the side chain
Scheme 1. Schematic representation of the synthesis of cationic poly(2-oxazoline)s. Reaction conditions: a) 140 8C, microwave reactor,
acetonitrile, b) room temperature, overnight, methanol, catalyst: 0.1mol% 2,2-dimethoxy-2-phenylacetophenone with respect to contained
double bonds, c) room temperature, overnight, dichloromethane/triﬂuroacetic acid. Product terms: s¼ short butyl side chain, l¼ long
decenyl side chain, N¼ amine content in mol%, h¼hexamethylene spacer, p¼primary amine, t¼ tertiary amine.
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protons occur between 1.00 and 2.60 ppm. By correlating
the proton signal of the double bond at 5.86 ppm with the
backbone signal, the monomer ratios within the polymer
could be calculated. They were found to be in agreement
with the ratios aimed for.
In general two different end groups are possible, namely
a hydroxyl or an ester end group.[72] Unfortunately, the
end group analysis, e.g., by ESI- or MALDI-TOF-MS, is not
possible due to the high DP. However, at this high molar
mass the inﬂuence of the end group should be only
marginal or even negligible.
3.3. Thiol-ene Functionalization of P(MeOx-co-
ButEnOx) and P(MeOx-co-DecEnOx) with Different
Amines
To obtain a cationic character, required for DNA-binding,
primary and tertiary amino groups were introduced into
the copolymers by thiol-ene photoaddition reaction
(Scheme 1). The primary amines were obtained by reaction
of the copolymers with 2-(boc-amino)ethanethiol under
UV irradiation (l¼ 365nm) and subsequent deprotection
with triﬂuoroacetic acid. Characterization by 1H NMR
spectrometry showed that for both copolymer types (3
and 4) the double bond signals of the starting materials at
5.86 and 5.00 ppm disappeared after the photoaddition,
indicating the complete functionalization with the thiol
(Figure 1, Figure S3, Supporting Information). Moreover, a
singlet of the boc protecting group at 1.44 ppm was
obtained. For both 3 and 4, the signals of the CH2 next to
the boc protected nitrogen can be found around 3.21ppm.
The protons signals at 2.60ppm can be assigned to the CH2
groups adjacent to the sulfur atom. After treatment with
TFA and precipitation into ice-cold diethyl ether, the
singlet of the boc protecting group disappeared, indicating
the successful deprotection. SEC characterization of the
MeOx/ButEnOx systems revealed a growing molar mass
(lower elution volume) after the photoaddition of 2-(boc-
amino)ethanethiol (Figure 2, Table S2, Supporting Informa-
tion). After deprotection, themolarmass decreases further.
For the MeOx/DecEnOx systems, SEC measurements were
performed for the starting materials 2 and the ﬁnal
products lNp. A growing molar mass of the end products
lNp compared to the starting materials 2 was observed.
This is in accordance with the MeOx/ButEnOx systems.
In all cases the ÐM values changed only slightly.
Figure 1. 1H NMR spectra of 1d (bottom), 3d (middle), s40p (top) (250MHz, solvent: CD3OD).
An Optimized Poly(2-oxazoline) for Gene Delivery
www.mbs-journal.de
Macromol. Biosci. 2015, 15, 414–425
 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 417www.MaterialsViews.com
In addition, copolymers with a tertiary amino group
were prepared from 1 and 2 by UV-initiated thiol-ene
reaction with dimethylaminoethanethiol hydrochloride.
The 1H NMR spectra of sNt and lNt showed a broad
peak around 2.92 ppm belonging to the two CH3 groups
of the amino thiol (Figure S3, Supporting Information).
The double bond signals of the starting materials dis-
appeared, indicating a complete conversion. Although
in theory the molar mass should increase after thiol-
addition, analysis by SEC revealed lower molar masses
of the cationic sNt polymers compared to the neutral
starting material (Table S2, Supporting Information).
Depending on the particular compound, the lNt polymers
showed both increasing and decreasing molar masses.
This is ascribed to the different hydrodynamic volumes of
the cationic polymers in DMAc, but also to the different
column interactions compared to the neutral PS standards
used for calibration. It also explains the large variation
in the molar masses and ÐM values, e.g., of s40p (Mn¼
29,100 gmol1, ÐM¼ 1.52) and s40t (Mn¼ 20,180, ÐM¼
1.35), which are both synthesized from the same starting
material and only differ by the type of amine.
3.4. Binding of Genetic Material
An essential requirement for non-viral vectors is their
interactionwithnegatively chargednucleic acids, resulting
in the formation of interelectrolyte complexes, also known
as polyplexes. The resulting pDNA condensation caused by
the interaction with the polymers was analyzed using the
ethidium bromide quenching assay (EBA). Due to electro-
static and hydrophobic interactions between polymer and
pDNA, ethidiumbromide (EB) is excluded fromapreformed
pDNA/EB complex and the decrease in the EB ﬂuorescence
intensity can be detected. All 16 polymers (sNp, sNt, lNp,
and lNt) led to a decrease in the ﬂuorescence intensity of EB
and, thus, showed interaction with the pDNA (Figure S6,
Supporting Information). As positive control, linear PEI
(lPEI)withaDPof200wasused, decreasing theﬂuorescence
intensity to 44.9 3.1% (Figure S7, Supporting Informa-
tion). Higher relative ﬂuorescence intensities of 65–80%
were observed for the sNp polymers without signiﬁcant
differences concerning their amine content.
For the investigated copolymers, three tendencies can
be observed: i) In the case of the polymers with long side
chains, primary amines bind better than tertiary, ii) the
amine content correlateswith thepDNAcondensation, and
iii) the pDNA condensation increases with the side chain
length (Figure 3A,B). The latter can be probably ascribed to
strongerhydrophobic interactionwith thepDNA,causedby
the higher number of CH2 groups in the side chains.
[49]
Figure 2. SEC curves of the copolymers 1d (straight), 3d (dotted),
and s40p (dashed) (eluent: DMAcþ0.21% LiCl; calibration: PS).
Figure 3. Ethidium bromide quenching assay of all 16 polymers with pDNA measured at physiological pH. A) Comparison at N/P ratio 40.
B) Comparison of 40 mol% amine content (N/P 40) polymers. Values represent the mean SD (n¼ 3); #represents a signiﬁcant
difference (p<0.05) to l40p.
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However, based on the obtained data it is evident that the
inﬂuence of the type of alky side chain (long vs. short) is
more pronounced. In detail, up to 30% difference in the
relative ﬂuorescence intensity of s40p and l40p compared
to 10% of l40p and l40t were found (Figure 3B). This
observation emphasizes the importance of understanding
the physicochemical interactions between the polymer
and the genetic material, and not only the inﬂuence of
electrostatic interactions for the polyplex formation
mainly discussed in literature.[73,74]
3.5. Transfection Efﬁciency
Since an interaction with the pDNA could be observed, the
polymer librarywas analyzed regarding the TE. To this end,
human embryonic kidney cells (HEK) and pDNA, encoding
the reporter geneEGFP,wereused.As transfectionoutcome,
the percentage of cells successfully expressing EGFP was
identiﬁed using ﬂow cytometry. Interestingly, one poly-
mer, the s40p, showed a TE (30.5 7.6%) comparable to
that of lPEI (31.2 1.7%) (Figure 4, Figure S18 and Table S3,
Supporting Information), whereas all other polymers
showed lower TEs (below 10%). The comparable TE of
s40p and lPEI is surprising, since the same DP was used
and, hence, s40p exhibits a much lower amine content
(only 80 of 200 repeating units bear an amino group).
The observed differences in TE of 2-oxazoline-based
polymers lead to the assumption that primary amino
groups in the side chain in combinationwith small spacers
to the backbone are beneﬁcial. These results were not
expected and highlight the inﬂuence of the polymer
constitution for the biological properties. Only slight
changes in the amine type, the amine content, or the side
chain length can have a great impact on the TE. To gain a
deeper insight into the structure–property relationship and
ﬁnd an answer to the question, why the other comparable
polymers are less efﬁcient, further investigations were
performed. Subsequently, the polymers were studied
concerning their polyplex properties, their cytotoxicity,
and their membrane interaction.
3.6. Size and Charge of Polyplexes
For a fast and efﬁcient internalization by endocytosis,
polyplex sizes between 100 and 200nm and a positive
surface charge are beneﬁcial.[6,75] It was found that all
polymers, except s10p, form polyplexes with diameters
below 200nm (Table 1). Moreover, with increasing amine
content a tendency to form smaller polyplexes was
observed. The polyplexes prepared from the four 10 mol%
amine-containing polymers exhibited a negative zeta
potential, indicating an insufﬁcient polyplex formation
and, thus, explaining the insufﬁcient TE (Figure 4 and
Table S3). All other polymers formed polyplexes with a
positive zeta potential (Table 1).
Furthermore, neither the hydrophobicity of the side
chain nor the amine type showed an inﬂuence on the size
and zeta potential of the investigated polyplexes. In
conclusion, a critical amine content of 20mol% is necessary
for an efﬁcient polyplex formation, indicated by a positive
zeta potential.
3.7. Cytotoxicity of Polymers and Interaction with
Cellular Membranes
In a next step, the biocompatibility of the polymers was
investigated. To study the interactions between polymers
and cellularmembranes a hemolysis assaywas performed.
Figure 4. Transfection efﬁciency of all polymers with short side chains (sNp and sNt) and lPEI200 for adherent HEK cells in serum reduced
media at different N/P ratios. Values represent the mean (n¼ 3), SD can be found in the Supporting Information.
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It was found that the polymers with short side chains (sNp
and sNt) exhibit a hemolysis below 3%, indicative of no
hemolytic activity (Table 1). In contrast, the polymers with
long side chains (lNp and lNt) showed high hemolytic
activity even at low concentrations (Table 1). This ﬁnding
can be ascribed to strong membrane interaction of
the more hydrophobic side chains leading to membrane
destruction, as also reported elsewhere.[61] Moreover, the
lNp polymers are more hemolytic compared to lNt, which
also indicates an enhanced interaction of primary amines
with the negative cellular membrane or their proteins.
Due to their low amine chain content and insufﬁcient
polyplex formation, l10p and l10t did not cause any
hemolytic effect (1.8%) (Table 1). The results show that
the interaction between the polymers and membranes is
much more inﬂuenced by the hydrophobic nature of the
polymers than by the amine type and content. This is in
accordance with the results of the pDNA condensation
(EBA) study (Figure 3).
Besides the hemolytic activity, the cytotoxicity was
investigated. It is a well-known problem that cationic
polymers, such as high molar mass PEI or PDMAEMA, lead
to low cell viabilities.[19,76] Both, PMeOx and PEtOx were
postulated to decrease the cytotoxicity. Hence, the cyto-
toxicity of the 16 PMeOx-containing copolymers was
analyzed using the AlamarBlue assay (Figure 5). This assay
is based on a non-ﬂuorescent indicator dye (resazurin)
that is converted into a ﬂuorescent dye by metabolically
active cells. While the sNp and sNt polymers caused
no cytotoxicity at concentrations up to 200mgmL1
(Figure 5A), lPEI showed an IC50 (concentration where
50% of cells are viable) at 3.6mgmL1 (data not shown).
In this context, it has to be noted that s40p shows the
same TE as lPEI but without any cytotoxic effects. In
contrast, higher cytotoxicities were observed for polymers
with long side chains (lNp and lNt), showing furthermore
a dependency on the amine content, amine type, and the
used concentration (Figure 5B). IC50 values of 4–14mgmL
1
were obtained, meaning they have a cytotoxicity compa-
rable to lPEI. In contrast to the lNp polymers, where l40p
showed a lower cytotoxicity than l30p, an increasing
cytotoxicity with increasing amine content was observed
for the lNt polymers. The decreased toxicity of l40pmight
be caused by (electrostatic) interactions with serum
Table 1. Polyplex properties and hemolysis assay: polyplexes of indicated polymers and pDNA were formed at N/P ratio 20 in HBG buffer
at pH 7.4 (PDIP see Figure S8, Supporting Information).
Polyplex properties Hemolysis [%]
Zeta
potential
[mV]
Diameter
[nm]
Concentration
10mgmL1 50mgmL1 100mgmL1
Short hydrophobic
side chain
Primary amines s10p 4.3 2.1 255 57 0.09 0.05 0.2
s20p 22 2.7 178 2.6 0.4 1.5 2.6
s30p 40 1.6 110 11 0.09 0.2 0.2
s40p 23 2.7 94 3.4 0.6 1.6 2.9
Tertiary amines s10t 5.5 2.5 151 14.7 0.5 0.6 0.7
s20t 19 1.7 158 0.4 0.8 0.6 0.5
s30t 29 4.7 124 3.5 0.6 0.6 0.7
s40t 29 1.7 105 1.2 0.8 0.7 0.8
Long hydrophobic
side chain
Primary amines l10p 17 1.1 152 3.1 0.9 18 17
l20p 28 1.8 105 3.2 83 107 107
l30p 29 1.3 84 0.5 105 124 102
l40p 34 1 97 3 106 104 108
Tertiary amines l10t 9 1.2 152 3.5 0.7 0.6 0.7
l20t 26 0.7 113 3.6 10 50 86
l30t 30 2.7 840.5 62 101 95
l40t 27 3 67 1.8 102 100 100
Hemolysis assay of the whole polymer library using blood of three different donors (n¼3). 1% Triton X-100 was used as positive control
and values were set to 100% hemolysis. Values represent the mean (n¼ 3) (SD can be found in the Supporting Information).
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components and will be investigated in further studies. In
summary, the alkyl content and the hydrophobicity of the
side chains showed again a high impact on the interaction
of the polymers with cellular membranes.
To further investigate the reason for the different
cytotoxicity of the polymers, in particular s40p and s40t
or l40p, a lactate dehydrogenase (LDH) assay was
performed with all four 40 mol% amine containing
polymers (Figure 6). Due to the possibility to determine
the released cellular LDH in a sensitive way, the LDH assay
is used to detect membrane destruction.[77]
In contrast to the hemolysis assay, the LDH assay can
be performed with HEK cells, which are also used for
transfection studies. Consequently, themembranedestruc-
tion ability of both, the polymers and thepolyplexes, canbe
analyzed. It was observed that the polymers s40p and s40t
as well as their polyplexes showed no membrane destruc-
tion, at anN/P ratio of 20. In case of l40p, the polyplex is less
toxic than the corresponding polymer, which was also
observed for PEI. Thiswas already reported in literature and
was ascribed to the shielding of the cationic charges of PEI
by interactions with the genetic material.[78] It is assumed
that this is also valid for l40p, since this polymer strongly
interacts with the pDNA (Figure 3). Interestingly, the
polyplexes of l40t showed a slightly higher membrane
destruction activity compared to the non-complexed
polymers. A possible explanation can be an enhanced
internalization of polyplexes compared to the polymers
resulting in high intracellular cytotoxicity.
A possible reason for the higher cytotoxicity of l40t
compared to l40p is the more hydrophobic character of
the tertiary amine compared to the primary counterpart.
In addition, the sterically demanding methyl groups of
the tertiary amine possibly reduce the pDNA binding
(Figure 3) and shield the cationic charges, as observed for
l40t. Thus, the LDH assay conﬁrms the assumption that
an increased side chain hydrophobicity enhances the
interaction with the membrane. In the case of s40p an
optimum between the amount of ‘‘stealth’’ (MeOx) units
for high biocompatibility, the amount and type of cationic
groups for pDNA interaction, and the ideal length of the
hydrophobic segment for membrane interactions was
found, making s40p the best performing polymer.
3.8. Uptake of Polyplexes
Hitherto, the performed experiments could not explain
the differences between the good performer s40p and the
bad performer s40t regarding its transfection mechanism.
Therefore, the uptake behavior was investigated using
YOYO-1 labeled pDNA. The uptake of the ﬂuorescent
polyplexes was determined by ﬂow cytometry.[79] To focus
on the inﬂuenceofamine typeandhydrophobicity, only the
40mol%polymerswere studied (Figure7). Polyplexesbased
on l40p showed a time-dependent uptake, similar to that of
lPEI. Compared to this, the s40p-based polyplexes, which
Figure 5. Cytotoxicity of indicated polymers (A, short side
chains; B, long side chains) using AlamarBlue and L929 cells.
A) Cells treated with sNp polymers and sNt polymers. B) Cells
treated with lNp polymers and with lNp polymers. Arrow
represents the increased cytotoxicity of lNp polymers. Values
represent the mean (n¼ 3), SD can be found in the Supporting
Information.
Figure 6. LDH assay of HEK cell. Cells were incubated with
polyplexes of indicated polymers for 1 h at N/P 20. Values
represent the mean (n¼ 3), SD can be found in the Supporting
Information; #represents a signiﬁcant difference (p<0.05)
compared to l40t.
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showedthehighestTE,were takenupmuchfasterandmore
efﬁciently. Seventy percent of the HEK cells internalized
s40p polyplexes already after 1h of incubation (LPEI: 34%).
In contrast to the s40p polyplexes, its corresponding
polymer with tertiary amines (s40t) showed the lowest
polyplex internalization. Only 60% of the cells internalized
polyplexes, even after 4h. For l40t polyplexes, no analysis
was possible since the cytotoxicity was too high to obtain
any reliable data, as also observed by the AlamarBlue and
the LDH assay (Figure 5 and 6). The reduced uptake of
polymerswith tertiaryaminesidechains (s40t)and/or their
high cytotoxicity (l40t) can explain their insufﬁcient TE,
compared to s40p. The bad TE of polymers with tertiary
amines coupled to long hydrophobic side chains is in
contrast to the poly(amine-co-ester) terpolymers systems
reported by Zhou et al.,[80] where polymers with long
hydrophobic domains and tertiary amines in the main
chain revealed an excellent transfection behavior and low
cytotoxicity. This once more highlights the importance of
the polymer hydrophobicity for gene delivery applications.
However, it also shows that results from different studies
cannot easily be transferred to other polymer classes.
Therefore, it is necessary to perform detailed analyses for
each compound.
3.9. Polyplex Stability
To understand, why some polymers perform better than
others, different bottlenecks were analyzed, starting from
the polyplex itself to the cellular mechanisms. Another
critical parameter is thepolyplex stability. Ononehand, the
pDNA has to be protected against digestion, on the other
hand, it has to be released inside cells. Hence, an optimum
between strong and weak binding has to be found. The
polyplex stability was analyzed using the heparin assay,
in which negatively charged heparin competes with the
pDNA. In Figure 8, the heparin concentration necessary
for complete polyplex dissociation is presented (data of all
compounds see Figure S9, Supporting Information). Com-
pared to the polyplexes formed from polymers with short
side chains (sNp and sNt), the ones of long side chain (lNp
and lNt) are more stable, as indicated by higher heparin
concentrations required to release the pDNA. This is
particularly the case for l40p, where 50UmL1 heparin
are required for the polyplex dissociation, which is in
good correlation with the strong pDNA condensation
(Figure 3). In contrast, the s40p polyplexes release the
pDNA already at heparin concentration of 10UmL1.
This indicates a stronger binding of l40p and could result
in an inefﬁcient release of pDNA in the cytoplasm and,
hence, a low TE (Figure 4 and 7). For the sNt and lNt
polyplexes, only a small amount of heparin leads to
dissociation. This is another indication that tertiary
amines interact less strongly with genetic material and,
hence, are not able to protect the pDNA at physiological pH
7 (Figure 3). As a consequence, the pDNA could be degraded
due to the polyplex instability during the incubation in
the transfection media or inside the cell (pH 7). The latter
could also explain their inefﬁcient uptake and the low
amount of internalized pDNA.
3.10. Inﬂuence of the Thioether Position and Higher
Amine Content
The type of polymer side chain showed a high impact on
the cytotoxicity and the TE. To test whether the location
of the sulfur within the side chain has an inﬂuence on the
properties another polymer (s40hp, Scheme 1), having a
hexamethylene spacer between the sulfur and the amine,
was prepared by thiol-ene photoaddition. The polymer
Figure 7. Uptake study: amount of cells transfected with YOYO-1
labeled pDNA for indicated time points using the polymers with
40 mol% amine content and pDNA and lPEI200 (N/P ratio 20) as
controls. Values represent the mean (n¼ 3), SD can be found in
the Supporting Information.
Figure 8. Polyplex stability: dissociation assay of polyplexes formed
at N/P 20. The bars represent the heparin concentration at which
the polyplexes are dissociated.
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exhibits the same total number of CH2 groups in the side
chain but a different position of the thioether group.
Analysis of the TE (data not shown) and the cytotoxicity
(Figure 9A) yielded similar results as for the analogous
l40p polymer. In detail, no TE and high cytotoxicity
was observed. This proves that the cytotoxicity and TE is
inﬂuenced by the side chain length and not by the location
of the thioether group in the side chain.
Another question that arises is, if a higher amine content
will lead to a further increased TE. Thus, a polymer with a
short side chain and 50 mol% of primary amines was
synthesized (s50p) according to the procedure described for
the other sNp polymers (Scheme 1). Again, the TE and the
cytotoxicity were investigated. For this polymer (s50p), the
TEwas slightly lower but showedno signiﬁcant differences
to the s40p polymer (Figure 9B). However, it was cytotoxic
at higher concentration (Figure 9A), whereas for s40p no
cytotoxicity was observed up to N/P ratio 700 (Figure 5A).
Since a higher amine content showed no advantage for the
transfection process and an increased cytotoxity, the s50p
was not investigated further. Obviously, the polymer s40p
represents an optimal combination of cationic charges,
hydrophobicity and biocompatible monomers for en-
hanced cellular interaction and TE as well as reduced
cytotoxicity.
4. Conclusion
Understanding the interplaybetweendifferent parameters
represents an important prerequisite for the development
of non-toxic cationic polymers used as non-viral vectors in
gene delivery applications. Here, we presented the synthe-
sis and biological screening of an 18-membered 2-oxazo-
line-based copolymer library. Different parameters, such as
the polymer side chain hydrophobicity, the type, and
content of amine groupswere systematically varied. MeOx
as biocompatible ‘‘stealth’’ comonomer and DecEnOx or
ButEnOx, respectively, have been copolymerized with
varying ratios. Subsequent functionalization of the double
bonds by thiol-ene photoaddition yielded cationic poly-
mers with primary and tertiary amine groups. The
inﬂuence of the different parameters on the pDNA
condensation, the TE, the cytotoxicity, and cellular mem-
brane interaction aswell as the size, charge, and stability of
the polyplexes was investigated (Figure 10).
Itwas found that independent of theamine content, long
hydrophobic side chains enhance the pDNA condensation
to the genetic material but interrupt the cellular mem-
branes, leading toahigher cytotoxicity, hemolysis, andLDH
release. Poly(2-oxazoline)s with short side chains and an
amine content below 50 mol% were found to be biocom-
patible at all studied concentrations.
In addition, it was observed that primary amines are
more suitable for an efﬁcient binding and protection of
pDNA. Here, an amine content of at least 40 mol% is
necessary, since lower amine mol% revealed a decreased
pDNA condensation. In case of tertiary amines, the
binding with pDNA was too weak for all investigated
polymers. Hence, the pDNA was released into the
transfection media or inside the endosomes, which
resulted in a reduced TE.
In the end, we could identify one polymer, namely
s40p, which showed superior properties over lPEI.
High transfection efﬁciencies similar to that of lPEI and
a faster internalization were found. Most importantly,
no cytotoxicity was observed in the tested concentration
range. The presented study demonstrates the high
potential of cationic poly(2-oxazoline)s for gene delivery
and shows that it is possible to design cationic polymers
having a high TE while being non-toxic. Further inves-
tigations will be executed, in particular on the best
Figure 9. A) Cytotoxicity of indicated polymers (s50p and s40hp) using AlamarBlue and L929 cells (n¼ 3) and B) transfection efﬁciency of
indicated polymers for adherent HEK cells in serum reduced media at different N/P ratios.
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performing polymer, to gain a deeper insight into the
transfection mechanism.
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Results Section 
 
 
 
Figure S1. First-order kinetic plots of the copolymerization of MeOx and ButEnOx in 
acetonitrile at 140 °C for A) MeOx : ButEnOx = 90 : 10(kpMeOx = 0.095 L mol-1 s-1; kpButEnOx
= 0.052 L mol-1 s-1) and for B) MeOx : ButEnOx = 180 : 20 (kpMeOx = 0.097 L mol-1 s-1;
kpButEnOx = 0.052 L mol-1 s-1). The conversion was determined by gas chromatography.
 
Table S1. Kinetic and SEC Data for the copolymerization of MeOx and ButEnOx. 
MeOx90-co-ButEnOx10 MeOx180-co-ButEnOx20
Time MeOx : 
ButEnOx
Mn ÐMb) Time MeOx : 
ButEnOx
Mn ÐMb)
[s] [%]a) [g mol-1]b) [s] [%]a) [g mol-1]b)
60 13 : 5 2,200 1.10 1 1 : 0 - -
300 48 : 24 5,780 1.11 300 27 : 14 6,510 1.20
600 72 : 46 7,400 1.13 600 44 : 24 8,690 1.28
900 82 : 59 8,310 1.14 1200 67 : 43 11,560 1.34
1500 95 : 80 9,190 1.15 2400 90 : 70 14,690 1.39
1800 96 : 82 9,470 1.16 3600 96 : 84 15,650 1.43
2400 99 : 92 9,550 1.16 4200 98 : 89 16,470 1.43
4800 99 : 91 16,140 1.40
a)Conversion determined by gas chromatography. b)Determined by SEC.
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Table S2. SEC Data of the different copolymers. 
MeOx-co-ButEnOx MeOx-co-DecEnOx
Sample
MeOx : 
ButEnOx
Mn
(g/mol)
ÐM Sample
MeOx : 
DecEnOx
Mn
(g/mol)
ÐM
1a 180 : 20 22,800 1.43 2a 180 : 20 19,800 1.47
1b 160 : 40 23,300 1.46 2b 160 : 40 25,500 1.47
1c 140 : 60 23,300 1.49 2c 140 : 60 19,800 1.45
1d 120 : 80 22,200 1.56 2d 120 : 80 22,900 1.63
1e 100 : 100 20,300 1.48
3a 180 : 20 26,000 1.43 4a 180 : 20 - -
3b 160 : 40 29,000 1.46 4b 160 : 40 - -
3c 140 : 60 29,500 1.47 4c 140 : 60 - -
3d 120 : 80 32,000 1.50 4d 120 : 80 - -
3e 100 : 100 27,700 1.47
s10p 180 : 20 24,100 1.44 l10p 180 : 20 23,600 1.51
s20p 160 : 40 23,200 1.40 l20p 160 : 40 31,600 1.43
s30p 140 : 60 27,400 1.40 l30p 140 : 60 30,500 1.54
s40p 120 : 80 29,100 1.52 l40p 120 : 80 38,100 1.62
s50p 100 : 100 28,500 1.26
s10t 180 : 20 20,440 1.43 l10t 180 : 20 20,300 1.49
s20t 160 : 40 19,560 1.43 l20t 160 : 40 28,100 1.47
s30t 140 : 60 18,120 1.45 l30t 140 : 60 23,900 1.37
s40t 120 : 80 20,180 1.35 l40t 120 : 80 30,300 1.57
s40hp 120 : 80 34,200 1.31
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Figure S2. SEC curves of the P(MeOx-grad-ButEnOx). 
Figure S3. 1H NMR spectra of 2d (bottom), 4d (middle), and l40p (top) (250 MHz, solvent: 
CD3OD). 
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Figure S4. 1H NMR spectra of s40t (bottom) and l40t (top) (250 MHz, solvent: CD3OD). 
Figure S5. 1H NMR spectrum of s40hp (300 MHz, solvent: CD3OD). 
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Ethidium bromide binding assay 
A) B)
C) D)
Figure S6. pDNA condensation of all 16 polymers with pDNA measured at physiological pH 
via EBA at indicated N/P ratios (n = 3). 
Figure S7. pDNA condensation of lPEI (DP = 200) with pDNA measured at physiological 
pH via EBA (n = 3). 
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Transfection efficiency 
Table S3. Transfection efficiency: Raw data and standard derivation of all polymer at the 
indicated N/P ratio (n = 3).
N/P 
ratio Sample
TE / 
% SD Sample
TE / 
% SD Sample
TE / 
% SD Sample
TE / 
% SD
10 s10p 0.33 0.57 s10t 1.15 1.63 l10p 0 0 l10t 0.33 0.58
20 0.67 0.57 0.85 1.2 0 0 0 0
30 0.67 0.57 0.5 0.71 0 0 0.17 0.29
40 0 0 0 0 0 0 0.77 0.40
10 s20p 4.73 3.59 s20t 2.65 3.75 l20p 3.65 3.89 l20t 0.43 0.35
20 8.7 8.16 7.8 0.99 4.2 4.53 2.1 1.51
30 5.27 2.34 2.55 0.07 3.75 0.21 1.37 0.49
40 5.33 1.38 1 0 6.1 0 2.52 1.35
10 s30p 3.4 0.2 s30t 5.15 4.31 l30p 2.4 2.26 l30t 6.48 3.76
20 2.73 1.16 2.35 1.91 3.95 3.04 2.98 2.4
30 5.33 2.97 2.05 1.77 2.65 1.63 1 0
40 5.77 2.91 0.5 0 2.7 2.97 1 0
10 s40p 30.5 7.64 s40t 2.25 1.77 l40p 2.7 0.85 l40t 1.33 0.58
20 26.77 3.30 3.2 1.56 5.85 3.89 1 0
30 27.17 7.51 3.05 2.19 7.4 3.25 0.67 0.58
40 19.93 2.15 2.8 0 8.8 5.52 0.33 0.58
10 s50p 22.1 3.55 lPEI200 31.27 1.75
20 24.07 2.54 25.23 8.81
30 23.63 2.17 12.17 11.6
40 21.6 2.63 4.57 6.18
8 
 
Polyplex properties PDIP
Besides size and zeta potential, also the PDIP was measured.   
A) B) 
  
Figure S8. PDIs of the polyplexes prepared at NP ratio of 20. 
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Cytotoxicity and hemolysis assay 
Table S4. Raw data with standard derivation for cytotoxicity (IC50) and hemolysis assay at 
the indicated polymer concentration. 
      Toxicity Hemolysis 
  
IC50 
  
STAB 
  
  raw data   STAB   
      10 
μg/mL 
50 
μg/mL 
100 
μg/mL 
10 
μg/mL 
50 
μg/mL 
100 
μg/mL 
Sh
or
t h
yd
ro
ph
ob
ic
 si
de
 c
ha
in
 
pr
im
ar
y 
am
in
es
 
10 0 - 0.0999 0.0544 0.1872 0.0269 0.0059 0.0642 
20 0 - 0.402 1.5459 2.5634 0.144 0.2172 0.4657 
30 0 - 0.0938 0.1925 0.188 0.0143 0.0291 0.0539 
40 0 - 0.5647 1.6672 2.8517 0.1148 0.0924 0.3764 
50 1 - - - - - - - 
te
ria
ry
 a
m
in
es
 10 0 - 0.47 0.57 0.71 3E-05 1E-07 3E-07 
20 0 - 0.76 0.56 0.47 4E-07 2E-07 7E-08 
30 0 - 0.55 0.57 0.69 0.5488 0.572 0.6938 
40 0 - 0.80 0.68 0.80 0.7989 0.6844 0.796 
Lo
ng
 h
yd
ro
ph
ob
ic
 si
de
 c
ha
in
 
pr
im
ar
y 
am
in
es
 10 0 0 0.8589 1.802 1.6973 0.1767 0.544 0.6171 
20 5 0.0794 83.206 107.42 107.07 27.032 44.606 45.089 
30 4.7127 0.0157 105 124.21 102.13 40.686 43.969 41.632 
40 34.853 0.0619 106.8 104.16 108.75 44.857 43.014 43.779 
te
ria
ry
 a
m
in
es
 10 0 0 0.6555 0.6133 0.7276 0.0616 0.0185 0.045 
20 13.795 0.059 10.204 50.688 85.833 0.4399 3.4895 3.3771 
30 13.795 0.0393 62.046 101.21 94.963 5.8019 5.557 17.997 
40 4.5983 0.1263 102.47 100.68 99.833 1.0602 3.8171 2.8269 
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Uptake studies 
Table S5. Raw data and standard derivation of time dependent uptake kinetic. 
  1 h 2 h 3 h 4 h 
  
amount of 
cells / % STAB 
amount 
of cells / 
% STAB 
amount 
of cells / 
% STAB 
amount of 
cells / % STAB 
pDNA 0.3 0.2646 0.25 0.2121 0.65 0.495 0.4666667 0.1155 
s40p 81.233333 7.9223 70 19 74.2 4.3841 73.4 3.2512 
s40t 37.85 2.6163 38.9 0 48.05 16.9 53.7 4.1328 
l40p 24.666667 6.8712 41.25 6.1518 69.65 16.051 74 14.47 
l40t 0 0 0 0 0 0 0 0 
lPEI200 33.8 0.8485 47.45 0.2121 81.85 13.647 88.033333 6.3058 
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Dissociation assay 
A)
B)
Figure S9. Dissociation assay with the indicated heparin concentration. 
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Experimental Section 
Chemicals and instrumentation 
Dry acetonitrile, MeOx and methyl tosylate (MeOTs) were obtained from Acros Organics. 
ButEnOx[1] and DecEnOx[2] were prepared according to literature procedure. All compounds 
were distilled to dryness over barium oxide (BaO), and stored under nitrogen. 2-(Boc-
amino)ethanethiol and 2-dimethylaminoethanethiol hydrochloride were purchased from 
Sigma Aldrich.  
Ethidium bromide solution 1% was purchased from Carl Roth (Karlsruhe, Germany). 
AlamarBlue and YOYO-1 was obtained from Life Technologies (Darmstadt, Germany). If not 
stated otherwise, cell culture materials, cell culture media, and solutions were obtained from 
PAA (Pasching, Austria). Plasmid pEGFP-N1 (4.7 kb, Clontech, USA) was isolated using 
Qiagen Giga plasmid Kit (Hilden, Germany). The CytoTox-One homogenous membrane 
integrity assay (LDH) was purchased from Promega (Mannheim, Germany) All other 
chemicals were purchased from Sigma Aldrich (Steinhausen, Germany) and are of analytical 
grade or better and used without further purification.  
The Initiator Sixty single-mode microwave synthesizer from Biotage, equipped with a 
noninvasive IR sensor (accuracy: ±2%), was used for polymerizations microwave irradiation. 
Prior to use, the microwave vials were heated to 110 °C overnight and allowed to cool to 
room temperature under a nitrogen atmosphere. Proton (1H) nuclear magnetic resonance 
(NMR) spectra were recorded on a Bruker AC 250 MHz at 298 K. Chemical shifts are 
reported in parts per million (ppm, δ scale) relative to the residual signal of the deuterated 
solvent. Size exclusion chromatographies (SEC) were measured on an Agilent Technologies 
1200 Series gel permeation chromatography system equipped with a G1329A autosampler, a 
G131A isocratic pump, a G1362A refractive index detector, and both a PSS Gram 30 and a 
PSS Gram 1000 column placed in series. As eluent a 0.21% LiCl solution in N,N-
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dimethylacetamide (DMAc) was used at 1 mL min-1 flow rate and a column oven 
temperature of 40 °C. Molar masses were calculated against poly(styrene). 
Gas chromatography (GC) was measured on a Shimadzu GC-2010 VP equipped with an 
AOC-20s autosampler, an AOC-20i injector, a FID detector, a Restek Rtx-5 column (30 m 
length, 0.25 mm inner diameter, 0.25 μm film thickness, stationary phase: 5% diphenyl/95% 
dimethyl polysiloxane), and chloroform as solvent. 
Kinetic investigation of the synthesis of P(MeOx-co-ButEnOx) 
For the kinetic studies, a stock solution containing initiator (MeOTs), monomer (MeOx and 
ButEnOx), and solvent (acetonitrile) was prepared. The total monomer concentration was 
adjusted to 2 M with a total monomer to initiator ratio ([M]/[I]) = 100 with 10 mol% of 
ButEnOx. The stock solution was divided over seven microwave vials and capped under 
argon. For the calculation of the conversion a t0 samples was taken. The vials were heated in 
the microwave synthesizer at 140 °C for different times. After cooling, the reaction was 
quenched. The monomer conversion was determined GC using the polymerization solvent as 
internal standard. 
Synthesis of P(MeOx-co-ButEnOx) (1a-d) and P(MeOx-co-DecEnOx) (2a-d)
A solution of initiator (MeOTs), monomers (MeOx, and ButEnOx or DecEnOx), and 
solvent (acetonitrile) was prepared. The total monomer to initiator ratio was [M]/[I] = 200, 
with a ButEnOx/DecEnOx amount of 10, 20, 30, and 40 mol%, respectively (corresponding to 
20, 40, 60, and 80 repeating units). For MeOx/ButEnOx also a 50 mol% solution was 
prepared (corresponding to 100 ButEnOx repeating units). The total monomer concentration 
was adjusted to of 4 M. The solution was heated in a microwave synthesizer for a 
predetermined time at 140 °C. After cooling to room temperature a sample was taken and the 
conversion was determined by 1H NMR. The solvent was removed under reduced pressure. 
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The residue was dissolved in dichloromethane and precipitated into ice-cold diethyl ether. 
After filtration the polymer was dried at 40 °C for 3 days under reduced pressure. 
Thiol-ene functionalization of P(MeOx-co-ButEnOx) with 2-(boc-amino)ethanethiol (3a-
d)
A 5% solution of P(MeOx-stat-ButEnOx), 0.1 mol% 2,2-dimethoxy-2-phenylacetophenone 
(DMPA) per double bond, and a 10-fold excess per double bond of 2-(boc-amino)ethanethiol 
in ethanol was prepared. After degassing with nitrogen for 30 min, the reaction mixture was 
stirred in a UV chamber (λ = 365 nm) overnight, and the polymer was precipitated in ice-cold 
diethyl ether. After filtration the polymer was dried under reduced pressure for 3 days at 
40 °C. 
Thiol-ene funtionalization of P(MeOx-co-DecEnOx) with 2-(boc-amino)ethanethiol 
(4a-d)
A 5% solution of P(MeOx-stat-DecEnOx), 0.1 mol% 2,2-dimethoxy-2-phenylacetophenone 
(DMPA) per double bond, and a 10-fold excess per double bond of 2-(boc-amino)ethanethiol 
in tetrahydrofurane was prepared. After degassing with nitrogen for 30 min, the reaction 
mixture was stirred in a UV chamber (λ = 365 nm) overnight, and the polymer was 
precipitated in ice-cold diethyl ether. After filtration the polymer was dried under reduced 
pressure for 3 days at 40 °C. 
Deprotection of P(MeOx-co-bocAmButEnOx) (sNp) and P(MeOx-co-bocAmDecEnOx) 
(lNp) 
The polymer dissolved in dichloromethane (3 mL). Trifluoracetic acid was added (5 mL) 
and the reaction mixture was stirred overnight at room temperature. After the addition of 
methanol, the polymer was precipitated in ice-cold diethyl ether. The precipitate was filtered, 
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dissolved in methanol and stirred over night with Amberlyst® A21 (free base). The solvent 
was removed and polymer dried at 40 °C under reduced pressure for 3 days.  
Thiol-ene funtionalization of P(MeOx-co-ButEnOx) (sNt) and P(MeOx-co-DecEnOx) 
(lNt) with 2-dimethylaminoethanethiol hydrochloride 
A 5% solution of P(MeOx-stat-ButEnOx) or P(MeOx-stat-DecEnOx), respectively, 0.1 
mol% 2,2-dimethoxy-2-phenylacetophenone (DMPA) per double bond, and a 10-fold excess 
per double bond of 2-dimethylaminoethanethiol hydrochloride in methanol was prepared. 
After degassing with nitrogen for 30 min, the reaction mixture was stirred in a UV chamber 
(λ = 365 nm) overnight. The reaction mixture was concentrated and purified by size exclusion 
chromatography using Sephadex® LH-20 running with methanol. The product was dried at 
40 °C for 3 days. 
Thiol-ene funtionalization of P(MeOx-co-ButEnOx) with 6-amino-1-hexanethiol 
hydrochloride (s40hp) 
A 5% solution of P(MeOx-stat-ButEnOx) (1d), 0.1 mol% 2,2-dimethoxy-2-
phenylacetophenone (DMPA) per double bond, and a 2-fold excess per double bond in 
methanol was prepared. After degassing with nitrogen for 30 min, the reaction mixture was 
stirred in a UV chamber (λ = 365 nm) overnight. The reaction mixture was concentrated and 
purified by size exclusion chromatography using Sephadex® LH-20 running with methanol. 
The product was dried at 40 °C for 3 days. 
Polyplex preparation  
Polyplexes of pDNA and polymers were prepared by mixing stock solutions of pDNA and 
polymers at a certain N/P ratio (nitrogen of polymer to phosphate of pDNA ratio) with 15 μg 
mL-1 pDNA solution in HBG buffer (20 mM 4-(2-hydroxethyl) piperazine-1-ethanesulfonic 
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acid (HEPES) and 5% (w/v) glucose, pH 7.2). Subsequently, the solutions were vortexed for 
10 sec at maximal speed, and incubated at room temperature for 20 min.  
Ethidium bromide quenching assay 
The polyplex formation of pDNA and polymers was detected by quenching of the ethidium 
bromide (EB) fluorescence as described previously.[3] Briefly, 15 μg mL-1 pDNA in a total 
volume of 100 μL HBG (hepes buffered glucose) were incubated with EB (0.4 μg mL-1) for 
10 min at room temperature. Then, polyplexes with increasing amounts of indicated polymers 
were prepared in black 96-well plates (Nunc, Langenselbold, Germany). The samples were 
equilibrated for 10 min before the fluorescence was measured using a Tecan Genios Pro 
fluorescence microplate reader (Tecan, Crailsheim, Germany); the excitation and emission 
wavelength were 525 and 605 nm, respectively. A sample containing only pDNA and EB was 
used to calibrate the device to 100% fluorescence against a background of 0.4 μg mL-1 of EB 
in HBG solution. The percentage of dye displaced upon polyplex formation was calculated 
using equation (1): 
     (1) 
Here, RFU is the relative fluorescence and Fsample, F0, and FpDNA are the fluorescence
intensities of a given sample, the EB in HBG alone, and the EB intercalated into pDNA alone. 
Cytotoxicity 
The cytotoxicity was tested with L929 cells, as this sensitive cell line is recommended by 
ISO10993-5. In detail, cells were seeded at 104 cells per well in a 96-well plate and incubated 
for 24 h. No cells were seeded in the outer wells. After exchanging the media with fresh one 
and 30 min incubation, polymers at the indicated end concentrations were added, and the cells 
were incubated at 37 °C for further 24 h. Subsequently, the medium was replaced by fresh 
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media and AlamarBlue as recommended by the supplier. After incubation for 4 h, the 
fluorescence was measured at Ex 570/Em 610 nm, with untreated cells on the same well plate 
serving as controls. The experiments were performed independently three times. 
Dynamic and electrophoretic light scattering 
Dynamic light scattering (DLS) was performed on an ALV-CGS-3 system (ALV, Langen, 
Germany) equipped with a He-Ne laser operating at a wavelength of λ = 633 nm. The counts 
were detected at an angle of 90°. All measurements were carried out at 25 °C after an 
equilibration time of 120 sec. For analyzing the autocorrelation function (ACF), the CONTIN 
algorithm[4] was applied. Apparent hydrodynamic radii were calculated according to the 
Stokes–Einstein equation. 
Electrophoretic light scattering was used to measure the electrokinetic potential, also 
known as zeta potential. The measurements were performed on a Zetasizer Nano ZS (Malvern 
Instruments, Herrenberg, Germany) by applying laser Doppler velocimetry.[5] For each 
measurement, 20 runs were carried out using the slow-field reversal and fast-field reversal 
mode at 150 V. Each experiment was performed in triplicate at 25 °C. The zeta potential (ζ) 
was calculated from the electrophoretic mobility (μ) according to the Henry Equation. Henry 
coefficient f(ka) was calculated according to Oshima.[6]
Transfection of adherent cells 
HEK-293 cells (CRL-1573, ATCC) cells were maintained in RPMI 1640 culture medium, 
L929 cells (CCL-1, ATCC) in DMEM culture medium. Both media were supplemented with 
10% fetal calf serum (FCS), 100 μg mL-1 streptomycin, 100 IU mL-1 penicillin, and 2 mM L-
glutamine. Cells were cultivated at 37 °C in a humidified 5% CO2 atmosphere.  
For transfection of the adherent cell lines, cells were seeded at a density of 104 cells per 
well in 24-well plates one day before transfection. One hour prior to transfection, cells were 
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rinsed with PBS and supplemented with 1 mL OptiMEM (Life Technologies) or fresh serum 
containing growth media (without antibiotics). After polyplexes formation (as described 
above), the polyplexes (100 μL) were added to the cells and the plates were incubated for 4 h 
in the incubator. Afterwards, the supernatant was replaced by1 mL of fresh growth medium, 
and the cells were further incubated for 20 h. For analysis, adherent cells were harvested by 
trypsinization. 
 For determination of the viability during flow cytometry, dead cells were identified via 
counterstaining with propidium iodide. The relative expression of EGFP fluorescence of 104
cells was quantified via flow cytometry using a Cytomics FC 500 (Beckman Coulter). For 
determination of the transfection efficiency viable cells expressing EGFP were gated. The 
experiments were performed independently three times. 
Hemolysis assay 
The membrane damaging properties of the polymers were quantified by analyzing the 
release of hemoglobin from human erythrocytes. The hemolysis assay was performed as 
described before.[7] Briefly, blood from sheep was centrifuged at 4.500 × g for 5 min and the 
pellet was washed three times with cold DPBS. The stock solutions were diluted in HBG of 
indicated pH, and polymer solutions were prepared in HBG buffer as well. 100 μL of each 
solution were mixed and further incubated for 60 min at 37 °C. The release of hemoglobin in 
the supernatant was determined at 580 nm after centrifugation (2,400 g for 5 min). The 
absorbance was measured using a plate reader (Genios Pro, Tecan, Germany). For 
comparison, collected erythrocytes were washed with DPBS and either lysed with 1% Triton 
X-100 yielding the 100% lysis control value (A100) or resuspended in DPBS as reference (A0).
The analysis was repeated with blood from at least six independent donors. The hemolytic 
activity of the polycations was calculated as follow (2): 
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    (2) 
Here, Asample, A0, and A100 are the absorbance intensities of a given sample, erythrocytes 
incubated with DPBS, and erythrocytes lysed with Titon X-100. 
Lactate dehydrogenase (LDH) assay 
For the LDH assay the CytoTox-ONE homogenouse membrane integrity assay was used. The 
assay was performed as recommended by the supplier. The samples (polymer as well as 
polyplexes) were incubated for 1 h with adHEK cells. 
Plasmid DNA labeling 
For labeling of a 1 μg pDNA, 0.026 μL of 1M YOYO-1 solution was mixed with pDNA in 
20 μL of pure water. The solution was incubated for 1 h at room temperature protected from 
light, before HBG was added to the used pDNA concentration described before. Polymers 
were added at the indicated N/P ratio, and the polyplex solution was treated as described 
before and added to the cells. After the indicated time points of incubation, the cells were 
harvested and 10% trypan blue was added to quench the outer fluorescence of cells and 
identify only those cells, which have taken up the genetic material. To determine the relative 
uptake of NPs, 10,000 cells were measured by flow cytometry and the amount of viable cells 
showing YOYO-1 signal were gated. For measuring the mean fluorescence intensity, all 
viable cells were measured. 
Heparin dissociation assay 
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To investigate the release of pDNA from polyplexes, the heparin dissociation assay was 
used. For this purpose, 15 μg mL-1 pDNA were incubated for 10 min with EB (0.4 μg mL-1) in 
a total volume of 100 μL HBG before polyplexes at N/P 20 were formed. After 15 min in the 
dark the polyplexes were transferred into black 96-well plates, and heparin was added at the 
indicated concentrations. The solution was mixed and incubated for further 30 min at 37 °C in 
the dark. The fluorescence of EB (Ex 525 nm / Em 605 nm) was measured, and the 
percentage of intercalated EB was calculated as described before (1). 
Statistical analysis 
The values represent the mean ± SD. For the calculation of the standard derivation of two 
different groups the two sample t-test (student’s t-test) was used. Statistical significant was 
defined with p-values of < 0,05.
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Figure S10. Overlay of the 1H NMR spectra of 1a (blue), 1b (red), 1c (green), 1d (purple), 
and 1e (orange). The signal intensities of the spectra were normalized to the peak of the 
polymer backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
22 
 
 
Figure S11. Overlay of the 1H NMR spectra of 3a (blue), 3b (red), 3c (green), 3d (purple), 
and 3e (orange). The signal intensities of the spectra were normalized to the peak of the 
polymer backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
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Figure S12. Overlay of the 1H NMR spectra of s10p (blue), s20p (red), s30p (green), s40p
(purple), and s50p (orange). The signal intensities of the spectra were normalized to the peak 
of the polymer backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
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Figure S13. Overlay of the 1H NMR spectra of s10t (blue), s20tp (red), s30t (green), and s40t
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
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Figure S14. Overlay of the 1H NMR spectra of 2a (blue), 2b (red), 2c (green), and 2d
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
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Figure S15. Overlay of the 1H NMR spectra of 4a (blue), 4b (red), 2c (green), and 4d
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
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Figure S16. Overlay of the 1H NMR spectra of l10p (blue), l20p (red), l30p (green), and l40p
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD).
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Figure S17. Overlay of the 1H NMR spectra of l10t (blue), l20t (red), l30t (green), and l40t
(purple). The signal intensities of the spectra were normalized to the peak of the polymer 
backbone signal at around 3.5 ppm (250 MHz, solvent: CD3OD). 
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control s40p transfected cells
A) B)
C) D)
E) F)
Figure S18. Histograms of non-transfected cells (A, C, E) and the corresponding HEK cell 
transfected with s40p (B, D, F) (NP 20). FL1 represents green fluorescence by EGFP 
expression.  
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Table S6. Mean fluorescence intensities (MFI) of non-transfected cells (control cells) and 
corresponding HEK cells transfected with s40p or lPEI (NP20). The values represent the MFI 
of the gated EGFP positive area (s. Figure S18).  
MFI control cells MFI transfected cells
s40p 
MFI transfected cells
lPEI 
Sample A, B 0,682 381 389
Sample C, D 4,37 317 297
Sample D, E 11,3 226 257
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ABSTRACT: In recent years, “high-throughput” (HT) has turned
into a keyword in polymer research. In this study, we present a novel
HT workﬂow for the investigation of cationic polymers for gene
delivery applications. For this purpose, various poly(ethylene imine)s
(PEI) were used as representative vectors and investigated via HT-
assays in a 96-well plate format, starting from polyplex preparation up
to the examination of the transfection process. In detail, automated
polyplex preparation, complex size determination, DNA binding
aﬃnity, polyplex stability, cytotoxicity, and transfection eﬃciency
were performed in the well plate format. With standard techniques,
investigation of the biological properties of polymers is quite time-
consuming, so only a limited number of materials and conditions
(such as pH, buﬀer composition, and concentration) can be
examined. The approach described here allows many diﬀerent polymers and parameters to be tested for transfection properties
and cytotoxicity, giving faster insights into structure−activity relationships for biological activity.
KEYWORDS: high-throughput screening, transfection, nonviral gene delivery, polyplex stability, poly(ethylene imine), heparin,
combinatorial workﬂow
■ INTRODUCTION
Nonviral gene delivery (transfection) methods are of great
interest for research and clinical applications. The use of
cationic polymers as nonviral vectors to form complexes
(polyplexes) with negatively charged plasmid DNA (pDNA)
has long been explored as a safer and more controllable
alternative to the use of possible infectious viral vectors.1,2 For
the evaluation of polymers as transfection agents, two main
aspects must be considered: the eﬃciency of gene delivery with
subsequent reporter gene expression and cytotoxicity.3
Biophysical properties, such as polyplex size, surface charge,
and binding aﬃnity between the polymer and the genetic
material play crucial roles in the required cellular uptake.4,5 The
binding within the interelectrolyte complex of polymer and
pDNA has to be strong enough to protect the pDNA but must
be reversible to release the pDNA inside the cells.6,7 While
much progress has been made, there is still an insuﬃcient
knowledge of how polymers should be constructed to be highly
eﬃcient and safe gene delivery vectors.8,9
This lack of predictability results in part from the great
diversity of polymer classes and methods reported in the
literature, which are diﬃcult to compare to each other. For
instance, transfection protocols diﬀer notably for diﬀerent cells
and media, and diﬀerent polymer solutions and buﬀers are used
in the preparation of polyplexes.10,11 While some examples have
been used for in vitro applications and biotechnology research
for decades, no polymer-based transfection agent has been
approved for clinical use.12−14
The development of robotic techniques for the preparation
of polymeric materials provides an opportunity for the high-
throughput (HT) synthesis and characterization of cationic
polymers in this context.15−20 Using this synthetic approach,
polymer properties such as molar mass, functional groups,
architecture, and the combination of diﬀerent monomers in
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statistic or block copolymers can be altered, yielding systematic
polymer libraries, which enable the elucidation of structure−
property relationships.15−23 Unfortunately, rapid methods for
biological evaluation have not been hyphenated with eﬃcient
automated synthesis to construct a combinatorial HT work-
ﬂow.24−27 For example, binding aﬃnity and polyplex stability
have commonly been assessed by agarose gel electrophoresis,
which is not well suited to HT screening. The use of an
intercalating dye to establish binding aﬃnities can provide an
alternative compatible with a microtiter plate format.28
Transfection and cytotoxicity assays can be similarly performed
in multiwell plates with repeating samples to reduce measure-
ment mistakes. Pioneers in this type of HT screening of a wide
range of polymers as transfection agents have been Langer and
co-workers (synthesis and transfection eﬃciency)29 and
Massing and co-workers (lipofection transfection eﬃciency
and toxicity).30
We describe here a simple and powerful combinatorial high-
throughput workﬂow that combines polyplex formation and
biological screening (Scheme 1). It starts with the automated
polyplex preparation via pipetting robots and continues with a
parallel and HT analysis of analytical and biological properties
of size, binding aﬃnity, stability, transfection eﬃciency, and
toxicity. We show that the novel workﬂow is applicable to a
variety of polymer systems and conditions, allowing for fast and
eﬃcient screening of important vector parameters, such as
polyplex formation, pDNA release, cytotoxicity, and trans-
fection.
■ RESULTS AND DISCUSSION
Poly(ethylene imine) (PEI), the most prominent cationic
polymer and most eﬃcient transfection agent for pDNA in
vitro, was used to validate the method.31,14 Linear PEI (LPEI),
obtained from poly(2-ethyl-2-oxazoline)s of diﬀerent molar
masses, was prepared.32,33 By application of automated
microwave synthesizers, poly(2-ethyl-2-oxazoline)s can be
obtained within 10 min and converted into PEI within 1 h
by acidic hydrolysis.32 These cationic PEI polymers oﬀer the
advantage to be molecularly designed in a highly reproducible
manner for speciﬁc applications in pharmacy or biotechnology.
Commercially available branched PEI (BPEI) materials were
also used in this study.
Evaluation of an Appropriate Buﬀer System. The
formation of polyplexes from cationic polymers and anionic
genetic material is driven by electrostatic interactions and a gain
of entropy.34 Thus, ionic strength, pH, and the ﬁnal polyplex
concentration have a major impact on the complexation
behavior and the resulting polyplex size.35,36 For the ex cellular
characterization, polyplexes are often prepared in high ionic
strength buﬀers, such as 150 mM sodium chloride (NaCl) or
buﬀer systems using phosphate (PBS) or TRIS (TBS). Such
high ionic strength media can have a negative impact on
particle size and stability and lead to fast polyplex
aggregation.36,37 Thus, a low ionic strength 20 mM HEPES
buﬀer with 5% glucose for physiological osmolarity (HBG
buﬀer) was examined for polyplex preparation in a HT manner,
as has been previously done for transfection.37 Preliminary
studies with linear PEI600 revealed that smaller polyplexes were
formed in HBG.35 A lower tendency to aggregate over time
compared to physiological salt solutions (150 mM NaCl) was
observed if the polyplexes were prepared in HBG.38−40 Our
measurements showed LPEI600 polyplexes to exhibit no
aggregation over 2 h in HBG (see Supporting Information),
no aggregation or particle growth before and after the addition
to serum containing culture media.36−38 Furthermore, HBG
buﬀer can be used for zeta potential measurements41 in this
concentration range as well as for electron microscopic
evaluations, where salts cause electrophoresis or artifacts,
respectively. Consequently, HBG was selected as most
appropriate buﬀer system for HT studies and was used here
for all polyplex preparations and analytical investigations.
Polyplex Preparation Using Pipetting Robots. A
standard liquid handling robot was used for automated
preparation of polyplexes from cationic polymers and DNA,
similar to reports of robotic production of polymeric
nanoparticles.42 The beneﬁt of such pipetting systems is the
ability to systematically alter diﬀerent parameters, such as
polymer concentration, pH, or buﬀer composition.43 Auto-
mated deposition of a buﬀered pDNA solution into wells
containing various buﬀered cationic polymer solutions at
desired concentrations was performed. While the reverse
Scheme 1. Workﬂow of the High-Throughput Transfection Studies for Structure−Property Evaluations Concerning Molar
Ratio, Size, Polyplex Formation, Polyplex Stability, Release, Transfection Eﬃciency, and Cytotoxicity
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addition (pipetting polymer to DNA solution, vortexing after
polymer addition) is the more conventional method,1 giving
better transfection results,44 we observed similar outcomes in
preliminary experiments using LPEI600 and BPEI600 (see
Supporting Information) and in scattered tests of the HT
method (data not shown). This may be due to more reversible
interelectrolyte formation in the low ionic strength HBG buﬀer
compared to high ionic strength buﬀers used previously.
To evaluate the dependence of polyplex properties on the
nature of the polymers and preparation conditions, various
cationic LPEI and BEI with varied degree of polymerization
(DP = 20, 200, and 600) were used to form polyplexes with
pDNA. Besides the molar mass and architecture, several
nitrogen (polymer) to phosphate (DNA) ratios (N/P = 2.5,
5, 10, and 20) were applied. To this end, pDNA solution was
added to a dilution series of polymer solutions, and the
resulting suspensions were directly mixed by repetitive suction
and release. After polyplex formation, the prepared suspensions
were distributed automatically into diﬀerent well plates for
parallel analysis studies.
Investigation of Polyplex Size and Stability. The
polyplex size allows a ﬁrst hint of the polymer’s capability to
be used as a transfection agent, since polyplexes larger than
500 nm are known to show relatively poor uptake.45 For this
purpose, the polyplexes were ﬁrst analyzed on a dynamic light
scattering (DLS) plate reader.46 As shown in Figure 1, all
polyplexes exhibited an average radius of less than 270 nm, with
materials mixed at N/P ratios above 5 showing smaller radii.
The smallest size (70 nm radius) was obtained for BPEI200. It
should be noted that the HT-DLS analysis data tended to
report larger radii than measurements performed with a single-
beam DLS instrument (see Supporting Information). HT-DLS
results should be always considered with care, and we consider
them informative only in a relative sense, to establish the
potential of polymers to form nanoscaled polyplexes and gain
information about their stability in comparison to standard
polymer controls. Our data revealed three tendencies, also
described in the literature: (i) increasing N/P ratios gave rise to
smaller polyplexes, (ii) BPEI with higher DPs showed a
stronger size dependency compared to LPEI, and (iii) BPEI
condensed DNA into smaller particles compared to LPEI.31
Interestingly, no systematic inﬂuence of the degree of
polymerization or the molar mass on polyplex size was
observed under the chosen conditions.
Fluorescence Displacement Assay. Considering the
interpretation of transfection results the determination of the
binding aﬃnity of the polymers to the genetic material is of
vital importance. As previously mentioned, the binding of a
polyplex is at its optimal state when having a strong and
reversible interaction. The required N/P ratio to form
polyplexes were either done by usage of gel retardation assays
or by ﬂuorescence measurement of intercalating dyes, such as
ethidium bromide (EB) or Pico Green. For an HT screening
application, the gel retardation method is not suitable in a 96-
well plate format, thus, the ﬂuorescence displacement assay
with EB (EBA) was chosen. Commonly, the binding of EB with
pure pDNA leads to a high ﬂuorescence signal. However,
provided that the pDNA forms interelectrolyte complexes with
the polymers, the displacement of dyes leads to a decrease of
ﬂuorescence signals. In Figure 2, the ﬂuorescence signals
(RFU) of all PEI polymers with increasing N/P ratio are
illustrated. It was found that BPEI200 and BPEI600 reached a
comparable RFU of around 30.5 ± 1.4% (p > 0.5) indicating a
strong DNA binding. Furthermore, the higher molar mass
LPEIs (LPEI200 and LPEI600) along with BPEI20 revealed
comparable RFUs in the range of 37.1 ± 6.2% (p > 0.1). The
weakest binding was obtained with LPEI20 also showing the
strong dependence of N/P. In particular, polyplexes formed at
N/P 20 revealed a mediate RFU of 48.7 ± 8% (p > 0.5) in
comparison to 73.8 ± 8.5% at N/P 5. The ﬁndings accredit that
the binding aﬃnity depends on the molar mass and the
architecture of the polymer as well as on the N/P ratio applied.
The relationship between the binding aﬃnity and the molar
mass of the polymer increases in a proportional manner. In
addition, a higher binding aﬃnity of branched structures
(BPEI) was detected in comparison to linear architectures.8,31
The literature47,48 reports similar trends and conﬁrms the
possible analysis of polyplexes by this HT assay. Moreover,
identical tendencies were obtained for this particular handmade
assay using polyplexes of linear PEIs (see Supporting
Information). At this point of the workﬂow, one should note
that after performing size measurements and binding aﬃnity
assays, it is possible to exclude nonsuitable polymers as
Figure 1. Hydrodynamic radii of polyplexes prepared using the
pipetting robot. The values represent the mean (n ≥ 3) of each
polymer at diﬀerent N/P ratios. PDIP values of 0.09 to 0.5 were found.
Figure 2. Fluorescence displacement assay using LPEI and BPEI with
varying DP. The RFU of pure pDNA represent 100% RFU. N/P ratios
of 2.5 up to 20 were studied using EB as intercalating agent. The
values represent the mean ± S.D., n ≥ 3, # indicate signiﬁcant
statistical diﬀerence (ANOVA, p < 0.05).
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transfection agents, which showed undesired interaction such as
aggregation or no polyplex formation.
DNA Release. Subsequent to the determination of binding
aﬃnity, the release of pDNA from the polyplexes was
investigated using the heparin assay. Heparin is a polyanion
and it was reported to be a good competitor to negatively
charged pDNA.48 As a result of the polymer-heparin
interaction, the pDNA is released and EB is repeatedly
intercalating into pDNA leading to increased ﬂuorescence
intensities. Studies using heparin are often quantiﬁed via gel
retardation assays or applying only one N/P ratio, which would
potentially lead to misinterpretations. In particular for in vitro
cultivations of adherent cells, the polyplex concentration at the
cell membrane at the beginning of the transfection and after
incubation diﬀers. The explanation for this behavior could be
justiﬁed by the polyplex sedimentation process.8,49,50 For a
more trustworthy outcome, all polyplex suspensions were
titrated automatically against two heparin stock solutions to
determine the critical heparin concentration at diﬀerent N/P
ratios. Using this approach, a wide range of heparin
concentrations (n = 20) could be tested for one sample. The
results obtained from the performed assay are displayed in
detail for LPEI600 (Figure 3A) and for all polymers and N/P
ratios in (Figure 3C). As expected, the release of pDNA
detected by RFU was dependent on the heparin concentration.
Moreover, it was explored that for the release of total pDNA at
higher N/P ratios, an increased amount of heparin was
required. This can be explained by the fact that the amount
of noncomplexed free polymer was increased at high N/P
ratios, whereas the amount of complexed polymer remained
constant.51 Thus, by the addition of heparin to polyplex
suspensions at high N/P ratios, ﬁrst the free polymers complex
with the heparin and no pDNA was released. Unless the critical
concentration of heparin was met, the pDNA was not released.
For an improved comparability, the inﬂection point of the
titration curves in Figure 3A and C was deﬁned as the critical
heparin concentration (HC50) and implemented as a
representative value of the concentration at which 50% of the
complexed pDNA was released (Figure 3B and D). The
correlation between the N/P ratio and the heparin concen-
tration was an apparent observation and conﬁrmed already
published trends.48 However, our ﬁndings underline the
relation between the architecture of PEI and the ability to
release pDNA.
Polyplexes prepared from BPEIs showed higher HC50 values
in comparison to the LPEIs (indicated by larger purple areas in
particular at N/P 2.5 and 5, Figure 3C and D). Furthermore,
the polyplexes prepared with the LPEI20 exhibited an early
release of the pDNA at low heparin concentration in contrast
to its branched analog (BPEI20) and the linear PEIs with higher
molar masses (LPEI200 and LPEI600). A ﬂagrant correlation
could be made of these with the weak binding aﬃnity (Figure
2).
Figure 3. pDNA release of polyplexes after titration with heparin. Release of pDNA was measured by incubation of polyplexes with increasing
heparin concentrations. (A) RFU of polyplexes prepared from LPEI600 at diﬀerent N/P ratios and increasing heparin concentrations. (B) Slope of
RFU of LPEI600 polyplexes at diﬀerent N/P ratios. (C) RFU of all polyplexes at diﬀerent N/P ratios and increasing heparin concentrations. Color
represents the RFU. (D) Slope of RFU of all polyplexes at diﬀerent N/P ratios. Color represents the slope. The values represent the mean ± S.D., n
≥ 3.
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Cytotoxicity. To study the cytotoxicity of the polyplexes,
HEK cells used as for transfection experiments, were seeded in
96-well plates and incubated for 24 h with the prepared
polyplex suspensions. Afterward, the viability of the cells was
detected by staining with Hoechst 33324. This dye crosses of
the cell membrane and stains the chromosomal DNA of
attached cells. Subsequently, the ﬂuorescence was measured
utilizing the ﬂuorescence plate reader. The obtained RFU
signals of Hoechst of all treated cells are presented in Figure 4.
No indication for cytotoxic eﬀects of the polyplexes was found
considering the fact that the obtained values were comparable
to nontreated cells (ANOVA, p > 0.05).
As the polyplexes exhibited a lower cytotoxicity than the
single polymers, due to neutralized cationic groups, the toxicity
of these polyplexes at N/P 20 would be a criterion for knock
out. However, for a comprehensive analysis, the polymers were
also screened with concentrations up to 72 μg mL−1,
correlating to N/P 500 (DP 20 and 600, see Supporting
Information). A relationship was elucidated between the
increasing DP of the cationic polymers and the higher
cytotoxicity level, which is in accordance to literature where
no signiﬁcant diﬀerence between linear and branched PEI was
observed.3,31 Interestingly, the polymers with the lowest DP
showed no cytotoxicity at all investigated concentrations (see
Supporting Information).
Transfection Eﬃciency. The transfection eﬃciency of the
polyplexes was quantiﬁed using EGFP as reporter protein. For
HT screening, the studies regarding the transfection eﬃciency
were performed with a ﬂuorescence plate reader by automatic
scanning of the bottom area of the wells and complemented by
Figure 4. Investigation of cytotoxicity. The viability of cells after incubation of the polyplexes up to N/P 20. Nontreated cells served as controls and
gave comparable results. The bottom of 96-well plates were measured at Em350/Ex461 (Hoechst 33324).
Figure 5. Transfection eﬃciency by microscopic evaluation and ﬂuorescence intensity measurements. (A) HEK cells transfected with EGFP coding
pDNA and LPEI600 at N/P 10. Cell nuclei were stained with Hoechst 33324 (blue). Scale bare indicates 500 μm. (B) Correlation of the microscopic
evaluation of EGFP content determined (RFUmicroscope) and bottom measurements using a plate reader (RFUplate reader). Three control wells, where
cells were not transfected, as well as cells only incubated with the polymer at concentrations correspond N/P 20 (N20) showed no RFU. (C)
Transfection eﬃciency and number of cells transfected with a pipetting robot in a 96-well plate. Values represent the mean ± S.D., n ≥ 3.
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microscope analysis. In Figure 5A, a representative overview of
the cells (blue) transfected with LPEI600 (green) is portrayed.
Microscopic analysis and, in particular, subsequent data
processing is not appropriate and eﬃcient enough for a rapid
HT screening, thus the quantiﬁcation of EGFP using a
ﬂuorescence plate reader were compared to the mean
ﬂuorescence in each picture (Figure 5B). Thereby, a good
correlation between the microscopic analysis and the
ﬂuorescence plate reader results was demonstrated, proving
the capability to screen the EGFP amount in a fast and facile
manner, in contrast to ﬂow cytometry or microscopy. In
general, it can be stated that there are some decent advantages
of a ﬂuorescence screening with a plate reader compared to
luciferase or galactose based assays, namely, (i) an easy and
cheap detection, (ii) the possibility to perform afterward single
cell analysis by ﬂow cytometry or microscopy of the same cells,
and (iii) the fact that EGFP is a stable reporter protein.
The EGFP expression for all investigated PEI polymers are
shown in Figure 5C. The polymers can be ranked from high to
low transfection eﬃciency: LPEI600 > LPEI200 > BPEI200 >
BPEI600 > BPEI20 > LPEI20, whereby the obvious increase in the
standard deviation compared to ﬂow cytometry measurements
(see Supporting Information) must be taken into account.
However, the HT investigation showed clear trends conﬁrming
a suitable approach to spot high potential candidates and to be
subsequently investigated in depth. Thus, LPEI20 revealed no
transfection eﬃciency, while LPEI600 shows the highest one,
also conﬁrmed by handmade polyplexes and the detection of
EGFP by ﬂow cytometry (see Supporting Information). This
observation further veriﬁes the potential of such a HT
screening using a ﬂuorescent plate reader for determination
of the transfection eﬃciencies of polymers.
■ CONCLUSION
Since HT synthesis and characterization of polymers could be
managed by synthetic robots and microwave synthesizers
combined with subsequent automated characterization of the
molecular properties, polymer libraries for biological applica-
tions can be prepared in a rapid manner.15−20 So far, an
eﬃcient and fast HT screening of these polymers for gene
delivery purposes regarding structure−property relationship
was not possible. Herein, a solution for the biological screening
for gene delivery applications has been presented. The
discussed HT workﬂow enables a rapid analysis of polymer
vectors in an automated way with respect to important polymer
characteristics, such as molar mass, architecture, and N/P ratio.
This supports the identiﬁcation and evaluation of polymers
with regard to their capability of eﬃcient complexation,
protection, and transfection eﬃciency. For instance, the
described heparin assay can be used for 23 polymers at four
diﬀerent N/P ratios resulting in 92 samples plus controls (n =
1). Furthermore, the HT approach was applied and
demonstrated the possible screening of the cytotoxicity and
the transfection eﬃciency of the polyplexes. As expected, the
study of the diﬀerent PEI model polymers revealed that linear
and branched PEI are noncytotoxic at the investigated
concentrations, but with rising molar mass and polymer
concentration the cytotoxic eﬀect was increasing.31 The
polymeric architecture itself showed thereby no inﬂuence on
the cell viability.3 As per literature, at low molar masses the
DNA binding aﬃnity is inﬂuenced by the polymeric
architecture, since BPEI20 revealed a stronger pDNA binding
than LPEI20.
15,26 The obtained results indicated that PEIs with
branched architectures and small molar masses have the highest
potential to be used as gene vectors in vitro, as they oﬀer the
advantage of low cytotoxicity combined with high pDNA
binding aﬃnity. Beyond, the best transfection results were
obtained for LPEI600 and the BPEI200.
In comparison with literature and handmade performances
proof was established that the developed workﬂow is applicable
for polymer systems. Furthermore, conditions enabling a fast
and eﬃcient screening in terms of important vector parameters,
such as polyplex formation, transfection, and release were
found. The possible screening of polymer libraries for the best
transfection candidate will help to elucidate main polymer
characteristics and to understand why some polymers are high
performers and others not. Thus, an enhanced development of
more eﬃcient polymers and polyplexes can be realized.
■ EXPERIMENTAL PROCEDURES
Material. Ethidium bromide solution 1% was purchased
from Carl Roth (Karlsruhe, Germany). AlamarBlue was
obtained from Life Technologies (Darmstadt, Germany). If
not otherwise stated, cell culture materials, cell culture media,
and solutions were obtained from PAA (Pasching, Austria).
Plasmid pEGFP-N1 (4.7 kb, Clontech, Mountain View, CA,
U.S.A.) was isolated using Qiagen Giga plasmid Kit (Hilden,
Germany). All other chemicals were purchased from Sigma
Aldrich (Steinhausen, Germany) and are of analytical grade or
better and used without further puriﬁcation. Linear PEI was
synthesized according to procedure described in literature.32
Polyplex Preparation Using Pipetting Robot. For an
automated polyplex preparation, 100 μL buﬀered DNA
solution (c = 15 μg mL−1) were injected into wells that
contain 300 μL of the desired polymer solution. As cationic
polymers, linear PEI with a DP of 20, 200, and 600, as well as
branched PEI with a DP of 20, 200, and 600 were applied. To
achieve diﬀerent polymer to DNA ratios (N/P ratios), a
dilution series in HBG of four diﬀerent polymer concentrations
(N/P ratio 2.5, 5, 10, 20) was prepared using a pipetting robot
from a polymer stock solution of c = 72 μg mL−1. After addition
of the DNA solution, the polyplex suspension was mixed ﬁve
times by suction and release using 200 μL tips and incubated at
least 20 min. Subsequently, 100 μL of each polyplex suspension
were transferred into three diﬀerent well plates for a detailed
analysis studies. The following assays were performed up to 2 h
after polyplex preparation.
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6XSSRUWLQJLQIRUPDWLRQ
3DUDOOHOKLJKWKURXJKSXWVFUHHQLQJRISRO\PHU
YHFWRUVIRUQRQYLUDOJHQHGHOLYHU\(YDOXDWLRQRI
VWUXFWXUHSURSHUW\UHODWLRQVKLSVRIWUDQVIHFWLRQ
$OH[DQGUD&5LQNHQDXHU$QWMH9ROOUDWK$QMD6FKDOORQ/XW]7DXKDUGW.ULVWLDQ
.HPSH6WHSKDQLH6FKXEHUW	'DJPDU)LVFKHU	8OULFK66FKXEHUWÁ
HTXDOFRQWULEXWLRQ
/DERUDWRU\RI2UJDQLFDQG0DFURPROHFXODU&KHPLVWU\,20&)ULHGULFK6FKLOOHU8QLYHUVLW\
-HQD+XPEROGWVWUDH-HQD*HUPDQ\
-HQD&HQWHUIRU6RIW0DWWHU-&60)ULHGULFK6FKLOOHU8QLYHUVLW\-HQD3KLORVRSKHQZHJ
-HQD*HUPDQ\
	,QVWLWXWHRI3KDUPDF\'HSDUWPHQWRI3KDUPDFHXWLFDO7HFKQRORJ\)ULHGULFK6FKLOOHU
8QLYHUVLW\-HQD2WWR6FKRWW6WU-HQD*HUPDQ\
Á'XWFK3RO\PHU,QVWLWXWH32%R[$;(LQGKRYHQ7KH1HWKHUODQGV
&XUUHQWDGGUHVV'HSDUWPHQWRI&KHPLFDODQG%LRPROHFXODU(QJLQHHULQJ7KH8QLYHUVLW\RI
0HOERXUQH9LFWRULD$XVWUDOLD

$GGUHVVFRUUHVSRQGHQFHWRXOULFKVFKXEHUW#XQLMHQDGH


([SHULPHQWDOVHFWLRQ



6\QWKHVLVRI/3(,
/3(,VZHUHV\QWKHVL]HGIURPWKHFRUUHVSRQGLQJSRO\HWK\OR[D]ROLQHV3(W2[E\DFLGLF
K\GURO\VLV DV GHVFULEHG LQ OLWHUDWXUH %ULHIO\ 3(W2[  J ZDV GLVVROYHG LQ  0 DTXHRXV
K\GURFKORULF DFLG  P/ DQG KHDWHG DW  & IRU  K LQ D ,QLWLDWRU 6L[W\ VLQJOHPRGH
PLFURZDYHV\QWKHVL]HUIURP%LRWDJHHTXLSSHGZLWKDQRQLQYDVLYH,5VHQVRUDFFXUDF\
7KH DFLG ZDV UHPRYHG XQGHU UHGXFHG SUHVVXUH 7KH UHVLGXH ZDV GLVVROYHG LQ ZDWHU DQG 0
DTXHRXV 1D2+ ZDV DGGHG XQWLO SUHFLSLWDWLRQ RFFXUUHG 7KH SUHFLSLWDWH ZDV ILOWHUHG RII
UHFU\VWDOOL]HG IURPZDWHU ILOWHUHGGLVVROYHG LQPHWKDQRO DQGSUHFLSLWDWHG LQWR LFHFROGGLHWK\O
HWKHU 6XEVHTXHQWO\ WKH /3(, ZDV GULHG IRU  GD\ DW  & 7KH GHJUHHV RI K\GURO\VLV ZHUH
GHWHUPLQHG E\ + 105 VSHFWURVFRS\ DQG IRXQG WR EH  IRU DOO /3(,V $ GHWDLOHG
FKDUDFWHUL]DWLRQ RI WKH VKRUW /3(, FDQ EH IRXQG HOVHZKHUH + 105  0+] &'2'
į W&+2+EU1&+V&+1,5)7,5Ȟ 1+&+
&+&+&+&1&1&1FP

7DEOH66(&'DWDRIWKH3(W2[SUHFXUVRUV
3(W2[SUHFXUVRU 5HSHDWLQJXQLWVD 0QJPROE 3',E
3(W2[   
3(W2[   
3(W2[   
D&DOFXODWHG IURP + 105 E'HWHUPLQHG E\ VL]H H[FOXVLRQ FKURPDWRJUDSK\ VROYHQW
FKORURIRUPWULHWK\ODPLQHLVRSURSDQRO>@FDOLEUDWLRQVWDQGDUG36

,QYHVWLJDWLRQRISRO\SOH[VL]HDQGVWDELOLW\
)RUILUVWVWXGLHVWKHSRO\SOH[VL]HVZHUHVWXGLHGE\XWLOL]DWLRQRID=HWDVL]HU1DQR=60DOYHUQ
,QVWUXPHQWV+HUUHQEHUJ*HUPDQ\ 7KHPHDVXUHPHQWVZHUH FDUULHG RXW LQ DPLQLPDO YROXPH
FXYHWWH =(1 %5$1'*PE+:HUWKHLP*HUPDQ\ZLWK D ODVHU EHDP DW QP DQG D


VFDWWHULQJ DQJOH RI  DW  & 7KH YLVFRVLW\  P3D V DQG UHIUDFWLYH LQGH[  RI
SXULILHG ZDWHU DW  & ZHUH XVHG IRU GDWD DQDO\VLV ȝ/ RI SRO\SOH[ VXVSHQVLRQV ZHUH
PHDVXUHG ILYH WLPHV IRU  VHF 7KH PHDQ SDUWLFOH VL]H ZDV DSSUR[LPDWHG DV WKH HIIHFWLYH
=DYHUDJH GLDPHWHU DQG FDOFXODWHG ZLWK WKH *HQHUDO SXUSRVH QRUPDO UHVROXWLRQ DOJRULWKP
XVLQJ WKH0DOYHUQ VRIWZDUH)RU WKHSRO\SOH[ VL]H DQDO\VLVE\G\QDPLF OLJKW VFDWWHULQJ D
'\QD3UR3ODWH5HDGHU3OXV:\DWW7HFKQRORJ\&RUSRUDWLRQ6DQWD%DUEDUD&$HTXLSSHGZLWKD
 P9 OLQHDUO\ SRODUL]HG JDOOLXP DUVHQLGH *D$V ODVHU RI Ȝ  QP DQG RSHUDWLQJ DW DQ
DQJOH RI  ZDV XWLOL]HG $JDLQ WKH YLVFRVLW\  P3D V DQG UHIUDFWLYH LQGH[  RI
SXULILHGZDWHUDW&ZHUHXVHGIRUGDWDDQDO\VLV7KHGDWDZHUHDQDO\]HGZLWKWKH'\QDPLFV
VRIWZDUHYHUE\WKHPHWKRGRIFXPXODQWVDVSUHYLRXVO\GHVFULEHGIRUQDQRSDUWLFOHDQDO\VLV
7KHPHDVXUHPHQW WLPHZDV VHW WR  VHFRQGV SHU UXQ DQG  DFTXLVLWLRQVZHUH FROOHFWHG ILYH
WLPHVSHUZHOODQGUHSHDWHGWLPHVLQLQGHSHQGHQWH[SHULPHQWV
3RO\SOH[SUHSDUDWLRQFRQYHQWLRQDOPHWKRGH
3RO\SOH[HVRIS'1$DQGSRO\PHUZHUHSUHSDUHGE\DGGLQJSRO\PHUVDWDFHUWDLQ13UDWLRWR
VWRFNVROXWLRQVRIS'1$ZLWKJP/LQ+%*EXIIHUP0K\GUR[HWK\OSLSHUD]LQH
HWKDQHVXOIRQLFDFLG+(3(6DQGZYJOXFRVHS+6XEVHTXHQWO\WKHVROXWLRQVZHUH
YRUWH[HGIRUVHFDWPD[LPDOVSHHGDQGLQFXEDWHGDWURRPWHPSHUDWXUHIRUPLQ
%LQGLQJDIILQLW\
7KH SRO\SOH[ IRUPDWLRQ DQG ELQGLQJ DIILQLW\ UHVSRQVLEOH IRU FRPSOH[DWLRQ RI S'1$ DQG
SRO\PHUVZHUHGHWHFWHG E\TXHQFKLQJRI WKH HWKLGLXPEURPLGH (% IOXRUHVFHQFH DVGHVFULEHG
SUHYLRXVO\ $IWHU WKH SRO\SOH[ SUHSDUDWLRQ YLD SLSHWWLQJ URERW RU SHU KDQG  / RI WKH
SRO\SOH[VROXWLRQZHUHLQFXEDWHGZLWK(%JP/IRUPLQDWURRPWHPSHUDWXUHLQEODFN
ZHOOSODWHV1XQF/DQJHQVHOEROG*HUPDQ\7KHIOXRUHVFHQFHZDVPHDVXUHGXVLQJD7HFDQ


*HQLRV 3UR IOXRUHVFHQFH PLFURSODWH UHDGHU 7HFDQ &UDLOVKHLP *HUPDQ\ ZLWK H[FLWDWLRQ DQG
HPLVVLRQZDYHOHQJWKDWDQGQPUHVSHFWLYHO\$VDPSOHFRQWDLQLQJRQO\S'1$DQG(%
ZDV XVHG WR FDOLEUDWH WKH GHYLFH WR  IOXRUHVFHQFH 7KH SHUFHQWDJH RI G\H GLVSODFHG XSRQ
SRO\SOH[IRUPDWLRQZDVFDOFXODWHGXVLQJHTXDWLRQ
	ሾΨሿ ൌ ୊౩౗ౣ౦ౢ౛୊౦ీొఽ         
+HUH 5)8 UHSUHVHQW WKH UHODWLYH IOXRUHVFHQFH )VDPSOH DQG )VL51$ LQGLFDWH WKH IOXRUHVFHQFH
LQWHQVLWLHVRIDJLYHQVDPSOHDQGWKH(%LQWHUFDODWHGLQWRS'1$DORQHUHVSHFWLYHO\
'1$UHOHDVHE\KHSDULQ
7RLQYHVWLJDWHWKHUHOHDVHRIS'1$IURPSRO\SOH[HVWKHKHSDULQGLVVRFLDWLRQDVVD\ZDVXVHG
)RUWKLVSXUSRVH/RISRO\SOH[VROXWLRQZHUHLQFXEDWHGIRUPLQZLWK(%JP/
LQ D EODFN ZHOO SODWH$IWHU WUDQVIHUULQJ LQWR WKH7HFDQ*HQLRV 3UR IOXRUHVFHQFHPLFURSODWH
UHDGHUKHSDULQVROXWLRQVZHUHDXWRPDWLFDOO\DGGHGDWWKHLQGLFDWHGFRQFHQWUDWLRQV7KHUHIRUH
F\FOHV RI WKH IROORZLQJ SURFHGXUH ZHUH XVHG  / RI KHSDULQ VWRFN VROXWLRQV 8P/ RU
8P/ZHUHGURSSHGWRHDFKZHOO$IWHUZDUGVWKHSODWHZDVVKDNHGRUELWDOVHFPP
DQGLQFXEDWHGIRUPLQDW&$IWHUHDFKF\FOHWKHIOXRUHVFHQFHRI(%ZDVPHDVXUHGDQGWKH
SHUFHQWDJHRILQWHUFDODWHG(%ZDVFDOFXODWHGDVGHVFULEHGEHIRUH
&HOO&XOWXUH
+(. &5/ $7&& FHOOV ZHUH PDLQWDLQHG LQ 530,  FXOWXUH PHGLXP /
&&/$7&&LQ'0(0FXOWXUHPHGLXP%RWKPHGLDZHUHVXSSOHPHQWHGZLWKIHWDOFDOI
VHUXP )&6 JP/ VWUHSWRP\FLQ  ,8P/ SHQLFLOOLQ DQG P0/JOXWDPLQH&HOOV
ZHUHFXOWLYDWHGDW&LQDKXPLGLILHG&2DWPRVSKHUH
&\WRWR[LFLW\


7KH F\WRWR[LFLW\ RI WKH VLQJOH SRO\PHUV ZDV WHVWHG ZLWK / FHOOV DV WKLV FHOO OLQH LV
UHFRPPHQGHGE\,62,QGHWDLOFHOOVZHUHVHHGHGDWFHOOVSHUZHOOLQDZHOOSODWH
DQG LQFXEDWHG IRU  K1R FHOOVZHUH VHHGHG LQ WKH RXWHUZHOOV $IWHUZDUGV SRO\PHUV DW WKH
LQGLFDWHGHQGFRQFHQWUDWLRQVZHUHDGGHGWKHSODWHVZHUHVOXHGDQGLQFXEDWHGDW&IRUIXUWKHU
K6XEVHTXHQWO\WKHPHGLXPZDVUHSODFHGE\3%6DQG$ODPDU%OXHDVUHFRPPHQGHGE\WKH
VXSSOLHU$IWHU LQFXEDWLRQIRUK WKHIOXRUHVFHQFHZDVPHDVXUHGDW([(PQPZLWK
XQWUHDWHGFHOOVRQWKHVDPHZHOOSODWHVHUYLQJDVFRQWUROV
ሾΨሿ ൌ ୊౩౗ౣ౦ౢ౛ି୊బ୊ౙ౥౤౪౨౥ౢି୊బ      
+HUH YLDELOLW\ LV WKH UHODWLYH IOXRUHVFHQFH DQG )VDPSOH ) DQG )FRQWURO DUH WKH IOXRUHVFHQFH
LQWHQVLWLHVRIDJLYHQVDPSOHWKHEODQNZHOOVZLWKRXWFHOOVDQGWKHFRQWUROFHOOVZLWKRXWSRO\PHU
WUHDWPHQW
7UDQVIHFWLRQRIFHOOV+7PDQQHU
+(.FHOOVZHUHPDLQWDLQHGLQ530,FXOWXUHPHGLXPVXSSOHPHQWHGZLWKIHWDO
FDOI VHUXP )&6 JP/ VWUHSWRP\FLQ  ,8P/SHQLFLOOLQ DQGP0/JOXWDPLQH
&HOOVZHUHFXOWLYDWHGDW&LQDKXPLGLILHG&2DWPRVSKHUH
)RU WUDQVIHFWLRQH[SHULPHQWV+(.FHOOVZHUHVHHGHGDWDGHQVLW\RIFHOOVSHUZHOO LQ
ZHOOSODWHVKEHIRUHWUDQVIHFWLRQ,QRUGHUWRDYRLGDQ\PLVOHDGLQJPHDVXUHPHQWUHVXOWVDQGWR
SUHYHQW D V\VWHPDWLF PLVWDNH WKH SRO\SOH[HV ZHUH DOZD\V SODFHG DQG PHDVXUHG DW GLIIHUHQW
SRVLWLRQVLQWKHZHOOSODWHWRDYRLGDOWHUDWLRQVGXHWRGLIIHUHQFHVLQWKHJDVH[FKDQJHEHWZHHQ
RXWHUDQGLQQHUZHOOVDQGPHDVXULQJSRLQWVSHUZHOOZHUHWDNHQ2QHKRXUSULRUWUDQVIHFWLRQ
FHOOV ZHUH ZDVKHG ZLWK 3%6 DQG VXSSOHPHQWHG ZLWK  / 2SWL0(0 /LIH 7HFKQRORJLHV
3RO\SOH[VROXWLRQVZHUHDGGHG/WRWKHFHOOVDQGWKHSODWHVZHUHVOXHGDQGLQFXEDWHGIRU
K DW  & $IWHUZDUGV WKH VXSHUQDWDQW ZDV UHSODFHG E\  / RI IUHVK JURZWK PHGLXP
530,EDVHGDQGWKHFHOOVZHUHIXUWKHULQFXEDWHGIRUK%HIRUHDQDO\VLVWKHFHOOVZHUH


LQFXEDWHGZLWKJP/+RHFKVWIRUPLQDW&ZDVKHG WZLFHZLWK3%6DQG WKH
SODWHVZHUH WUDQVIHUUHG WR WKHSODWH UHDGHU7KHH[SUHVVLRQRI(*)3IOXRUHVFHQFH([QP
(P  QP DQG YLDELOLW\ +RHFKVW (P  QP  ([  QP ZDV TXDQWLILHG E\ XVLQJ WKH
IOXRUHVFHQFHPHDVXUHGIURPWKHERWWRPRIWKHSODWHV7KHWUDQVIHFWLRQHIILFLHQF\ZDVFDOFXODWHG
UHODWLYHWRFHOOQXPEHUDQGFRQWUROFHOOVXVLQJWKHIROORZLQJHTXDWLRQZKHUHDQG(*)3VDPSOH
(*)3FRQWURO +RHFKVWVDPSOH +RHFKVWFRQWURO DUH WKH IOXRUHVFHQFH VLJQDO RI (*)3 DQG +RHFKVW RI
WUHDWHGVDPSOHDQGQRQWUHDWHGFRQWUROFHOOVUHVSHFWLYHO\([SHULPHQWVZHUHUHSHDWHGWLPHV
LQGHSHQGHQWO\
 ൌ ୉ୋ୊୔౩౗ౣ౦ౢ౛ି୉ୋ୊୔ౙ౥౤౪౨౥ౢୌ୭ୣୡ୦ୱ୲౩౗ౣ౦ౢ౛Ȁୌ୭ୣୡ୦ୱ୲ౙ౥౤౪౨౥ౢ     
7UDQVIHFWLRQRIFHOOVFRQYHQWLRQDOPHWKRG
)RUWUDQVIHFWLRQRIWKH+(.FHOOOLQHVFHOOVZHUHVHHGHGDWDGHQVLW\RIFHOOP/LQ
ZHOOSODWHVRQHGD\EHIRUHWUDQVIHFWLRQ2QHKRXUSULRUWRWUDQVIHFWLRQFHOOVZHUHULQVHGZLWK3%6
DQGVXSSOHPHQWHGZLWKP/2SWL0(0/LIH7HFKQRORJLHV3RO\SOH[HV/ZHUHDGGHGWR
WKHFHOOVDQGWKHSODWHVZHUHLQFXEDWHGIRUKLQWKHLQFXEDWRU$IWHUZDUGVWKHVXSHUQDWDQWZDV
UHSODFHG E\P/ RI IUHVK JURZWKPHGLXP DQG WKH FHOOVZHUH IXUWKHU LQFXEDWHG IRU  K )RU
DQDO\VLVDGKHUHQWFHOOVZHUHKDUYHVWHGE\WU\SVLQL]DWLRQ
)RUGHWHUPLQDWLRQRIGHDGFHOOVWKH\ZHUHFRXQWHUVWDLQHGZLWKSURSLGLXPLRGLGH7KHUHODWLYH
H[SUHVVLRQ RI (*)3 IOXRUHVFHQFH RI  FHOOV ZDV TXDQWLILHG YLD IORZ F\WRPHWU\ XVLQJ D
&\WRPLFV )&  %HFNPDQ &RXOWHU )RU GHWHUPLQDWLRQ RI WKH WUDQVIHFWLRQ HIILFLHQF\ YLDEOH
FHOOVH[SUHVVLQJ(*)3ZHUHJDWHGXVLQJQRQWUHDWHGFHOOVDVQHJDWLYHFRQWURO([SHULPHQWVZHUH
UHSHDWHGWLPHVLQGHSHQGHQWO\
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T
he controlled delivery of genetic ma-
terial into eukaryotic cells has been
the focus of interdisciplinary scientiﬁc
activities during the last three decades.1,2
Within the ﬁeld of nanomedicine, successful
nonviral gene delivery holds great promise
for the treatment of awidevarietyofdiseases,
as a suitable transfection agent,3 once identi-
ﬁed, might be used in diﬀerent approaches.
Besides evolutionary qualiﬁed and very eﬃ-
cient viral transfection, nonviral delivery is of
high interest, reﬂected in the large number of
nonviral transfection agents being proposed.
Thereby, among polymeric materials, poly-
(ethylene imine) (PEI) represents the “gold
standard” for in vitro applications.4
The eﬃcient protection of nucleic acids
like plasmid DNA (pDNA) during delivery
while maintaining utmost biocompatibility
is one of the key requirements for such
materials. In general, cationic polyelectro-
lytes are capable of forming polyplexeswith
negatively charged pDNA, the main driving
forces being electrostatic interactions and
a gain in entropy for the whole system.5,6
Polyplexeswith an excess ofpositive charges
support both protection against degradation
and uptake via the negatively charged cell
membrane. Several studies show that the
polymer architecture and the overall molar
mass have amajor inﬂuence on the transfec-
tion eﬃciency (TE).7,8 Nevertheless, it is still
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ABSTRACT The controlled nonviral delivery of genetic material using
cationic polymers into cells has been of interest during the past three
decades, yet the ideal delivery agent featuring utmost transfection
eﬃciency and low cytotoxicity still has to be developed. Here, we
demonstrate that multicompartment micelles from stimuli-responsive
triblock terpolymers, polybutadiene-block-poly(methacrylic acid)-block-
poly(2-(dimethylamino)ethyl methacrylate) (BMAAD), are promising can-
didates. The structures exhibit a patchy shell, consisting of amphiphilic
(interpolyelectrolyte complexes, MAA and D) and cationic patches (excess D),
generating a surface reminiscent to those of certain viruses and capable of
undergoing pH-dependent changes in charge stoichiometry. After polyplex
formation with plasmid DNA, superior transfection eﬃciencies can be
reached for both adherent cells and human leukemia cells. Compared to the
gold standard PEI, remarkable improvements and a number of advantages
were identiﬁed for this system, including increased cellular uptake and an improved release of the genetic material, accompanied by fast and eﬃcient
endosomal escape. Furthermore, high sedimentation rates might be beneﬁcial regarding in vitro applications.
KEYWORDS: multicompartment micelles . interpolyelectrolyte complexes . nonviral gene transfection . polyplexes .
human leukemia cells
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challenging to design systems comprising high TE
and low cytotoxicity for gene delivery applications, as
in the case ofmost cationic polymers, like PEI, high TEs
are accompanied by increasing cytotoxicity. The use
of poly(ethylene glycol) (PEG) as, e.g., biocompatible
shell is one straightforward approach to decrease the
cytotoxicity but usually leads to lower TE.9,10
In addition, up to now most nonviral transfection
agents fail in case of suspension cells, e.g., Jurkat T cells,
a model cell line for human leukemia cells. This has
been attributed to the fact that 3D cultivation de-
creases the contact probability between cells and
polyplexes in general, if compared to the mechanism
proposed for the transfection of adherent cells.11,12
Hence, designing polymers that are capable of eﬃcient
gene transfer into suspension cells would allow target-
ing immune cells for the therapy of immune defects
(e.g., HIV), for cancer (e.g., leukemia), or to improve
transient transfection in biotechnological approaches.13
All these issues are further impeded by the fact that
the underlying transfection mechanism for pDNA in
contrast to siRNA (short interfering RNA) is far from
being completely understood, rendering the design of
eﬃcient transfection agents for this purpose extraordi-
narily diﬃcult.14,15
Here, we demonstrate for the ﬁrst time the advan-
tage of pH-responsive multicompartment micelles
formed via self-assembly of a stimuli-responsive triblock
terpolymer, polybutadiene-block-poly(methacrylic acid)-
block-poly(2-(dimethylamino)ethyl methacrylate)
(BMAAD, PB800-b-PMAA200-b-PDMAEMA285; the sub-
scripts denote thedegrees ofpolymerization; theoverall
molar mass of BMAAD is 105 300 g/mol), as promising
transfection agents for pDNA.Multicompartment struc-
tures represent a unique class ofmaterials where either
core, shell, or corona are further subdivided. Several
strategies have been used to induce compartmentaliza-
tion in block copolymer derived materials, including
combinations of highly incompatible segments, kinetic
control, or stepwise self-assembly by applying solvent
mixtures.1618 Although multicompartment architec-
tures have been in the focus formore than twodecades,
applications have been scarcely demonstrated. One
very elegant example, however, was shown by Lodge
and co-workers, where the segregated domains within
micellar cores could be used to store two diﬀerent hy-
drophobic guest molecules.19 Regarding pH-responsive
micellar carriers as gene delivery vehicles, pioneering
work was performed by Kataoka and co-workers.
For example, they used ABC triblock terpolymers with
two cationic segments of diﬀerent pKa, facilitating
the disruption of the endosome upon decrease of the
pH20 or, in another example, segments which under-
went charge conversion during the uptake process.21
Also, the use of pH-sensitive linkers between unlike
segments of AB diblock copolymers has proven to be
advantageous.22
The aim of this work was to investigate how the
rather heavy and voluminous BMAAD micelles can
be used as eﬃcient and pH-responsive nonviral gene
transfection agents for adherent cells and human
T-lymphocytes. We were interested whether the pres-
ence of diﬀerent surface patches, also known from
viral structures (e.g., alpha viruses),2325 inﬂuences
important process bottlenecks such as cytotoxicity
or carrier/serum interaction. Further, insights into the
underlying mechanism for pDNA transfection (which
is far from being completely understood) by using
a combination of diﬀerent analytical techniques in-
cluding asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4),
cryogenic electron microscopy (cryo-TEM), analytical
ultracentrifugation (AUC), and confocal laser scanning
microscopy (CLSM) are presented.
RESULTS AND DISCUSSION
In our case, for BMAAD (PB800-b-PMAA200-b-
PDMAEMA285), the hydrophobic PB forms the micellar
core, which, at low pH, is surrounded by a PMAA
shell and a PDMAEMA corona (Figure 1). Such micelles
are dynamic and show a strong pH-dependence con-
cerning their shape, size, and surface charge.26 At en-
dosomal pH (∼ 5), PMAA is uncharged, and PDMAEMA
forms a cationic corona (Figure 1a and d), whereas at
pH10, PDMAEMA isunchargedandpartially collapsed,and
merely PMAA now forms a negatively charged corona
(Figure 1b and e). Under physiological conditions (pH ∼
7.4) both blocks are charged, leading to the formation
of an intramicellar interpolyelectrolyte complex (im-
IPEC) shell (Figure 1c and f). Hence, themicellar surface
is patchy, featuring both charge neutral (im-IPEC) and
Figure 1. Cryo-TEM micrographs and schematic depictions
of BMAAD micelles at pH 5 (a, d), pH 10 (b, e), and pH 7.4
(c, f). Structure and block lengths of the used BMAAD
triblock terpolymer (g). Cryo-TEM images of pure BMAAD
(a, b, c) and schematic illustrations thereof (d, e, f).
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cationic domains (the DP of PDMAEMA is higher
than for the PMAA segment, resulting in an excess
positive net charge). These IPEC patches may lead to
an increased polycation density within parts of the
corona, and this in turn favors the formation of patchy
structures upon further complex formation.27
First, transfection studies of BMAAD with pDNA
under serum-reduced conditions as well as with
media containing 10% serum were performed with
adherent HEK293 cells, using linear PEI570 (25 kDa) and
PDMAEMA191 (30 kDa) as comparison. The BMAAD
micelles showed very high TE, even compared to PEI
(BMAAD: 70 ( 12% at N/P 20; PEI: 55 ( 8% at N/P 20)
under serum-reduced conditions (Figure 2a and
Figure S1, Supporting Information). In contrast, linear
PDMAEMA reaches only 12 ( 9% at N/P 15. This
increased TE for adherent cells by using BMAAD mi-
celles is in agreement with earlier studies on star-
shaped PDMAEMA or micelles with a PDMAEMA coro-
na.28 In the presence of serum even superior results
were obtained for BMAAD (74 ( 8% at N/P 30),
comparable to Lipofectamine 2000,29 whereas the TE
decreased signiﬁcantly for PEI (43 ( 7% at N/P 30;
Figure 2b). The fact that BMAAD performs even better
under serum conditions is remarkable as in general
serum leads to unspeciﬁc interactions and lower TEs in
case of cationic polymers.28,30
As the next step, the transfection of Jurkat T suspen-
sion cells with pDNA was evaluated. Figure 2c shows
a TE of up to 19 ( 6% with polyplexes formed
from BMAAD and pDNA (N/P 20), whereas both PEI
and PDMAEMA show a signiﬁcantly reduced TE,
which is in agreement with literature.31 The fact that
BMAAD micelles reach a 5-fold higher TE compared
to PEI highlights the potential of these structures as
powerful transfection agents. It should be noted that
the presence of PMAA within the im-IPEC shell does
not decrease the TE. Moreover, transfection experi-
ments under non static conditions (shaking) resulted in
similar transfection eﬃciencies (Figure S8, Supporting
Information).We also found no detectable cytotoxicity
of BMAAD using sensitive L929 cells (Figure 2d)
for concentrations up to 320 μg mL1, in contrast to
PDMAEMA and PEI, which show IC50 values of 30 and
6 μg mL1, respectively. Even polyplexes of PEI/pDNA
show lower values (IC50 ∼ 10 μg mL1).32 We propose
that the PMAA block of BMAAD is responsible for
the decreased cytotoxicity, without decreasing the TE
in contrast to PEG.10,33 Hence, the patchy micellar
surface featuring cationic domains and neutral
im-IPECs might serve as leverage to circumvent what
is often called the “PEG-dilemma” (decreasing TE in the
presence of a shielding PEG corona). The outstanding
biocompatibility in combinationwith high TE values for
Figure 2. Transfection eﬃciencies of BMAAD, PEI570, and PDMAEMA191 for adherent HEK cells in serum-reduced (a) and serum-
containing media (b) and human leukemia cells (c) at diﬀerent N/P ratios. An EGFP (pEGFP-N1) was used as reporter gene.
Cytotoxicity tests using L929 cells (d). Values represent the mean ( S.D; * represents a signiﬁcant diﬀerence (p < 0.01).
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BMAAD is impressive, as generally increases in eﬃciency
are accompanied by higher cytotoxicity for transfection
agents.7,34 Thus, using an ampholytic triblock terpolymer
containingboth a cationic and ananionic segment allows
constructing eﬃcient nonviral gene delivery agents even
though the cationic part, PDMAEMA, is usually regarded
as being not very eﬃcient.35
As such an outstanding performance was not anti-
cipated for BMAAD, we were interested in the under-
lying mechanism. Therefore, all formed polyplexes
were investigated with an ethidium bromide exclu-
sion assay (EBA)36 and dynamic light scattering (DLS)
experiments. Both BMAAD and PDMAEMA show simi-
lar binding aﬃnities to pDNA, but the values are lower
compared to PEI (Figure S2, Supporting Information).
This indicates the successful formation of polyplexes in
all cases, as EBA only provides a qualitative assessment.37
In addition, we performed a DNA gel migration assay,
conﬁrming the successful pDNA complexation at N/P 5
as no free pDNA could be detected (Figure S3, Support-
ing Information).
All polyplexes investigated exhibit a positive net
charge at physiological pH, as shown in zeta-potential
measurements (Figure 3c).Hydrodynamic diameters of
64 nm (PEI), 237 nm (BMAAD), and 52 nm (PDMAEMA)
can be observed (Figure 3c). For BMAAD, the formed
polyplexes are of comparable size as the “bare” mi-
celles (212 nm),26 which can be explained by a rather
tight wrapping of pDNA around the particles.38
pH-dependent surface characteristics of BMAAD are
schematically presented in Figure 3a. At physiological
pH (7.4) most of the PDMAEMA forms im-IPECs
with PMAA (white), whereas a slightly positive surface
charge is caused by excess protonated PDMAEMA
(DP PDMAEMA > DP PMAA).26 At endosomal pH (∼5),
PDMAEMA is highly protonated and stretched,
whereas PMAA partially collapses. This is supported
by pH-dependent zeta potential measurements. The
appearance of neutral im-IPECs, cationic patches on
the polyplex surface, and strong changes as a response
to variations of the pH are also known from clusters of
viral particles.2325
The results could also be conﬁrmed by asymmetric
ﬂow ﬁeld-ﬂow fractionation (AF4, Figure 3b), where an
Rg of 97 nm was obtained for BMAAD and 111 nm
for the corresponding polyplex; the obtained molar
Figure 3. Proposed surface characteristics of the BMAADmicelle (color code: red, positive charges/PDMAEMA; blue, negative
charges/PMAA; white, neutral im-IPEC domains; a). Detailed characteristics of BMAADmicelles obtained by asymmetric ﬂow
ﬁeld ﬂow fractionation (AF4) at pH 7 (b, d). Sedimentation velocity, hydrodynamic diameter, and zeta potential of polyplexes
formed at N/P 20 (c). Mean ﬂuorescence intensity (MFI) of cells transfected with YOYO-1 labeled pDNA for indicated time
points using BMAAD, PEI570, and PDMAEMA191 (e). Values represent the mean ( S.D; * represents a signiﬁcant diﬀerence
(p<0.05) to PEI570 andPDMAEMA191; ** represents a signiﬁcant diﬀerence (p<0.01) to PEI570 andPDMAEMA191,
# represents a
signiﬁcant diﬀerence (p < 0.01) to PDMAEMA191. Transfection eﬃciencies using EGFP as reporter gene of BMAAD and PEI for
adherent HEK cells treated with Baﬁlomycin (f).
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masseswereMn = 3.87 108 gmol1 andMw = 4.36
108 g mol1 for the micelle (Figure 3b and d). From the
molar mass of the single triblock terpolymer (105 300
g mol1) the aggregation number can be calculated
to roughly 3 700. Combining these resultswith theDLS
data, the general ratio Rg/Rh, which provides informa-
tion about the shape and the conformation of the
sample, can be calculated. Typical values are 0.775 for a
hard sphere, 1.0 for a soft sphere, or 1.78 for a mono-
disperse linear polymer chain in a good solvent.39 In
this study a value of 0.92 for themicelle and 0.94 for the
corresponding polyplex were obtained, which both ﬁt
to the expected model of a soft sphere. With decreas-
ing pH, the zeta potential as well as the hydrodynamic
diameter increases from 16.5mV and 237 nm to 30.3mV
and 420 nm (Figures 3c and 5). In addition, the stability
of the BMAAD polyplexes in the presence of serum
after 4 h was analyzed, and no signiﬁcant changes
could be observed (hydrodynamic diameter 230 nm),
suggesting that no protein based aggregation takes
place.
To achieve successful transfection in case of human
leukemia cells, the binding aﬃnity between polymer
and pDNA, size, and zeta potential of the polyplexes
is crucial. However, this has to be complemented by
an enhanced recognition and uptake by the cells. The
uptake is mainly inﬂuenced by the charge and a high
concentration of polyplexes at the cell surface.40 The
latter can be accessed via the sedimentation rate of the
polyplexes, as determined by analytical ultracentrifu-
gation (AUC). Presumably, larger particles with higher
sedimentation coeﬃcients lead to an increased parti-
cle uptake in case of in vitro transfection.41,42 Indeed,
the trends observed from DLS studies (Figure 3c) can
be conﬁrmed, as polyplexes from BMAAD micelles
revealed a higher sedimentation rate (6480 S) com-
pared to PEI (3140 S) and PDMAEMA (230 S), most
probably due to the rather dense PB core. This leads
to longer and more intensive interactions between
the cells and the polyplexes and, hence, an increased
internalization.
To investigate the time-dependent cellular uptake of
polyplexes, YOYO-1 labeled pDNAwas used (Figure 3e
and S8, Supporting Information). An enhanced uptake
can be clearly achieved with BMAAD micelles com-
pared to PEI or PDMAEMA. Already after 1 h the
majority of cells internalized the labeled polyplexes
with BMAAD, whereas 4 h are necessary in case of
PEI (Figure S8, Supporting Information). Even more
impressive, the overall amount of labeled pDNA taken
up by all viable cells (mean ﬂuorescence intensity, MFI,
Figure 3e) is almost doubled for BMAAD at all indicated
time points, demonstrating the enormous potential of
these structures.
One previously identiﬁed bottleneck during trans-
fection studies is the endosomal escape of polyplexes.
For PEI, a rather high buﬀer capacity is known, causing
the so-called proton sponge eﬀect.43 In contrast to PEI,
PDMAEMA has lower buﬀer capacities,26,44 which
might explain a lower TE of linear PDMAEMA but
not the high TE of BMAAD. Therefore, the behavior
of BMAAD at endosomal pH (∼ 5) was studied in more
detail.Here, a rather stretched PDMAEMA corona and a
partially collapsed PMAA shell can be anticipated.26
The increased amount of positive charges lead to
strong interactions with cellular membranes and, po-
tentially, destabilization. This was conﬁrmed both for
the polymers and the polyplexes by a hemolysis assay
at diﬀerent pH values (Figure 4a and Figure S7, Sup-
porting Information). While both PEI and PDMAEMA
did not exhibit any hemolytic activity (Figure S7,
Supporting Information), a strong pH-dependence
with up to 30 and 8% at pH 5was found for the BMAAD
micelles andpolyplexes, respectively. This supports our
assumption that BMAAD destabilizes the endosomal
membrane under acidic conditions and that the poly-
plex is released into the cytoplasm. The fact that this
endosomal disruption is pH-dependent demonstrates
the unique potential of such structures to react on
subtle environmental changes and thereby induce
endosomal escape.45 To conﬁrm the endosomal up-
take and the necessity of acidiﬁcation for an eﬃcient
transfection using BMAAD, transfections with baﬁlo-
mycinwere performed. Baﬁlomycin is known to inhibit
the ATPases in the endosomes and therefore prevents
acidiﬁcation. The TEs of BMAAD and PEI are signiﬁcantly
decreased (Figure 3f) to 13 and 1%, respectively. It
supports our assumption that endosomal pH facilitates
destabilization and destruction of the endosomal
membrane by shape/surface charge changes of the
proposed BMAAD polyplexes. In addition, transfec-
tions were performed at 4 C (Figure S8, Supporting
Information), also signiﬁcantly reducing the TE. To
prove the fast and eﬃcient endosomal escape, the
colocalization of transported pDNA was investigated
using confocal laser scanning microscopy (CLSM,
Figure 4c). Therefore YOYO-1 labeled pDNA (green,
Figure 4c) and LysoTracker Red (red, Figure 4c) were
used to visualize the polyplexes as well as the late
endosomes and lysosomes, respectively. Even after 1 h,
a strong correlation of pDNA from PEI and PDMAEMA
polyplexes and endosomes could be detected (yellow
signal, Figure 4c) in contrast to BMAAD-based poly-
plexes. To verify the uptake of the BMAAD polyplexes
via endocytosis, the colocalization of BMAAD poly-
plexes and early endosomes was demonstrated
(Figure S8, Supporting Information).
Once the polyplexes are released into the cytoplasm,
their dissociation is of great importance and was
investigated using heparin, a negatively charged poly-
saccharide (Figure 4b). Typically, heparin concentra-
tions of 10 U mL1 are necessary to achieve a total
release of pDNA from PEI-based polyplexes,4 whereas
50 UmL1 were needed for linear PDMAEMA, which is
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a reason for the lower TE. Although BMAAD and
PDMAEMA showed comparable binding aﬃnities, the
addition of only 10 UmL1 of heparin led to an almost
complete release of pDNA from BMAAD-based poly-
plexes. We attribute this to the PMAA block acting
as a competing polyanion. In addition, the dissocia-
tion assay performed at pH 5 (Figure S5, Supporting
Information) demonstrated a higher binding to pDNA,
and thus, no polyplex dissociation in the endosome
can be assumed.
The structure of the formed polyplexes was further
investigated using cryo-TEM measurements at diﬀer-
ent pH-values (Figure 5). At pH 7.4, the BMAADmicelles
are close to their isoelectric point,26 and polyplex
Figure 4. pH-dependent hemolysis assay of BMAAD of three diﬀerent donators, each n = 3 (a). Dissociation assay of
polyplexes formed at N/P 10 with increasing heparin concentrations (b). CLSM images of HEK cells transfected with indicated
polymer based polyplexes and YOYO-1 labeled pDNA (green); late endosomes/lysosomeswere stainedwith LysoTracker Red
(red), and cell nuclei were stained with Hoechst 33342 (blue); each scale bar represents 20 μm; colocalization of pDNA and
endosomal compartments are depicted in yellow (c).
Figure 5. Schematic depiction of the proposed polyplex structure and the corresponding cryo-TEM micrographs at pH 7.4;
the black arrow indicates the presence of im-IPECs (a), pH 5 (b), and pH 7.4 (c). Zeta potentials (ZP) of BMAAD polyplexes at
pH 7.4 (16.5 mV) and pH 5 (30.3 mV). Color code: gray (PB), blue (PMAA), red (PDMAEMA), white (im-IPEC), and black
(pDNA-polyplex). Scale bars indicate 200 nm and 50 nm in the insets.
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formation with pDNA leads to rather homogeneous
structures of spherical shape (cryo-TEM, Figure 5a).
The observed clustering can be explained by the rather
low zeta potential of 16.5 mV. A decrease in pH
within the endosome was simulated by the titration
with diluteHCl until a pH of 5was reached. This leads to
full protonation and stretching of the PDMAEMA co-
rona (pKa ∼ 7.7, zeta potential of 30.3 mV). Afterward,
severe structural changes occur, as shown in Figure 5b:
parts of the micellar core are covered by collapsed
PMAA patches (blue), and in addition, the polyplexes
formed of PDMAEMA (red) and pDNA (black) appear
more dense and rigid, as seen in the protrusions
connecting several micellar structures.26
These observations support our assumption of
an endosomal burst occurring under these conditions
and the data provided by hemolysis (Figure 4a).
Subsequently, if the polyplex leaves the endosome,
the pHwithin the cytoplasm rises to approximately 7.4,
which was simulated for the same polyplex solu-
tion (Figure 5c). The cryo-TEM micrograph now shows
polyplexes with the combined characteristics of
Figure 5a and b: PMAA is resolubilized via deprotona-
tion, leading to a more homogeneous overall appear-
ance, and the rather rigid PDMAEMA/pDNA strands
are still present, interconnecting several micelles.
The latter can be explained by a closer look at the
linear homopolymer of PDMAEMA, showing a rather
strong binding between PDMAEMA and pDNA (linear
PDMAEMA in Figure 4b). Since the polyplex is formed,
neither an increase in pH (4 to 9, data not shown)
nor the addition of heparin facilitated an easy release
of pDNA. Hence, in the case of the BMAAD the nega-
tively charged PMAA block acts as a competing poly-
electrolyte, presumably reduces the binding between
PDMAEMA and pDNA, and enables the release of
genetic material in the cytoplasm. Comparable struc-
tural rearrangements induced by changes in pH have
been reported for the Sindbis virus.25
So far, the use of BMAAD led to high TE and was
accompanied by surprisingly low cytotoxicity and a
facilitated release of pDNA. To highlight the advantage
of this system, the proposed transfection mechanism
with respect to the biological hurdles was schemati-
cally illustrated in Figure 6. After polyplex forma-
tion with pDNA, the internalization of the resulting
structures crucially depends on the interaction with
proteins and the cellular membrane. As we observed
high transfection eﬃciency in the presence of serum
proteins (Figure 2b) and no protein dependent aggre-
gation, a good shielding behavior can be assumed.
On the other hand, extremely fast cellular uptake
Figure 6. Schematic illustration of the proposed transfection mechanism for BMAAD-based polyplexes, with respect to the
biological hurdles. The BMAADmicelle protects the genetic material (pDNA), prevents aggregation, and the cationic corona
enables a fast and eﬃcient cellular binding and uptake. Inside the endosomes, a decrease in pH leads to a swelling of the
cationic corona and to adestabilizationof the endosomalmembrane. The release of the geneticmaterial inside the cytoplasm
is promoted by the middle block, PMAA, acting as a competing polyanion.
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(Figure 3e and S8, Supporting Information) is caused by
the presence of cationic surface patches, reminiscent
to the surface clusters of certain viruses.46,47 After inter-
nalization via endocytosis, prompt escape of the poly-
plexes from the endosome is facilitated by an increase
in size and zeta potential due to protonation and
swelling of the PDMAEMA segments (Figure 3a and
Figure 5), avoiding both digestion and exocytosis
(Figure 4c). In the cytoplasm, the release of the genetic
material is supported by the presence of the middle
block, PMAA, acting as a competing polyanion, result-
ing in an eﬃcient expression of the reporter gene.
CONCLUSION
The successful design of powerful gene delivery
agents imposes a range of bottlenecks,15 but research
eﬀorts are justiﬁed by the potential applicationswithin
medicine and biotechnology.48 Here, we presented
a ﬁrst study on the use of multicompartment micelles
from stimuli-responsive triblock terpolymers as a new
class of potential transfection agents.We propose that
this might be the ﬁrst step of a paradigm change for
nonviral gene transfection agents as low cytotoxicity
can be combined with outstanding TE for both adher-
ent cells and rather hard-to-transfect human leukemia
cells. In particular in the latter case, remarkable im-
provements compared to PEI and linear PDMAEMA
were shown.
Detailed investigations of the underlying mechan-
ism revealed a number of advantages for this system:
the dense core of the BMAAD micelles leads to higher
sedimentation rates and a superior cellular uptake.
Furthermore, the interaction of two oppositely
charged weak polyelectrolytes (PMAA and PDMAEMA)
leading to im-IPECs and charge-neutral patches is
to our opinion responsible for the reduced serum
aggregation, unaﬀected viability, enhanced cellular
uptake, and an improved pDNA release. In addition,
under acidic conditions PDMAEMA provokes an in-
crease in size and zeta potential, responsible for mem-
brane destabilization and the release of the polyplex
from the endosome.
Moreover, we believe that our results may aid in
a profound understanding of the transfectionmechan-
ism of pDNA. Our mechanism was developed based
on a combination of hemolysis data, cryo-TEM
investigations (which provide structural insight into a
model system), and microscopic images. All this is
supported by pH-dependent zeta potential and size
measurements.
In consequence, these eﬀects render BMAAD a
powerful advanced carrier for pDNA transfection stud-
ies, outperforming the “gold standard” PEI while main-
taining superior biocompatibility. This work shows
that by adopting certain design concepts from viruses
(deﬁned and responsive surface patches2325) via the
synthesis of well-deﬁned block copolymers and the
corresponding self-assembled aggregates superior
control over (mainly) interface-dominated processes
can be achieved. Of course, the next step would be to
perform electron microscopy under cell culture condi-
tions at diﬀerent stages of the transfection process.
To achieve this, we are currently working on strategies
targeting the in situ immobilization of cells during
diﬀerent stages of transfection using fast gelation
processes in aqueous media.
METHODS
Materials. Linear 25 kDa PEI was purchased from Polysciences
(Eppelheim, Germany). Ethidium bromide solution 1% was pur-
chased from Carl Roth (Karlsruhe, Germany). AlamarBlue, cell
light early endosomes-RFP, BacMAM and YOYO-1 were obtained
from Life Technologies (Darmstadt, Germany). If not stated
otherwise, cell culture materials, cell culture media, and solutions
were obtained from PAA (Pasching, Austria). Plasmid pEGFP-N1
(4.7 kb, Clontech, USA) was isolated using Qiagen Giga plasmid
Kit (Hilden, Germany). All other chemicals were purchased from
SigmaAldrich (Steinhausen, Germany) andare of analyticalgrade
or better and used without further purification. 2-Cyano-2-butyl
dithiobenzoate (CBDB) was purchased from Aldrich and used
without further purification. Azobis(isobutyronitrile) (AIBN,
Aldrich) was recrystallized from methanol. 2-(Dimethylamino)-
ethyl methacrylate (DMAEMA) was purchased from Aldrich and
passed over a column filledwith inhibitor remover prior tousage.
Synthesis of BMAAD Micelles. Synthesis and characterization
of the BMAAD micelles were described previously.26 Briefly,
linear BTD triblock terpolymerswere synthesized via sequential
living anionic polymerization of the corresponding monomers
in THF at low temperatures using sec-BuLi as initiator. Prior
to the reaction, freshly distilled THF (600 mL) was treated with
sec-BuLi at 20 C, followed by stirring overnight at room
temperature to produce alkoxides to stabilize the living poly-
butadienyl chain ends during the polymerization. In a typical
reaction, 1,3-butadiene (20.5mL, 13.3 g, 0.246mol) was initiated
with sec-BuLi (0.2 mL, 0.3 mmol) at 70 C in THF and
polymerized at 10 C for 8 h. After polymerization of the
first block, the living butadienyl chain ends were end-capped
with 1,1-diphenylethylene (0.11mL, 0.11 g, 0.6mmol) for 1 h at
50 C to attenuate the nucleophilicity. In this way, transfer
reactions upon addition of the second monomer, tBMA, could
be suppressed. Subsequently, tBMA (9.3 mL, 8.2 g, 0.057 mol)
was added to the reactionmixture via syringe and stirred for 1 h
at 40 C. After polymerization of the second block, DMAEMA
(20.2 mL, 18.9 g, 0.12 mol) was added via syringe.
Hydrolysis of the PtBMA Block. The BTD terpolymers were
dissolved in dioxane at a concentration of 1 g L1. A spatula
of the stabilizer 2,6-di-tert-butyl-p-cresol (BHT) anda10-foldexcess
of hydrochloric acid relative to the ester moietieswere added and
the reaction mixture was refluxed at 120 C for 24 h. Afterward,
the excess of HCl was removed by dialysis against deionized
water. After dialysis, micellar stock solutions in deionized water
with concentrations of approximately 0.5 g L1 were obtained.
From these stock solutions changes in pH or salinity were per-
formed by dialyzing against the corresponding buffer solutions.
Polyplex Preparation. Polyplexes of pDNA and polymers were
prepared bymixing stock solutions of pDNA and polymers at a
certain N/P ratio with 15 μg mL1 of pDNA solution in HBG
buffer (20 mM 4-(2-hydroxethyl) piperazine-1-ethanesulfonic
acid (HEPES) and 5% (w/v) glucose, pH 7.2). Subsequently, the
solutions were vortexed for 10 s at maximal speed and incu-
bated at room temperature for 20 min.
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Transfection of Adherent and Suspension Cells. HEK-293 cells
(CRL-1573, ATCC) and Jurkat (TIB-152, ATCC) cells were main-
tained in RPMI 1640 culture medium, L929 cells (CCL-1, ATCC)
in DMEM culture medium. Both media were supplemented
with 10% fetal calf serum (FCS), 100 μg mL1 of streptomycin,
100 IU mL1 of penicillin, and 2 mM L-glutamine. Cells were
cultivated at 37 C in a humidified 5% CO2 atmosphere.
For transfection of the adherent cell lines, cells were
seeded at a density of 105 cells per well in 12-well plates one
day before transfection. One hour prior to transfection, cells
were rinsedwith PBS and supplementedwith 1mL of OptiMEM
(Life Technologies) or fresh serum-containing growth media
(without antibiotics). Polyplexes (100 μL) were added to the
cells, and the plates were incubated for 4 h in the incubator.
Afterward, the supernatant was replaced by 1 mL of fresh
growth medium, and the cells were further incubated for
20h. For analysis, adherent cellswereharvestedby trypsinization.
In the case of the Baﬁlomycin experiments, 175 nM Baﬁlomycin
was added brieﬂy before polyplex addition to OptiMEM.
For transfection of suspension cells (Jurkat), 0.25 105 cells
were seeded in 0.25 mL of OptiMEM in 24-well plates, one
hour prior to transfection. The polyplex solutions (50 μL) were
added, and the plates were incubated for 4 h in the incubator.
Afterward, 0.25 mL of growth medium were added, and the
cells were incubated for further 20 h. For determination of
the viability during ﬂow cytometry, dead cells were identiﬁed
via counterstaining with propidium iodide. The relative expres-
sion of EGFP ﬂuorescence of 104 cells was quantiﬁed via
ﬂow cytometry using a Cytomics FC 500 (Beckman Coulter).
For determination of the transfection eﬃciency viable cells
expressing EGFP were gated. The experiments were performed
independently three times. Confocal laser scanningmicroscopy
(CLSM) was performed using as LSM510 (Carl Zeiss).
Plasmid DNA Labeling. For labeling of 1 μg pDNA, 0.026 μL of
1 M YOYO-1 solution was mixed with pDNA in 20 μL of pure
water. The solution was incubated for 1 h at room temperature
protected from light, before HBG was added to the used pDNA
concentration described before. Polymers were added at the
indicated N/P ratio, and the polyplex solution was treated as
described before and added to the cells. After 4 h of incubation,
the cells were harvested and 10% trypan blue was added to
quench the outer fluorescence of cells and identify only those
cells, which have taken up the genetic material. To determine
the relative uptake of NPs, 10 000 cells were measured by flow
cytometry, and the amount of viable cells showing YOYO-1
signal were gated. For measuring the mean fluorescence in-
tensity, all viable cells were measured.
Cytotoxicity. The cytotoxicity was tested with L929 cells, as
this sensitive cell line is recommended by ISO10993-5. In detail,
cells were seeded at 104 cells per well in a 96-well plate and
incubated for 24 h. No cells were seeded in the outer wells.
Afterward, polymers at the indicated concentrations were
added, and the cells were incubated at 37 C for further 24 h.
Subsequently, the mediumwas replaced by D-PBS and Alamar-
Blue as recommended by the supplier. After incubation for 4 h,
the fluorescence was measured at Ex 570/Em 610 nm, with
untreated cells on the same well plate serving as controls.
The experiments were performed independently three times.
Analytical Ultracentrifugation. Analytical ultracentrifugation
(AUC) was performed on a Beckman XL-I analytical ultracentri-
fuge (Krefeld, Germany). Experimentswere carried out in double-
sector aluminum centerpieces with an optical path length of
12 mm in a four holes rotor setup. Each cell was filled with
0.42 mL of solvent (HBG) and 0.4 mL of sample. A rotor speed
between 1000 to 10 000 rpm was used, depending on the sam-
ple. The system was equilibrated for 40 min at 25 C in the
centrifuge. Sedimentation data were recorded by absorbance
optics. Data analysis was done by the Sedfit software.49
Asymmetric Flow Field-Flow Fractionation (AF4). Asymmetric flow
field-flow fractionation (AF4) was performed on an AF2000 MT
System (Postnova Analytics, Landsberg, Germany) coupled to
a UV (PN3211, 260 nm), RI (PN3150), and MALLS (PN3070,
633 nm) detector. The eluent is delivered by three different
pumps (tip, focus, cross-flow), and the sample is injected by
an autosampler (PN5300) into the channel. The channel has a
trapezoidal geometry and an overall area of 31.6 cm2. The
nominal height of the spacer was 500 μm, and a regenerated
cellulose membrane with a molar mass cutoff of 10 kDa was
used as accumulation wall. All experiments were carried out at
25 C, and the eluent was degassed water containing 0.02%
NaN3 to avoid bacterial growth. To prevent attractive interac-
tions between the negative surface of the membrane and
the positive charges in the corona of themicelle, themembrane
surface was saturated by injection of 100 μg of pure
PDMAEMAwith the same procedure as for the micellar systems
described below. Twenty microliters of samples were injected
with an injection flow rate of 0.2 mL min1 and a cross-flow
rate of 0.9 mL min1 for 7 min (detector flow rate was set to
1 mL min1). After a focusing step, the cross-flow rate was
reduced under an exponential gradient (0.3) within 15 min to
0.05 mL min1 and kept constant for 25 min. Afterward the
cross-flow ratewas reduced to 0 mLmin1 for 15 min to ensure
complete elution. The refractive index increment for BMAAD
was measured by manual injection of a known concentration
directly into the channel without any focusing or cross-flow.
Integration of the RI signal gives a dn/dc of 0.156 mL g1. For
calculation of the molar mass and the radius of gyration the
Berry plotwas used.50 Allmeasurementswere repeated 5 times.
Cryo-TEM Measurements. For cryo-TEM, 5 μL of the sample
solution (in HBG) were applied to copper grids covered with a
holey carbon film (Quantifoil R3.5/1 Micro Tools GmbH, Jena,
Germany). The excess of the solution was automatically blotted
with a filter paper (1 s), and the grid was then plunged rapidly
into liquid ethane (180 C) in a cryobox (Carl ZeissNTSGmbH).
After removing excess ethane with a filter paper, the samples
were transferred with a cryotransfer unit (Gatan 626-DH, Gatan
GmbH, Munich, Germany) into the precooled cryoelectron
microscope operated at 120 kV (Philips CM 120, Eindhoven,
Netherlands) and viewed under low dose conditions with a
bottom-mounted 1k CCD camera.
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Experimental section
Synthesis of PDMAEMA
A solution of 1.54 mL DMAEMA (1.43 g, 9.1 mmol), 8.5 mg CBDB (0.03 mmol) and 1 mg AIBN (0.0061 mmol) in 
4 mL anisole was prepared in a microwave vial. The reaction vessel was capped, flushed with argon for 30 minutes and 
placed in an oil bath at 70 °C for 15 hours. Afterwards, the reaction solution was cooled down to ambient temperature and 
precipitated into 30 mL hexane to receive the final polymer. The dried polymer was characterized by size exclusion 
chromatography (SEC), providing its molar mass (Mn) of 27,600 and a PDI value of 1.28.
Size exclusion chromatography 
SEC was measured on a Shimadzu system equipped with a SCL-10A system controller, a LC-10AD pump, and a RID-
10A refractive index detector using a solvent mixture containing chloroform, triethylamine, and isopropanol (94:4:2) at a 
flow rate of 1 mL min-1 on a PSS-SDV-OLQHDU0ȝPFROXPQDW&7KHV\VWHPZDVFDOLEUDWHGZLWKSRO\VW\UHQHWR
67,500 g mol-1) and PMMA (2000 to 88,000 g mol-1) standards.
Ethidium bromide quenching assay
The polyplex formation of pDNA and polymers was detected by quenching of the ethidium bromide (EB) fluorescence as 
described previously.1 Briefly, 15 μg mL-1 pDNA in a total volume of 100 μL HBG were incubated with EB (0.4 μg mL-1)
for 10 min at room temperature. Then, polyplexes with increasing amounts of indicated polymers were prepared in black 96-
well plates (Nunc, Langenselbold, Germany). The samples were equilibrated for 20 min before the fluorescence was 
measured using a Tecan Genios Pro fluorescence microplate reader (Tecan, Crailsheim, Germany); the excitation and 
emission wavelength were 525 and 605 nm, respectively. A sample containing only pDNA and EB was used to calibrate the 
device to 100% fluorescence against a background of 0.4 μg mL-1 of EB in HBG solution. The percentage of dye displaced 
upon polyplex formation was calculated using equation (1):
     (1) 
Here, RFU is the relative fluorescence and Fsample, F0, and FDNA are the fluorescence intensities of a given sample, the EB 
in HBG alone, and the EB intercalated into pDNA alone.
Gel migration assay
The polyplexes were formed as described before in a volume of 50μL at the indicated N/P ratios and after 15 
minutes incubation 5μL loading buffer (0.25% Bromphenolblue, 40% saccharose) was added. Afterwards the 
solutions were loaded to an 1% agarose gel, electrophorese (Bio-Rad, Munich, Germany, Mini-Sub Cell GT 
System) was carried out with a current of 80 V (PowerPacTM Basic as power supply) for 1 h in TBE running 
buffer solution (107,8 g/L trise-base, 7,4g/L EDTA, 55g/L borate). Subsequently the agarose gel was incubated 
30 min in TBE containing ethidium-bromid.  
Heparin dissociation assay
To investigate the release of pDNA from polyplexes, the heparin dissociation assay was used. For this purpose, 15 μg mL-1
pDNA were incubated for 10 min with EB (0.4 μg mL-1) in a total volume of 100 μL HBG (pH 7 and 5) before polyplexes at 
N/P 10 were formed. After 15 min in the dark the polyplexes were transferred into black 96-well plates, and heparin was 
added at the indicated concentrations. The solution was mixed and incubated for further 30 min at 37 °C in the dark. The 
fluorescence of EB (Ex 525 nm / Em 605 nm) was measured, and the percentage of intercalated EB was calculated as 
described before (1).
Hemolysis assay
The membrane damaging properties of the polymers were quantified by analyzing the release of hemoglobin from human 
erythrocytes. The hemolysis assay was performed as described before.2 Briefly, blood from sheep was centrifuged at 4.500 × 
g for 5 min and the pellet was washed three times with cold DPBS. The stock solutions were diluted in HBG of indicated pH, 
and polymer solutions were prepared in HBG buffer as well. 100 μL of each solution were mixed and further incubated for 
60 min at 37 °C. The release of hemoglobin in the supernatant was determined at 580 nm after centrifugation (2,400 g for 
5 min). The absorbance was measured using a plate reader (Genios Pro, Tecan, Germany). For comparison, collected 
erythrocytes were washed with DPBS and either lysed with 1% Triton X-100 yielding the 100% lysis control value (A100) or 
resuspended in DPBS as reference (A0). The analysis was repeated with blood from at least six independent donors. The 
hemolytic activity of the polycations was calculated as follow (2):
 
    (2) 
Here, Asample, A0, and A100 are the absorbance intensities of a given sample, erythrocytes incubated with DPBS, and 
erythrocytes lysed with Titon X-100.
Dynamic and electrophoretic light scattering
Dynamic light scattering (DLS) was performed on an ALV-CGS-3 system (ALV, Langen, Germany) equipped with a 
He-1HODVHURSHUDWLQJDWDZDYHOHQJWKRIȜ = 633 nm. The counts were detected at an angle of 90°. All measurements were 
carried out at 25 °C after an equilibration time of 120 sec. For analyzing the autocorrelation function (ACF), the CONTIN 
algorithm3 was applied. Apparent hydrodynamic radii were calculated according to the Stokes–Einstein equation.
Electrophoretic light scattering was used to measure the electrokinetic potential, also known as zeta potential. The 
measurements were performed on a Zetasizer Nano ZS (Malvern Instruments, Herrenberg, Germany) by applying laser 
Doppler velocimetry.4 For each measurement, 20 runs were carried out using the slow-field reversal and fast-field reversal 
mode at 150 V. Each experiment was performed in triplicate at 25 & 7KH ]HWD SRWHQWLDO ȗ ZDV FDOFXODWHG IURP WKH
HOHFWURSKRUHWLFPRELOLW\ȝDFFRUGLQJWRWKH+HQU\(TXDWLRQ+HQU\FRHIILFLHQWINDZDVFDOFXODWHGDFFRrding to Oshima.5
Serum stability by DLS
Polyplexes were incubated with serum containing growth media in a micro-cuvette for 4h at 37°C under a CO2 atmosphere. 
Afterwards the cuvette was closed and directly transferred to the DLS device (Malvern Zetasizer). Measurements were done 
at 37 °C, detection at scattering angle of 173° and laser wavelength of 633 nm. Cumulant analysis and a non-negative least-
square algorithm were used to obtain distribution of hydrodynamic radius, z-average and PDI.
Results section
Flow Cytometer Analysis
The transfection efficiency was determined by measuring the amount of cells that express EGFP (encoded on the 
transported pDNA). Therefore, non-transfected cells serve as controls and were analyzed by flow cytometry. The histogram 
of control cells was used to define the amount of EGFP expressing cells (see Figure S1, control). The percentage of cells in 
the specific area was defined as transfection efficiency in percentage.
Control BMAAD
Figure S1. Histograms of non-transfected cells (control) and HEK cell transfected with BMAAD (N/P20). FL1 Log 
represents green fluorescence by EGFP expression.  
Interaction between used polymers and genetic material  
Indicated by the decrease of ethidium bromide fluorescence it is obvious that all polymers lead to a full complexation of 
the pDNA. Nevertheless, there are differences in the binding affinity. PEI shows a stronger interaction compared to 
PDMAEMA and BMAAD. The dependence of EBA on the chemical nature of the monomer was previously described.1
Figure S2. Ethidium bromide quenching assay of pDNA complexed with the indicated polymers. Binding of polymer to the 
pDNA results in a decrease in fluorescence intensity. The binding affinity was investigated dependent on the N/P ratio. 
 
 
The agarose gel migration assay was performed with the BMAAD micelle to confirm the full complexation of the pDNA. 
The results confirm the previous investigations (Figure S2) of the EBA. At an N/P ratio of 5 the pDNA is fully complexed 
with BMAAD micelles and no free pDNA is detectable. 
Figure S3. Agarose gel migration assay. Polyplexes were formed at indicated N/P ratio with BMAAD and 15 μg pDNA
 
 
NP 0 NP 1    NP 5     NP 10       
pDNA release at pH 5
To investigate the polyplex dissociation and, thus, the pDNA release both cryo-TEM investigations (at pH 5 and 7) and a 
heparin dissociation assay at pH5 were performed. 
Cryo-TEM 
The polyplexes were formed as described at a N/P ratio of 20, after 10 min incubation heparin (10 U/mL) was added and 
incubated for another 10 min. As can be seen in the micrographs, at pH 5 the polyplex surface remains patchy (Figure S4b), 
although less protrusions can be observed. For pH 7, in both cases the polyplex surface is rather smooth.
a b
c d
Figure S4. Cryo-TEM micrographs of BMAAD polyplexes incubated without (a, c) and with 10 U/mL heparin (b, d) at pH 5 (a, 
b) and pH 7 (c, d). 
Heparin dissociation assay 
Besides the cryo-TEM investigations a heparin dissociation assay was performed at pH 5. In contrast to the release assay 
at pH 7 no full decomplexation of the pDNA could be achieved. Moreover at heparin concentration of 2.5 U/mL no 
fluorescence changes compared to 0.5 U/mL heparin could be detected. Thus, the BMAAD micelles have a much higher 
binding to the pDNA at pH 5, indicating no polyplex dissociation in the endosome occurring. 
 
Figure S5: Dissociation assay of polyplexes formed at N/P 10 in pH 5 with increasing heparin concentrations (n=2)
Polyplex stability in presence and absence of serum
To analyze the aggregation behavior of the BMAAD polyplexe in HBG, their size was investigated over several hours. 
As obvious no changes in size were detected and thus no aggregation occured. 
Figure S6: BMAAD polyplex stability in HBG (pH7). The relative diameters are demonstrated over 15 h.  
pH dependent hemolysis assay of polyplexes
The hemolysis assay of the polyplexes confirms the results of the hemolysis assay using the single polymers. The 
BMAAD polyplexes shows, membrane-perturbing activity at pH 5 (endosomal pH), in contrast to physiological pH. PEI 
shows no dependency of pH, regarding its hemolysis activity.
a b
Figure S7. pH-dependent hemolysis assay of polyplexes (a) and single indicated polymers (b). Polyplexes of BMAAD, 
PDMAEMA, and PEI were formed at N/P ratio 20 and the values represent the mean of three different donators.
Analysis of polyplex uptake mechanism
To analyze the uptake mechanism of the BMAAD polyplexes in more detail the transfection were performed at 4 °C as 
endocytosis is energy dependent and should be reduced at this temperature (figure S8b)
a b
c d
Figure S8: Fraction of cells with Yoyo-1 labled pDNA for indicated time points using BMAAD, PEI and PDMAEMA (a). 
Transfection efficiencies with EGFP as reporter gen of BMAAD and PEI for adherent HEK cells performed at 4°C at N/P 
ratio 20 (b). Transfection efficiencies of Jurkat T cells under non-static conditions (c). CLSM images of HEK cells 
transfected with indicated BMAAD based polyplexes and YOYO-1 labeled pDNA (green), the early endosomes were stained 
by cell light early endosome BacMAM2.0 (red), and cell nuclei were stained with Hoechst 33342 (blue). Values represent the 
mean ± S.D; * represents a significant difference (p < 0.01).
The transfection efficiency of BMAAD as well as PEI is significant decreased when incubated for 4 h at 4 C°. This 
indicates an energy dependent uptake of BMAAD. The remaining TE of 25 % yielded with BMAAD can be explained by a
very efficient binding to the cellular membrane.
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ABSTRACT: We introduce a versatile ABC triblock terpoly-
mer platform based on poly(ethylene oxide)-block-poly(allyl
glycidyl ether)-block-poly(tert-butyl glycidyl ether) (PEO-b-
PAGE-b-PtBGE) and subsequent functionalization of the
PAGE segment with thiogalactose (hydroxyl), cysteamine
(amino), and 2-mercaptopropionic acid (carboxy) by thiol−
ene chemistry. These materials are used to prepare core-shell-
corona micelles with a PtBGE core, a PAGE shell, and a PEO
corona and sizes below 30 nm in aqueous media. We
investigate the inﬂuence of diﬀerent functional groups on
micelle formation and cellular uptake. Moreover, co-assembly
of diﬀerently functionalized materials allows to create micelles
with a mixed shell and adjustable charge and, in that way, important characteristics such as cell uptake or cytotoxicity can be
controlled. Furthermore, we demonstrate that even the uptake mechanism depends on the substitution pattern of the underlying
triblock terpolymer.
■ INTRODUCTION
The synthesis and self-assembly of amphiphilic block
copolymers into micellar structures of deﬁned size, shape,
and composition represents a very active ﬁeld of research and
such nanostructures show high potential for their use in
potential biomedical and pharmaceutical applications.1,2 The
introduction of further functionalities or stimuli-responsive
segments as well as the morphological variety being accessible
beneﬁt from the introduction of a third segment (C) resulting
in ABC triblock terpolymers.3 Since ﬁrst attempts in the 1980s
and the pioneering work of Stadler and co-workers later in the
1990s, increasing research eﬀorts have been devoted to the
preparation and application of such materials.4−7 One
intriguing aspect of ternary materials is that multicompartment
micelles can be realized, structures which are further subdivided
in core, shell, or corona. As a consequence of their architecture,
multicompartment micelles can be used to simultaneously store
two diﬀerent payloads within one micellar core or to implement
several responsive segments.8−11 In this context, we recently
reported that multicompartment micelles with pH-dependent
charge and morphology bear enormous potential as nonviral
gene transfection agents, enabling high delivery eﬃciency in
combination with low cytotoxicities.12,13
Typically, each segment of ABC triblock terpolymers is
attributed a speciﬁc “task” in solution: One block (e.g., A)
ensures solubility in the desired environment. In water, often
poly(ethylene oxide) (PEO) is used as this material is water-
soluble, nontoxic, and prevents unspeciﬁc protein interactions
(“stealth” eﬀect).14−17 Another segment (B) can be used to
introduce functional groups or the possibility to carry out
postpolymerization functionalization reactions (e.g., allyl
glycidyl ether) to further ﬁne-tune the material properties or
to attach targeting moieties.18−21 The third block (C) often is
utilized as solvophobic block, resulting in amphiphilic triblock
terpolymers in the case of hydrophobic segments. Related to
this, we recently reported that hydrophobic glycidyl ethers, for
example, tert-butyl glycidyl ether or furfuryl glycidyl ether, can
be used as core forming segments in micellar aggre-
gates.18,19,22,23 These micellar cores can be applied, for example,
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to encapsulate hydrophobic guest compounds such as drugs or
dyes.24 If suitable building blocks are realized, the response of
block copolymer nanostructures toward changes in temperature
or pH value can be easily realized.25,26 This often induces quite
drastic changes of the material properties and can be used to
trigger the controlled release of encapsulated cargo or to enable
endosomal release after cell internalization.12,27,28 Nevertheless,
to date, the number of solution applications involving ABC
triblock terpolymers is rather low, probably due to high
synthetic eﬀorts that often involve the combination of diﬀerent
polymerization techniques, modiﬁcation sequences, or stepwise
assembly procedures.
An alternative approach for the design of complex block
copolymer micelles is the simple mixing of block copolymers.
For instance, AB and AC diblock copolymers, where A
represents identical hydrophobic blocks, which are mixed in
nonselective solvents and then transferred to a solvent or
solvent mixture selective for B and C. It is generally believed
that comparable degrees of polymerization (DP) for block A
are beneﬁcial. This could be shown, for example, for PEO-b-
PLA and PNIPAM-b-PLA diblock copolymers. Co-assembly in
aqueuos solution leads to the formation of micelles with a PLA
core and a mixed PEO/PNIPAM shell. These materials showed
potential as smart carriers in drug delivery processes.29−32 In
this context, Kabanov and co-workers have demonstrated that
comicelles prepared from mixtures of amphiphilic and cationic
copolymers based on Pluronics can be applied for an eﬃcient
delivery of oligonucleotide sequences.33 Such concepts have
also been employed for the preparation of multicompartment
micelles.34,35
Besides eﬀorts to design structures of increased complexity
for drug delivery applications, Kataoka et al. demonstrated that
size does indeed matter and showed that micelles with
diameters below 100 nm are highly interesting candidates in
such approaches.36 Commonly, nanostructures with diameters
between 50 to 200 nm are used because endocytosis as
predominant internalization process can be assumed, the
interaction with the immune system is reduced, and renal
clearance can be avoided.37,38 In contrast, polymeric micelles
with sizes far below 100 nm are scarce in literature and, up to
now, rarely studied with regard to interactions with biological
matter.37 In this context, spherical core−shell micellar
structures of approximately 30 nm were found to eﬀectively
penetrate poorly permeable tumor membranes.36 Besides size,
also charge signiﬁcantly inﬂuences cell interactions of polymeric
micelles, as well as their cytotoxicity and hemocompatibility. In
general, the presence of cationic charges leads to increased
interactions with the negatively charged cell membrane.
Although this is advantageous for uptake, it also favors
membrane destabilization and increases cytotoxicity. These
side eﬀects can be circumvented by using PEO as corona, but
often at the cost of decreased cell interaction.39,40 As an
alternative, the presence of negatively charged segments allows
to decrease both the cytotoxicity and nonspeciﬁc interactions
with serum proteins.41 Hence, direct control over the charge
balance in (block co-) polymer nanostructures seems to be a
promising strategy to balance cellular interactions, eﬃcient
uptake, and simultaneously suppress nonspeciﬁc interactions
and lower cytotoxicity. This can be achieved, e.g., via the
combination of positively and negatively charged blocks in
block copolymers and has been recently demonstrated for
multicompartment micelles from polybutadiene-block-poly-
(methacrylic acid)-block-poly(2-dimethylaminoethyl methacry-
late) (BMAAD) triblock terpolymers. These structures
comprise a polybutadiene core, a patchy shell consisting of
intra-micellar interpolyelectrolyte complexes (im-IPEC) be-
tween PMAA and PDMAEMA, and a cationic corona of excess
PDMAEMA.12 We could demonstrate that the presence of the
im-IPECs and the inherent pH-dependent dynamics of the
system favor cellular uptake, while the PMAA middle segment
acts as competing polyelectrolyte during delivery of pDNA and,
at the same time, reduces cytotoxicity and facilitates release of
the genetic material. Nevertheless, this approach suﬀers from a
severe drawback: Preparation conditions, micellar size, and pH-
dependent characteristics depend strongly on the terpolymer
composition and, thus, have to be investigated and optimized
for each new material being synthesized. This motivated us to
probe a diﬀerent, more versatile and general approach: Co-
assembly of a small library of structurally similar ABC triblock
terpolymers with diﬀerent functional groups being present
within the segment B.
We therefore introduce a triblock terpolymer platform based
on poly(ethylene oxide)-block-poly(allyl glycidyl ether)-block-
poly(tert-butyl glycidyl ether) (PEO-b-PAGE-b-PtBGE), syn-
thesized by sequential living anionic ring-opening polymer-
ization (AROP), as versatile carriers for hydrophobic
compounds. The pendant double bonds of the PAGE block
were functionalized by thiol−ene chemistry to introduce model
ligands (thiogalactose), amine groups to provide positive
charges (cysteamine), as well as carboxylic groups to generate
negative charges (3-mercapto propionic acid). The obtained
triblock terpolymers are subsequently used for the co-assembly
into well-deﬁned spherical core-shell-corona micelles with
diameters below 30 nm and precisely adjustable charge and
composition. Depending on the latter, we found synergistic
eﬀects regarding cellular uptake and cytotoxicity. In addition,
the internalization eﬃciency (and pathway) was analyzed under
serum-reduced and serum-containing conditions, showing an
eﬀective shielding by the PEO corona and providing ﬁrst
insights into the underlying uptake mechanism.
■ EXPERIMENTAL SECTION
Instruments and Methods. 1H NMR spectra were recorded on a
Bruker AC 300 MHz spectrometer in deuterated chloroform.
Size Exclusion Chromatography (SEC). Size exclusion chromatog-
raphy (SEC) was performed on a Shimadzu SCL-10A system (with a
LC-10AD pump, a RID-10A refractive index detector, and a PL gel 5
μm mixed-D column at RT), the eluent was a mixture of chloroform/
triethylamine/isopropanol (94:4:2) with a ﬂow rate of 1 mL/min. The
system was calibrated with poly(ethylene glycol) standards from PSS
(Mn = 1470 to 42000 g/mol).
Matrix Assisted Laser Desorption Ionization - Time of Flight Mass
Spectrometry (MALDI-ToF). MALDI−ToF mass spectra were
obtained using an Ultraﬂex III ToF/ToF mass spectrometer (Bruker
Daltonics) with trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenyli-
dene] malononitrile (DCTB) or 2,5-dihydroxybenzoic acid (DHB) as
matrix in reﬂector as well as in linear mode. The instrument was
calibrated prior to each measurement with an external PMMA
standard from PSS Polymer Standards Services GmbH.
Dynamic Light Scattering (DLS). Dynamic light scattering (DLS)
was performed at a scattering angle of 90° on an ALV CGS-3
instrument and a He−Ne laser operating at a wavelength of λ = 633
nm at 25 °C. The CONTIN algorithm was applied to analyze the
obtained correlation functions. Apparent hydrodynamic radii were
calculated according to the Stokes−Einstein equation. All CONTIN
plots are number-weighted.
Cryogenic Transmission Electron Microscopy (cryo-TEM). Cryo-
TEM measurements were carried out at 120 kV using a Philips-CM
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120 equipped with a 1k × 1k CCD camera. Sample preparation was
performed on Quantifoil grids (holey carbon R2/2) after plasma
cleaning. Vitriﬁcation of the samples was carried out in a home-built
system with a temperature control unit. A drop of the polymer
solution (5 μL) was placed on the grid, which was blotted and
subsequently plunged into a cryogen reservoir containing liquid
ethane. The samples were afterward stored in liquid nitrogen and were
transferred to the TEM keeping the temperature below −176 °C to
avoid the formation of crystalline ice layers.
Asymmetric Flow Field-Flow Fractionation (AF4). Asymmetric
ﬂow ﬁeld-ﬂow fractionation (AF4) was performed on an AF2000 MT
System (Postnova Analytics, Landsberg, Germany) coupled to an UV
(PN3211, 260 nm), RI (PN3150), MALLS (PN3070, 633 nm), and
DLS (ZetaSizer Nano ZS) detector. The eluent is delivered by three
diﬀerent pumps (tip, focus, cross-ﬂow) and the sample is injected by
an autosampler (PN5300) into the channel. The channel has a
trapezoidal geometry and an overall area of 31.6 cm2. The nominal
height of the spacer was 500 μm and a regenerated cellulose
membrane with a molar mass cutoﬀ of 10 kg/mol was used as
accumulation wall. All experiments were carried out at 25 °C and the
eluent was degassed water containing 20 mM NaCl. The detector ﬂow
rate was set to 0.5 mL/min for all samples and 20 μL (5 mg/mL) were
injected with an injection ﬂow rate of 0.2 mL/min for 7 min. For EAT
the cross-ﬂow was set to 2 mL/min and decreased under an
exponential gradient (0.5) to 0 within 20 min. For EGT the cross-ﬂow
was set to 2 mL/min and decreased under a linear gradient to 0 within
20 min. For ECT the cross-ﬂow was set to 2 mL/min and decreased
under an exponential gradient (0.5) to 0 within 25 min. For ENT the
cross-ﬂow was set to 1.3 mL/min and decreased under an exponential
gradient (0.7) to 0 within 25 min. For (ENT/ECT)1:2.6 the cross-ﬂow
was set to 2 mL/min and decreased under a linear gradient to 0 within
35 min. For (ENT/ECT)1.2:1, the cross-ﬂow was set to 2 mL/min and
decreased under a linear gradient to 0 within 30 min. For (ENT/
ECT)3.5:1, (ENT/ECT/EGT)3.5:1:0.5, and (ENT/ECT/EGT)3.4:1:2.3, the
cross-ﬂow was set to 1.3 mL/min and decreased under an exponential
gradient (0.7) to 0 within 25 min. After the cross-ﬂow reaches zero, for
all samples, the cross-ﬂow was kept constant at zero for at least 30 min
to ensure complete elution. For calculation of the molar mass and the
radius of gyration a Berry plot was used.42 All measurements were
repeated three times. The refractive index increment (dn/dc) of all
samples was measured by manual injection of a known concentration
directly into the channel without any focusing or cross-ﬂow. The dn/
dc was calculated as the average of at least three injections from the
area under the RI curve (AUCRI).
Electrophoretic Light Scattering (ELS). Electrophoretic light
scattering was used to measure the electrokinetic potential, also
known as zeta potential. The measurements were performed on a
Zetasizer Nano ZS (Malvern Instruments, Herrenberg, Germany) by
applying laser Doppler velocimetry.43 For each measurement, 20 runs
were carried out using the slow-ﬁeld reversal and fast-ﬁeld reversal
mode at 150 V. Each experiment was performed in triplicate at 25 °C.
The zeta potential (ζ) was calculated from the electrophoretic mobility
(μ) according to the Henry equation. Henry coeﬃcient f(ka) was
calculated according to Ohshima.44
Gel Migration Assay. The micelles (40 μg) were incubated with 5
μL loading buﬀer (0.25% bromphenolblue, 40% saccharose). After-
ward, the solutions were loaded to an 1% agarose gel, electrophorese
(Bio-Rad, Munich, Germany, Mini-Sub Cell GT System) was carried
out with a current of 80 V (PowerPac Basic as power supply) for 30
min in TBE running buﬀer solution (107.8 g/L tris-base, 7.4 g/L
EDTA, 55 g/L borate). Subsequently, the agarose gel was irradiated
with an UV-lamp to induce ﬂuorescence of the bands.
HEK-293 cells (CRL-1573, ATCC) were maintained in RPMI 1640
culture medium, L929 cells (CCL-1, ATCC) in DMEM culture
medium, and HepG2 (HB-8065, ATCC) in DMEM-F12 culture
medium. Both media were supplemented with 10% fetal calf serum
(FCS), 100 μg/mL streptomycin, 100 IU/mL penicillin, and 2 mM L-
glutamine. Cells were cultivated at 37 °C in a humidiﬁed 5% CO2
atmosphere.
Cytotoxicity. For L929 cells, the cytotoxicity assay was performed as
described by ISO10993-5. In detail, cells were seeded at 1 × 104 cells
per well in a 96-well plate and incubated for 24 h. No cells were seeded
in the outer wells. Afterward, polymers at the indicated concentrations
were added, and the cells were incubated at 37 °C for further 24 h.
Subsequently, the medium was replaced by fresh media and
AlamarBlue, as recommended by the supplier. After incubation for 4
h, the ﬂuorescence was measured at Ex 570/Em 610 nm, with
untreated cells on the same well plate serving as controls.
Hemolysis Assay. The membrane damaging properties of the
polymers were quantiﬁed by analyzing the release of hemoglobin from
human erythrocytes. The erythrocyte-containing blood was centri-
fuged at 700 g for 10 min. The obtained pellet was washed three times
with D-PBS pH 7.4 by centrifugation at 700 g for 10 min and
resuspended in HBG buﬀer of pH 7. Polymer solutions were added to
the erythrocytes (100 μL) and incubated for 60 min under constant
shaking at 37 °C. After centrifugation (700 g, 10 min), the supernatant
was analyzed for released hemoglobin at 580 nm. The absorbance was
measured using a plate reader (Genios Pro, Tecan, Germany). For
comparison, collected erythrocytes were washed with DPBS and either
lysed with 0.2% Triton X-100, yielding the 100% lysis control value
(A100) or resuspended in DPBS as reference (A0). The analysis was
repeated with blood from at least six independent donors. The
hemolytic activity of the polycations was calculated as follow:
= × − −A A A A%hemolysis 100 ( )/( )sample 0 100 0 (1)
Here, Asample, A0, and A100 are the absorbance intensities of a given
sample, erythrocytes incubated with D-PBS, and erythrocytes lysed
with Titon X-100.
Uptake Studies. For uptake of the adherent cell lines, cells were
seeded at a density of 105 cells per well in 12-well plates 1 day before
internalization experiment. A total of 1 h prior to addition of micelles,
cells were rinsed with PBS and supplemented with 1 mL OptiMEM
(Life Technologies) or fresh serum containing growth media. Micelles
were added at indicated end concentration to the cells and the plates
were incubated for 24 h in the incubator. For analysis, the cells were
harvested by trypsinization and 10% trypan blue was added.
Subsequently, the cells were analyzed via ﬂow cytometry using a
Cytomics FC 500 (Beckman Coulter). For determination of the
viability during ﬂow cytometry, dead cells were identiﬁed in the SSC/
FSC dot plot. The relative uptake of encapsulated nile red ﬂuorescence
of 104 cells was quantiﬁed. For determination of the uptake eﬃciency,
viable cells containing nile red were gated. The experiments were
performed at least independently three times.
Materials. The triblock terpolymer precursor PEO42-b-PAGE15-b-
PtBGE12 (SEC: Mn = 3350 g/mol; Mw = 3500 g/mol; Đ = 1.05;
obtained with PEO calibration; NMR: Mn = 5122 g/mol) as well as
2,3,4,6-tetra-O-acetyl-1-thio-β-D-galactopyranose (acetylated thiogalac-
tose) were synthesized as reported previously.19,45,46 2,2-Dimethoxy-2-
phenylacetophenone (DMPA), cysteamine, 3-mercapto propionic
acid, sodium methanolate (0.5 M in methanol), nile red, DOWEX
50WX8−200, methanol, N,N-dimethylformamide (DMF), tetrahydro-
furan (THF), and ethanol were purchased from Aldrich and used as
received. AlamarBlue was obtained from Life Technologies (Darm-
stadt, Germany). If not stated otherwise, cell culture materials, cell
culture media, and solutions were obtained from PAA (Pasching,
Austria). All other chemicals were purchased from Sigma-Aldrich
(Steinhausen, Germany) and are of analytical grade or better and were
used without further puriﬁcation.
Cysteamine Functionalization of PEO42-b-PAGE15-b-PtBGE12. A
total of 300 mg (0.059 mmol, corresponding to 0.88 mmol of PAGE)
of the triblock terpolymer were dissolved in 5 mL of a mixture of
DMF, EtOH, and MeOH (ratio 1:0.3:1). Aliquots of 45 mg (0.18
mmol, 0.2 equiv) DMPA and 339 mg cysteamine (4.39 mmol, 5
equiv) were added to the mixture. The reaction mixture was degassed
and stirred under UV irradiation (366 nm, 6 W) for 24 h. The increase
of the molar mass (Mn) and the decrease of the signal intensity of the
peaks of the double bond were monitored by SEC and 1H NMR,
respectively. The reaction mixture was puriﬁed by dialysis against
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water, a THF/water mixture (1:1) and pure THF. The solvent was
removed by distillation under reduced pressure and the product dried
under vacuum. Yield: 250 mg.
1H NMR (300 MHz, CDCl3-d6, δ in ppm): 6.00−5.75 (m, 1H),
5.34−5.07 (m, 2H), 4.04−3.9 (m, 2H), 3.9−3.2 (m, PEO backbone),
2.74−1.94 (br, 4H, CH2-CH2-S), 2.74−1.93 (br, 2H, S-CH2), 1.3−
0.97 (s, 9H). f = 53%. SEC: Mn = 3500 g/mol, Mw = 3600 g/mol, Đ =
1.06.
3-Mercapto Propionic Acid Functionalization of PEO42-b-PAGE15-
b-PtBGE12. A total of 450 mg (0.088 mmol, corresponding to 1.32
mmol of PAGE) of the triblock terpolymer was dissolved in 5 mL of a
mixture of DMF/EtOH (ratio 3:1). Subsequently, 68 mg (0.27 mmol,
0.2 equiv) DMPA and 0.23 mL of 3-mercapto propionic acid (2.64
mmol, 2 equiv) were added. The reaction mixture was degassed and
stirred under UV irradiation (366 nm, 6 W) for 24 h. The increase of
the molar mass (Mn) and the decrease of the signal intensity of the
peaks of the double bond were monitored by SEC and 1H NMR,
respectively. The reaction mixture was puriﬁed by dialysis against a
THF/water mixture (5:1) and pure THF. The solvent was removed by
distillation under reduced pressure and the product dried under
vacuum. Yield: 600 mg.
1H NMR (300 MHz, CDCl3-d6, δ in ppm): 3.94−3.24 (m, PEO
backbone), 2.87−2.72 (m, 4H, CH2 linker), 1.92−1.76 (m, 2H),
1.24−1.09 (s, 9H). Degree of functionalization: f = 100%. SEC: Mn =
3550 g/mol, Mw = 3700 g/mol, Đ = 1.05.
Thiogalactose Functionalization of PEO42-b-PAGE15-b-PtBGE12. A
total of 450 mg (0.088 mmol, corresponding to 1.32 mmol of PAGE)
of the triblock terpolymer were dissolved in 5 mL of a mixture of
DMF/EtOH (ratio 3:1). To the mixture, 68 mg (0.27 mmol, 0.2
equiv) DMPA and 963 mg acetylated thiogalactose (2.64 mmol, 2
equiv) were added. The reaction mixture was degassed and stirred
under UV irradiation (366 nm, 6 W) for 72 h. The increase of the
molar mass (Mn) and the decrease of the signal intensity of the peaks
of the double bond were monitored by SEC and 1H NMR,
respectively. The reaction mixture was puriﬁed by size exclusion
chromatography (Biobeads SX-1) and the product was dried under
vacuum. Yield: 600 mg.
1H NMR (300 MHz, CDCl3-d6, δ in ppm): 6.00−5.76 (m, 1H),
5.7−4.9 (m, 3H, Gal), 4.56−4.43 (m, 1H, Gal), 4.40−4.21 (m, 3H,
Gal), 4.20−3.03 (m, PEO backbone), 2.86−2.62 (m, 2H), 2.57−1.47
(m, 12H−Ac), 1.28−1.04 (s, 9H). Degree of functionalization: f =
70%. SEC: Mn = 4200 g/mol, Mw = 4350 g/mol, Đ = 1.04.
Deprotection of PEO42-b-(PAGE5-co-PAGE10,Gal)-b-PtBGE12. A total
of 600 mg (0.066 mmol, corresponding to 2.64 mmol of acetyl
groups) of the triblock terpolymer was dissolved in 15 mL of dry
methanol. To the mixture, 7 mL (3.5 mmol, 1.3 equiv) of a 0.5 M
sodium methanolate solution was added and the mixture was allowed
to stir for 1 h. Afterward, a DOWEX 50WX8−200 ion-exchange resin
was added and stirred for 15 min to neutralize the reaction mixture.
The resin was ﬁltered oﬀ, and the crude product was dialyzed against a
water/THF mixture (5:1), pure water, and pure THF. The solvent was
removed by distillation under reduced pressure and product was dried
under vacuum. Yield: 250 mg.
1H NMR (300 MHz, CDCl3-d6, δ in ppm): 6.0−5.76 (m, 1H), 5.5−
4.84 (m, 3H-Gal), 4.10−2.80 (m, PEO backbone), 1.26−1.01 (s, 9H).
SEC: Mn = 10400 g/mol, Mw = 11500 g/mol, Đ = 1.10.
Preparation of Triblock Terpolymer Micelles. The following
procedures with the respective stoichiometry were used for the
preparation of all micellar nanostructures with a concentration of 10
g/L in aqueous solution.
A total of 100 mg of the corresponding triblock terpolymer was
dissolved in 5 mL of THF, and 4 mg of nile red was added to the
solution. To the mixture was then added slowly 10 mL of Milli-Q
water via syringe, and the THF was allowed to evaporate by stirring
overnight. Non-encapsulated dye was ﬁltered oﬀ by a 0.45 μm nylon
syringe ﬁlter. In case of evaporation of water, the solution was ﬁlled up
again to a volume of 10 mL. After ﬁltration, a clear pink solution could
be obtained.
Binary Co-micelles. Here, the preparation of a 1.2:1 mixture of
PEO42-b-(PAGE8,NH2-co-PAGE7)-b-PtBGE12 and PEO42-b-PA-
GE15,COOH-b-PtBGE12 is reported. Due to the diﬀerent degrees of
functionalization, a 2:1 ratio regarding the masses was used.
A total of 6.6 mg of PEO42-b-(PAGE8,NH2-co-PAGE7)-b-PtBGE12
and 3.3 mg of PEO42-b-PAGE15,COOH-b-PtBGE12 were dissolved in 0.3
mL of THF, and approximately 2 mg of nile red was added to the
solution. The solution was then slowly added to 1 mL of Milli-Q water
and the THF was allowed to evaporate by stirring overnight.
Nonencapsulated dye remained as precipitate in the solution and
was ﬁltered oﬀ by a 0.45 μm nylon syringe ﬁlter. In case of evaporation
of water, the solution was ﬁlled up again to a volume of 1 mL. After
ﬁltration, a clear pink solution could be obtained.
Scheme 1. Schematic Representation of the Thiol−Ene Modiﬁcation of PEO42-b-PAGE15-b-PtBGE12 Using Cysteamine (N), 3-
Mercapto Propionic Acid (C), and Acetylated Thiogalactosea
aThe abbreviations (EAT, ENT, ECT) will be used later on for the nomenclature of the micelles generated via self-assembly of the modiﬁed triblock
terpolymers.
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Ternary Comicelles. Here, the preparation of a 3.4:1:2.3 mixture of
PEO42-b-(PAGE8,NH2-co-PAGE7)-b-PtBGE12, PEO42-b-PAGE15,COOH-
b-PtBGE12, and PEO42-b-(PAGE10,AcGal-co-PAGE5)-b-PtBGE12 is re-
ported. Due to the diﬀerent degrees of functionalization, a 6:1:3.5 ratio
regarding the stoichiometry of the amino and carboxy functionalized
triblock terpolymers was used.
A total of 12 mg of PEO42-b-(PAGE8,NH2-co-PAGE7)-b-PtBGE12, 2
mg of PEO42-b-PAGE15,COOH-b-PtBGE12, and 7 mg PEO42-b-
(PAGE10,AcGal-co-PAGE5)-b-PtBGE12 were dissolved in 0.4 mL of
THF, and approximately 3 mg of nile red was added to the solution.
The solution was then slowly added to 2.1 mL of Milli-Q water, and
the THF was allowed to evaporate by stirring overnight. Non-
encapsulated dye remained as precipitate in the solution and was
ﬁltered oﬀ by a 0.45 μm nylon syringe ﬁlter. In the case of evaporation
of water, the solution was ﬁlled up again to a volume of 2.1 mL. After
ﬁltration, a clear pink solution could be obtained.
■ RESULTS AND DISCUSSION
Synthesis and Postpolymerization Functionalization
of PEO42-b-PAGE15-b-PtBGE12. Based on earlier studies
regarding the synthesis and functionalization, we used a
polyether-based triblock terpolymer, poly(ethylene oxide)-
block-poly(allyl glycidyl ether)-block-poly(tert-butyl glycidyl
ether) (PEO-b-PAGE-b-PtBGE), as starting material for the
synthesis of triblock terpolymers with identical A and C
segments but diﬀerent functionalities present in the B
block.18,19 The synthesis of PEO42-b-PAGE15-b-PtBGE12 by
AROP has been described previously (the subscripts denote the
degrees of polymerization of the respective segment).19 To
generate diﬀerently functionalized examples for co-assembly,
PEO42-b-PAGE15-b-PtBGE12 was modiﬁed by thiol−ene
chemistry: Cysteamine (2-aminoethanethiol) was used to
introduce NH2 groups and the possibility to form cationic
charges in aqueous media, 3-mercapto propionic acid enables
the introduction of carboxylic acid moieties and, hence,
negative charges, and thiogalactose represents a model targeting
moiety to ensure selective cellular uptake in hepatocytes.47,48 In
the latter case, acetyl-protected thiogalactose was used initially
(Scheme 1).
The reactions were performed in mixtures of DMF/EtOH
for tetraacetyl thiogalactose and 3-mercapto propionic acid,
whereas a mixture of DMF/EtOH/MeOH was used for
cysteamine due to the rather low solubility of this compound.
The reaction progress was monitored by size exclusion
chromatography (SEC, shift to lower elution volumes in all
cases) and 1H NMR spectroscopy (Figures S1−S3). The
degree of functionalization was determined by 1H NMR
spectroscopy through the decrease in intensity of the
characteristic signals for the pendant double bonds of PAGE
at 5.85 and 5.20 ppm compared to the t-butyl group of the
PtBGE block at 1.15 ppm (Table 1). For the functionalization
with 3-mercapto propionic acid, full conversion could be
reached after 24 h of irradiation. In contrast, only 53%
functionalization could be obtained for cysteamine despite
probing longer reaction times, higher irradiation intensity, or
diﬀerent triblock terpolymer/thiol ratios. We attribute this to
the lower solubility observed for cysteamine. Similarly, in case
of the acetylated thiogalactose only 70% functionalization could
be reached, presumably also due to solubility issues of either
the starting material or the triblock terpolymer after
modiﬁcation. Therefore, PEO42-b-(PAGE8,NH2-co-PAGE7)-b-
PtBGE12 (ENT), PEO42-b-PAGE15,COOH-b-PtBGE12 (ECT),
Table 1. Characterization Data of the Synthesized Triblock Terpolymersa
SEC 1H NMR
sample abbreviation Mn (g/mol) Mw (g/mol) Đ Mn (g/mol) f (%)
PEO42-b-PAGE15-b-PtBGE12 EAT 3350 3500 1.05 5100
PEO42-b-(PAGE8,NH2-co-PAGE7)-b-PtBGE12 ENT 3500 3600 1.06 5750 53
PEO42-b-PAGE15,COOH-b-PtBGE12 ECT 3550 3700 1.05 6700 100
PEO42-b-(PAGE10,AcGal-co-PAGE5)-b-PtBGE12 4200 4350 1.04 8800 70
PEO42-b-(PAGE10,Gal-co-PAGE5)-b-PtBGE12 EGT 10400 11500 1.10 7100 70
aThe subscripts represent the degree of polymerization. The shown abbreviations are used later on when describing self-assembled structures of the
materials.
Scheme 2. Schematic Representation of the Deprotection of Acetylated Thiogalactose (G) Attached to a PEO-b-PAGE-b-PtBGE
Triblock Terpolymera
aThe abbreviation EGT will be used later on for the nomenclature of micelles generated via self-assembly of the modiﬁed triblock terpolymer.
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and PEO42-b-(PAGE10,AcGal-co-PAGE5)-b-PtBGE12 (EGT after
deprotection) could be successfully prepared using thiol−ene
chemistry.
In a second step, the acetylated galactose was deprotected by
treatment with sodium methanolate (Scheme 2). For this
purpose, the polymer was dissolved in dry methanol, an excess
of sodium methanolate was added, and the solution was stirred
for 1 h. The crude product was puriﬁed by dialysis and the
complete deprotection was conﬁrmed by 1H NMR measure-
ments (Figure S3, Table 1). As shown in Figure S3, an increase
of the molar mass was detected, contrary to what would be
expected. We assume that the deprotection and, therefore,
Figure 1. Schematic representation of a core−shell-corona micelle formed by PEO42-b-PAGE15-b-PtBGE12 in aqueous media with a PtBGE core
(gray), a PAGE shell (purple), and a PEO corona (brown).
Figure 2. Number-weighted DLS CONTIN plots (upper section) for EAT (A, ⟨Rh⟩n,app = 7 nm), ENT (B, ⟨Rh⟩n,app = 4 nm), ECT (C, ⟨Rh⟩n,app = 6
nm), and EGT (D, ⟨Rh⟩n,app = 6 nm), as well as the corresponding cryo-TEM images (lower section) of the prepared micelles. Due to the rather low
contrast an arrow highlights representative ENT (B) and EGT (D) micellar cores. All cryo-TEM images are displayed as recorded.
Table 2. DLS and AF4 Data for the Investigated Triblock Terpolymer Micelles and Co-Micellesa
sample Mn × 10
−5 (g/mol) ⟨Rh⟩n,app
b (nm) Nagg ⟨Rg⟩ (nm) ⟨Rh⟩
c (nm) ⟨Rg/Rh⟩
d ⟨Rh⟩
e (nm)
EAT 11.48 ± 0.078 7.0 225 ± 2 10.1 ± 0.6 13.0 ± 0.4 0.777 ± 0.021 11.8 ± 0.1
ENT 18.58 ± 0.314 4.2 323 ± 56 15.8 ± 1.1 17.4 ± 1.8 0.916 ± 0.148 9.5 ± 0.3
ECT 10.45 ± 0.007 6.1 156 ± 1 12.2 ± 0.8 14.4 ± 0.1 0.844 ± 0.054 13.5 ± 0.3
EGT 2.224 ± 0.070 6.0 31 ± 1 5.4 ± 0.6 5.3 ± 0.3 1.018 ± 0.136 7.1 ± 0.3
(ENT/ECT)3.5:1 11.97 ± 0.366 6.3 204 ± 6 12.3 ± 0.4 15.2 ± 0.5 0.810 ± 0.042
(ENT/ECT)1.2:1 7.323 ± 0.127 4.3 121 ± 2 8.9 ± 0.8 10.6 ± 1.5 0.844 ± 0.051 10.5 ± 0.2
(ENT/ECT)1:2.6 6.192 ± 0.039 4.9 99 ± 1 9.0 ± 1.6 10.4 ± 0.5 0.875 ± 0.196 10.5 ± 0.1
(ENT/ECT/EGT)3.5:1:0.5 11.34 ± 0.714 8.2 190 ± 12 13.6 ± 1.2 15.9 ± 0.1 0.856 ± 0.084 12.3 ± 0.5
(ENT/ECT/EGT)3.4:1:2.3 9.654 ± 0.482 6.7 155 ± 8 13.5 ± 1.2 15.1 ± 0.1 0.899 ± 0.076 11.5 ± 0.5
aAF4 was performed using aqueous 20 mM NaCl solution. bBatch DLS in pure water. cOnline DLS (AF4-DLS) in 20 mM NaCl. dRh from AF4-
DLS. eBatch DLS in 20 mM NaCl.
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changes in solubility signiﬁcantly inﬂuence the hydrodynamic
radius, resulting in a shift to lower elution volume. This
behavior has also been reported in earlier studies.49
For simplicity, the nomenclature ENT, ECT, and EGT will
be used for micellar structures generated by self-assembly or co-
assembly of these compounds.
Micelle Formation in Aqueous Media. We have shown
earlier that PEO-b-PAGE-b-PtBGE triblock terpolymers as well
as their thiogalactose-functionalized counterparts undergo self-
assembly in aqueous media into micelles with a PtBGE core, a
PAGE shell, and a PEO corona (Figure 1).19 Prior to co-
assembly studies, micelles separately formed by EAT (before
thiol−ene modiﬁcation), ENT, ECT, and EGT in aqueous
solution were investigated.
Micellar solutions with a concentration of 10 g/L were
prepared by the addition of THF solutions of the respective
triblock terpolymer to water, followed by evaporation of the
organic co-solvent. Subsequently, the solutions were analyzed
by dynamic light scattering (DLS) and cryogenic transmission
electron microscopy (cryo-TEM). In Figure 2, the number
weighted hydrodynamic radii from DLS are depicted. For all
samples, radii (Rh) in the range of 4 to 7 nm were detected in
ultrapure water (pH = 7), and the results are summarized in
Table 2. The corresponding intensity weighted DLS CONTIN
plots of all samples are shown in Figure S7.
In addition to DLS experiments, also cryo-TEM measure-
ments were performed. In that way, block copolymer
nanostructures in aqueous solution can be visualized without
drying artifacts.50−52 As shown in Figure 2, spherical micelles
were found for all samples discussed here. For micelles formed
by ENT (Figure 2B) and EGT (Figure 2D) black arrows were
added to highlight a representative micellar core. In some cases,
a small distribution of worm-like structures was also found in
cryo-TEM, presumably due to aggregation of spherical micelles
(Figure S4). This phenomenon was also observed in our
previous studies.18,19 In general, for all samples micelles with a
particle diameter ranging from 10 to 15 nm could be detected,
conﬁrming the results from DLS studies. To ensure the stability
Figure 3. Zeta-potential measurements of diﬀerent triblock terpolymer micelles and comicelles in water.
Figure 4. Number-weighted DLS CONTIN plots (upper row), for (ENT/ECT)3.5:1 (A, ⟨Rh⟩n,app = 6 nm), (ENT/ECT/EGT)
3.5:1:0.5 (B, ⟨Rh⟩n,app = 8
nm), and (ENT/ECT/EGT)3.4:1:2.3 (C, ⟨Rh⟩n,app = 7 nm), as well as the corresponding cryo-TEM images (lower row) of the prepared comicelles.
Due to the low contrast, one micellar core is highlighted with an arrow for (ENT/ECT/EGT)3.4:1:2.3 (C). All cryo-TEM images are displayed as
recorded.
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of the prepared nanoparticles even at low concentrations, in
particular for the later shown internalization tests, DLS
measurements with diluted solutions of ECT were performed
(Figure S5). For this purpose, a sample of 2.06 g/L was diluted
stepwise up to a concentration of 0.005 g/L. Even at this
concentration, micelles could be detected using DLS experi-
ments. The sample was chosen, as this polymer showed the
highest degree of functionalization and, therefore, also the
highest hydrophilicity.
Mixed Micelles Formed via Co-Assembly of Triblock
Terpolymers. We have recently shown that a combination of
positively and negatively charged segments within triblock
terpolymers (i.e., ampholytic materials) and the resulting
multicompartment micelles in aqueous media led to pH-
dependent interaction with cells, enhanced cellular uptake, and
superior transfection eﬃciencies for pDNA.12,28 However, in
this particular case, one single material has been used, and it can
be anticipated that the charge ratio (cationic/anionic) plays an
important role. We were, therefore, interested in the co-
assembly of diﬀerent triblock terpolymers as an alternative
strategy to control charge and functionality within such
micelles.29,30 In this context, the above-described triblock
terpolymers (ENT, ECT, EGT) represent a versatile and highly
ﬂexible tool box. Co-assembly should again lead to the
formation of core-shell-corona micelles, featuring a PEO
corona and a hydrophobic PtBGE core formed by identical
segments A and C. The shell (B segment), however, should
now be composed of diﬀerent functional groups, depending on
which material combinations are used. As a ﬁrst example,
micelles with diﬀerent charge ratios (NH2/COOH) were
prepared by co-assembly of ENT and ECT. For this purpose,
mixtures of both triblock terpolymers were dissolved in THF
and slowly added into water. Binary comicelles with an excess
of positive charges (ENT/ECT)3.5:1, a slight excess of positive
charges (ENT/ECT)1.2:1, and an excess of negative charges
(ENT/ECT)1:2.6 were assembled using this pathway. In all
cases, the superscripts represent the mixing ratio regarding the
functional groups of the involved triblock terpolymers. The
micellar solutions were afterward analyzed by DLS and cryo-
TEM (Figure 4, the DLS CONTIN plots for (ENT/ECT)1.2:1
and (ENT/ECT)1:2.6 can be found in Figure S6). A schematic
representation of the co-assembly and the formation of
comicelles is presented in Figure 5.
Again, spherical micelles with hydrodynamic radii of 4 to 6
nm were obtained by DLS and these results were conﬁrmed by
cryo-TEM measurements (diameters of 12−14 nm were
observed). As both middle blocks of ENT (NH2) and ECT
(COOH) are weak polyelectrolytes, we anticipated that the pH
value might have an inﬂuence during the assembly process.
Therefore, the co-assembly was carried out under acidic (pH ∼
4) as well as basic conditions (pH ∼ 12), and the results were
compared to the data obtained under neutral conditions (pH ∼
7). Additionally, also, the preparation pathway was changed,
that is, addition of water to THF solutions instead of vice versa.
In all cases, no signiﬁcant inﬂuence on the micellar size and the
dispersity was observed (Table S1) and, therefore, all
subsequent co-assembly procedures were carried out at pH 7
and via the addition of the THF solution containing the
triblock terpolymers into water.
Subsequently, a detailed characterization of the micelles and
comicelles regarding charge was carried out using zeta-potential
measurements. As structures of rather small size were obtained,
it is at the same time highly demanding and crucial to
investigate if, for example, comicelles of ENT and ECT or if
two separate populations are formed. This is diﬃcult to
estimate using only DLS and cryo-TEM. For the zeta-potential
measurements and, also, later, for AF4 measurements, gel
electrophoresis, and cell uptake studies, nile red, a hydrophobic
red ﬂuorescent dye, was encapsulated into the hydrophobic
PtBGE core. Nile red is poorly soluble in water and exhibits a
strong ﬂuorescence in hydrophobic environment.53 Therefore,
the respective triblock terpolymer (or mixtures) and a small
Figure 5. Schematic representation of the co-assembly of functionalized triblock terpolymers into binary and ternary core-shell-corona micelles with
a mixed shell. The fractions of the modiﬁed PAGE shell (color code: green = cysteamine functionalized, red = 3-mercapto propionic acid
functionalized, blue = thiogalactose functionalized) represent the mixing ratio during co-assembly.
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amount of the dye were dissolved in THF and slowly added
into a deﬁned amount of water (identical preparation pathway
as has been described earlier). Afterward, the organic solvent
was evaporated and the excess of non-encapsulated dye was
ﬁltered oﬀ.
In a ﬁrst approach, the zeta potential of diﬀerent micellar
populations at a pH value of 7 was analyzed, and the results are
depicted in Figure 3. As expected, a negative value is found for
ECT (−36 mV) whereas the zeta potential for ENT is positive
(47.5 mV). Both EAT and EGT revealed negative values
(−39.5 and −27 mV), which can be attributed to the
complexation of ions within the PEO corona or charge−dipole
and dipole−dipole interactions, which are both known to
inﬂuence the zeta potential.43,54
For binary comicelles (ENT/ECT), a clear dependence of
the zeta potential on the mixing ratio can be observed, as with
increasing amount of ENT the zeta potential increases (from
−23.6 mV for (ENT/ECT)1:2.6 to 14.2 mV for (ENT/
ECT)3.5:1). Thus, zeta potential measurements indicate that
comicelles are formed. If the co-assembly in the case of, for
example, (ENT/ECT)3.5:1 would lead to two separate
populations of ENT and ECT, aggregation of oppositely
charged micelles due to electrostatic interactions might be
expected. In this case, an increase of the aggregates size and,
presumably, precipitation might occur. As an attempt to clarify
this, mixtures of ENT and ECT micelles after self-assembly via
the above-described protocol were prepared at comparable
charge ratios and were investigated using time-dependent DLS
measurements (Figure S10A), revealing an increase of the Rh
from 4 to 10 nm within 2 h and partial precipitation of the
material after 12 h (Figure S10B). As the comicelles proved to
be stable over several weeks, as conﬁrmed by zeta-potential
measurements and the presence of a monomodal size
distribution (DLS), an eﬃcient preparation of comicelles by
our protocol can be assumed.
Besides charge control in binary systems, also ternary
systems were targeted where NH2 groups (ENT), COOH
moieties (ECT), and galactose as model targeting ligand
(EGT) are combined. Galactose was chosen to enable selective
cellular uptake into hepatocytes, which has been already
demonstrated.47,48 For the ternary systems, two ratios were
prepared via co-assembly: (ENT/ECT/EGT)3.5:1:0.5 and
(ENT/ECT/EGT)3.4:1:2.3, featuring almost identical charge
ratios and mainly diﬀering in the amount of incorporated
galactose. The as-prepared micellar solutions were character-
ized by DLS and cryo-TEM, and the results are depicted in
Figure 4B,C and Table 2. In both cases, spherical micelles with
Rh = 8 nm for (ENT/ECT/EGT)
3.5:1:0.5 and 7 nm in the case of
(ENT/ECT/EGT)3.4:1:2.3 were found in DLS experiments. In
cryo-TEM, again spherical micelles with diameters of 10 to 16
nm could be detected. A decreased contrast was observed for
higher amounts of incorporated sugar moieties.
In all cases, evaluation by DLS and cryo-TEM led to
comparable results regarding size and shape of both binary and
ternary comicelles. Moreover, the ternary comicelles exhibit a
decreased zeta potential if compared to the binary (ENT/
ECT)3.5:1 structures with 6 mV for (ENT/ECT/EGT)3.5:1:0.5
and 6.5 mV for (ENT/ECT/EGT)3.4:1:2.3, thus, indicating the
presence of EGT within the structures (Figure 3). Also, in this
case, the zeta potential measurements indicate that comicelles
are formed.
Asymmetric Flow Field−Flow Fractionation of Tri-
block Terpolymer Micelles. To obtain further insights into
size, shape, and aggregation number of micelles formed by
diﬀerent triblock terpolymers (and combinations), asymmetric
ﬂow ﬁeld-ﬂow fractionation (AF4) coupled online to multi-
Figure 6. AF4 fractograms of triblock terpolymer micelles from EAT (A), ENT (B), (ENT/ECT)3.5:1 (C), and (ENT/ECT/EGT)3.5:1:0.5 (D) in 20
mM NaCl solution.
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angle light scattering (MALS) and DLS was applied. Here, a
10000 g/mol membrane of regenerated cellulose and an
aqueous eluent containing 20 mM NaCl was used for all
systems investigated. Fractograms are shown in Figures 6 and
S8. For all samples, the main peak represents spherical micelles
and, in addition, a small second aggregate population could be
detected after the cross-ﬂow reaches zero (labeled “aggregates”
in Figure 6). We attribute this to the presence of a small
fraction of worm-like structures in accordance with earlier
observations and the cryo-TEM experiments.18 In the case of
EGT and (ENT/ECT/EGT)3.4:1:2.3, also a small fraction of
triblock terpolymer unimers could be identiﬁed. Number
weighted molar masses Mn of the micelles and aggregation
numbers Nagg, as well as the diﬀerent radii (Rg, Rh) and the
shape ratio (Rg/Rh) derived from AF4 measurements are listed
in Table 2. Thereby, the ratio Rg/Rh provides information about
the shape of a macromolecule or colloid. Typical values are
0.778 for a hard sphere, 1.0 for a soft sphere, or 1.78 for a
monodisperse linear polymer chain in a good solvent.55
Additional characteristics (dn/dc values, Mw, Mz, and Đ) can
be found in Table S2. Aggregation numbers Nagg were
calculated by dividing the molar mass (Mn) of the micelles
by the molar mass (Mn,
1H NMR) of the single triblock
terpolymer chain. The hydrodynamic radii measured by AF4-
MALS-DLS were signiﬁcantly higher (around 10−15 nm) in
contrast to batch DLS experiments for all samples. We attribute
this to the diﬀerent medium (20 mM NaCl) and, indeed, DLS
measurements under these conditions could conﬁrm the results
from AF4. The increase in size in the presence of salt might
originate from the complexation of sodium ions by the PEO
corona or, in case of micelles prepared via co-assembly of ENT
and ECT, an increase in ionic strength, and the screening of
attractive electrostatic forces between diﬀerently charged side
chains (COO− for ECT; NH3
+ for ENT) within the shell.56
Nevertheless, in all cases the ratio Rg/Rh scales between 0.775
(hard sphere) and 1.0 (soft sphere), indicating a spherical
shape.55,57
By AF4 experiments, also the absolute molar mass of the
micelles could be detected: Comparable values (Mn) of 1000 to
2000 kg/mol were obtained for EAT, ENT, and ECT micelles,
whereas only 220 kg/mol were found in the case of EGT. This
corresponds to Nagg = 30 (EGT), 225 (EAT), 323 (ENT), and
156 (ECT), respectively. At this point, we attribute the lower
values observed for EGT to the steric demand of the
thiogalactose side chains within the PAGE shell, preventing a
more compact assembly. This is also in good accordance with
the observation of a small fraction of triblock terpolymer
unimers in the AF4 fractograms (Figure S8B). The aggregation
numbers Nagg of binary and ternary comicelles were calculated
by consideration of the diﬀerent molar masses of the
terpolymers and under the assumption that the ratios of
polymer chains in the micelles are the same as the mixing ratios
of the triblock terpolymers.
Molar masses of binary and ternary comicelles are in between
620 kg/mol [(ENT/ECT)1:2.6, Nagg = 99] and 1200 kg/mol
[(ENT/ECT)3.5:1, Nagg = 204]. This indicates the formation of
more compact structures with increasing amounts of ENT for
the investigated range of charge ratios.
Gel Electrophoresis. In addition to zeta potential measure-
ments, another powerful method for the separation of charged
macromolecules (e.g., DNA) is gel electrophoresis. Here, the
samples are placed in an agarose gel and an electrical ﬁeld is
applied. The electrical ﬁeld induces movement within the gel
toward the positive or negative pole, depending on the charge
of the sample investigated.
A small amount of labeled micelles and comicelles was placed
in an agarose gel and an electric ﬁeld was applied. We
anticipated that comicelles should feature only one band, as
additional conﬁrmation of the zeta-potential measurements. As
shown in Figure 7, micelles formed by ENT reveal the highest
shift to the negative pole, whereas ECT moved toward the
positive pole. The bands observed for ENT/ECT comicelles of
diﬀerent mixing ratios are, in accordance with their zeta-
potential, in between. If two separate populations of ENT and
ECT would be formed, two separate bands in gel electro-
phoresis toward opposite poles might be expected. As only one
band is visible for all samples, we regard this as another
indication for an eﬃcient co-assembly. In addition, ternary
ENT/ECT/EGT exhibited movement toward the negative
pole, again conﬁrming the results from zeta-potential measure-
ments. EGT did not show any movement in gel electrophoresis.
Contrary to the negative zeta potential of −39.5 mV, EAT
micelles exhibited a clear shift to the negative pole (Figure S9).
Up to now, we have no conclusive explanation for this behavior
as also zeta potential measurements in comparable buﬀer
solutions (the exact composition is given in the experimental
part) yielded negative values.
Cellular Interactions. Cytotoxicity and Hemolysis of
Triblock Terpolymer Micelles. Aiming for a later use of such
triblock terpolymer micelles in targeting and/or delivery
applications, their cytotoxicity was investigated using an Alamar
blue assay. At ﬁrst, triblock terpolymer micelles formed via the
self-assembly of one single material were investigated. Micelles
formed of EAT, ECT, or EGT did not show any cytotoxic
eﬀects for concentrations up to 0.5 mg/mL (cell viability was
above 70%), only in case of ENT the situation was diﬀerent
(Figure 8A). Regarding EAT, ECT, and EGT, these results are
in accordance with literature, as all structures exhibited negative
zeta potentials.39,58 For micelles based on ENT, the IC50 of 300
μg/mL can be explained by the presence of cationic charges
within the shell (zeta potential of +47.5 mV), which could lead
to stronger interactions with or even disruption of the cell
membrane. These results can be taken as further proof that the
functionalization of the middle block (PAGE) signiﬁcantly
inﬂuences interactions of such micelles with biological matter,
Figure 7. Gel electrophoresis using 1% agarose gel and TBE buﬀer (1
= ENT, 2 = (ENT/ECT)3.5:1, 3 = (ENT/ECT)1.2:1, 4 = (ENT/
ECT)1:2.6, 5 = ECT, 6 = (ENT/ECT/EGT)3.5:1:0.5, 7 = (ENT/ECT/
EGT)3.4:1:2.3, 8 = EGT).
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even though all structures feature a rather long PEO corona
(compared to the degrees of polymerization for PAGE and
PtBGE).59
A hemolysis assay was performed to gain deeper insight into
the interaction of EAT, ENT, ECT, and EGT micelles with
negatively charged cell membranes: Here, ENT exhibited slight
hemolytic activity at concentrations of 50 μg/mL (3.8 ± 0.6%
hemolysis, Figure 8B). No hemolytic activity was found for
both EAT and ECT. In contrast, 2.9 ± 0.6% hemolysis was
observed for EGT micelles. We attribute this to hydrophobic
interactions with the cell membrane, possibly even incorpo-
ration of EGT into the latter.
Internalization of Triblock Terpolymer Micelles. Further-
more, the internalization eﬃciency of micelles from EAT, ENT,
ECT, and EGT into human embryonic kidney (HEK) cells, a
model cell line for unspeciﬁc uptake studies, was analyzed
under serum-reduced and serum-containing conditions. As nile
red was encapsulated in the micelles, the internalization was
analyzed by ﬂow cytometry, at which untreated cells were
applied as control (Figure S12). Under serum-reduced
conditions the critical concentration, that is, the concentration
where EAT shows nearly no uptake (1 ± 1.1%), was
determined to be 10 μg/mL (Figure 8C). From this data set,
it becomes obvious that ENT revealed the best uptake into 79.7
± 4.5% (at 10 μg/mL) of the cells. This can be attributed to the
presence of positive charges in the shell and an increased
interaction with the cell membrane, also conﬁrmed by the
earlier discussed hemolysis assay. Higher concentrations of 50
μg/mL could not be analyzed as the cell viability was too low
under serum reduced condition. Compared to ENT, the
decreased uptake of ECT and EGT at a concentration of 10
μg/mL with 26.8 ± 6.3% and 15.3 ± 21.7%, respectively, can be
explained by the negative zeta potential of these particles,
resulting in decreased interactions with cells. Nevertheless, even
ECT and EGT show signiﬁcantly increased cellular uptake
induced either by the introduction of charges (COOH) or
Figure 8. Cytotoxicity test of triblock terpolymer micelles using L929 cells (A) and hemolysis assay using three diﬀerent donators (B). Cellular
uptake under serum reduced (C) and serum containing conditions (D) in HEK cells. Values represent the mean ± SD.
Figure 9. Cytotoxicity test of binary and ternary comicelles using L929 cells (A) and cellular uptake in HEK cells (B). Values represent the mean ±
SD; n = 3.
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targeting units (thiogalactose) if compared to EAT at 10
μg/mL (1 ± 1.11%). As the presence of a PEO corona has been
shown in many examples to prevent unspeciﬁc protein
adsorption (“stealth eﬀect”),17 the uptake was also analyzed
in the presence of serum (Figure 8D). Here, only the uptake of
ENT decreased signiﬁcantly from 86 ± 11% to 13 ± 0.6% at 10
μg/mL (p < 0.005), presumably due to stronger interactions
with negatively charged serum proteins.60,61 Nevertheless, the
uptake of both ENT and ECT is signiﬁcantly higher compared
to EAT with 2 ± 0.5% (p < 0.05). The internalization of EGT is
similar to EAT at 10 μg/mL, thus, also reduced from 15 to
2.9% in the presence of serum proteins. As the functionalization
with thiogalactose is supposed to result in speciﬁc uptake into
liver cells, we also incubated the EGT micelles with HepG2
cells.47 Unfortunately, no increased uptake at low concen-
trations (3.9 ± 5% at 10 μg/mL) could be detected, which
would hint toward a targeted internalization process (Figure
S11). One explanation might be that the galactose side chains
are not suﬃciently exposed at the surface and, thus, the
interaction with the asialoglycoprotein receptor, speciﬁc for
galactose in HepG2 cells, is hampered. Further, the PEO
corona might form hydrogen bonds with the galactose
residues,62 additionally reducing their accessibility.
Cytotoxicity and Internalization of Comicelles. As the up
to now used triblock terpolymer micelles (EAT, ENT, ECT,
and EGT) already showed signiﬁcant diﬀerences regarding
cellular uptake and cytotoxicity, the inﬂuence of the
composition in binary and ternary comicelles on the
cytotoxicity was studied (Figure 9A). (ENT/ECT)3.5:1
exhibited a positive zeta potential and a similar cytotoxicity
(IC50 of 350 μg/mL), if compared to ENT (Figure 8A). In the
case of (ENT/ECT)1.2:1 and (ENT/ECT)1:2.6, no cytotoxicity
was observed, in accordance with the negative zeta potential.
Interestingly, both the ternary comicelles, (ENT/ECT/
EGT)3.5:1:0.5 and (ENT/ECT/EGT)3.4:1:2.3, which feature the
same charge ratio as (ENT/ECT)3.5:1 and exhibited positive
zeta potentials, did not show any cytotoxicity at all tested
concentrations. This is indeed remarkable, and we propose that
this originates from the presence of EGT terpolymer chains in
these structures. All prepared comicelles were further
investigated regarding their internalization behavior. In this
case, (ENT/ECT)3.5:1 demonstrated outstanding uptake
compared to all other samples as already at 10 μg/mL under
serum-containing conditions 75 ± 11.5% of the cells showed
internalization (Figure 9B). These results are comparable to
ENT micelles under serum-reduced conditions, thus, indicating
decreased nonspeciﬁc interactions of (ENT/ECT)3.5:1 with
serum proteins. For both (ENT/ECT)1.2:1 and (ENT/
ECT)1:2.6, reduced uptake with 8.9 ± 11% and 6.7 ± 5.5%
(compared to (ENT/ECT)3.5:1) was found. In the case of
ternary comicelles, (ENT/ECT/EGT)3.5:1:0.5 exhibited de-
creased uptake compared to (ENT/ECT)3.5:1, presumably
due to the presence of EGT (Figure 9B). A further increase
of the galactose content leads to even lower values, which is in
accordance with lower uptake of EGT compared to ECT and
ENT. Nevertheless, it should be noted that, in contrast to
(ENT/ECT)3.5:1, both (ENT/ECT/EGT)3.5:1:0.5 and (ENT/
ECT/EGT)3.4:1:2.3 did not show any cytotoxicity. In summary,
by adjusting the micellar composition via co-assembly of ENT,
ECT, and EGT, both cellular uptake and cytotoxicity can be
controlled and optimized (according to our results).
Further Investigations Regarding the Pathway for Cellular
Uptake. We were also interested in a more detailed analysis of
the internalization process. The size of the core−shell-corona
micelles used in the present study is below 30 nm in diameter, a
size where studies on the internalization process are rarely
found, as normally nanostructures between 50 to 200 nm are
used in drug delivery applications. Here, internalization via
endocytosis is under debate, as this process is usually observed
for structures with sizes between 50 to 500 nm.63−65 As
endocytosis is energy dependent, the uptake eﬃciencies were
investigated at 4 °C, conditions which are known to inhibit
energy-dependent mechanisms (Figure 10A).66 Interestingly,
no signiﬁcant changes under these conditions were found for
EAT, ECT, and ENT if compared to 37 °C. In contrast, the
internalization eﬃciency for EGT decreased signiﬁcantly to 15
± 7.8% (at 50 μg/mL), indicating an energy-dependent
mechanism.
Besides, ENT micelles are already cytotoxic at a concen-
tration of 50 μg/mL at 4 °C, in contrast to 37 °C. The
increased cytotoxicity at 4 °C might originate from the reduced
ﬂuidity of the cell membrane at low temperatures. Therefore, it
might occur that cationically charged micelles lead to
destabilization and local disruption of the membrane.67 As
the size of the micelles is rather small, these perforations can be
easily closed at 37 °C at normal membrane ﬂuidity. At 4 °C,
however, this process is signiﬁcantly slowed down, leading to
cell leakage. It has been described in the literature that
structures of a few nanometers in size can lead to pore
formation and translocation through the cell membrane.68,69
To evaluate if cell leakage is caused in our case, a lactate
dehydrogenase (LDH) assay was performed,70 which was used
Figure 10. Cellular uptake of triblock terpolymer micelles at 4 and 37 °C in HEK cells after 4 h (A) and lactate dehydrogenase assay with HEK cells
and 25 μg/mL of the micelles (B). Values represent the mean ± S.D; n = 3.
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to detect the release of cytosolic LDH into the surrounding
media through membrane perforations. For ECT and EAT
micelles, no signiﬁcant LDH release could be observed in
contrast to ENT (Figure 10B). This provides a ﬁrst hint and
supports our assumption that EAT and ECT micelles cross the
cellular membrane by the formation of reversible membrane
pores or penetrate the cell membrane via diﬀusion. ENT seems
to cause larger pores, resulting in LDH release. These ﬁrst
investigations of the internalization process demonstrate that
diﬀerences in shell composition and functionality of triblock
terpolymer micelles inﬂuence not only cytotoxicity and uptake
eﬃciency, but also alter the overall internalization process. In
that respect, the herein presented toolbox of triblock
terpolymers represents an ideal starting point for the purposeful
variation of micellar composition and charge and more detailed
investigations of the uptake mechanism will follow.
■ CONCLUSION
Multifunctional and well-deﬁned triblock terpolymers represent
very promising materials for the preparation of eﬃcient drug
delivery vehicles. Here, we introduce a concept for the co-
assembly of ABC triblock terpolymers with identical A and C
segments but diﬀerent functionalities in the middle block (B)
into core−shell-corona micelles with a mixed shell. In that way,
sub-30 nm particles with superior control over charge and the
location of targeting ligands with the micellar shell were
formed. The materials employed are poly(ethylene oxide)-
block-poly(allyl glycidyl ether)-block-poly(tert-butyl glycidyl
ether) (PEO-b-PAGE-b-PtBGE) triblock terpolymers where
the PAGE segments has been subsequently modiﬁed using
thiol−ene chemistry to introduce −NH2 (cysteamine, ENT),
−COOH (3-mercaptopropionic acid, ECT), and thiolgalactose
residues (EGT). Depending on whether binary (ENT/ECT) or
ternary comicelles (ENT/ECT/EGT) were prepared, charge
and, directly linked to that, cytotoxicity of the resulting
nanoparticle could be adjusted. In the case of ENT/ECT/EGT
comicelles, eﬃcient cellular uptake (even in the presence of
serum proteins) could be combined with low cytotoxicity.
Diﬀerent characterization methods, including dynamic light
scattering (DLS), asymmetric ﬂow ﬁeld-ﬂow fractionation
(AF4), zeta potential measurements, and cryo-TEM indicate
that indeed co-micellization occurs. Moreover, ﬁrst insights into
the internalization process of these sub-30 nm micelles could be
provided and our results hint toward uptake via direct
penetration through the cell membrane and not via
endocytosis, oﬀering interesting possibilities for further detailed
studies.
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Schmalz, H.; Müller, A. H. E. Nature 2013, 503, 247−251.
(12) Rinkenauer, A. C.; Schallon, A.; Günther, U.; Wagner, M.;
Betthausen, E.; Schubert, U. S.; Schacher, F. H. ACS Nano 2013, 7,
9621−9631.
(13) Schallon, A.; Synatschke, C. V.; Jerome, V.; Müller, A. H. E.;
Freitag, R. Biomacromolecules 2012, 13, 3463−3474.
(14) Huang, X. Y.; Chen, S.; Huang, J. L. J. Polym. Sci., Part A: Polym.
Chem. 1999, 37, 825−833.
(15) Arnal, M. L.; Balsamo, V.; Lopez-Carrasquero, F.; Contreras, J.;
Carrillo, M.; Schmalz, H.; Abetz, V.; Laredo, E.; Müller, A. J.
Macromolecules 2001, 34, 7973−7982.
(16) Jing, R. K.; Wang, G. W.; Zhang, Y. N.; Huang, J. L.
Macromolecules 2011, 44, 805−810.
(17) Knop, K.; Hoogenboom, R.; Fischer, D.; Schubert, U. S. Angew.
Chem., Int. Ed. 2010, 49, 6288−6308.
(18) Barthel, M. J.; Babiuch, K.; Rudolph, T.; Vitz, J.; Hoeppener, S.;
Gottschaldt, M.; Hager, M. D.; Schacher, F. H.; Schubert, U. S. J.
Polym. Sci., Part A: Polym. Chem. 2012, 50, 2914−2923.
(19) Barthel, M. J.; Mansfeld, U.; Hoeppener, S.; Czaplewska, J. A.;
Schacher, F. H.; Schubert, U. S. Soft Matter 2013, 9, 3509−3520.
(20) Obermeier, B.; Frey, H. Bioconjugate Chem. 2011, 22, 436−444.
(21) Hruby, M.; Konak, C.; Ulbrich, K. J. Controlled Release 2005,
103, 137−148.
(22) Lin, S. L.; Zhu, W. J.; He, X. H.; Xing, Y. H.; Liang, L. Y.; Chen,
T.; Lin, J. P. J. Phys. Chem. B 2013, 117, 2586−2593.
(23) Libera, M.; Trzebicka, B.; Kowalczuk, A.; Walach, W.; Dworak,
A. Polymer 2011, 52, 250−257.
(24) Kataoka, K.; Harada, A.; Nagasaki, Y. Adv. Drug Delivery Rev.
2001, 47, 113−131.
Biomacromolecules Article
dx.doi.org/10.1021/bm5002894 | Biomacromolecules 2014, 15, 2426−24392438
(25) Sun, P. J.; Zhang, Y.; Shi, L. Q.; Gan, Z. H. Macromol. Biosci.
2010, 10, 621−631.
(26) Van Butsele, K.; Cajot, S.; Van Vlierberghe, S.; Dubruel, P.;
Passirani, C.; Benoit, J. P.; Jerome, R.; Jerome, C. Adv. Funct. Mater.
2009, 19, 1416−1425.
(27) Fukushima, S.; Miyata, K.; Nishiyama, N.; Kanayama, N.;
Yamasaki, Y.; Kataoka, K. J. Am. Chem. Soc. 2005, 127, 2810−2811.
(28) Lee, Y.; Miyata, K.; Oba, M.; Ishii, T.; Fukushima, S.; Han, M.;
Koyama, H.; Nishiyama, N.; Kataoka, K. Angew. Chem., Int. Ed. 2008,
47, 5163−5166.
(29) Wu, C. L.; Ma, R. J.; He, H.; Zhao, L. Z.; Gao, H. J.; An, Y. L.;
Shi, L. Q. Macromol. Biosci. 2009, 9, 1185−1193.
(30) Attia, A. B. E.; Ong, Z. Y.; Hedrick, J. L.; Lee, P. P.; Ee, P. L. R.;
Hammond, P. T.; Yang, Y. Y. Curr. Opin. Colloid Interface Sci. 2011, 16,
182−194.
(31) Liu, X.; Liu, Y.; Zhang, Z. K.; Huang, F.; Tao, Q.; Ma, R. J.; An,
Y. L.; Shi, L. Q. Chem. Eur. J. 2013, 19, 7437−7442.
(32) Lin, J. P.; Zhu, J. Q.; Chen, T.; Lin, S. L.; Cai, C. H.; Zhang, L.
S.; Zhuang, Y.; Wang, X. S. Biomaterials 2009, 30, 108−117.
(33) Vinogradov, S. V.; Batrakova, E. V.; Li, S.; Kabanov, A. V. J. Drug
Targeting 2004, 12, 517−526.
(34) Zheng, R.; Liu, G.; Yan, X. J. Am. Chem. Soc. 2005, 127, 15358−
15359.
(35) Li, Z.; Hillmyer, M. A.; Lodge, T. P. Macromolecules 2006, 39,
765−771.
(36) Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami,
M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.;
Nishiyama, N.; Kataoka, K. Nat. Nanotechnol. 2011, 6, 815−823.
(37) Dong, H.; Dube, N.; Shu, J. Y.; Seo, J. W.; Mahakian, L. M.;
Ferrara, K. W.; Xu, T. ACS Nano 2012, 6, 5320−5329.
(38) Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Mol.
Pharmaceutics 2008, 5, 505−515.
(39) Nguyen, J.; Xie, X.; Neu, M.; Dumitrascu, R.; Reul, R.;
Sitterberg, J.; Bakowsky, U.; Schermuly, R.; Fink, L.; Schmehl, T.;
Gessler, T.; Seeger, W.; Kissel, T. J. Gene Med. 2008, 10, 1236−1246.
(40) Mishra, S.; Webster, P.; Davis, M. E. Eur. J. Cell. Biol. 2004, 83,
97−111.
(41) Sun, J.; Zeng, F.; Jian, H.; Wu, S. Biomacromolecules 2013, 14,
728−736.
(42) Andersson, M.; Wittgren, B.; Wahlund, K. G. Anal. Chem. 2003,
75, 4279−4291.
(43) Delgado, A. V.; Gonzalez-Caballero, F.; Hunter, R. J.; Koopal, L.
K.; Lyklema, J. J. Colloid Interface Sci. 2007, 309, 194−224.
(44) Ohshima, H. J. Colloid Interface Sci. 1994, 168, 269−271.
(45) Gottschaldt, M.; Koth, D.; Müller, D.; Klette, I.; Rau, S.; Görls,
H.; Schafer, B.; Baum, R. P.; Yano, S. Chem. Eur. J. 2007, 13, 10273−
10280.
(46) Ibatullin, F. M.; Shabalin, K. A.; Janis, J. V.; Shavva, A. G.
Tetrahedron Lett. 2003, 44, 7961−7964.
(47) Babiuch, K.; Pretzel, D.; Tolstik, T.; Vollrath, A.; Stanca, S.;
Foertsch, F.; Becer, C. R.; Gottschaldt, M.; Biskup, C.; Schubert, U. S.
Macromol. Biosci. 2012, 12, 1190−1199.
(48) Yang, R.; Meng, F. H.; Ma, S. B.; Huang, F. S.; Liu, H. Y.;
Zhong, Z. Y. Biomacromolecules 2011, 12, 3047−3055.
(49) Babiuch, K.; Becer, C. R.; Gottschaldt, M.; Delaney, J. T.;
Weisser, J.; Beer, B.; Wyrwa, R.; Schnabelrauch, M.; Schubert, U. S.
Macromol. Biosci. 2011, 11, 535−548.
(50) Cui, H.; Hodgdon, T. K.; Kaler, E. W.; Abezgauz, L.; Danino,
D.; Lubovsky, M.; Talmon, Y.; Pochan, D. J. Soft Matter 2007, 3, 945−
955.
(51) Holder, S. J.; Sommerdijk, N. A. J. M. Polym. Chem. 2011, 2,
1018−1028.
(52) Zhong, S.; Pochan, D. J. Polym. Rev. 2010, 50, 287−320.
(53) Greenspan, P.; Mayer, E. P.; Fowler, S. D. J. Cell. Biol. 1985,
100, 965−973.
(54) Wagner, M.; Reiche, K.; Blume, A.; Garidel, P. Colloids Surf., A
2012, 415, 421−430.
(55) Burchard, W. Adv. Polym. Sci. 1999, 143, 113−194.
(56) Benincasa, M. A.; Caldwell, K. D. J. Chromatogr., A 2001, 925,
159−169.
(57) Glantz, M.; Hakansson, A.; Mansson, H. L.; Paulsson, M.;
Nilsson, L. Langmuir 2010, 26, 12585−12591.
(58) Vollrath, A.; Pretzel, D.; Pietsch, C.; Perevyazko, I.; Schubert, S.;
Pavlov, G. M.; Schubert, U. S. Macromol. Rapid Commun. 2012, 33,
1791−1797.
(59) Verbaan, F. J.; Oussoren, C.; Snel, C. J.; Crommelin, D. J. A.;
Hennink, W. E.; Storm, G. J. Gene Med. 2004, 6, 64−75.
(60) Ogris, M.; Brunner, S.; Schuller, S.; Kircheis, R.; Wagner, E.
Gene Ther. 1999, 6, 595−605.
(61) Cherng, J. Y.; vandeWetering, P.; Talsma, H.; Crommelin, D. J.
A.; Hennink, W. E. Pharm. Res. 1996, 13, 1038−1042.
(62) Belbekhouche, S.; Dulong, V.; Picton, L.; Le Cerf, D. Colloids
Surf., A 2013, 428, 25−31.
(63) Albanese, A.; Tang, P. S.; Chan, W. C. Annu. Rev. Biomed. Eng.
2012, 14, 1−16.
(64) Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Biochem. J.
2004, 377, 159−169.
(65) Lai, S. K.; Hida, K.; Man, S. T.; Chen, C.; Machamer, C.;
Schroer, T. A.; Hanes, J. Biomaterials 2007, 28, 2876−2884.
(66) Steinman, R. M.; Mellman, I. S.; Muller, W. A.; Cohn, Z. A. J.
Cell Biol. 1983, 96, 1−27.
(67) Leroueil, P. R.; Hong, S. Y.; Mecke, A.; Baker, J. R.; Orr, B. G.;
Holl, M. M. B. Acc. Chem. Res. 2007, 40, 335−342.
(68) Ting, C. L.; Wang, Z. G. Soft Matter 2012, 8, 12066−12071.
(69) Ding, H. M.; Tian, W. D.; Ma, Y. Q. ACS Nano 2012, 6, 1230−
1238.
(70) Choksakulnimitr, S.; Masuda, S.; Tokuda, H.; Takakura, Y.;
Hashida, M. J. Controlled Release 1995, 34, 233−241.
Biomacromolecules Article
dx.doi.org/10.1021/bm5002894 | Biomacromolecules 2014, 15, 2426−24392439


6XSSRUWLQJLQIRUPDWLRQIRU
³6PDOOEXWSRZHUIXO&RDVVHPEO\RISRO\HWKHUEDVHGWULEORFNWHUSRO\PHUV
LQWRVXEQPPLFHOOHVDQGV\QHUJLVWLFHIIHFWVRQFHOOXODULQWHUDFWLRQV´

0DUNXV - %DUWKHO $OH[DQGUD & 5LQNHQDXHU 0LFKDHO :DJQHU 8OULFK 0DQVIHOG
6WHSKDQLH+RHSSHQHU-XVW\QD$&]DSOHZVND0LFKDHO*RWWVFKDOG$QMD7UlJHU)HOL[+
6FKDFKHU8OULFK66FKXEHUW
%RWKDXWKRUVFRQWULEXWHGHTXDOO\WRWKLVZRUN
/DERUDWRU\RI2UJDQLF DQG0DFURPROHFXODU&KHPLVWU\ ,20&)ULHGULFK6FKLOOHU8QLYHUVLW\
-HQD+XPEROGWVWUDVVH-HQD*HUPDQ\
 -HQD &HQWHU IRU 6RIW 0DWWHU -&60 )ULHGULFK 6FKLOOHU 8QLYHUVLW\ -HQD 3KLORVRSKHQZHJ 
-HQD*HUPDQ\
'XWFK3RO\PHU,QVWLWXWH'3,32%R[$;(LQGKRYHQWKH1HWKHUODQGV
(PDLOXOULFKVFKXEHUW#XQLMHQDGHIHOL[VFKDFKHU#XQLMHQDGH

7DEOH6,QIOXHQFHRIWKHS+YDOXHRIWKHVROXWLRQRQWKHVHOIDVVHPEO\SURFHVV
6DPSOH 5K!QDSS>QP@
(17(&7S+  
(17(&7S+  
(17(&7S+  





$ %
)LJXUH66(&WUDFHV $DQG +105VSHFWUXP%RI WKH3(2E3$*(E3W%*(SUHFXUVRUDV
ZHOODVWKHF\VWHDPLQHIXQFWLRQDOL]HGWULEORFNWHUSRO\PHU


$ %
)LJXUH66(&WUDFHV $DQG +105VSHFWUXP%RI WKH3(2E3$*(E3W%*(SUHFXUVRUDV
ZHOODVWKHPHUFDSWRSURSLRQLFDFLGIXQFWLRQDOL]HGWULEORFNWHUSRO\PHU








$ %

)LJXUH66(&WUDFHV$DQG+105VSHFWUXP%RIWKH3(2E3$*(E3W%*(SUHFXUVRUWKH
DFHW\ODWHGWKLRJDODFWRVHIXQFWLRQDOL]HGWULEORFNWHUSRO\PHUDVZHOODVWKHGHSURWHFWHGSURGXFW




)LJXUH 6 &U\R7(0 LPDJH RI 3(2E3$*(&22+E3W%*( (&7 DV H[DPSOH GLVSOD\LQJ WKH
PLQRUGLVWULEXWLRQRIZRUPOLNHVWUXFWXUHV









$ %
)LJXUH6&RUUHODWLRQIXQFWLRQVRIWKH'/6PHDVXUHPHQWVRIWKH(&7VDPSOHDWGLIIHUHQWFRQFHQWUDWLRQV
$DVZHOODVWKHUHODWHGQXPEHUZHLJKWHG&217,1SORWV%

$ %
 
)LJXUH61XPEHUZHLJKWHG'/6&217,1SORWV IRU WKH $DQG %PL[WXUHRI3(2E
3$*(1+FR3$*(E3W%*(3(2E3$*(&22+E3W%*((17(&7



)LJXUH6,QWHQVLW\ZHLJKWHG'/6&217,1SORWVIRU3(2E3$*(E3W%*(($7$3(2E
3$*(1+FR3$*(E3W%*( (17 % 3(2E3$*(&22+E3W%*( (&7 & 3(2E
3$*(*DOFR3$*(E3W%*( (*7 ' 3(2E3$*(1+FR3$*(E3W%*(  3(2E
3$*(&22+E3W%*( (17(&7 ( 3(2E3$*(1+FR3$*(E3W%*(  3(2E
3$*(&22+E3W%*( (17(&7 ) 3(2E3$*(1+FR3$*(E3W%*(  3(2E
3$*(&22+E3W%*( (17(&7 * 3(2E3$*(1+FR3$*(E3W%*(  3(2E
3$*(&22+E3W%*(  3(2E3$*(*DOFR3$*(E3W%*( (17(&7(*7 + DQG
3(2E3$*(1+FR3$*(E3W%*(3(2E3$*(&22+E3W%*(3(2E3$*(*DOFR
3$*(E3W%*((17(&7(*7,


          







1R
UP
DOL
]H
GG
HWH
FWR
UU
HV
SR
QV
H
7LPHPLQ
(&7

[
[
[
[
[
[
[
0R
ODU
P
DV
V
J
PR
O











5 +
Q
P
PLFHOOHV
DJJUHJDWHV
$ 89
/6
            







1R
UP
DOL
]H
GG
HWH
FWR
UU
HV
SR
QV
H
7LPHPLQ
(*789 /6

[
[
[
[
[
[
0R
ODU
P
DV
V
J
PR
O











XQLPHUV
5 +
Q
P
PLFHOOHV
DJJUHJDWHV
%
            







1R
UP
DOL
]H
GG
HWH
FWR
UU
HV
SR
QV
H
7LPHPLQ
(17(&7&
89
/6

[
[
[
[
[
[
[
[
[
[
0R
ODU
P
DV
V
J
PR
O











5 +
Q
P
PLFHOOHV DJJUHJDWHV
            







1R
UP
DOL
]H
GG
HWH
FWR
UU
HV
SR
QV
H
7LPHPLQ
89
/6

[
[
[
[
[
[
[
[
[
[
0R
ODU
P
DV
V
J
PR
O











XQLPHUV
(17(&7(*7
5 +
Q
P
PLFHOOHV
DJJUHJDWHV
'

)LJXUH6$)IUDFWRJUDPVRIVHOIDVVHPEOHGVWUXFWXUHVRI3(2E3$*(&22+E3W%*((&7$
3(2E3$*(*DOFR3$*(E3W%*( (*7 % 3(2E3$*(1+FR3$*(E3W%*( 
3(2E3$*(&22+E3W%*( (17(&7 & 3(2E3$*(1+FR3$*(E3W%*( 
3(2E3$*(&22+E3W%*( (17(&7' DQG3(2E3$*(1+FR3$*(E3W%*( 
3(2E3$*(&22+E3W%*(  3(2E3$*(*DOFR3$*(E3W%*( (17(&7(*7
&LQP01D&O

7DEOH6([SHULPHQWDOGQGFYDOXHVRIWKHGLIIHUHQWSRO\PHUV\VWHPVLQP01D&O
6DPSOH GQGFP/J
0Z
JPRO
0]
JPRO ç
($7  ( ( 
(17  ( ( 
(&7  ( ( 
(*7  ( ( 
(17(&7  ( ( 
(17(&7  ( ( 
(17(&7  ( ( 
(17(&7(*7  ( ( 
(17(&7(*7  ( ( 



)LJXUH6*HOHOHFWURSKRUHVLVVWXG\RIWKHDVV\QWKHVL]HGPDWHULDO($7(17PL[WXUHVRI(17
DQG(&7LQUDWLRVRI(&7DPL[WXUHRI(&7DQG(*7LQDUDWLRRIDQG
(*7

$ %

)LJXUH61XPEHUZHLJKWHG'/6&217,1SORWVRIDPL[WXUHRI3(2E3$*(1+FR3$*(
E3W%*((17PLFHOOHVZLWK3(2E3$*(&22+E3W%*((17(&7GLUHFWO\DIWHUPL[LQJDQG
K(17(&7$DQGDSKRWRJUDSKRIWKHVROXWLRQDIWHUKVKRZLQJSUHFLSLWDWHGPDWHULDO%




)LJXUH6,QWHUQDOL]DWLRQHIILFLHQF\RIWULEORFNWHUSRO\PHUPLFHOOHVLQ+HS*FHOOV


)LJXUH 6 )ORZ F\WRPHWHU KLVWRJUDP RI FRQWURO FHOOV FRQWLQXHV OLQH DQG FHOO WUHDWHG ZLWK
(17(&7PLFHOOHVGDVKHGOLQH
Ϭ
ϮϬ
ϰϬ
ϲϬ
ϴϬ
ϭϬϬ
ϭϮϬ
ĐŽ
Ŷƚ
ƌŽ
ů ϭ ϭϬ Ϯϱ ϱϬ ϭ ϭϬ Ϯϱ ϱϬ ϭ ϭϬ Ϯϱ ϱϬ ϭ ϭϬ Ϯϱ ϱϬ
d d Ed 'd
Ăŵ
ŽƵ
Ŷƚ
Ž
ĨĐ
Ğůů
Ɛͬ
й

RAFT Made Methacrylate Copolymers for Reversible pH-Responsive
Nanoparticles
Turgay Yildirim,1,2 Alexandra C. Rinkenauer,1,2 Christine Weber,1,2 Anja Traeger,1,2
Stephanie Schubert,2,3 Ulrich S. Schubert1,2
1Laboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstr. 10, 07743 Jena,
Germany
2Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743 Jena, Germany
3Institute of Pharmacy, Department of Pharmaceutical Technology, Friedrich Schiller University Jena, Otto-Schott-Str. 41, 07745
Jena, Germany
Correspondence to: U.S. Schubert; (E -mail: ulrich.schubert@uni-jena.de)
Received 1 May 2015; accepted 1 June 2015; published online 2 July 2015
DOI: 10.1002/pola.27734
ABSTRACT: In this study, we designed and investigated pH-
responsive nanoparticles based on different ratios of mono-
mers with primary, secondary or tertiary amino groups. For
this purpose, copolymers of methyl methacrylate (MMA) with
different compositions of amino methacrylates (2-(dimethyl-
amino)ethyl methacrylate (DMAEMA), 2-(tert-butylamino)ethyl
methacrylate (tBAEMA) and 2-aminoethyl methacrylate hydro-
chloride (AEMAHCI)) were synthesized using the reversible
addition-fragmentation chain transfer (RAFT) polymerization
process. The controlled nature of the radical polymerization
was demonstrated by kinetic studies. All copolymers show low
dispersities (-DM<1.2) with amino contents between 9 and
21 mol %. For the nanoparticle formation, nanoprecipitation
with subsequent solvent evaporation was used. All suspen-
sions were characterized by dynamic light scattering (DLS) and
scanning electron microscopy (SEM). Different initial condi-
tions of the formulations resulted in differently sized nanopar-
ticles that have monomodal size distributions, relatively
narrow polydispersity index (PDI) values and positive zeta
potential values. The pH-stability test results demonstrated
that, depending on the structure and amount of the amino con-
tent, the obtained nanoparticles reveal a reversible pH-
response, such as dissolution at acidic pH values. The ability of
the nanoparticles to encapsulate guest molecules was con-
firmed by pyrene fluorescence studies. The cytotoxicity assay
results showed that the nanoparticles did not have any signifi-
cant cytotoxic effect. VC 2015 Wiley Periodicals, Inc. J. Polym.
Sci., Part A: Polym. Chem. 2015, 53, 2711–2721
KEYWORDS: copolymerization; nanoparticles; nanoprecipitation;
pH-responsive polymers; pH-responsive nanoparticles; poly-
merization kinetics; RAFT polymerization; self-assembly
INTRODUCTION Stimuli-responsive polymeric nanoparticles
recently gained increasing attention due to their potential
applications in numerous fields, in particular for pharmaceu-
tical applications.1–3 Depending on the chemical composition,
such “smart” nanoparticles respond to external and/or inter-
nal stimuli by physicochemical changes driven by tempera-
ture,4 light,5 redox reaction,6 ultrasound,7 or pH value.8
Among these, pH-responsive nanoparticles are regarded as
highly promising vehicles for the selective delivery of phar-
maceutical agents to the diseased tissues. Due to the fact
that cancer cells have an abnormal acidic extracellular envi-
ronment,9 the pH-sensitivity of the matrix material can trig-
ger the release of the encapsulated drugs. Several pH-
responsive nanoparticle systems were reported to increase
the efficacy of anticancer drugs in cancer therapy.10–12 More-
over, a drug delivery vehicle with pH-responsive shedding
would be useful for endosomal escape due to the acidifica-
tion of the late endosome and lysosome.13
There are two main strategies to fabricate polymeric pH-
responsive nanoparticle systems. The first category com-
prises the nanoparticles prepared from polymers that have
pH-sensitive bonds, such as hydrazone or acetal bonds.14,15
The second category involves the nanoparticle formation
from polymers containing ionizable segments, such as amino
and/or carboxyl groups.16,17 Although there are several
methodologies to prepare polymeric nanoparticles,18 most of
the pH-responsive structures in literature are based on the
supramolecular self-assembly of copolymer micelles. How-
ever, the instability of the micelles below their critical
micelle concentration represents a serious drawback.19
Additional Supporting Information may be found in the online version of this article.
VC 2015 Wiley Periodicals, Inc.
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Moreover, uniform size and morphology of the assembled
structure is confined with block type copolymers that are
harder to synthesize compared to statistical copolymers,20
also in terms of upscaling.
In this study, a library of well-defined copolymers of methyl
methacrylate (MMA) with three amino comonomers with
ionizable segments (2-(dimethylamino)ethyl methacrylate
(DMAEMA), 2-(tert-butylamino)ethyl methacrylate (tBAEMA)
and 2-aminoethyl methacrylate hydrochloride (AEMAHCI))
were synthesized via RAFT polymerization (Scheme 1) to
obtain a novel pH-responsive drug delivery vehicle for the con-
trolled release of loaded pharmaceutical agents in acidic envi-
ronment.21 MMA was used as main monomer in the copolymer
chains due to the required hydrophobicity for the nanoparticle
formation. DMAEMA, tBAEMA, and AEMAHCI were used as
comonomers since their polymers act as weak polybases with
pKa values between 7.6 and 8.22–24 All nanoparticles were pre-
pared by means of nanoprecipitation25,26 of the synthesized
copolymers. To investigate a possible effect of the amino con-
tent on the pH-response of corresponding nanoparticles, the
copolymer composition was varied by using different monomer
feed ratios. Compared to the well-known pH-responsive sys-
tems, such as Eudragit E100,27 the main advantage of our
approach is the possibility to tune the nanoparticle’s size, solu-
bility, amino content and distribution of the amino moieties
along the polymer chain, which could improve loading and
release profiles of the pharmaceutical agents encapsulated.
EXPERIMENTAL SECTION
Materials
The monomers methyl methacrylate (MMA), 2-(N,N-dimethyla-
mino)ethyl methacrylate (DMAEMA), 2-(tert-butylamino)ethyl
methacrylate (tBAEMA) and 2-aminoethyl methacrylate hydro-
chloride (AEMAHCI) were purchased from Sigma Aldrich and
purified by stirring in the presence of inhibitor remover prior
to use. 2,20-Azobis(iso-butyronitrile) (AIBN) was purchased
from Acros and recrystallized from methanol prior to use.
4-Cyano-4-(phenylcarbonothioylthio) pentanoic acid (CPADB),
AmberlystV
R
A21, 1,3,5-trioxane, inhibitor remover and pyrene
were purchased from Sigma Aldrich. AlamarBlue was obtained
from Life Technologies. If not stated otherwise, cell culture
materials, cell culture media, and solutions were obtained from
PAA. All other chemicals were obtained from standard suppli-
ers and used without purification unless specified.
Instruments and Methods
Proton nuclear magnetic resonance (1H NMR) spectra were
recorded at room temperature in CDCl3 or CD3OD on a
Brucker Avance 300 MHz using the residual solvent reso-
nance as an internal standard. The chemical shifts are given
in ppm.
Gas chromatography (GC) measurements were performed on
a Shimadzu GC-2010 instrument.
Size-exclusion chromatography (SEC) measurements were
performed on two different setups: (SEC in CHCl3) Shimadzu
system equipped with a SCL-10A system controller, a LC-
10AD pump, a RID-10A refractive index detector and a
PSSSDV-linear S column (5 mm particle size; Polymer Stand-
ards Service GmbH, Mainz, Germany) at 40 8C using a chloro-
form, triethylamine and 2-propanol (94:4:2) mixture as eluent
at a flow rate of 1 mL min21. The system was calibrated with
PMMA standards (Mp5 410 to 88,000 g mol
21); (SEC in
DMAc) Agilent 1200 series equipped with a G1310A pump, a
G1315D DA detector, a G1362A RI detector, and PSS GRAM 30
Å/1000 Å (10 mm particle size) columns in series at 40 8C
using N,N-dimethylacetamide (DMAc) with 2.1 g L21 LiCl as
eluent at a flow rate of 1 mL min21. The system was cali-
brated with PMMA standards (Mp5 505 to 981,000 g mol
21).
Chlorine analysis was carried out on a Titrator TLalpha 20
instrument.
Dynamic light scattering (DLS) was performed on a Zetasizer
Nano ZS (Malvern Instruments, Herrenberg, Germany). After
an equilibration time of 180 s, 3 3 30 runs were carried out
at 25 8C (k5 633 nm). The counts were detected at an angle
of 1738. Each measurement was performed in triplicate. The
mean particle size was approximated as the effective (Z-aver-
age) diameter and the width of the distribution as the poly-
dispersity index of the particles (PDI) obtained by the
cumulants method assuming a spherical shape.
Electrophoretic light scattering was used to measure the elec-
trokinetic potential, also known as zeta potential. The mea-
surements were performed on a Zetasizer Nano ZS (Malvern
Instruments, Herrenberg, Germany) by applying laser Doppler
velocimetry. For each measurement, 10 runs were carried out
using the slow-field and fast-field reversal mode at 150 V.
Each experiment was performed in triplicate at 25 8C.
For scanning electron microscopy (SEM), 5 lL of the suspen-
sions were placed on a mica surface and dried overnight at
room temperature under atmospheric pressure. Afterwards,
images were taken using a Gemini 1530 type LEO field emis-
sion scanning electron microscope (Carl-Zeiss AG, Germany).
The samples were coated with a thin layer (4 nm) of platinum
via sputter coating using a Bal-TEC 020 HR Sputtering Coater.
For the cytotoxicity tests a Tecan Infinite 200 Pro fluores-
cence microplate reader (Crailsheim, Germany) was used.
The fluorescence spectra of pyrene solutions were recorded
on a Jasco FP-6500 fluorometer applying an excitation wave-
length of 335 nm. The emission spectra were recorded from
350 to 600 nm. The excitation and emission bandwidths
were 3.0 and 3.0 nm, respectively. For the pH-response test
of the nanoparticles a BioShake instrument (Analytik Jena
AG, Germany) was used.
Synthesis
RAFT Polymerization
MMA was copolymerized with three different amino metha-
crylates (DMAEMA, tBAEMA and AEMAHCI) using CPADB as
chain transfer agent (CTA) and AIBN as initiator. The initial
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monomer feed ratios of the monomers were varied whereas
the overall monomer to CTA ratio was kept constant at 100.
All polymerizations were carried out at 70 8C in an oil bath.
The copolymerizations with DMAEMA and tBAEMA (P1–P4)
were performed in a 2 M ethanolic solution. Methanol was
used as solvent for the copolymerizations with AEMAHCI
(P5–P6). The polymerization conditions are summarized in
Table 1. An exemplary RAFT copolymerization procedure
(Table 1, P1) is as follows: 30 g MMA (0.300 mol), 5.234 g
DMAEMA (0.033 mol), 930 mg CPADB (3.329 mmol), and
137 mg AIBN (0.832 mmol) were dissolved in ethanol in a
250 mL two-necked round-bottom flask equipped with a
magnetic stir bar. The total volume of the reaction mixture
was 166 mL. After degassing for 4 h by argon purging, the t0
sample for GC was taken and the flask was immersed in a pre-
heated oil bath under stirring at 70 8C. After 10 h, the poly-
merization was stopped by cooling to room temperature and
exposing to air. Monomer conversions were determined via
GC by using the reaction solvent (ethanol) as internal stand-
ard. The polymer was purified by precipitating in cold hexane
(approximately six times). The resulting pink colored polymer
was dried under high vacuum at room temperature until con-
stant weight to produce an overall yield of 40%. The number
average molar mass (Mn) and molar mass dispersities were
determined by two different SEC systems by using PMMA
standards. SEC in CHCl3: Mn5 6100 g mol
21 and -DM5 1.16.
SEC in DMAc: Mn5 6300 g mol
21 and -DM5 1.13.
1H NMR
(CDCl3, 300 MHz): d5 7.87, 7.52 and 7.36 (Ar-H, CPADB),
4.13 (AOCH2CH2NH(CH3)2), 3.60 (AOCH3), 2.64
(AOCH2CH2NH(CH3)2), 2.4–0.7 (backbone) ppm.
The degree of polymerization (DP) for each polymer was cal-
culated from the signal integrals in the 1H NMR spectrum of
the purified copolymer using the following equations:
DPMMA5
Iðpeak aÞ=3
I peak cð Þ=2 (1)
DPDMAEMA5
Iðpeak bÞ=2
I peak cð Þ=2 ; (2)
with I(a) corresponding to the integral of methyl proton
peaks of the MMA at 3.60 ppm, I(b) corresponding to the
integral of methylene proton peaks of the DMAEMA at 4.13
ppm, and I(c) corresponding to the integral of two aromatic
protons of the dithiobenzoate end group at 7.87 ppm. Molar
mass values were calculated by using the following equation:
Mn;NMR5 ðDPMMA3MMMAÞ1 ðDPDMAEMA3MDMAEMAÞ1MCTA;
(3)
in which the molar mass of the MMA, DMAEMA and RAFT
agent are 100.12, 157.21, and 279.38 g mol21, respectively.
Kinetic Study of the Polymerizations
During each polymerization, aliquots of 0.2 mL were taken
periodically from the reaction mixture by a syringe purged
with argon. From each sample, conversions were calculated
via GC (P1-P4) or 1H NMR (P5-P6) by using the reaction
solvents (P1-P4) or 1,3,5-trioxane (P5-P6) as internal stand-
ards. Molar masses and dispersities were determined via
SEC analysis (CHCl3, RI detection).
SCHEME 1 Schematic representation of the RAFT copolymerization of MMA with amino-functionalized methacrylates. [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
TABLE 1 RAFT Copolymerization Conditions of MMA (M1) and Corresponding Amino-Functionalized Methacrylates (M2)a
Entry M2 M1/M2/CTA/AIBN Solvent Polymerization Time [h]
P1 DMAEMA 90/10/1/0.25 Ethanol 10
P2 DMAEMA 80/20/1/0.25 Ethanol 10
P3 tBAEMA 95/5/1/0.25 Ethanol 13
P4 tBAEMA 85/15/1/0.25 Ethanol 10
P5b AEMAHCI 90/10/1/0.25 Methanol 9
P6b AEMAHCI 80/20/1/0.25 Methanol 10
a All polymerizations were carried out at total monomer concentrations
of 2 mol L21.
b Polymerization was carried out under reflux.
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Deprotonation of the Polymers
Ion exchange resin Amberlyst A21
VR
was used to deprotonate
P5 and P6. For a typical deprotonation reaction, P5 was dis-
solved in methanol, mixed with Amberlyst
VR
A21 and stirred
for 1 h at room temperature. Subsequently, the correspond-
ing polymer P7 was obtained by filtration, precipitation into
ice-cold hexane and by removal of the volatiles under
reduced pressure at room temperature. 1H NMR (CDCl3, 300
MHz): d5 7.87, 7.52, and 7.36 (Ar-H, CPADB), 4.00
(AOCH2CH2NH2), 3.60 (AOCH3), 2.97 (AOCH2CH2NH2), 2.5–
0.7 (backbone) ppm. SEC in CHCl3: Mn5 5300 g mol
21 and
-DM5 1.15, SEC in DMAc: Mn5 9000 g mol
21 and -DM5 1.10.
Elemental anal. found: C 58.31%, H 8%, N 1.73%, S 0.85%,
Cl 1.01%.
Preparation of the Nanoparticle Suspensions
For nanoprecipitation, the corresponding polymers (P1, P2,
P3, P4, P7, and P8) were dissolved in acetone at a concen-
tration of 1 or 10 mg mL21, respectively, and subsequently
added dropwise to deionized water under continuous stir-
ring at 500 rpm (acetone to water, AW method). For the
water to acetone (WA) method, deionized water was added
drop-wise to the acetone polymer solution under stirring at
500 rpm. The acetone/water (solvent/nonsolvent) ratio was
kept constant at 0.5 for all suspensions. After removal of the
acetone by stirring overnight at room temperature (GC anal-
ysis ensured complete removal of acetone), all suspensions
were diluted to the final volume of 10 mL. The nanoparticles
were characterized by DLS (performed in pure water) and
SEM without filtration.
pH-Response Test of the Nanoparticles
For the pH stability test of the nanoparticles (c5 0.3 mg
mL21), 0.0667 M acetate buffer (pH values 3.4, 4, 5, 6) and
0.0667 M tris buffer (pH values 7, 8, 9) were used. 500 mL
of nanoparticle suspensions were mixed with 500 mL of
buffer solutions in Eppendorf tubes and stored at 37 8C
while mixing at 200 rpm in a BioShake instrument. After
24 h, DLS and zeta potential measurements were performed
(particle concentration of 0.15 mg mL21 in all corresponding
buffer systems).
Fluorescence Spectroscopic Study of the Nanoparticles
1 mL stock solution of pyrene (6 3 1025 mol L21) in ace-
tone was added to 1 mL nanoparticle suspensions (0.15 mg
mL21 polymer concentrations) at various pH values. The
samples were incubated at 37 8C for 24 h to remove acetone
and to give a final pyrene concentration of 3 3 1025 mol
L21.
Cell Lines, Culture Conditions, and Cytotoxicity Test of
Nanoparticles
The L929 (CCL-1, ATCC) cell lines used in the cytotoxicity
experiments were maintained in DMEM culture media sup-
plemented with 10% fetal calf serum (FCS), 100 mg mL21
streptomycin and 100 IU mL21 penicilin. The cells were cul-
tured at 37 8C in humidified 5% CO2 atmosphere. The cyto-
toxicity was tested with L929 cells, as this sensitive cell line
is recommended by ISO10993-5 (n5 6). In detail, cells were
seeded at 10 cells per well in a 96-well plate and incubated
for 24 h. No cells were seeded in the outer wells. After-
wards, the media were replaced by fresh media and incu-
bated for 30 min. The nanoparticle suspensions were added
in the end concentration range from 10 to 1000 mg mL21,
and the cells were incubated at 37 8C for further 24 h. Sub-
sequently, the medium was replaced by fresh media and Ala-
marBlue as recommended by the supplier. After incubation
for 4 h, the fluorescence was measured at Ex 570/Em
610 nm, with untreated cells on the same well plate serving
as controls.
RESULTS AND DISCUSSION
A series of amino-functionalized PMMA based copolymers
was synthesized via RAFT polymerization due to its versatil-
ity and suitability for the synthesis of well-defined amino
methacrylate copolymers.28,29 Three different commercially
available amino methacrylates that have tertiary (DMAEMA),
secondary (tBAEMA) and protonated primary amine func-
tionalities (AEMAHCI) were used as comonomers. The uti-
lized CTA CPADB has previously been successfully applied to
mediate the RAFT polymerization of amino methacry-
lates.29,30 [M]/[CTA] was kept constant at a ratio of 100/1
with a monomer concentration of 2 mol L21 in order to
obtain relatively low molar mass polymers, considering the
increased toxicity of high molar mass polycations.31 Depend-
ing on previous research in our group, the [CTA]/[AIBN]
ratio was kept at 1/0.25 regarding polymerization rate and
control over the molar mass.32 All polymerizations were car-
ried out in ethanol at 70 8C, except for P5-P6, where metha-
nol under reflux was used as solvent because of the poor
solubility of AEMAHCI in ethanol. The primary amine con-
taining monomer AEMA can easily rearrange to its thermo-
dynamically more stable isomer 2-hydroxyethyl
methacrylamide, and the dithiobenzoate moiety of the CTA is
prone to an aminolysis reaction if the free amine monomer
is used.24 Thus, the hydrochloride salt of the monomer
AEMA was used for the polymerization. Two different initial
monomer feed ratios were applied for each copolymerization
to vary the amino content in the copolymers. The amino
methacrylate content in the copolymers was kept low (in
between 9 and 21) due to the required hydrophobicity of
the copolymers for the capability to form nanoparticles via
nanoprecipitation.
Kinetic Studies
The distribution of the amine functionality among the PMMA
chain might be an important parameter that could affect the
particle formation or structure. To obtain information about
the sequence arrangements of the monomers in the PMMA
based copolymer chains, kinetic studies were performed for
each copolymerization. The obtained data from the kinetic
studies of the RAFT copolymerizations of MMA with 10 mol%
comonomer (DMAEMA, tBAEMA and AEMAHCI, respec-
tively) are displayed in Figure 1. The corresponding data
derived from the kinetic studies with 20 mol% comonomer
content are given in the supporting information (Supporting
ARTICLE WWW.POLYMERCHEMISTRY.ORG
JOURNAL OF
POLYMER SCIENCE
2714 JOURNAL OF POLYMER SCIENCE, PART A: POLYMER CHEMISTRY 2015, 53, 2711–2721
Information Fig. S2). Analysis of the kinetic samples by
means of SEC in CHCl3 revealed monomodal molar mass dis-
tributions that shift to lower elution volumes throughout the
course of the polymerization (Supporting Information Fig.
S1). The molar mass Mn was found to increase linearly with
respect to the total monomer conversion (B, Fig. 1). These
results indicate the controlled nature of the RAFT
polymerization.
The semilogarithmic kinetic plots are linear (A, Fig. 1) for
both monomers in each copolymerization, indicating a
pseudo first order polymerization behaviour. At the begin-
ning of the DMAEMA and AEMAHCI polymerizations, induc-
tion periods of around 2 h were observed for each monomer,
which is often reported for RAFT polymerizations.33–36 How-
ever, for tBAEMA copolymerizations an increase in the induc-
tion period of the MMA was observed. This is due to the
selective addition of the tBAEMA to the growing polymer
chains at the beginning of the polymerizations.
The slopes of MMA and DMAEMA in the semilogarithmic
plot, which are directly proportional to the polymerization
rates of MMA and DMAEMA, respectively, are close to each
other, which indicates that both monomers are consumed at
close rates. In accordance to the results of the kinetic stud-
ies, the ratio of the monomers in the isolated copolymers is
similar to the initial monomer feed ratio. These results are
also in a good agreement with the reported reactivity ratios
of MMA and DMAEMA for the RAFT and free radical copoly-
merizations (rMMA  0.8, rDMAEMA  0.9).37,38 Therefore, it
can be concluded that MMA and DMAEMA arrange in the
polymer chain in a random sequence.
In contrast, the increased slope of the tBAEMA in the semilo-
garthmic plot reveals that tBAEMA is consumed faster than
MMA. Indeed, the compositions in the isolated polymers
deviated significantly from the initial monomer feed ratios in
favor of tBAEMA at moderate monomer conversions. The
reported relative reactivity ratios of MMA (rMMA  0.7) and
tBAEMA (rtBAEMA  1.4)39 for the free radical copolymeriza-
tion are in a good agreement with these results. Thus, it can
be concluded that the copolymers of MMA and tBAEMA dis-
play a gradient composition.40,41
To the best of our knowledge there are no relative reactivity
ratios reported for the copolymerization of MMA and
AEMAHCI. However, almost identical slopes of MMA and
AEMAHCI in the semilogarithmic plot hint towards a ran-
dom arrangement of the monomers along the polymer chain
for both 10 as well as 20 mol% AEMAHCI.
The kinetic plots for the copolymerizations of same mono-
mers with different initial monomer feed ratios revealed sim-
ilar results (Supporting Information Fig. S2).
Copolymer Synthesis and Characterization
Based on the results obtained from preliminary kinetic stud-
ies, the final copolymers were synthesized under similar con-
ditions with a total M/CTA of 100 aiming at 10 as well as
20% amino content for each monomer. All polymerizations
were stopped at moderate monomer conversions to exclude
undesired coupling reactions that could take place at higher
monomer conversions. Each purified polymer was character-
ized by 1H NMR spectroscopy and SEC measurements on
two systems (Table 2).
FIGURE 1 Kinetic studies of the RAFT copolymerization of MMA with 10 mol% comonomer DMAEMA (P1), tBAEMA (P3) and
AEMAHCI (P5). [M]/[CPADB]/[AIBN]5 100/1/0.25; [M]052 mol L21. Polymerization conditions for (P1 and P3): Solvent ethanol, T5 70
8C. Polymerization conditions for P5: Solvent methanol under reflux. (A) Semilogarithmic kinetic plots. (B) Mn and Mw/Mn evolution
with total monomer conversion. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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The compositions of the isolated copolymers (F(M1/M2),
Table 2) were calculated from the 1H NMR spectra by using
the integrals of appropriate signals derived from both como-
nomers (methyl proton signal “a” for MMA and methylene
proton signal “b” for the amino monomers in Fig. 2, see the
experimental section for details). Although DMAEMA and
AEMAHCI copolymers had close initial monomer feed ratios
and monomer compositions in the polymers, tBAEMA
copolymers revealed a composition drift. These results are in
accordance with the kinetic studies of the corresponding
monomers described above. However, by adjustment of the
corresponding monomer feed ratios it was possible to obtain
two sets of polymers that contained 10 and 20 mol% of
amine comonomer, respectively. All 1H NMR spectra clearly
indicate the presence of the dithiobenzoate end-groups
derived from the CTA (signals of the aromatic protons at
7.3–7.9 ppm) enabling an estimation of the DP for MMA and
for each amino methacrylate. The according number average
molar mass (Mn) values calculated by
1H NMR are in good
agreement with the theoretical values that were calculated
from the [monomer] to [CTA] ratio and the monomer con-
versions. It should be noted that the 1H NMR spectrum of
P6 was measured in methanol due to the insufficient solubil-
ity of P6 in CDCl3.
The isolated copolymers were analysed using two different
SEC systems, which both revealed monomodal traces for all
polymers with low dispersity values (-DM< 1.2) (Fig. 3, Sup-
porting Information Fig. S3, Table 2). In general, higher Mn
values were obtained from both SEC systems using PMMA
calibration compared to the Mn values calculated from the
1H NMR spectra. This is attributed to the difference in
hydrodynamic volumes of the polymers in both eluents that
TABLE 2 Selected Characterization Data of the MMA (M1) Copolymers with Corresponding Amino Methacrylates (M2)
Entry M2
f(M1/
M2)a
F(M1/
M2)b,c
Conv. (%)
M1 M2
Mn, theo.
d
(g mol21)
DPc
M1 M2
Mn
c
(g mol21)
Mn
e
(g mol21) -DM
e
Mn
f
(g mol21) -DM
f
P1 DMAEMA 9 7.4 39g 45g 4,500 41 5.5 5,200 6,100 1.16 6,300 1.13
P2 DMAEMA 4 4 42g 50g 5,200 40 10 5,900 7,600 1.17 7,800 1.15
P3 tBAEMA 19 9.5 29g 70g 3,700 35 3.7 4,500 5,200 1.19 7,100 1.17
P4 tBAEMA 5.7 3.8 36g 72g 5,300 35 9.2 5,500 7,900 1.15 11,900 1.16
P5 AEMAHCI 9 9.1 45c 44c 5,000 42 4.6 5,200 5,100 1.13 9,200 1.15
P6 AEMAHCI 4 3.7 48c 52c 5,900 30 8.2 4,600 4,500 1.19 11,000 1.15
P7h AEMA 9 45 5 5,200 5,300 1.18 9,000 1.10
P8i AEMA 3.6 35 9.8 5,000 4,800 1.18 10,000 1.15
a Initial monomer feed ratio.
b Monomer ratio in the isolated copolymer.
c Determined by 1H NMR spectroscopy.
d Determined by the formula Mn,theo.5 [([M]M1/[CTA] 3 Conv. 3
MM1)1 ([M]M2/[CTA] 3 Conv. 3 MM2)1 (MCTA)].
e Determined by SEC in CHCl3 analysis (RI detection, PMMA
calibration).
f Determined by SEC in DMAc analysis (RI detection, PMMA
calibration).
g Determined by GC.
h Deprotonated form of P5.
i Deprotonated form of P6.
FIGURE 2 1H NMR spectra (300 MHz, CDCl3) of P1, P3, and P5
and the assignment of the peaks used to calculate the DP.
[Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
FIGURE 3 Normalized SEC traces in CHCl3 (RI detection, elu-
ent: CHCl3) of isolated copolymers of P1-P6. [Color figure can
be viewed in the online issue, which is available at wileyonline-
library.com.]
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are used in these SEC systems compared to PMMA homopo-
lymers. In particular the polar eluent of the SEC in DMAc
apparently results in an increased hydrodynamic volume of
the amine-containing polymers, which directly leads to an
increased apparent molar mass.
Finally the charged copolymers that contain AEMAHCI (P5-
P6) were treated with AmberlystV
R
A21 to obtain the desired
primary amino-functionalized copolymers (P7-P8). Elemental
analysis results demonstrated a significant decrease in the
chlorine content after the deprotonation reactions (Support-
ing Information Table S1). Both SEC systems revealed no
change after the deprotonation reactions (Supporting Infor-
mation Figs. S4–S7), which ensures the absence of disulfide
bond formation, which could possibly occur subsequent to
an end group cleavage of the polymers with AmberlystV
R
A21.
It should also be noted that the 1H NMR spectrum of P8
(Supporting Information Fig. S15) was measured in CDCl3
instead of MeOD since the polymer solubility after deproto-
nation changed dramatically, indicating the decreased polar-
ity of the deprotonated polymer.
Preparation of Nanoparticle Suspensions
Polymeric nanoparticles were prepared from the synthesized
tertiary (P1, P2), secondary (P3, P4) and primary (P7, P8)
amino-functional MMA based copolymers by means of nano-
precipitation with subsequent solvent evaporation without
any need of stabilizers/surfactants. The acetone/water ratio
was kept at 0.5 for all suspensions. In order to obtain differ-
ently sized nanoparticles, two different initial acetone-
polymer solution concentrations (1 mg mL21, 10 mg mL21)
and two different dropping methods (dropping acetone poly-
mer solution to water (AW) and dropping water to acetone
polymer solution (WA)) were applied for each polymer. In
general, smaller nanoparticles were obtained with dropping
acetone polymer solution to water (AW) than dropping
water to acetone polymer solution (WA) (Fig. 4), which is
commonly observed for the nanoprecipitation method.42 For
the initial acetone-polymer solution concentration of 1 mg
mL21, nanoparticles with monomodal size distributions (Fig.
4) and low polydispersity (PDI) values (Table 3) were
obtained from all polymers.
However, with the initial acetone-polymer concentration of
10 mg mL21, nanoparticles with monomodal size distribu-
tions could only be obtained from the copolymers that con-
tained DMAEMA and AEMA (P1, P2, P7, and P8), which
both have a random comonomer distribution. In contrast,
the gradient copolymers of tBAEMA (P3-P4) yielded nano-
particles and undefined aggregates which result in multimo-
dal size distributions and high PDI values. This might be due
to the tightly spaced amino groups along the polymer chain,
FIGURE 4 Intensity size distributions of nanoparticles in water
(P1, P3, and P7) with the initial acetone-polymer concentration
of 1 mg mL21, prepared by dropping acetone-polymer solution
to water (AW) or dropping water to acetone-polymer solution
(WA). [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
TABLE 3 Characterization Results of the Prepared Nanoparticles
Z-averageb [d, nm] PDIb Zeta potentialc [mV]
Polymer Methoda c5 1 g L21 c5 10 g L21 c51 g L21 c5 10 g L21 c5 1 g L21 c510 g L21
P1 AW 15262 1236 1 0.1660.02 0.126 0.01 1356 4.4 1376 0.3
WA 34063 7206 18 0.1160.03 0.076 0.05 1256 4.3 1486 1.1
P2 AW 18462 1316 2 0.1660.01 0.116 0.04 1526 0.4 1316 0.7
WA 47363 6366 4 0.1860.04 0.076 0.05 1476 0.4 1516 0.7
P3 AW 12661 2006 1d 0.1260.02 0.196 0.03d 1446 3.3 1 566 9d
WA 31463 1079628d 0.1460.04 0.266 0.12d 1296 0.4 1 406 3d
P4 AW 16962 1586 1d 0.1560.01 0.156 0.03d 1366 6.4 1 416 3d
WA 33163 6106 12d 0.0960.05 0.146 0.01d 1206 2.1 1 266 2d
P7 AW 12161 1106 1 0.1760.01 0.146 0.02 1566 3.2 1596 0.6
WA 30662 3396 2 0.1160.02 0.106 0.03 1616 0.5 1646 1.0
P8 AW 13361 1826 1 0.1460.02 0.086 0.04 1546 2.1 1596 0.8
WA 25463 5826 13 0.0760.05 0.176 0.02 1536 3.7 1616 0.6
a AW, dropping acetone to water; WA, dropping water to acetone.
b Average values of three DLS measurements.
c Average values of three zeta potential measurements.
d Nanoprecipitation with acetate buffer (pH55) as nonsolvent.
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which result in strong intrachain electrostatic repulsion caus-
ing retardation of the protonation of the amino groups.43
This would result in lower pKa values of gradient tBAEMA
copolymers, although all used amino methacrylate monomers
have similar pKa values22–24 and prevent the nanoparticles
from acquiring an appreciable cationic character at neutral
pH values. Thus, favored van der Waals attraction results in
particle aggregation. To support this assumption, instead of
pure water an acetate buffer system with a pH value of 5
was used as nonsolvent for the nanoprecipitaion of P3 and
P4 with an initial acetone-polymer concentration of 10 mg
mL21. In this case, nanoparticles with monomodal size dis-
tributions and low PDI values could be obtained, presumably
due to the electrostatic stabilization of the nanoparticles as a
consequence of protonation of the closely spaced amino
chains at acidic pH values. By dropping acetone-polymer
solution to water (AW), small nanoparticles with comparable
sizes (Z-average diameter between 110 and 184 nm) were
obtained for both initial acetone-polymer concentrations
(c5 1 mg mL21, c5 10 mg mL21, for P3 and P4 at pH 5).
The acetone-polymer concentration did not affect the nano-
particle size significantly. However, by dropping water into
acetone-polymer solution, relatively smaller nanoparticles (Z-
average diameter between 254 and 473 nm) were formed at
an initial acetone-polymer concentration of 1 mg mL21 com-
pared to 10 mg mL21 (Z-average diameter between 339 and
720 nm) (Fig. 4). As intended, the zeta potential of all sus-
pensions shows positive values in between 120 to 164 mV
indicating a high colloidal stability. The long term stability of
the nanoparticle suspensions was tested at room tempera-
ture for three weeks, showing no change in size and size dis-
tributions. SEM investigations revealed that all nanoparticles
have spherical shapes (Fig. 5, Supporting Information Figs.
S16–S18).
pH-Response Test of the Nanoparticles
The pH-responsive behavior behavior was tested by storing
nanoparticle suspensions at various pH values. Dilute buffer
systems were used to prevent salting out effects. The DLS
measurements (A, Fig. 6) revealed that nanoparticles from
P1 at pH 7 to 8 were not stable and are significantly larger
with higher PDI values compared to water suspensions.
Undefined aggregates were also observed at pH 7 to 8. This
can be explained by the low zeta potential of the nanopar-
ticle suspensions (B, Fig. 6) at these pH values. At low zeta
potential values, van der Waals attractions become stronger
than electrostatic repulsions, which result in aggregation. In
general, stable colloidal dispersions have zeta potentials
beyond 620 mV.44 In agreement with this, P1 nanoparticles
are stable at pH values of 3.4, 4, 5, 6 and 9 with relatively
high absolute zeta potentials. It should be noted that P1
nanoparticles have negative zeta potentials at pH 9 as
already reported for the p(DMAEMA) microgels above their
isoelectric point.45 Unlike P1, P2 nanoparticles did not show
any sign of instability at pH 7, only at pH values of 8 and 9
due to the higher DMAEMA content in P2, meaning a stron-
ger cationic character. At pH values of 3.4 to 5, P2 nanopar-
ticles are protonated and dissolve as already reported for
DMAEMA functional micelles at acidic conditions. The disso-
lution is also monitored by the significant decrease in the
derived count rate obtained from DLS measurements that is
directly proportional to the size and the number of the nano-
particles.46 A subsequent increase of the pH value back to
the initial pH value of 7.5 resulted in a significant increase
in the derived count rate and a Z-average diameter slightly
larger than the original nanoparticles (Z-average
diameter5 180 nm, PDI5 0.38), which hints toward the
reversible dissolution ability of the nanoparticles. Further-
more, the copolymer P2 itself also revealed complete
FIGURE 5 SEM images of nanoparticles that were prepared from P1, P3, and P7 (1 mg mL21) by dropping acetone-polymer solu-
tion to water (AW) or dropping water to acetone-polymer solution (WA).
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dissolution in aqueous media (0.3 mg/mL) at a pH value of
3.4. A dynamic increase of the pH value to the pH value of
7.5 resulted in spontaneous nanoparticle formation; DLS
measurements ensured the nanoparticle formation (Z-aver-
age diameter5 124 nm, PDI5 0.34). In contrast, copolymer
P1 did not show any solubility in acidic aqueous media. Sim-
ilar results were also obtained with nanoparticles prepared
from Eudragit E100 as a reference pH-responsive material
(Supporting Information Fig. S19).27
Due to the tightly spaced tBAEMA moieties that prevent pro-
tonation at neutral pH values, nanoparticles of P3 and P4
demonstrated less stability around neutral pH values com-
pared to the DMAEMA functional nanoparticles. As shown in
Figure 6, P3 nanoparticles aggregate between pH 6 to 8 and
P4 nanoparticles aggregate between pH 7 to 9 as a conse-
quence of the low zeta potential values. At acidic pH values,
P3 and P4 nanoparticles were both stable due to the proto-
nation of the tBAEMA. It should be noted that there was no
nanoparticle dissociation observed even for P4 that contains
21% tBAEMA.
Nanoparticles derived from the AEMA copolymers (P7 and
P8) revealed a higher stability compared to the DMAEMA
and tBAEMA based nanoparticles around neutral pH values.
Compared to the DMAEMA and tBAEMA nanoparticles,
higher isoelectric points of the AEMA nanoparticles at a pH
value around 9, as estimated from Figure 6(B), also support
the higher stability of the AEMA based nanoparticles around
neutral pH values. This can be explained by the primary
amino structure of the AEMA that renders nanoparticles to
protonate easily under neutral conditions. As shown in Fig-
ure 6, P7 and P8 nanoparticles are stable at pH values of 6
and 7 with relatively high zeta potential values. However,
they tend to aggregate at pH values of 8 and 9 as a conse-
quence of the low zeta potential values. Although P7 nano-
particles are stable at pH values of 3.4, 4, and 5, P8
nanoparticles with larger amino content were protonated
and dissolved at these pH values.
Fluorescence Spectroscopic Study of the Nanoparticles
Pyrene as hydrophobic fluorescent probe was encapsulated
as a model drug in P2 and P8 nanoparticles due to their dis-
solution ability at acidic pH values. The fluorescence emis-
sion spectra of pyrene against P2 nanoparticles at various
pH values are shown in Figure 7. Pyrene in pure water is
FIGURE 6 (A) Z-Average diameter (represented up to 1000 nm) and PDI values of nanoparticles as a function of the pH value. (B)
Zeta potentials of the nanoparticles as a function of the pH value. [Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
FIGURE 7 Fluorescence emission spectra of pyrene (6 3 1025
mol L21) against P2 nanoparticles (0.15 mg mL21) at various
pH values. Pyrene in pure water was used as control. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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used as control. The total intensities of the emission spectra
of the nanoparticle suspensions at pH values from 7 to 9 are
significantly higher compared to the emission intensity of
the control. This indicates that pyrene is transferred into the
hydrophobic domains of the nanoparticles and/or aggre-
gates. However, at pH values of 3.4 to 5, the emission inten-
sity of the pyrene is similar to the intensity of the control,
which clearly reveals the dissolution of P2 nanoparticles at
these pH values. P8 nanoparticles showed similar results
(Supporting Information Fig. S20). However, compared to the
same concentration of P2 nanoparticles they have lower
pyrene fluorescence intensities at pH values 7 to 9. This can
be due to the lower hydrophobicity of the P8 nanoparticles
compared to the P2 nanoparticles, meaning that P2 might
show in general higher encapsulation efficiencies for hydro-
phobic drugs.
Cytotoxicity of the Nanoparticles in L929 Cells
To evaluate the cytotoxicity of the nanoparticles, one nano-
particle sample of each copolymer prepared from 1 mg
mL21 AW technique and water soluble polymer P6 was
investigated at the indicated concentrations (Fig. 8). The
cytotoxicity assay results showed that the nanoparticles did
not have any significant cytotoxic effect on L929 cells after
24 h incubation at up to 1 mg mL21. These results are
promising in comparison to the previous reports because
cationic nanoparticles have frequently been associated with
toxic effects in cell studies.47,48 It should be noted that nano-
particles based on PMMA are known as nontoxic, whereas
homopolymers based on PDMAEMA and PAEMA are known
to be toxic.49 P6 showed a severe toxic effect on the cells,
which is due to the primary amino functional AEMA moieties
in the copolymer. However, nanoparticles, which are derived
from P8 (the deprotonated form of P6), are nontoxic. This
might be due to the change of the cationic charge of the
polymer. P8 contains pH-responsive primary amines that are
not fully protonated at the pH values applied. This leads to a
decreased water solubility enabling nanoparticle formation.
Due to the fact that the cationic charges are mainly responsi-
ble for cytotoxicity, the reduced charge content possibly also
results in less destructive effects on the cell membrane.50
Moreover, it was already demonstrated that cationic poly-
plexes with a comparable size to the nanoparticles show less
cytotoxic effects in contrast to the free cationic polymer
chains.51 The cytotoxicity of single cationic polymer chains is
based on the disruption of the lipid double layer by the for-
mation of nanoscale pores or membrane thinning (2 to
5 nm).52 Thus, the reduced cytotoxicity of the nanoparticle
can be attributed to the combination of reduced cationic
charge and less disruptive cell membrane interaction.
CONCLUSIONS
A library of well-defined copolymers of MMA with DMAEMA,
tBAEMA and AEMAHCI was synthesized via RAFT polymer-
ization by varying the initial monomer feed ratios to alter
the amino content in the copolymers and in the correspond-
ing nanoparticle. The controlled nature of the polymeriza-
tions was certified by kinetic studies. By variation of the
initial formulation conditions during the nanoprecipitation
method, such as polymer concentration and dropping
method, well-defined nanoparticles from the synthesized
copolymers with varying sizes were successfully prepared.
Moreover, pH-stability tests demonstrated that, depending on
the structure and amount of the amino functionality in the
copolymers, the corresponding nanoparticles reveal a pH
response. Fluorescence spectroscopic studies of pyrene as
model drug revealed the dissolution of two nanoparticle
batches at acidic pH values. Moreover, none of these nano-
particles exhibited any cytotoxic effect on L929 cells.
The results encourage the use of these polymeric nanopar-
ticles as novel carriers for the controlled release of loaded
pharmaceutical agents in acidic environment, for example,
cancer cells or endosomal cellular compartments. To opti-
mize the release profile, the polymeric composition can be
varied. Future investigations will deal with the controlled
release of active payloads such as anticancer drugs but also
with the delivery and release of genetic material, where the
cationic moieties might favor the encapsulation efficiency
and the burst release from endosome.
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FIGURE 8 Cytotoxicity test of nanoparticles (NPs) that were pre-
pared from P1, P2, P3, P4, P7, P8 and water soluble polymer P6
in L929 cells. The relative viability is expressed as percentage to
control cells not treated with nanoparticles. Untreated cells on
the same well plate were used as positive controls. Data repre-
sent means6SD, n6. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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Figure SI-1 Overlay of the SEC traces (CHCl3) from kinetic studies of the RAFT copolymerization of MMA with 
10% comonomer: DMAEMA (P1), tBAEMA (P3) and AEMA·HCI (P5). [M]/[CPADB]/[AIBN] = 100/1/0.25; [M]0
= 2 mol L-1. Polymerization conditions for (P1 and P3): Solvent ethanol, T = 70 °C. Polymerization conditions for 
P5: Solvent methanol under reflux.
 
 
 
Figure SI-2 Kinetic studies of the RAFT copolymerization of MMA with 20 mol% comonomer DMAEMA (P2), 
tBAEMA (P4) and AEMA·HCI (P6). [M]/[CPADB]/[AIBN] = 100/1/0.25; [M]0 = 2 mol L-1. Polymerization 
conditions for (P2 and P4): Solvent ethanol, T = 70 °C. Polymerization conditions for P6: Solvent methanol under 
reflux. (A) Semilogarithmic kinetic plots. (B) Mn and Mw/Mn evolution with total monomer conversion. (C) SEC 
overlay traces (CHCl3).
S3 
 
 
Figure SI-3 Normalized SEC traces (DMAc, RI detection) of the isolated copolymers of P1-P6.
 
Figure SI-4 Normalized SEC traces (CHCl3, RI detection) of the isolated copolymers P5 and P7.
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Figure SI-5 Normalized SEC traces (DMAc, RI detection) of isolated copolymers P5 and P7.
 
 
Figure SI-6 Normalized SEC traces (CHCl3, RI detection) of isolated copolymers P6 and P8.
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Figure SI-7 Normalized SEC traces (DMAc, RI detection) of isolated copolymers P6 and P8.
 
Figure SI-8 1H NMR spectrum (300 MHz, CDCl3) of P1.
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Figure SI-9 1H NMR spectrum (300 MHz, CDCl3) of P2.
 
Figure SI-10 1H NMR spectrum (300 MHz, CDCl3) of P3.
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Figure SI-11 1H NMR spectrum (300 MHz, CDCl3) of P4.
 
Figure SI-12 1H NMR spectrum (300 MHz, CDCl3) of P5.
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Figure SI-13 1H NMR spectrum (300 MHz, MeOD) of P6.
 
Figure SI-14 1H NMR spectrum (300 MHz, CDCl3) of P7.
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Figure SI-15 1H NMR spectrum (300 MHz, CDCl3) of P8.
 
 
Figure SI-16 SEM images of nanoparticles that were prepared from P2, P4 and P8 (1 mg mL-1) by dropping 
acetone-polymer solution to water (AW) or dropping water to acetone-polymer solution (WA).
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Figure SI-17 SEM images of nanoparticles that were prepared from P1 and P2 (10 mg mL-1) by dropping acetone-
polymer solution to water (AW) or dropping water to acetone-polymer solution (WA).
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Figure SI-18 SEM images of nanoparticles that were prepared from P7 and P8 (10 mg mL-1) by dropping acetone-
polymer solution to water (AW) or dropping water to acetone-polymer solution (WA).
 
Figure SI-19 (A) Z-Average diameter (represented up to 1000 nm) and PDI values of Eudragit E100 nanoparticles 
as a function of the pH value. (B) Zeta potential of the Eudragit E100 nanoparticles as a function of the pH value.
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Figure SI-20 Fluorescence emission spectra of pyrene (6 × 10-5 mol L-1) with P8 nanoparticles (0.15 mg mL-1) at
various pH values. Pyrene in pure water was used as control. 
Table SI-1 C, H, N, S and Cl contents (mass % in dry sample) in the copolymers of P5, P6, P7 and P8 that were
determined by elemental analysis.
Polymer C H N S Cl
P5 56.30 7.86 1.73 0.81 3.03
P7 58.31 8.00 1.73 0.85 1.01
P6 52.97 7.85 2.95 0.94 4.92
P8 55.80 7.75 3.02 0.89 0.92
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Polymer-based nanoparticles are promising drug delivery systems allowing the development of new drug and
treatment strategies with reduced side effects. However, it remains a challenge to screen for new and effective
nanoparticle-based systems in vitro. Important factors inﬂuencing the behavior of nanoparticles in vivo cannot
be simulated in screening assays in vitro, which still represent the main tools in academic research and pharma-
ceutical industry. These systems have serious drawbacks in the development of nanoparticle-based drug delivery
systems, since they do not consider the highly complex processes inﬂuencing nanoparticle clearance, distribu-
tion, and uptake in vivo. In particular, the transfer of in vitro nanoparticle performance to in vivomodels often
fails, demonstrating the urgent need for novel in vitro tools that can imitate aspects of the in vivo situation
more accurate. Dynamic cell culture, where cells are cultured and incubated in the presence of shear stress has
the potential to bridge this gap by mimicking key-features of organs and vessels. Our approach implements
and compares a chip-based dynamic cell culture model to the common static cell culture and mouse model to
assess its capability to predict the in vivo successmore accurately, by using a well-deﬁned poly((methyl methac-
rylate)-co-(methacrylic acid)) and poly((methyl methacrylate)-co-(2-dimethylamino ethylmethacrylate))
based nanoparticle library. After characterization in static and dynamic in vitro cell culture we were able to
show that physiological conditions such as cell–cell communication of co-cultured endothelial cells and macro-
phages as well as mechanotransductive signaling through shear stress signiﬁcantly alter cellular nanoparticle
uptake. In addition, it could be demonstrated by using dynamic cell cultures that the in vivo situation is simulated
more accurately and thereby can be applied as a novel system to investigate the performance of nanoparticle
systems in vivomore reliable.
© 2015 Published by Elsevier B.V.
1. Introduction
Drug delivery via polymer-based nanoparticles has the potential to
be used for novel treatment strategies offering improved pharmacolog-
ical properties, higher efﬁciencies as well as reduced side effects, com-
pared to direct drug application [1]. In order to develop optimized
nanoparticle-based drug delivery systems, the investigation of key-
factors inﬂuencing their pharmacokinetic and pharmacodynamic prop-
erties is necessary. Numerous factors affect the uptake of nanoparticles
in vitro, including the protein corona, surface charge, size and shape
[2–5]. For instance, it is well-known that nanoparticles with 50 to
200 nm in diameter are internalized by a wide variety of cells [6].
However, direct translation of their uptake efﬁciency in vitro to their
behavior in vivo is challenging. In particular, the prediction concerning
biodistribution and interaction with the reticuloendothelial system
(RES) remains a challenge [7,8]. Thus, resource and time consuming
in vivo experiments are applied to evaluate new nanoparticle systems
and to answer the question, whether they improve the biodistribution
and the availability of a compound to the target cell and whether a
reduced uptake by off-target tissues and cells is realized to limit
detrimental effects. As a consequence, different targeting moieties
such as antibodies, aptamers, metabolites, and anti-genes were used
to coat the nanoparticle surface, creating new cell-type speciﬁc
nanotherapeutics, -diagnostics, and -theranostic systems. [9–13] The
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biodistribution of nanoparticles is inﬂuenced by the RES as nanoparti-
cles once in the circulation interact with various plasma proteins such
as opsonins (immune globulins and complement factor) as well as
albumins inﬂuencing their fate in differentmanners [14,15]. The formed
protein corona is strongly under investigation, but so far only a few
interacting proteins were identiﬁed resulting in a predictable impact
on the fate of nanoparticles [16,17]. Due to the complexity of the plasma
protein composition with more than 3.700 proteins and several other
factors, the corona is still rarely understood and its dynamic makes it
difﬁcult to analyze [14]. An important role in the RES for drug- and
nanoparticle clearance plays the liver [18]. In particular Kupffer cells,
the local tissue-macrophages but although their endothelial cells, pos-
sess phagocytic or endocytic activity against blood-borne materials
entering the liver and contribute to tissue modulation and regulation of
the immune system in response to stimulants [19–21]. Their close cellu-
lar interaction and communicationwas described as relevant for different
diseases [22]. For a rational drug development, possible immune-
modulatory effects as well as nanoparticle clearance are key factors that
need to be investigated under physiological conditions [23].
Promising new developments to more accurately model the in vivo
environments are dynamic (co)-cultures where cells are cultured and
incubated under shear stress and different cell-types might interact
with each other. Endothelial cells line the inner layer of the blood
vessels and are in direct contact with the bloodstream. For this purpose,
their cell biology as morphology, cytoskeleton, permeability, and the
expression of important markers and surface proteins aswell as cellular
interactions are affected by shear stress [24,25]. This mechanical force
evolved to an important factor investigating physiological processes in
the context of endothelial substance interaction and internalization.
Endothelial cells represent the ﬁrst tissue barrier nanoparticles have to
overcome to reach parenchymal target cells as it is often aimed. Not
only endothelial cells but also local macrophages, in particular in the
liver but also in other vessels, have direct contact to nanoparticles and
might clear them, why we co-cultured primary macrophages with
human umbilical vein endothelial cells (HUVECs) to better understand
their inﬂuence on uptake. In particular new screening methods to test
toxicity, permeability and transport of drugs are under investigation
[23,26]. In a recent study, where liver-speciﬁc PLGA-based nanoparti-
cles were used, the relevance of shear stress on nanoparticle-uptake in
an artiﬁcial liver was presented [13]. To gain more insight into the
impact of shear stress and co-culture of HUVECs and primary macro-
phages, well-known methacrylate-based nanoparticles can be applied.
Methacrylates are non-biodegradable and, thus, particularly suited to
analyze the internalization behavior depending on structural properties
of nanoparticles, e.g., surface charge or size. In addition, poly(methyl
methacrylates) (PMMA) are proposed for vaccination [6,27].
Herein, we used a library consisting of co-polymers for nanopar-
ticle preparation, poly((methyl methacrylate)-co-(methacrylic
acid)) (P(MMA-co-MAA)) and poly((methyl methacrylate)-co-(2-
dimethylamino ethyl-methacrylate)) (P(MMA-co-DMAEMA)) repre-
senting polymers with pH dependent anionic and cationic charges,
respectively. Moreover, in the case of P(MMA-co-MAA) the amount
of methacrylic acid was varied. Nanoparticles were formed via
nanoprecipitation to circumvent the use of surfactants and to obtain
narrow size distribution [28–30]. Previous results gathered from in vitro
studies are only of limited use to screen nanoparticles for drug applica-
tions, since the results hardly represent the in vivo situation [31,32],
revealing the lack of appropriatemethods allowing investigation of nano-
particle uptake and clearance under physiological relevant conditions. In
the case of the applied methacrylate-based nanoparticle library with
comparable size we were able to demonstrate a different internalization.
On one hand attributed to different charge density (3% PMAA vs. 13%
PMAA) and on the other hand due to different charges (PMAA vs.
PDMAEMA) were investigated under static in vitro and dynamic cell
culture. The impact of particle charge and the inﬂuence of shear stress
on nanoparticle internalization in vitrowere systematically characterized.
Finally, the results were compared to an in vivomouse model verifying
the dynamic co-cell culture as promising tool for screening nanoparticle
uptake and clearance.
2. Results and discussion
2.1. Polymer and nanoparticle preparation and characterization
The co-polymers were synthesized via the reversible addition–
fragmentation chain transfer (RAFT) polymerization technique [33,34]
to obtain polymers with narrow molar mass distribution and tailored
polymer properties, i.e., a deﬁned amount of carboxylic acid or amines
and, therefore, a deﬁned number of charges within the polymer. Here,
pH dependent co-polymers were synthesized consisting on the one
hand of negatively charged MAA units at basic conditions and on the
other hand of cationic charges (DMAEMA units) at acidic conditions.
The amount of charges of the polymer represents a crucial parameter
for the nanoparticle formation and stability. Nanoparticles with zeta
potentials above ±20 mV are more stabilized by the repulsion forces
compared to particles with zeta potentials below [35]. A ﬁne-tuning of
the pH dependency, which goes hand in hand with negative charges
(–COOH groups), as well as the hydrophobicity (MMA units) was real-
ized by synthesizing co-polymer libraries with a systematic variation
in the compositions. Thus, MAA amounts of 3, 5, 8 and 13%, as well as
20% of DMAEMA were used as a co-monomer in the polymerization
procedure. Both monomers MMA and MAA (or DMAEMA) were statis-
tically distributed along the polymer chain due to the same reactivity
ratio [36]. The low amounts of MAA or DMAEMA ensure the formation
and stability of hydrophobic particles under physiological pH values.
In the case of 20% PDMAEMA nanoparticles a swelling is assumed
due to the protonation of the amine group at a decreased pH value
(PDMAEMA pKa = 7.5) [37,38] in endosomes/lysosomes [39].
Molar masses between Mn = 11.700 g mol−1 to 12.700 g mol−1
with dispersities lower than 1.2 were determined by size exclusion
chromatography (SEC) for the ﬁnal co-polymers (Table 1 and Fig. S1).
The compositions (content of MMA and MAA or MMA and DMAEMA)
were calculated using 1H NMR spectroscopy. The observed values
agree well with prospected theoretical amounts and are listed in
Table 1. The beneﬁt of these polymers for preparation of deﬁned
nanoparticles via nanoprecipitation was already demonstrated earlier
[28,40,41]. An advantage of nanoprecipitation is the absence of surfac-
tants, as they can inﬂuence the properties of nanoparticles and their
biological impact [42,43]. Furthermore, nanoparticles with different di-
ameters with narrow size distributions can easily be obtained. In this
study nanoparticles of around 200 nm in diameter were chosen as at
this size cellular internalization via endocytosis could be assumed [28].
The characterization of the nanoparticles was performed using dynamic
light scattering (DLS) as well as scanning electron microscopy (SEM)
measurements (Table 1, Figs. 1 and S2). The zeta potential measure-
ments conﬁrm the negative surface charges of nanoparticles consisting
of PMMA-co-PMAA and positive charges for PMMA-co-PDMAEMA
nanoparticles (Table S2).
2.2. Internalization of methacrylate-based nanoparticles in static cell
cultures
Initially, the nanoparticles were investigated regarding their inter-
nalization in HEK293 cells. For this purpose, ﬂow cytometry and confo-
cal microscopy was used. Methacrylate-based particles are known to
lead to an increased granularity or rather increased side scatter (SSC)
in ﬂow cytometry after internalization [28,44], To exclude the inﬂuence
of cell size (forward scatter, FSC) the relative SSC/FSC was used as
indication for successful nanoparticle internalization as it was also
conﬁrmed by nile red ﬂuorescent intensity, encapsulated into different
nanoparticles as a cargo. A clear correlation of cellular internalization
rates depending on the PMAA amount of nanoparticles was observed.
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Increasing amounts of PMAA resulted in an increased uptake of nano-
particles (Fig. 2A). In particular, the differences in the uptake behavior
of 3% PMAA (rel. SSC/FSC = 1.2) and 13% PMAA (rel. SSC/FSC = 1.7)
is remarkable. The differences in polymer composition and related
negative charge increase of the particle surface as well as a decreased
hydrophobicity appear to be beneﬁcial for the cellular uptake. The
cationic charged nanoparticles (20% PDMAEMA) displayed the highest
cellular uptake (rel. SSC/FSC = 2). Increased internalization rate might
be explained by the cationic charges that are known to be beneﬁcial
for interaction with the cell membrane [5]. Nanoparticles carrying neg-
ative as well as positive charges show an adsorption of serum proteins
that impact their uptake efﬁciency [14,18]. The question arises whether
the different cellular uptake of the methacrylate-based nanoparticles
can be ascribed to the interaction with the cell membrane or rather to
different protein coronas. Therefore, we tested the nanoparticle uptake
of 3% PMAA, 13% PMAA and 20% PDMAEMA in the presence of fetal calf
serum(FCS) in the cell culturemedium (Fig. 2B).We foundno impact of
FCS on internalization of 13% PMAA and 20% PDMAEMA nanoparticles.
In contrast, we observed a more efﬁcient cellular uptake of 3% PMAA
in the absence of FCS. Thus, we speculate that differences in cellular up-
take of 3% and 13% PMAA nanoparticle are triggered by varying protein
coronas depending on the exposed surface charges of nanoparticles and
their interaction with the cell membrane. That the cellular uptake rates
of 13% PMAA and 20% PDMAEMA are independent of the presence of
proteins was not expected before, as in general a decreased uptake
due to an increased protein interaction is assumed for nanoparticles
formed of hydrophobic polymers [45,46]. Thus, further investigations
are required to characterize the formation of the protein corona de-
pending on surface charge density and the impact of its composition
on cellular internalization. SDS-PAGE of nanoparticle bound proteins
reveals a lack of distinct protein binding as well as a total reduction of
bound proteins to the higher charged nanoparticles irrespectively if
positively or negatively charged (Fig. S 3A, B).
As the sensitivity of relative SSC/FSC is limited and, moreover,
restricted to ﬂow cytometry analysis the hydrophobic dye nile red
was encapsulated into the nanoparticles. The encapsulation efﬁciency
varies depending on the hydrophobicity of the polymers. We tackled
this obstacle by applying a correction factor determined for each nano-
particle batch (Table S3) [47]. To conﬁrm the uptake measured by the
relative SSC/FSC, the ﬂuorescence intensity was also used showing
a good correlation (Fig. S4). In addition, confocal microscopy was
performed to verify the internalization of nanoparticles measured by
ﬂow cytometry (Fig. 3). All investigated nanoparticles were detectable
inside the cells. 20% PDMAEMA shows higher ﬂuorescence intensity
and a more diffuse distribution compared to PMAA nanoparticle. This
supports the assumption of swelling of nanoparticles under acidic
conditions within the endosome.
The dependency of cellular uptake on charge amount and type were
further conﬁrmed in various cell types, including primary murine
muscle cells (Table 2). Beside cell-type speciﬁc variations concerning
the amount of internalized nanoparticles, two general trends were
observed: With increasing negative charge, the cellular uptake was in-
creased; however, the cationic charged nanoparticles were internalized
more efﬁciently. Thus, the performance of the nanoparticles is mainly
inﬂuenced by the particle composition depending on the polymer
chemistry with an impact on the protein corona [48–50]. Therefore,
the observed trends are independent of the used cell-types or if co-
culture is used (Figs. 4 and S6). The nanoparticle uptake of HUVECs is
signiﬁcantly decreased due to cellular interactions. Further a signiﬁcant
decreased uptake in both cell-types was observed in contrast to the
mono-culture.
Cytotoxicity is another highly relevant parameter for in vivo applica-
tion of nanoparticles. Therefore, the hemo-compatibility of the nano-
particle library was tested using erythrocytes. We observed no release
of hemoglobin or aggregation of erythrocytes promoting the nanoparti-
cles suitable for in vivo investigations (Fig. S5).
Taken together, static in vitro studies depict relevant properties of
nanoparticles: (i) Uptake effectiveness depending on nanoparticle char-
acteristics, (ii) they enable crucial assays to understand the interaction
of nanoparticles with soluble molecules of, e.g., serum proteins, and
(iii) they allow a ﬁrst assessment of nanoparticle toxicity. In addition,
by analyzing the cellular uptake in different cell types the same trend
concerning an enhanced uptake of charged nanoparticles was observed.
Interaction of particles and proteins were shown by SDS-PAGE,
Table 1
Polymer and nanoparticle characterization.
Polymer Mna Ða Theo. ratiob MAA/D [%] Exp. ratioc MAA/D [%] Nanoparticle DH [nm]d PDIP
P(MMA-co-MAA) 11.700 1.17 3.0 3.3 3% PMAA 196 0.061
P(MMA-co-MAA) 12.200 1.20 5.0 5.1 5% PMAA 193 0.097
P(MMA-co-MAA) 12.700 1.19 7.5 8.2 8% PMAA 207 0.099
P(MMA-co-MAA) 12.600 1.19 10.0 13.3 13% PMAA 205 0.079
P(MMA-co-DMAEMA) 11.000 1.10 20.0 20.8 20% PDMAEMA 207 0.101
a Calculated from SEC (CHCl3), PMMA calibration.
b Molar ratio in the polymer feed solutions, MAA = methacrylic acid and D = dimethylamino ethyl methacrylate.
c Calculated from 1H NMR spectroscopy. The homopolymer PMMA was used as reference (adjustment of the broad backbone integral from 0.5 to 2.5 ppm to exclude impurities like
water) and all spectra were corrected with this ratio between –OCH3 to the backbone signal of PMMA (correction factor 0.964).
d DH represents the Z-average intensity weighted diameter.
Fig. 1. SEM micrographs of methacrylate-based nanoparticles A (3% PMAA), B (13% PMAA) and C (20% PDMAEMA) conﬁrm their spherical shape. Scale bar = 500 nm.
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indicating serum interaction as one aspect of the internalization of
nanoparticles, rising evidence for opsonization and RES interaction
[16]. Common used in vitro blood compatibility tests like complement
activation can be applied for ﬁrst investigations, but these tests are
also known to lead in false-positive results due to the optical properties
of the nanoparticles [8]. In addition, static cell culture conditions pro-
vide sedimentation effects which are strongly altered under dynamic
condition, e.g., in the blood stream [51].
2.3. Internalization of methacrylate-based nanoparticles in dynamic cell
cultures
Cell culture under dynamic conditions allows the investigation of
nanoparticle binding and internalization under physiologically relevant
in vitro conditions. In particular, the impact of different cell phenotypes
of HUVECs [52] on the nanoparticle uptake under shear stress can be in-
vestigated in dynamic cell cultures [24,25]. Shear stress values from 0.7,
3.0, 6.0 and 10.0 dyn cm−2 were applied representing basal nutrient
exchange with minimal mechanical stimulation observed e.g., in hepatic
sinusoids (0.7 dyn cm−2) and shear stress values observed in human
veins and venules (3.0 and 6.0 dyn cm−2) [53], human suprarenal aorta
(6.0 dyn cm−2) and human common carotid artery (10.0 dyn cm−2)
[54]. Interestingly, increasing shear stress positively correlates with the
total amount of internalized nanoparticles in mono-cultures (Fig. 5A, B).
This indicates that nanoparticle-cell interactions are sufﬁcient to induce
adhesion and internalization even at high shear stress. In comparison,
other studies investigating inorganic SiO2-nanoparticles or polystyrene
nanoparticles showed a reduced uptake under increasing shear stress
conditions, even when antibodies where used as targeting moiety,
suggesting that these nanoparticles would have sufﬁcient target-cell in-
teractions in vivo [25,55,56]. The ﬁndings of the methacrylate-based
nanoparticle concerning shear stress can be attributed to a higher fre-
quency of nanoparticle interaction per cell compared to static in vitro
conditions. Dynamic cell culture revealed a different nanoparticle uptake
as seen under static in vitro conditions: Uptake of 13% PMAA nanoparti-
cles occurred more efﬁciently compared to 20% PDMAEMA, whereas
the uptake of 3% PMAA was of signiﬁcant lower efﬁciency (Fig. 4B).
Shear stress higher than 6 dyn cm−2 does not increase the uptake of
20% PDMAEMA but reaches a plateau. Nanoparticles composed of 20%
PDMAEMA differ from PMAA containing particles in respect to their abil-
ity of swelling under acidic conditions. A plateau for cellular uptake was
reached at 3 dyn cm−2 for 20% PDMAEMA indicating a sufﬁcient interac-
tion of nanoparticleswith the cellmembrane, since theuptakewas signif-
icantly decreased at even higher shear stress. Thus, tendencies between
different nanoparticles, which were obtained under static conditions,
differ under dynamic conditions. In particular, the uptake rate of the
20% PDMAEMA under ﬂow conditions is reduced to comparable levels
as 13% PMAA. This might be due to an activation of HUVEC under
Fig. 2. Internalization of methacrylate-based nanoparticles in HEK293 cells treated for 24 h with 100 μg mL−1 nanoparticle in media containing FCS, rel. SSC/FSC regarding the control.
A) Negative and cationic charged nanoparticle uptake, # represent signiﬁcant differences compared to 20% PDMAEMA and B) comparison of nanoparticle uptake inmediawith andwith-
out serum. A, B) bars show mean + s.e.m of three independent experiments, signiﬁcance tested using A) two-way ANOVA with Turkey's post-hoc test and using B) Kruskal-Wallis and
Dunn's multiple comparison test, p b 0.05.
Fig. 3. Internalization of methacrylate-based nanoparticles. HEK293 cells were stained with Hoechst for DNA-staining (blue) and CellMask DeepRed (red) for plasmamembrane staining
previous to the addition of nanoparticles (green). Images were taken 25 to 30 min after addition of nanoparticles. Scale bar = 10 μm. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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dynamic conditions leading to a different surface receptor expression
pattern [25,33].
Furthermore cell–cell interactions, known to inﬂuence cellular
physiology, have to be taken into consideration. For this purpose, a co-
culture composed ofMΦ and HUVEC, assembled in a reproducible com-
position and cultured under standardized conditions, was used for dy-
namic cell culture experiments (Fig. 5). In particular, the contribution
ofmacrophages for nanoparticle uptakewith consideration to heteroge-
neous cell interactions betweenmacrophages and the endothelial lining
was investigated. MΦs are known to be responsible for clearance of cir-
culating nanoparticles in the blood stream by phagocytosis [8]. In the
presence of MΦ, a shear stress dependent increased uptake of nanopar-
ticles in HUVECswas observed.MΦ in general exhibited a higher uptake
rate compared to HUVEC. Compared to the HUVEC mono-culture, the
presence of MΦ strongly decreased the nanoparticle uptake through
HUVECs (Fig. 5B). It is not likely that reduced nanoparticle uptake by
HUVECs is simply due to an increased uptake rate through MΦ. It can
be assumed that the proportion of nanoparticles in themedium in rela-
tion to the perfused cell cluster of HUVEC and MΦwill outbalance pos-
sible local concentration gradients formed by elevated uptake kinetics.
This gains importance in particular under high perfusion conditions,
where most of the prominent differences in uptake rates have been ob-
served. The presence of primary humanMΦ in co-culturewas accompa-
nied by a decreased endothelial uptake observed for all applied
nanoparticles. In addition, a releasemechanism for 13%PMAA can be as-
sumed as 13% PMAA as well as 20% PDMAEMA lead to a homogeneous
staining of the cytoplasm (Figs. 3, 5A). The investigations in static and
dynamic cell culture conditions lead to the assumptions that the 13%
PMAA as well as the 20% PDMAEMA would be also taken up by macro-
phages in vivo. In addition, the uptake of 13% PMAA and 20% PDMAEMA
nanoparticles should be enhanced compared to the 3% PMAA nanopar-
ticle. Concerning the uptake-tendencies between the different nanopar-
ticles in the co-culture experiments, similar patterns were obtained
under static and dynamic conditions at 3 and 6 dyn cm−2, respectively
(Figs. 4, 5). However, at 0.7 dyn cm−2, which is assumed to bepresent in
hepatic sinusoids, the uptake of 13% PMAA and 20% PDMAEMA did not
signiﬁcantly differ in contrast to the results under static conditions.
2.4. Internalization of methacrylate-based nanoparticles in vivo
The liver is composed of fourmajor cell types: endothelial cells, local
macrophages (Kupffer cells), stellate cells and hepatocytes. The liver
sinusoidal endothelial cells (LSECs) represent a specialized subset of en-
dothelial cells, whereas HUVEC reﬂect endothelial cells of the vascula-
ture [57]. A major obstacle in in vitro studies and their translation to
the in vivo situation is themissing consideration of biodistributionwith-
in an organism. It is considered as necessary to avoid the accumulation
of nanoparticles in the RES, however often it is hardly discriminated,
which cell type is affected. While hepatocyte mainly function as meta-
bolic and detoxifying cells, Kupffer cells are known to clear all kinds xe-
nobiotics effectively and trigger local and global responses to these
molecules. Using intravital microscopy we could observe the cellular-
distribution of 3%, 13% PMAA and 20% PDMAEMA nanoparticles in the
liver. In vivo Kupffer cells mainly cleared all tested nanoparticles in the
liver. However to a lesser extend also LSECs— liver-speciﬁc endothelial
cells — took up especially 13% PMAA and 20% PDMAEMA nanoparticles
(Fig. 6A). Beside the differences in the cellular distribution also the
speed and kinetic of nanoparticle-uptake varies between nanoparticles.
20% PDMAEMA were taken up fastest (4.6% per min) followed by 13%
PMAA nanoparticles (3.8% per min). The slowest uptake had low-
charged (3% PMAA) nanoparticles (1.9% permin) (Fig. 6B). These differ-
ent uptake kinetics and cellular distribution represent the different
ability to unspeciﬁcally interact with cellular membranes and subse-
quently activate endocytotic or phagocytotic pathways. The uptake of
all nanoparticles reached a plateau after 30 to 60 min reﬂecting a
saturation of the processes or a clearance of the nanoparticles in the
Table 2
Internalization of methacrylate-based nanoparticles in cell lines of different origin ana-
lyzed after 24 h via ﬂow cytometry. The MFI was used as readout (n = 3) and was rated
into very low uptake (−=MFI b 15), media uptake (+= 15 bMFI b 50), high uptake
(++= 50 bMFI b 150) and very high uptake (+++=MFI N 150).
Cell line 3% PMAA 13% PMAA 20% PDMAEMA
Immortal HEK 293 − + +
L929 − + ++
HepG2 − − +
primary Primary muscle cells − + ++
Differentiated muscle cells + ++ +++
HUVEC − + ++
MΦ − + ++
Fig. 4. Internalization ofmethacrylate-based nanoparticles inmono-culture and co-culture of HUVEC andMΦ treated for 1 h with 200 μgmL−1 nanoparticles. A) Analysis via ﬂow cytom-
etry and B) viamicroscopy # represent signiﬁcant differences of 3 and 13% PMAA compared to 20% PDMAEMAwithin the different cultures, Δ represent signiﬁcant differences of the cell
types in co-culture compared to the correspondingmono-culture. The bars showmean+ s.e.m of three independent experiments, signiﬁcance using two-wayANOVAwith Turkey's post-
hoc test p b 0.05.
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body (Fig. 6B). TheMFI of 20% PDMAEMA even decreased constantly by
0.5% per min after 30 min within the time of observation, implying a
release of nile red from 20% PDMAEMA. Finally we also compared the
uptake of the nanoparticles in Kupffer cells in vivo revealing that higher
charged ones (13% PMAA and 20% PDMAEMA) are cleared more effec-
tive than the low charged 3% PMAA and that Kupffer cells showed a
higher uptake than endothelial cells. However, higher charged nanopar-
ticles excerpt a smaller difference between the uptake in Kupffer cells
and endothelial lining (Fig. 6C). The uptake in the static cell culture
clearly showed a signiﬁcant increased uptake of 20% PDMAEMA,
which was also present in the co-culture experiments at 3 and
6 dyn cm−2. However, at 0.7 dyn cm−2 the differences between 13%
PMAA and 20% PDMAEMA are less pronounced in the co-culture
(Fig. 5B).
3. Conclusion
Studies on nanoparticle uptake and transferability from in vitro to
in vivo are necessary but challenging. Thus, methods for pre-screening
of nanoparticle-cell interaction under physiological relevant conditions
are required. In particular, the interaction of nanoparticleswith immune
cells responsible for unwanted clearance is important but unknown
after in vitro investigations. It was previously shown that static in vitro
studies underestimate effects and effectiveness of nanoparticle uptake
and clearance in vivo [13]. In this study, we could demonstrate
that the dynamic cell culture mimics shear-stress as one key-factor
inﬂuencing nanoparticle uptake in general and might represent an im-
portant screening option for cell-type speciﬁc nanoparticle uptake. In
particular in the case of the HUVEC mono-culture the tendencies of
nanoparticle uptake were different between static and dynamic condi-
tions. The dynamic cell culture inﬂuences the uptake tendencies of the
tested nanoparticles, leading to decreased uptake of 20% PDMAEMA
whereas under static conditions 20% PDMAEMA showed the highest
uptake. Previously it was shown that applying shear-stress results in
different surface receptor expression patterns which might lead to
an increased uptake of the 13% PMAA whereas the uptake of 20%
PDMAEMA seems to be not inﬂuenced by this HUVEC activation.
Diminished cell-interactions of low-charged non-targeted nanopar-
ticles (3% PMAA) might lead to reduced and unspeciﬁc uptake. Howev-
er, insufﬁcient cellular membrane interactions might also compromise
the nanoparticle uptake resulting in a shear-stress dependent decrease
of uptake efﬁciency, demonstrated by previous studies of CdTe-
quantum dots and SiO2-based nanoparticles [25]. Another study tested
vascular cell adhesionmolecule (VCAM)-1-antibodies as targetingmoi-
ety conjugated to the surface of inorganic nanoparticles to address only
activated endothelial cells [55]. Despite an increased uptake in cells
expressing VCAM-1 under static culture conditions, subjecting these
cells to ﬂow lead to a decrease of uptake effectiveness. However, nano-
particle carrying VCAM-1-conjugated antibodies still showed a signiﬁ-
cant higher uptake. These studies reveal the importance of balancing
the interaction of nanoparticles to ensure a speciﬁc uptakeunder certain
circumstances but preventing unspeciﬁc nanoparticle interaction.
Fig. 5. Different nanoparticles in the dynamic cell culture. A, B) Uptake of different nanoparticles containing nile red in a HUVEC monoculture or a co-culture with MΦwhich were sub-
jected to different shear stress (0.7, 3, 6 or 10 dyn cm−2) were analyzed after 60 min. A) Uptake and distribution of different nanoparticles (purple) in the HUVEC monoculture (upper
panels) and co-culture (lower panels) with MΦ. Cells were subsequently stained with DAPI (blue) and macrophages were stained using CMFDA (green). All scale bars = 10 μm.
B) Measured and analyzed MFI in HUVECs or MΦ. MFI were corrected using the calculated correction factor mentioned earlier. Differences between groups were analyzed using a
two-way ANOVA with Tukey's post-hoc test performed on three independent experiments. #: p b 0.05 signiﬁcant differences to 3% PMAA of corresponding dyn cm−2. Δ: p b 0.05 for
the differences between the 13% PMAA NP-uptake to the corresponding dyn cm−2. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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Beside the inﬂuence of shear stress, monocultures lack cell–cell
interactions and the resulting impact on the nanoparticle uptake.
Based on the cell culture and supported by in vivo investigations, we
showed that co-cultured macrophages have a severe impact on endo-
thelial uptake of all nanoparticles tested. Further studies are required
to characterize the underlying mechanism and to design nanoparticles
in a way to prevent this inhibitory effect on endothelial cells. Besides,
the question arises if also tumor-associated macrophages play a role in
modulating the nanoparticle uptake in cancer cells leading to a reduced
efﬁcacy of nanoparticle-based tumor therapy orwhether this is an effect
restricted by the vascular endothelium [58].
This study shows that static cell cultures represent a fast and useful
tool to assess nanoparticle uptake in general. Assessing nanoparticle
uptake in primary endothelial cells is signiﬁcantly inﬂuenced by
physiological shear stress. We therefore suggest that investigation of
nanoparticle uptake in endothelial cells should be performed under dy-
namic conditions where physiological relevant shear stress conditions
could be resembled. In macrophage rich environments the effects of
endothelial cell activation seems to be overwhelmed, likely due to
macrophage derived factors effecting endothelial nanoparticle uptake.
Considering the applied shear stress of 0.7 dyn cm−2 less pronounced
differences between the uptake of 13% PMAA and 20% PDMAEMA
under dynamic conditions were obtained in contrast to static condi-
tions. This demonstrates the importance of shear stress on nanoparticle
uptake. Since animal experiments are resource and time consuming,
new models and automated systems for dynamic cell culture should
be developed for screening purposes to increase the success of new
animal studies.
Fig. 6. A) Intravital microscopy of different nanoparticles in the liver (liver architecture: blue, nile red containing nanoparticles red) showing accumulation of nanoparticles mostly in
Kupffer cells (examples marked with white arrows) and only little in endothelial cells (examples marked with a white triangle); scale bar for upper column is 250 μm, lower column is
50 μm. Contrast of all imageswere harmonized. B)Uptake kinetic of nile red containing nanoparticles in Kupffer cells in vivo; graph showmean± s.e.m. of three independent experiments.
C) Maximal ﬂuorescence intensity of PMAA and PDMAEMA-nanoparticles containing nile red in murine Kupffer cells and endothelial lining in the liver 30 min (PDMAEMA) or 60 min
(PMAAs) after administration. Signiﬁcance was tested using a two-way ANOVA with Tukey's post-hoc test performed on three independent experiments; p b 0.01 between 13% PMAA
or 20% PDMAEMA and 3% PMAA in * Kupffer cells or # endothelial lining. # p b 0.01 between both cell types of one nanoparticle. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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4. Experimental section
4.1. Materials
MMA, MAA and DMAEMA were purchased from Sigma Aldrich and
puriﬁed with an inhibitor-remover before use. 2,2′-azobis-(iso-
butyronitrile) (AIBN) was recrystallized from methanol prior to use.
The chain transfer agent 2-cyano-2-propyl dithiobenzoate (CPDB) and
the dye nile red was purchased from Sigma Aldrich.
4.2. Polymer synthesis and characterization
The co-polymers P(MMA-stat-MAA), were prepared by co-
polymerization of MMA with MAA using the RAFT polymerization
method [33,34]. In a typical RAFT co-polymerization experiment
(3 mol% MAA as example, all polymerization conditions are listed in
the SI), 5.827 g of MMAmonomer (58.2 mmol), 0.155 g of MAA mono-
mer (1.8 mmol), 24.63 mg of AIBN initiator (0.15 mmol), 132.8 mg of
CPDB RAFT agent (0.6mmol) and 5.16mL ethanol weremixed together
in a 25 mL reaction vial. The monomer concentration was kept at
4 mol L−1. Subsequently, the reaction solution was placed in a
preheated oil bath at 70 °C for 10 h. The copolymer was puriﬁed by
precipitation into a large volume of cold diethyl-ether and dried
under reduced pressure. 1H NMR (CD2Cl2, 300 MHz): δ = 7.89 (d, Ar-
H, CPDB), 7.57 (t, Ar-H, CPDB), 7.41 (t, Ar-H, CPDB), 3.60 (–OCH3),
2.25–0.5 (backbone) ppm. SEC (CHCl3, PMMA standard): Mn =
12.700 g mol−1, Ð= 1.17. All RAFT polymerizations and polymer anal-
ysis by SEC and 1HNMR can be found in the supplementary information.
4.3. Instrumentation
Size-exclusion chromatography (SEC) experiments were performed
on a Shimadzu systemequippedwith a SCL-10A system controller, a LC-
10AD pump, a RID-10A refractive index detector, a UVD SPD-10AD
UV/Vis detector and a PSS SDV linear S, 5 μm column (8 × 300 mm)
with chloroform/triethylamine/2-propanol (94:4:2) as eluent at
1 mL min−1, and the column oven was set to 40 °C. A calibration
with low dispersity polystyrene standards (ranging Mn from 376 to
128,000 g mol-1) was used.
1H NMR spectra were recorded on a Bruker AC 300 (300MHz) spec-
trometer at 298 K. The chemical shifts are reported in parts per million
(ppm, δ scale) relative to the signals from the NMR solvents.
4.4. Preparation and characterization of nanoparticles
The nanoparticles used in this study were prepared by
nanoprecipitation [28]. For this purpose, 25 to 30 mg of the distin-
guished polymer was dissolved in 1 mL acetone. For the preparation
of nile red containing nanoparticles, 1 mg mL−1 nile red was diluted
in acetone as stock-solution. Then, 250 to 300 μg of nile red was
added from the stock- to the polymer-solution. The obtained solution
was dropped into 10 mL of type 1-water. A 120 × 0.8 mm syringe was
used to drop 100 to 200 μL of the polymer-solution per minute into
the 10 mL type 1-water under permanent stirring (300 to 500 rpm)
on a magnetic stirrer (Magnetic Stirrer MR Hei-Standard). Afterwards,
the nanoparticle-suspension was stirred overnight for evaporation of
acetone. The acetone-free nanoparticles with encapsulated nile red
were shortly centrifuged for 10 to 20 s at 1620 ×g to remove all non-
encapsulated nile red. Finally, the supernatant was diluted with type
1-water to the desired concentration.
The sizes of the nanoparticles were characterized by DLS on a
Zetasizer Nano ZS (Malvern Instruments, Germany) with a He–Ne
laser operating at a wavelength of λ = 633 nm. The detection of the
counts occurs at an angle of 173°. All measurements were carried out
at 25 °C after an equilibration time of 120 s. For analyzing the autocor-
relation function the CONTIN algorithm was applied [59]. The apparent
hydrodynamic diameter was calculated according to the Stokes–
Einstein equation. The zeta potential of the nanoparticles was analyzed
using the Zetasizer Nano ZS by applying laser doppler velocimetry. 20
runs were performed for eachmeasurement using the slow-ﬁeld rever-
sal and fast-ﬁeld reversal mode at 150 V. The experiment was
performed in triplicate at 25 °C. The zeta potential (ζ) was calculated
from the electrophoretic mobility (μ) according to the Henry Equation.
Henry coefﬁcient f(ka) was calculated according to Oshima [60].
Scanning electron microscopy (SEM) characterization was per-
formed as follow: Nanoparticle suspensions were diluted with deion-
ized water (~1.0 mg mL−1). One droplet of the suspension was placed
on amica surface and dried in vacuum. Finally, the sampleswere coated
with platinum (4 nm), using a BAL-TECMED020 sputtering device (Bal-
Tec AG, Lichtenstein). SEM measurements were performed on a Zeiss
SIGMA VP Field Emission SEM equipped with the GEMINI column
(Carl-Zeiss AG, Germany) operating at 3 to 7 kV using the InLens or
SE2 detector.
The encapsulation efﬁciency and thus the ﬂuorescence intensity
vary dependent on the used polymers. For comparison of the ﬂuores-
cence intensities a correction factor was applied [47]. Therefore,
the nanoparticle stock solutions were diluted to 0.2 μg mL−1,
100 μg mL−1 and 200 μg mL−1 and the ﬂuorescence intensity was ana-
lyzed at the GENios Pro ﬂuorescence microplate reader (Tecan,
Germany). The nanoparticleswere excited atλEx=488 nm(bandwidth
9 nm) and the emission was measured at λEm = 575 nm (bandwidth
20 nm). The correction factor represents the relative values of
the slope of the ﬂuorescence intensity against the nanoparticle
concentration [47].
4.5. Hemolysis assay and erythrocyte aggregation
The membrane damaging properties of the polymers were quanti-
ﬁed by analyzing the release of hemoglobin from erythrocytes. The
hemolysis assay was performed as described before [41]. Brieﬂy, blood
from sheep was centrifuged at 4 500 ×g for 5 min and the pellet was
washed three timeswith cold Dulbecco-PBS (DPBS). The stock solutions
were diluted in DPBS and 100 μL of each nanoparticle solution at the in-
dicated concentration were mixed and further incubated for 60 min at
37 °C. The release of hemoglobin in the supernatant was determined
at 580 nm after centrifugation (2 400 ×g for 5 min). The absorbance
wasmeasured using a plate reader. For comparison, the collected eryth-
rocytes were washed with DPBS and either lysed with 1% Triton X-100
(SigmaAldrich, Germany) yielding the100% lysis control value (A100) or
re-suspended in DPBS as reference (A0). The hemolytic activity of the
nanoparticles was calculated as follow (1):
Hemolysis ¼ 100 	 Asample−A0
 
A100−A0ð Þ : ð1Þ
Here, Asample, A0, and A100 are the absorbance intensities of a given
sample, erythrocytes incubated with DPBS, and erythrocytes lysed
with Titon X-100.
For the erythrocyte aggregation 100 μL of the suspension were
mixed with nanoparticle solution of the same volume and incubated
for 2 h at 37 °C. bPEI 25 kDawas used as negative control at a concentra-
tion of 50 μg mL−1. The erythrocytes aggregation was evaluated by
microscopy. The analysis of hemolysis and erythrocyte aggregation
was repeated with blood from at least three independent donors.
4.6. Culture of immortal cells
If not stated otherwise, cell culturematerials, cell culture media, and
solutions were obtained from Biochrom GmbH (Germany). The cells
were cultured at 37 °C in a humidiﬁed 5% CO2 atmosphere. HEK293
cells (CLR-1573, ATCC) were maintained in RPMI 1640, L929 cells
(CCL-1, ATCC) in Dulbecco's MEM with stable L-glutamine and HepG2
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(DSMZ, Germany) were cultured in DMEM/Ham's F-12. The media
were supplemented with 10% fetal calf serum, 100 μg mL−1 of strep-
tomycin, 100 IU mL−1 of penicillin and in the case of the HEK293
cells 2 mM L-glutamine were added.
4.7. Human umbilical vein endothelial (HUVEC) cell culture
HUVEC were isolated from human umbilical cord veins through
collagenase digestion as previously described [61]. Experiments were
performed with HUVECs up to passage 4 cultured in Endothelial Cell
Growth Medium MV (PromoCell, Germany).
4.8. Peripheral blood mononuclear cell (PBMC) culture and macrophage
differentiation
PBMCs were freshly isolated immediately after collecting donor
blood from healthy volunteers. The donors were informed about the
aim of the study and gave written informed consent. Blood sample vol-
ume was diluted two times with PBS without calcium and magnesium
(Biochrom AG, Germany) containing 0.1% bovine serum albumin (BSA,
Carl Roth, Germany) and 2 mM EDTA (Sigma-Aldrich, Germany; isola-
tion buffer). PBMCswere obtained from density gradient centrifugation
using Biocoll separating solution (Biochrom AG, Germany). The cells
were washed subsequently in isolation buffer for several times and
were ﬁnally strained by a 40 μm molecular mesh (BD Bioscience,
Germany). For monocyte enrichment 107 PBMCs per well were
plated on a six well plate in 2 mL X-VIVO 15 (Lonza, Germany) supple-
mented with 10% autologous serum, 10 ng mL−1 GM-CSF (PeproTech,
Germany), 100 units mL−1 penicillin, and 100 μg mL−1 streptomycin
(Life Technologies, Germany). The cells were washed with plain X-
VIVO 15medium after 3 h of incubation and freshmediumwith supple-
ments (stated above) was added. Including the preparation time for
ﬂow culture nanoparticle experiments, macrophage (Mϕ) differentia-
tion was performed for ﬁve days.
4.9. Fluorescence activated cell sorting (FACS) of satellite cells andmyotube
differentiation
For the culture of primary myoblasts, satellite cells were puriﬁed by
FACS as described elsewhere [62,63]. 8 to 12 weeks old C57BL/6 were
sacriﬁced and themuscles fromhind limbswere prepared and collected
in PBS. Muscle tissue was washed in PBS, minced with scissors and
digested in DMEM containing 650 U mL−1 collagenase-solution
(Biochrom, Germany) for 90 min at 37 °C with agitation (70 rpm).
Digested muscle tissue was washed with PBS supplemented with
10% fetal calf serum, triturated and incubated again in Collagenase
(100 U mL−1, Biochrom, Germany) and Dispase (2.4 U mL−1, Life
Technologies, Germany) for 30 min at 37 °C with agitation (100 rpm).
The muscle slurry was further diluted with PBS supplemented with
10% fetal calf serum, ﬁltered through 100 μm cell strainers and pelleted
at 500 ×g for 5 min. Pellets were re-suspended in 10 mL FACS buffer
(Hank's Balanced Salt Solution (HBSS), Life Technologies, Germany)
containing 2% fetal calf serum (Biochrom, Germany) and ﬁltered
through 40 μm cell strainers and pelleted again at 500 ×g for 5 min.
Pellets were re-suspended in 500 μL FACS buffer and stained
with anti-mouse CD45 APC conjugate (30-F11, 1:200, eBioscience),
anti-mouse CD11b APC conjugate (M1/70, 1:800, eBioscience, USA),
anti-mouse Sca-1 APC conjugate (D7, 1:800, eBioscience, USA), anti-
mouse/rat CD29 PE conjugate (ß1-Integrin, 1:400, Biolegend, USA)
and biotinylated anti-mouse CD184 (CXCR4, 1:100, BD Bioscience,
USA) for 20 min at 4 °C on a rotating wheel. Cells were washed with
5 mL FACS buffer and pelleted at 500 ×g for 5 min. Pellets were re-
suspended in 500 μL FACS buffer and incubated with Streptavidin
Cy7-PE conjugate (1:100, eBioscience, USA) for 20 min at 4 °C on a
rotating wheel. Live cells were identiﬁed as calcein blue positive
(1:1000, Life Technologies, Germany) and propidium iodide negative
(1 μg mL−1, BD Bioscience). Satellite cells were identiﬁed as CD45−
Sca-1−CD11b−CXCR4+β1-integrin+ [63]. Cell sorting was performed
on FACSAriaIII (BD Bioscience, USA) equipped with 405 nm, 488 nm
and 633 nm lasers, respectively.
Satellite cells were sorted into growth medium comprised of F10
(Life Technologies, Germany)with 20% horse serum (PAA Laboratories),
500 U mL−1 penicillin/streptomycin (Life Technologies, Germany) and
5 ng mL−1 basic ﬁbroblast growth factor (bFGF) (Sigma Aldrich,
Germany) and maintained in 3% oxygen in collagen and laminin coated
well-plates with fresh bFGF added daily. For the coating, well plates
were incubated with collagen type I from rat tail (1 mg mL−1, Sigma
Aldrich, Germany) and laminin (10 mg mL−1, Life Technologies,
Germany) in type 1-water for at least 1 h at 37 °C and allowed to air-
dry. To be considered as primarymyoblasts, satellite cells were cultured
for at least 1 week. For passaging, primary myoblasts were incubated
with 0.5% trypsin (Life Technologies, Germany) in PBS for 3 min at
37 °C and collected in FACS buffer.
Primary myoblasts were passaged up to 70 to 80% conﬂuence, and
growth medium was replaced by differentiation medium comprised of
DMEM with 2% horse serum and 500 U mL−1 penicillin/streptomycin
(all Life Technologies, Germany). Myoblasts were allowed to differenti-
ate into myotubes for ﬁve days.
4.10. Internalization of nanoparticles in static cell cultures
Cells were seeded with a density of 105 cells per well in 12-well
plates. The growth medium was replaced by fresh medium 30 min be-
fore the addition of nanoparticles with indicated concentrations. After
24 h or 1 h incubation at 37 °C and with 5% CO2, cells were analyzed
via ﬂow cytometry (FC 500, Beckman Coulter, Germany). Viable cells
were identiﬁed by SSC/FSC and nanoparticle containing cells identiﬁed
via their increased ﬂuorescence (for nanoparticles with encapsulated
nile red) or by increased side scatter (SSC). To avoid the detection of
cells with attached nile red containing nanoparticles at the cell surface,
10% trypan blue (Sigma Aldrich, Germany) was added before the
measurement to quench outer ﬂuorescence. The relative SSC/FSC or
mean ﬂuorescence intensity (MFI) of at least 104 viable cells was
used to quantify internalization of the nanoparticles. In case of the
co-culture experiments (HUVECs and MΦ) the MΦ cells were
stained with speciﬁc anti-human CD45 antibody (FITC-conjugated,
ImmunoTools, Friesoythe, Germany). For this purpose, the cells were
centrifuged at 200 g for 5 min at room temperature (RT), the pellet
was washed with 200 μL DPBS and further centrifuged (300 g, 5 min,
RT). Before adding 2 μL antibody, the pellet was suspended in 50 μL
DPBS and afterwards incubated for 30 min on ice. Subsequently,
the cells were centrifuged (300 g, 5 min, RT) and re-suspended in
500 μL DPBS for ﬂow cytometry investigations. All experiments were
performed independently for three times.
4.11. Confocal live-cell imaging
HEK293 cells were seeded in cell-view chamber slides (Greiner Bio-
One, Germany) at a density of 105 cells per well and cultured as
described above. After 24 h, cells were stained by adding 2 μg mL−1
bisBenzimide H 33258 (Sigma Aldrich, Germany) and 5 μg mL−1
CellMask DeepRed (Life Technologies, Germany). After 10 min under
normal growth conditions cells were washed twice with pre-warmed
HBSS (Life Technologies, Karlsruhe, Germany) twice and OptiMEM
(Life Technologies, Germany) was added. Confocal live-cell imaging
was performed on a laser scanning microscope (LSM-780, Zeiss AG,
Germany) at 37 °C in a humidiﬁed 5% CO2 atmosphere. H33258 was
excited with a laser diode at 375 to 405 nm. Emitted light of 410 to
485nmwas collected on a photomultiplier tube. Different nanoparticles
containing nile red at a concentration of 25 μg mL−1 were imaged
through excitation at 488 nm (argon-ion laser) and ﬂuorescence
was detected using a gallium arsenide phosphide detector through a
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500 nm long pass for 40 min. Fluorescence analysis of nanoparticle
uptake were performed with ImageJ 1.46r (NIH, USA).
4.12. Internalization of nanoparticles in dynamic cell cultures
Rhombic chamber chips (RCC) were obtained from microﬂuidic
ChipShop (Jena, Germany). Microﬂuidic cell culture experiments were
performed under sterile environmental conditions of 5% CO2, 70% air
humidity and 37 °C. Monocytes were harvested 24 h after isolation by
treatment with 4 mg mL−1 lidocaine (Sigma-Aldrich, Germany) and
5 mM EDTA. Conﬂuent HUVECs were detached using trypsin. Mono-
cytes were stained with 1 μM CellTracker green CMFDA (Life Technolo-
gies, Karlsruhe, Germany) for 45 min in serum-free X-VIVO 15.
Subsequently monocytes and HUVECs were pooled 1:3 in Endothelial
Growth Medium MV supplemented with 10% autologous serum,
10 ngmL−1 GM-CSF and 100 UmL−1 penicillin and 100 μgmL−1 strep-
tomycin and seeded at a density of 1.3 × 105 HUVECs cm−2 and
0.43 × 105 monocytes cm−2 into RCC. Medium was changed on a
daily basis. Mϕ differentiation was performed in presence of GM-CSF
for 72 h under static culture conditions. HUVEC were perfused using
peristaltic pumps (Ismatec REGLO digital MS-CA-4/12-100, Germany).
Shear stress within RCC was calculated as previously described [24].
Shear stress of 0.7, 3.0, 6.0 and 10.0 dyn cm−2 was applied for 24 h fol-
lowing 60 min nanoparticle uptake at a concentration of 200 μg mL-1.
Negative charged nanoparticles containing nile red were solved in
Endothelial Cell Growth Medium MV without additives. Cells were
mounted with VectaShield Hard Set H-1500 with DAPI (Biozol,
Germany).
Immunoﬂuorescence microscopy was performed with Axio
Observer.Z1 controlled by AxioVision 4.8.2 SP 3 software (both from
Zeiss, Germany). Fluorescence analysis and quantiﬁcation of nanoparti-
cle uptake were performed with ImageJ 1.46r (NIH, USA).
4.13. Protein binding to nanoparticles and SDS-PAGE
To assess serum protein binding to nanoparticles, 0.5 mg nanoparti-
cles were added to 1 mL RPMI 1640 containing 10% fetal calf serum,
mixed gently by inverting the tube several times and incubate for
10 min at 37 °C and humidiﬁed 5% CO2 atmosphere. Afterwards, nano-
particles were washed twice using centrifugation (10 600 ×g, 10 min).
Medium was removed and nanoparticles were re-suspended in 2 mL
PBS without calcium and magnesium.
4.14. Animals
Animal studies were conducted in accordance with animal welfare
legislation under pathogen-free conditions in the animal facility of the
Jena University Hospital. During all procedures and imaging methods,
animals remained under deep general anesthesia using Desﬂurane
(Baxter, USA) and pain-reﬂexes were assessed to gauge the depth of
anesthesia. The body temperature further was permanently kept on
37 °C using feed-back controlled heating plates.
4.15. Intravital microscopy
A tail-vein catheter was made attaching the tip of a 30 gauge-needle
to polyurethane tubing (inner diameter of 0.30mm and an outer diam-
eter of 0.64 mm) (AgnTho's, Sweden). The catheter was then sterilized
by formaldehyde fumigation before placed in the tail-vein of male
FVB/NRj mice. Afterwards the left lateral abdomen was shaved and
opened by a 1 cm vertical incision. The ligamentum falciforme was
further dissected and the left lateral liver lobe was exposed on a cover
slip. It thenwas ﬁxedwith a drop of n-butyl-2-cyanoacrylat (Histoacryl,
B. Braun Melsungen AG, Germany) on the cover slide to avoid move-
ments. For the analysis an inverted confocal laser scanning microscope
(LSM-780, Zeiss AG, Jena, Germany) was used.
The liver architecture was visualized using the NAD(P)H/H+ auto-
ﬂuorescence of hepatocytes by excitation with a laser diode at 375
to 405 nm, and collecting emitted light of 410 to 485 nm with a
photomultiplier tube. Different nanoparticles containing nile red were
imaged as described above. After localizing ≥3 areas of interest of each
liver, different nanoparticles containing nile red were administered via
the tail-veil catheter. Then, images were taken every 5 min to monitor
kinetics. Analysis of N30 Kupffer cells or of the endothelial lining from
3 areas of interest per mouse and three mice resulted in the mean
gray values shown in the table. The analysis was done at 30 min
(PDMAEMA) or 60min (PMAA)when kinetic analysis showed a plateau
in the ﬂuorescence intensity. Fluorescence analysis of nanoparticle
uptake was performed with ImageJ 1.46r (NIH, MD, USA).
4.16. Statistical analysis
All results are reported as average of the performed experiments
with standard error of mean (s.e.m.). All tests were performed using a
signiﬁcance level of 0.05. Detailed test information is stated in the ﬁgure
legends. The analysis was performed using GraphPad Prism 6 software
(Graphpad Software, USA).
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1 Polymerizations 
Table S 1: Overview of the selected RAFT polymerization conditions. 
Polymer Feed ratio
[a] Feed ratio m in g time
sample MMA/MAA CPDB/AIBN MMA MAA CPDB AIBN [h]
PMMA 100/0 1/0.25 6.007 0 0.1328 0.0246 13
P(MMA-co-MAA) 97/3 1/0.25 5.827 0.155 0.1328 0.0246 13
P(MMA-co-MAA) 95/5 1/0.25 5.707 0.258 0.1328 0.0246 13
P(MMA-co-MAA) 92.5/7.5 1/0.25 5.557 0.387 0.1328 0.0246 13
P(MMA-co-MAA) 90/10 1/0.25 5.406 0.516 0.1328 0.0246 13
P(MMA-co-DMAEMA) 80/20 1/0.25 4.806 1.033 0.1328 0.0246 12.5
[a] Molar ratio in the polymer feed solutions between MMA and MAA or DMAEMA. 
1.1 Polymer characterization: 
SEC chromatograms and 1H NMR spectra of the final copolymers. 
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Figure S 1: SEC chromatograms and 1H NMR spectra’s of the final copolymers. The homopolymer PMMA was used 
as reference (adjustment of the broad backbone integral from 0.5 to 2.5 ppm to exclude impurities like water) and all 
spectra were corrected with this ratio between –OCH3 and the backbone signal of PMMA (correction factor 0.964). 
2 Nanoparticle characterization 
Table S 2: Zeta potential of methacrylate-based nanoparticles with concentrations of 50 μg mL-1 in type 1-water. 
Nanoparticle Zeta potential [mV]
3% PMAA – 43.3
5% PMAA – 32.7
8% PMAA – 32.5
13% PMAA – 38.3
20% PDMAEMA + 31.3
Figure S 2: DLS curves of methacrylate-based nanoparticles with concentrations of 50 μg mL-1 in type 1-water.
2.1 SDS-PAGE of nanoparticle incubated in serum containing media 
 
Figure S 3: In vitro investigation of protein binding to nanoparticles. SDS-PAGE of serum proteins bound to nanoparticles 
and densitometric analysis of total protein binding revealed a trend of lower protein binding to 13% PMAA and 
20%DMAEMA compared to 3%PMAA. Bars show mean + s.e.m of three independent experiments, significance tested 
using Kruskal-Wallis and Dunn’s multiple comparison test,#p<0.05. 
 
2.2 Diameter and PDI of different nanoparticle batches 
Table S 3: Nanoparticle batches containing nile red. Size and PDIP are determined by DLS. The applied correction 
factors are given. 
polymer diameter / nm PDIP
correction 
factor
3% PMAA 206 0.099 0.49
3% PMAA 215 0.081 0.32
13% PMAA 188 0.064 1
13% PMAA 183 0.039 0.8
20% PDMAEMA 209 0.122 0.64
20% PDMAEMA 186 0.1 0.5
2.3 Correlation of SSC/FSC using nile red. 
Figure S 4: Correlation of the uptake of methacrylate-based nanoparticle using rel. SSC/FSC and the corrected mean 
fluorescence intensity (MFI). HEK293 cells were incubated in media containing serum proteins for 24 h. Values 
represent the mean of three independent experiments ± SD. 
 
 
2.4 Hemolysis and aggregation 
A) B)
Figure S 5: Hemolysis and aggregation assay of the methacrylate-based nanoparticles. 
2.5 Uptake investigations of methacrylate-based nanoparticles under static conditions 
 
Figure S 6: Different nanoparticles in the microfluidically-assisted cell culture. Uptake of different nanoparticles 
containing nile red in a HUVEC monoculture or a co-culture with MΦ which were analyzed after 60 min. Uptake and 
distribution of different nanoparticles (purple) in the HUVEC monoculture (upper panels) and co-culture (lower panels) 
with MΦ. Cells were subsequently stained with DAPI (blue) and macrophages were stained using CMFDA (green). All 
scale bars = 10 μm. 
